1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	aware.a	Awareness	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	S-Entity
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	effective.a	Usefulness	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	S-Goods
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	cost.n	Expensiveness	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	S-Entity
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	effective.a	Usefulness	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	adult.n	People_by_age	S-Person
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	type.n	Type	S-Subtype
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	person.n	People	S-Person
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	B-Item
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	I-Item
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	I-Item
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	I-Item
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	I-Item
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	I-Item
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Item
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	consider.v	Categorization	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	there.adv	Locative_relation	S-Ground
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	B-Ground
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	I-Ground
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	I-Ground
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	I-Ground
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	I-Ground
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Ground
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	I-Ground
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	I-Ground
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	I-Ground
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	I-Ground
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	I-Ground
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	I-Ground
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Ground
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	B-Aggregate_property
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	I-Aggregate_property
20	combination	_	combination	_	NN	1	_	_	_	_	_	combination.n	Aggregate	S-Aggregate
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	contain.v	Containing	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	B-Contents
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	I-Contents
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	I-Contents
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	I-Contents
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	I-Contents
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	I-Contents
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	I-Contents
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Contents
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	B-Entity
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	I-Entity
24	can	_	can	_	MD	1	_	_	_	_	_	can.v	Capability	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	B-Event
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	I-Event
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	I-Event
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	I-Event
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Event
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	1	_	_	_	_	_	first.a	Ordinal_numbers	O
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	S-Type
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	risk.n	Run_risk	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	B-Total
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	I-Total
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	include.v	Inclusion	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	B-Part
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	I-Part
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	S-Item
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	S-Relative_time
10	age	_	age	_	NN	2	_	_	_	_	_	age.n	Calendric_unit	S-Unit
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	manufacturer.n	Manufacturing	S-Producer
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	S-Entity
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	characteristic.n	Distinctiveness	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	B-Speaker
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Speaker
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	I-Speaker
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	I-Speaker
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	I-Speaker
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	I-Speaker
7	(	_	(	_	(	3	_	_	_	_	_	_	_	I-Speaker
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	I-Speaker
9	)	_	)	_	)	3	_	_	_	_	_	_	_	I-Speaker
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	I-Speaker
11	(	_	(	_	(	3	_	_	_	_	_	_	_	I-Speaker
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	I-Speaker
13	)	_	)	_	)	3	_	_	_	_	_	_	_	I-Speaker
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	advise.v	Telling	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	B-Message
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Message
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	I-Message
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	I-Message
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	I-Message
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	I-Message
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Message
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Message
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	I-Message
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Message
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	I-Message
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	I-Message
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	I-Message
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	I-Message
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	I-Message
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	I-Message
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	I-Message
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	I-Message
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	I-Message
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	I-Message
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	safety.n	Being_at_risk	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	individual.n	People	S-Person
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	S-Count
29	months	_	month	_	NNS	3	_	_	_	_	_	month.n	Calendric_unit	S-Unit
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	B-Whole
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	I-Whole
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	treatment.n	Cure	S-Patient
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	S-Manner
41	continue	_	continue	_	NN	3	_	_	_	_	_	continue.v	Process_continue	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	B-Event
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	I-Event
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	I-Event
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	I-Event
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	treat.v	Medical_intervention	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	S-Patient
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	4	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	4	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	4	_	_	_	_	_	_	_	O
6	:	_	:	_	:	4	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	4	_	_	_	_	_	_	_	O
8	(	_	(	_	(	4	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	4	_	_	_	_	_	_	_	O
10	)	_	)	_	)	4	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	4	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	4	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
14	)	_	)	_	)	4	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	4	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	4	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	4	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	4	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	4	_	_	_	_	_	_	_	O
8	(	_	(	_	(	4	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	4	_	_	_	_	_	_	_	O
10	)	_	)	_	)	4	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	4	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	4	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
14	)	_	)	_	)	4	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	5	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	5	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	5	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	5	_	_	_	_	_	_	_	O
5	1	_	1	_	CD	5	_	_	_	_	_	_	_	O
6	recommendations	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	6	_	_	_	_	_	_	_	B-Instrument
2	wording	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Instrument
3	used	_	use	_	VBN	6	_	_	_	_	_	use.v	Using	O
4	in	_	in	_	IN	6	_	_	_	_	_	_	_	B-Purpose
5	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Purpose
6	recommendations	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Purpose
7	in	_	in	_	IN	6	_	_	_	_	_	_	_	I-Purpose
8	this	_	this	_	DT	6	_	_	_	_	_	_	_	I-Purpose
9	guideline	_	guideline	_	NN	6	_	_	_	_	_	_	_	I-Purpose
10	(	_	(	_	(	6	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	6	_	_	_	_	_	_	_	O
12	example	_	example	_	NN	6	_	_	_	_	_	_	_	O
13	,	_	,	_	,	6	_	_	_	_	_	_	_	O
14	words	_	word	_	NNS	6	_	_	_	_	_	_	_	O
15	such	_	such	_	JJ	6	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
18	'	_	'	_	''	6	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
21	'	_	'	_	POS	6	_	_	_	_	_	_	_	O
22	)	_	)	_	)	6	_	_	_	_	_	_	_	O
23	denotes	_	UNK	_	VBZ	6	_	_	_	_	_	_	_	O
24	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
25	certainty	_	certainty	_	NN	6	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	6	_	_	_	_	_	_	_	O
27	which	_	which	_	WDT	6	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
29	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	O
31	made	_	make	_	VBN	6	_	_	_	_	_	_	_	O
32	(	_	(	_	(	6	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
34	strength	_	strength	_	NN	6	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
37	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
38	)	_	)	_	)	6	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	6	_	_	_	_	_	_	_	O
2	wording	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
3	used	_	use	_	VBN	6	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
6	recommendations	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	6	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	6	_	_	_	_	_	_	_	O
10	(	_	(	_	(	6	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	6	_	_	_	_	_	_	_	O
12	example	_	example	_	NN	6	_	_	_	_	_	example.n	Instance	S-Instance
13	,	_	,	_	,	6	_	_	_	_	_	_	_	O
14	words	_	word	_	NNS	6	_	_	_	_	_	_	_	O
15	such	_	such	_	JJ	6	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
18	'	_	'	_	''	6	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
21	'	_	'	_	POS	6	_	_	_	_	_	_	_	O
22	)	_	)	_	)	6	_	_	_	_	_	_	_	O
23	denotes	_	UNK	_	VBZ	6	_	_	_	_	_	_	_	O
24	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
25	certainty	_	certainty	_	NN	6	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	6	_	_	_	_	_	_	_	O
27	which	_	which	_	WDT	6	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
29	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	O
31	made	_	make	_	VBN	6	_	_	_	_	_	_	_	O
32	(	_	(	_	(	6	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
34	strength	_	strength	_	NN	6	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
37	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
38	)	_	)	_	)	6	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	6	_	_	_	_	_	_	_	O
2	wording	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
3	used	_	use	_	VBN	6	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
6	recommendations	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	6	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	6	_	_	_	_	_	_	_	O
10	(	_	(	_	(	6	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	6	_	_	_	_	_	_	_	O
12	example	_	example	_	NN	6	_	_	_	_	_	_	_	O
13	,	_	,	_	,	6	_	_	_	_	_	_	_	O
14	words	_	word	_	NNS	6	_	_	_	_	_	_	_	O
15	such	_	such	_	JJ	6	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
18	'	_	'	_	''	6	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
21	'	_	'	_	POS	6	_	_	_	_	_	_	_	O
22	)	_	)	_	)	6	_	_	_	_	_	_	_	O
23	denotes	_	UNK	_	VBZ	6	_	_	_	_	_	_	_	O
24	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
25	certainty	_	certainty	_	NN	6	_	_	_	_	_	certainty.n	Certainty	O
26	with	_	with	_	IN	6	_	_	_	_	_	_	_	B-Content
27	which	_	which	_	WDT	6	_	_	_	_	_	_	_	I-Content
28	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Content
29	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Content
30	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Content
31	made	_	make	_	VBN	6	_	_	_	_	_	_	_	I-Content
32	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Content
33	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Content
34	strength	_	strength	_	NN	6	_	_	_	_	_	_	_	I-Content
35	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Content
36	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Content
37	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Content
38	)	_	)	_	)	6	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	S-Descriptor
4	approach	_	approach	_	NN	7	_	_	_	_	_	approach.n	Means	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	S-Person
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	tailor.n	People_by_vocation	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	B-Person
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Person
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	I-Person
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Person
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	I-Person
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Person
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	I-Person
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	I-Person
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	I-Person
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	I-Person
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Person
22	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Person
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	I-Person
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	I-Person
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	I-Person
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	I-Person
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	I-Person
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Person
29	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Person
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Person
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	need.n	Needing	S-Requirement
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	adult.n	People_by_age	S-Person
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	type.n	Type	S-Subtype
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	B-Category
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Category
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	take.v	Taking	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	B-Theme
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	I-Theme
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	I-Theme
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	I-Theme
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Theme
29	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Theme
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Theme
31	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Theme
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	I-Theme
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	I-Theme
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Theme
35	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Theme
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Theme
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	I-Theme
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	I-Theme
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	I-Theme
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	I-Theme
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	I-Theme
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Theme
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Theme
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	account.n	Text	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	S-Protagonist
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	risk.n	Run_risk	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	B-Action
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Action
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	S-Entity
38	ability	_	ability	_	NN	7	_	_	_	_	_	ability.n	Capability	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	B-Event
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	I-Event
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	I-Event
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Event
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Event
44	because	_	because	_	IN	7	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	7	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	7	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	7	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	7	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	7	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	7	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	7	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	7	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	7	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	7	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	7	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
22	,	_	,	_	,	7	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	7	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	7	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	7	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	7	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
29	,	_	,	_	,	7	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	7	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	7	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
35	,	_	,	_	,	7	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	7	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	7	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	7	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	7	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	7	_	_	_	_	_	_	_	B-Cause
42	long-term	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Cause
43	interventions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Cause
44	because	_	because	_	IN	7	_	_	_	_	_	because.c	Causation	O
45	of	_	of	_	IN	7	_	_	_	_	_	_	_	B-Cause
46	reduced	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Cause
47	life	_	life	_	NN	7	_	_	_	_	_	_	_	I-Cause
48	expectancy	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Cause
49	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	8	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	8	_	_	_	_	_	person.n	People	S-Person
4	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
5	needs	_	need	_	NNS	8	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	8	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	8	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	8	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	8	_	_	_	_	_	_	_	O
13	about	_	about	_	IN	8	_	_	_	_	_	_	_	O
14	whether	_	whether	_	IN	8	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	8	_	_	_	_	_	_	_	O
16	stop	_	stop	_	VB	8	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
18	medicines	_	medicine	_	NNS	8	_	_	_	_	_	_	_	O
19	that	_	that	_	WDT	8	_	_	_	_	_	_	_	O
20	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	8	_	_	_	_	_	_	_	O
22	effective	_	effective	_	JJ	8	_	_	_	_	_	_	_	O
23	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	8	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	8	_	_	_	_	_	_	_	B-Cognizer
4	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Cognizer
5	needs	_	need	_	NNS	8	_	_	_	_	_	need.n	Needing	S-Requirement
6	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	8	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	8	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	8	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	8	_	_	_	_	_	_	_	O
13	about	_	about	_	IN	8	_	_	_	_	_	_	_	O
14	whether	_	whether	_	IN	8	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	8	_	_	_	_	_	_	_	O
16	stop	_	stop	_	VB	8	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
18	medicines	_	medicine	_	NNS	8	_	_	_	_	_	_	_	O
19	that	_	that	_	WDT	8	_	_	_	_	_	_	_	O
20	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	8	_	_	_	_	_	_	_	O
22	effective	_	effective	_	JJ	8	_	_	_	_	_	_	_	O
23	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	8	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	8	_	_	_	_	_	_	_	O
4	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
5	needs	_	need	_	NNS	8	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	8	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	8	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	8	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	8	_	_	_	_	_	think.v	Opinion	O
13	about	_	about	_	IN	8	_	_	_	_	_	_	_	B-Opinion
14	whether	_	whether	_	IN	8	_	_	_	_	_	_	_	I-Opinion
15	to	_	to	_	TO	8	_	_	_	_	_	_	_	I-Opinion
16	stop	_	stop	_	VB	8	_	_	_	_	_	_	_	I-Opinion
17	any	_	any	_	DT	8	_	_	_	_	_	_	_	I-Opinion
18	medicines	_	medicine	_	NNS	8	_	_	_	_	_	_	_	I-Opinion
19	that	_	that	_	WDT	8	_	_	_	_	_	_	_	I-Opinion
20	are	_	be	_	VBP	8	_	_	_	_	_	_	_	I-Opinion
21	not	_	not	_	RB	8	_	_	_	_	_	_	_	I-Opinion
22	effective	_	effective	_	JJ	8	_	_	_	_	_	_	_	I-Opinion
23	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	8	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	8	_	_	_	_	_	_	_	O
4	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
5	needs	_	need	_	NNS	8	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	8	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	8	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	8	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	8	_	_	_	_	_	_	_	O
13	about	_	about	_	IN	8	_	_	_	_	_	_	_	O
14	whether	_	whether	_	IN	8	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	8	_	_	_	_	_	_	_	O
16	stop	_	stop	_	VB	8	_	_	_	_	_	stop.v	Preventing_or_letting	O
17	any	_	any	_	DT	8	_	_	_	_	_	_	_	B-Event
18	medicines	_	medicine	_	NNS	8	_	_	_	_	_	_	_	I-Event
19	that	_	that	_	WDT	8	_	_	_	_	_	_	_	I-Event
20	are	_	be	_	VBP	8	_	_	_	_	_	_	_	I-Event
21	not	_	not	_	RB	8	_	_	_	_	_	_	_	I-Event
22	effective	_	effective	_	JJ	8	_	_	_	_	_	_	_	I-Event
23	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	8	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	8	_	_	_	_	_	_	_	O
4	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
5	needs	_	need	_	NNS	8	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	8	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	8	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	8	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	8	_	_	_	_	_	_	_	O
13	about	_	about	_	IN	8	_	_	_	_	_	_	_	O
14	whether	_	whether	_	IN	8	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	8	_	_	_	_	_	_	_	O
16	stop	_	stop	_	VB	8	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	8	_	_	_	_	_	_	_	B-Entity
18	medicines	_	medicine	_	NNS	8	_	_	_	_	_	_	_	I-Entity
19	that	_	that	_	WDT	8	_	_	_	_	_	_	_	I-Entity
20	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	8	_	_	_	_	_	_	_	O
22	effective	_	effective	_	JJ	8	_	_	_	_	_	effective.a	Usefulness	O
23	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	9	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	9	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	9	_	_	_	_	_	account.n	Text	O
4	any	_	any	_	DT	9	_	_	_	_	_	_	_	B-Text
5	disabilities	_	disability	_	NNS	9	_	_	_	_	_	_	_	I-Text
6	,	_	,	_	,	9	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	9	_	_	_	_	_	_	_	O
8	visual	_	visual	_	JJ	9	_	_	_	_	_	_	_	O
9	impairment	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
10	,	_	,	_	,	9	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	9	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	9	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	9	_	_	_	_	_	_	_	O
15	care	_	care	_	NN	9	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	9	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	9	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	9	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	9	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
22	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	9	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	9	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	9	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	9	_	_	_	_	_	_	_	B-Total
5	disabilities	_	disability	_	NNS	9	_	_	_	_	_	_	_	I-Total
6	,	_	,	_	,	9	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	9	_	_	_	_	_	include.v	Inclusion	O
8	visual	_	visual	_	JJ	9	_	_	_	_	_	_	_	B-Part
9	impairment	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Part
10	,	_	,	_	,	9	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	9	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	9	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	9	_	_	_	_	_	_	_	O
15	care	_	care	_	NN	9	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	9	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	9	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	9	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	9	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
22	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	9	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	9	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	9	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	9	_	_	_	_	_	_	_	O
5	disabilities	_	disability	_	NNS	9	_	_	_	_	_	_	_	O
6	,	_	,	_	,	9	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	9	_	_	_	_	_	_	_	O
8	visual	_	visual	_	JJ	9	_	_	_	_	_	_	_	O
9	impairment	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
10	,	_	,	_	,	9	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	9	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	9	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	9	_	_	_	_	_	deliver.v	Delivery	O
15	care	_	care	_	NN	9	_	_	_	_	_	_	_	S-Theme
16	for	_	for	_	IN	9	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	9	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	9	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	9	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
22	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	9	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	9	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	9	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	9	_	_	_	_	_	_	_	O
5	disabilities	_	disability	_	NNS	9	_	_	_	_	_	_	_	O
6	,	_	,	_	,	9	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	9	_	_	_	_	_	_	_	O
8	visual	_	visual	_	JJ	9	_	_	_	_	_	_	_	O
9	impairment	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
10	,	_	,	_	,	9	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	9	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	9	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	9	_	_	_	_	_	_	_	O
15	care	_	care	_	NN	9	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	9	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	9	_	_	_	_	_	adult.n	People_by_age	S-Person
18	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	9	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	9	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
22	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	9	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	9	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	9	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	9	_	_	_	_	_	_	_	O
5	disabilities	_	disability	_	NNS	9	_	_	_	_	_	_	_	O
6	,	_	,	_	,	9	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	9	_	_	_	_	_	_	_	O
8	visual	_	visual	_	JJ	9	_	_	_	_	_	_	_	O
9	impairment	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
10	,	_	,	_	,	9	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	9	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	9	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	9	_	_	_	_	_	_	_	O
15	care	_	care	_	NN	9	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	9	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	9	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	9	_	_	_	_	_	type.n	Type	S-Subtype
20	2	_	2	_	CD	9	_	_	_	_	_	_	_	B-Category
21	diabetes	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Category
22	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	10	_	_	_	_	_	education.n	Education_teaching	O
4	to	_	to	_	TO	10	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	10	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	10	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	10	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	10	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	10	_	_	_	_	_	_	_	O
12	family	_	family	_	NN	10	_	_	_	_	_	_	_	O
13	members	_	member	_	NNS	10	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	10	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
16	(	_	(	_	(	10	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	10	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	10	_	_	_	_	_	_	_	O
19	)	_	)	_	)	10	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	10	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	10	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	10	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
27	,	_	,	_	,	10	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	10	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	10	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	10	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	10	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	10	_	_	_	_	_	type.n	Type	S-Subtype
8	2	_	2	_	CD	10	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	10	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	10	_	_	_	_	_	_	_	O
12	family	_	family	_	NN	10	_	_	_	_	_	_	_	O
13	members	_	member	_	NNS	10	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	10	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
16	(	_	(	_	(	10	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	10	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	10	_	_	_	_	_	_	_	O
19	)	_	)	_	)	10	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	10	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	10	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	10	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
27	,	_	,	_	,	10	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	10	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	10	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	10	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	10	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	10	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	10	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	10	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	10	_	_	_	_	_	_	_	O
12	family	_	family	_	NN	10	_	_	_	_	_	family.n	Kinship	S-Relatives
13	members	_	member	_	NNS	10	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	10	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
16	(	_	(	_	(	10	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	10	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	10	_	_	_	_	_	_	_	O
19	)	_	)	_	)	10	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	10	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	10	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	10	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
27	,	_	,	_	,	10	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	10	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	10	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	10	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	10	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	10	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	10	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	10	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	10	_	_	_	_	_	_	_	S-Member
12	family	_	family	_	NN	10	_	_	_	_	_	_	_	S-Group
13	members	_	member	_	NNS	10	_	_	_	_	_	member.n	Membership	S-Member
14	or	_	or	_	CC	10	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
16	(	_	(	_	(	10	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	10	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	10	_	_	_	_	_	_	_	O
19	)	_	)	_	)	10	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	10	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	10	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	10	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
27	,	_	,	_	,	10	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	10	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	10	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	10	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	10	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	10	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	10	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	10	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	10	_	_	_	_	_	_	_	O
12	family	_	family	_	NN	10	_	_	_	_	_	_	_	O
13	members	_	member	_	NNS	10	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	10	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
16	(	_	(	_	(	10	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	10	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	10	_	_	_	_	_	appropriate.a	Suitability	O
19	)	_	)	_	)	10	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	10	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	10	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	10	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
27	,	_	,	_	,	10	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	10	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	11	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	11	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	11	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	11	_	_	_	_	_	_	_	O
6	:	_	:	_	:	11	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	11	_	_	_	_	_	_	_	O
8	(	_	(	_	(	11	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	11	_	_	_	_	_	_	_	O
10	)	_	)	_	)	11	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	11	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	11	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
14	)	_	)	_	)	11	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	11	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	11	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	11	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	11	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	11	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	11	_	_	_	_	_	_	_	O
8	(	_	(	_	(	11	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	11	_	_	_	_	_	_	_	O
10	)	_	)	_	)	11	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	11	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	11	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
14	)	_	)	_	)	11	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	12	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	12	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	12	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	12	_	_	_	_	_	_	_	O
5	annual	_	annual	_	JJ	12	_	_	_	_	_	_	_	O
6	reinforcement	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
8	review	_	review	_	NN	12	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	12	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	12	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	12	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	12	_	_	_	_	_	_	_	O
5	annual	_	annual	_	JJ	12	_	_	_	_	_	annual.a	Frequency	S-Interval
6	reinforcement	_	UNK	_	NN	12	_	_	_	_	_	_	_	S-Event
7	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
8	review	_	review	_	NN	12	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	13	_	_	_	_	_	_	_	O
4	structured	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
5	education	_	education	_	NN	13	_	_	_	_	_	education.n	Education_teaching	O
6	programme	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	13	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
13	includes	_	include	_	VBZ	13	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
15	following	_	following	_	JJ	13	_	_	_	_	_	_	_	O
16	components	_	component	_	NNS	13	_	_	_	_	_	_	_	O
17	:	_	:	_	:	13	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	13	_	_	_	_	_	_	_	O
4	structured	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
5	education	_	education	_	NN	13	_	_	_	_	_	_	_	O
6	programme	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	13	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	13	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
13	includes	_	include	_	VBZ	13	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
15	following	_	following	_	JJ	13	_	_	_	_	_	_	_	O
16	components	_	component	_	NNS	13	_	_	_	_	_	_	_	O
17	:	_	:	_	:	13	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	13	_	_	_	_	_	_	_	O
4	structured	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
5	education	_	education	_	NN	13	_	_	_	_	_	_	_	O
6	programme	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	13	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	13	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	13	_	_	_	_	_	_	_	B-Category
12	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Category
13	includes	_	include	_	VBZ	13	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
15	following	_	following	_	JJ	13	_	_	_	_	_	_	_	O
16	components	_	component	_	NNS	13	_	_	_	_	_	_	_	O
17	:	_	:	_	:	13	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	13	_	_	_	_	_	_	_	B-Total
4	structured	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Total
5	education	_	education	_	NN	13	_	_	_	_	_	_	_	I-Total
6	programme	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Total
7	for	_	for	_	IN	13	_	_	_	_	_	_	_	I-Total
8	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	I-Total
9	with	_	with	_	IN	13	_	_	_	_	_	_	_	I-Total
10	type	_	type	_	JJ	13	_	_	_	_	_	_	_	I-Total
11	2	_	2	_	CD	13	_	_	_	_	_	_	_	I-Total
12	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Total
13	includes	_	include	_	VBZ	13	_	_	_	_	_	include.v	Inclusion	O
14	the	_	the	_	DT	13	_	_	_	_	_	_	_	B-Part
15	following	_	following	_	JJ	13	_	_	_	_	_	_	_	I-Part
16	components	_	component	_	NNS	13	_	_	_	_	_	_	_	I-Part
17	:	_	:	_	:	13	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	13	_	_	_	_	_	_	_	O
4	structured	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
5	education	_	education	_	NN	13	_	_	_	_	_	_	_	O
6	programme	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	13	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
13	includes	_	include	_	VBZ	13	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
15	following	_	following	_	JJ	13	_	_	_	_	_	_	_	O
16	components	_	component	_	NNS	13	_	_	_	_	_	component.n	Ingredients	S-Material
17	:	_	:	_	:	13	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	aim.n	Purpose	S-Goal
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	S-Goal
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	learn.v	Becoming_aware	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	S-Phenomenon
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	objective.n	Purpose	S-Goal
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	support.v	Taking_sides	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	B-Side
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	I-Side
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	I-Side
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	I-Side
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	I-Side
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	I-Side
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	I-Side
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	I-Side
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	I-Side
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	I-Side
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	I-Side
22	,	_	,	_	,	14	_	_	_	_	_	_	_	I-Side
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	I-Side
24	,	_	,	_	,	14	_	_	_	_	_	_	_	I-Side
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	I-Side
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	I-Side
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	I-Side
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	I-Side
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	I-Side
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	I-Side
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	person.n	People	S-Person
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	family.n	Kinship	S-Relatives
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	S-Member
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	S-Group
16	members	_	member	_	NNS	14	_	_	_	_	_	member.n	Membership	S-Member
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	develop.v	Cause_to_make_progress	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	S-Project
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	belief.n	Opinion	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	S-Cognizer
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	knowledge.n	Awareness	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	14	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	14	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	14	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	14	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	14	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	14	_	_	_	_	_	_	_	O
8	,	_	,	_	,	14	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	14	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	14	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	14	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	14	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	14	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	14	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	14	_	_	_	_	_	_	_	O
22	,	_	,	_	,	14	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	14	_	_	_	_	_	_	_	O
24	,	_	,	_	,	14	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	14	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	14	_	_	_	_	_	skill.n	Expertise	S-Protagonist
28	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	14	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	14	_	_	_	_	_	_	_	O
31	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	15	_	_	_	_	_	_	_	S-Speaker
2	is	_	be	_	VBZ	15	_	_	_	_	_	_	_	O
3	quality	_	quality	_	JJ	15	_	_	_	_	_	_	_	O
4	assured	_	assure	_	VBN	15	_	_	_	_	_	assure.v	Telling	O
5	,	_	,	_	,	15	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	15	_	_	_	_	_	_	_	O
7	reviewed	_	review	_	VBN	15	_	_	_	_	_	_	_	O
8	by	_	by	_	IN	15	_	_	_	_	_	_	_	O
9	trained	_	trained	_	JJ	15	_	_	_	_	_	_	_	O
10	,	_	,	_	,	15	_	_	_	_	_	_	_	O
11	competent	_	competent	_	JJ	15	_	_	_	_	_	_	_	O
12	,	_	,	_	,	15	_	_	_	_	_	_	_	O
13	independent	_	independent	_	JJ	15	_	_	_	_	_	_	_	O
14	assessors	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	15	_	_	_	_	_	_	_	O
16	measure	_	measure	_	VBP	15	_	_	_	_	_	_	_	O
17	it	_	it	_	PRP	15	_	_	_	_	_	_	_	O
18	against	_	against	_	IN	15	_	_	_	_	_	_	_	O
19	criteria	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
20	that	_	that	_	IN	15	_	_	_	_	_	_	_	O
21	ensure	_	ensure	_	VB	15	_	_	_	_	_	_	_	O
22	consistency	_	UNK	_	NN	15	_	_	_	_	_	_	_	O
23	.	_	.	_	.	15	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	15	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	15	_	_	_	_	_	_	_	O
3	quality	_	quality	_	JJ	15	_	_	_	_	_	_	_	O
4	assured	_	assure	_	VBN	15	_	_	_	_	_	_	_	O
5	,	_	,	_	,	15	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	15	_	_	_	_	_	_	_	O
7	reviewed	_	review	_	VBN	15	_	_	_	_	_	_	_	O
8	by	_	by	_	IN	15	_	_	_	_	_	_	_	O
9	trained	_	trained	_	JJ	15	_	_	_	_	_	_	_	O
10	,	_	,	_	,	15	_	_	_	_	_	_	_	O
11	competent	_	competent	_	JJ	15	_	_	_	_	_	competent.a	Expertise	O
12	,	_	,	_	,	15	_	_	_	_	_	_	_	O
13	independent	_	independent	_	JJ	15	_	_	_	_	_	_	_	O
14	assessors	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	15	_	_	_	_	_	_	_	O
16	measure	_	measure	_	VBP	15	_	_	_	_	_	_	_	O
17	it	_	it	_	PRP	15	_	_	_	_	_	_	_	O
18	against	_	against	_	IN	15	_	_	_	_	_	_	_	O
19	criteria	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
20	that	_	that	_	IN	15	_	_	_	_	_	_	_	O
21	ensure	_	ensure	_	VB	15	_	_	_	_	_	_	_	O
22	consistency	_	UNK	_	NN	15	_	_	_	_	_	_	_	O
23	.	_	.	_	.	15	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	15	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	15	_	_	_	_	_	_	_	O
3	quality	_	quality	_	JJ	15	_	_	_	_	_	_	_	O
4	assured	_	assure	_	VBN	15	_	_	_	_	_	_	_	O
5	,	_	,	_	,	15	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	15	_	_	_	_	_	_	_	O
7	reviewed	_	review	_	VBN	15	_	_	_	_	_	_	_	O
8	by	_	by	_	IN	15	_	_	_	_	_	_	_	O
9	trained	_	trained	_	JJ	15	_	_	_	_	_	_	_	O
10	,	_	,	_	,	15	_	_	_	_	_	_	_	O
11	competent	_	competent	_	JJ	15	_	_	_	_	_	_	_	O
12	,	_	,	_	,	15	_	_	_	_	_	_	_	O
13	independent	_	independent	_	JJ	15	_	_	_	_	_	_	_	B-Object
14	assessors	_	UNK	_	NNS	15	_	_	_	_	_	_	_	I-Object
15	who	_	who	_	WP	15	_	_	_	_	_	_	_	I-Object
16	measure	_	measure	_	VBP	15	_	_	_	_	_	measure.v	Dimension	S-Dimension
17	it	_	it	_	PRP	15	_	_	_	_	_	_	_	S-Object
18	against	_	against	_	IN	15	_	_	_	_	_	_	_	O
19	criteria	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
20	that	_	that	_	IN	15	_	_	_	_	_	_	_	O
21	ensure	_	ensure	_	VB	15	_	_	_	_	_	_	_	O
22	consistency	_	UNK	_	NN	15	_	_	_	_	_	_	_	O
23	.	_	.	_	.	15	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	16	_	_	_	_	_	_	_	B-Supplier
3	unk	_	UNK	_	NN	16	_	_	_	_	_	_	_	I-Supplier
4	programme	_	UNK	_	NN	16	_	_	_	_	_	_	_	I-Supplier
5	provides	_	provide	_	VBZ	16	_	_	_	_	_	provide.v	Supply	O
6	the	_	the	_	DT	16	_	_	_	_	_	_	_	B-Theme
7	necessary	_	necessary	_	JJ	16	_	_	_	_	_	_	_	I-Theme
8	resources	_	resource	_	NNS	16	_	_	_	_	_	_	_	I-Theme
9	to	_	to	_	TO	16	_	_	_	_	_	_	_	I-Theme
10	support	_	support	_	VB	16	_	_	_	_	_	_	_	I-Theme
11	the	_	the	_	DT	16	_	_	_	_	_	_	_	I-Theme
12	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	I-Theme
13	,	_	,	_	,	16	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	16	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
17	are	_	be	_	VBP	16	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	16	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	16	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	16	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	16	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	16	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	O
28	skills	_	skill	_	NNS	16	_	_	_	_	_	_	_	O
29	.	_	.	_	.	16	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	16	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	16	_	_	_	_	_	necessary.a	Being_necessary	O
8	resources	_	resource	_	NNS	16	_	_	_	_	_	_	_	S-Requirement
9	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	16	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
13	,	_	,	_	,	16	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	16	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
17	are	_	be	_	VBP	16	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	16	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	16	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	16	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	16	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	16	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	O
28	skills	_	skill	_	NNS	16	_	_	_	_	_	_	_	O
29	.	_	.	_	.	16	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	16	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	16	_	_	_	_	_	_	_	O
8	resources	_	resource	_	NNS	16	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	16	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
13	,	_	,	_	,	16	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	16	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	S-Student
17	are	_	be	_	VBP	16	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	16	_	_	_	_	_	_	_	S-Manner
19	trained	_	train	_	VBN	16	_	_	_	_	_	train.v	Education_teaching	O
20	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	16	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	16	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	16	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	O
28	skills	_	skill	_	NNS	16	_	_	_	_	_	_	_	O
29	.	_	.	_	.	16	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	16	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	16	_	_	_	_	_	_	_	O
8	resources	_	resource	_	NNS	16	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	16	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
13	,	_	,	_	,	16	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	16	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	S-Agent
17	are	_	be	_	VBP	16	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	16	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	16	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	16	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	16	_	_	_	_	_	develop.v	Cause_to_make_progress	O
25	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	16	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	B-Project
28	skills	_	skill	_	NNS	16	_	_	_	_	_	_	_	I-Project
29	.	_	.	_	.	16	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	16	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	16	_	_	_	_	_	_	_	O
8	resources	_	resource	_	NNS	16	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	16	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
13	,	_	,	_	,	16	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	16	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	S-Agent
17	are	_	be	_	VBP	16	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	16	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	16	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	16	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	16	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	16	_	_	_	_	_	maintain.v	Activity_ongoing	O
27	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	B-Activity
28	skills	_	skill	_	NNS	16	_	_	_	_	_	_	_	I-Activity
29	.	_	.	_	.	16	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	16	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	16	_	_	_	_	_	_	_	O
8	resources	_	resource	_	NNS	16	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	16	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
13	,	_	,	_	,	16	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	16	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
17	are	_	be	_	VBP	16	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	16	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	16	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	16	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	16	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	16	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	O
28	skills	_	skill	_	NNS	16	_	_	_	_	_	skill.n	Expertise	S-Protagonist
29	.	_	.	_	.	16	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	member.n	Membership	S-Member
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	B-Group
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	I-Group
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Group
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	team.n	Aggregate	S-Aggregate
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	B-Protagonist
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	I-Protagonist
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	I-Protagonist
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	I-Protagonist
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Protagonist
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	I-Protagonist
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	I-Protagonist
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	familiar.a	Expertise	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	B-Knowledge
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	I-Knowledge
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	I-Knowledge
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Knowledge
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	I-Knowledge
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	I-Knowledge
18	,	_	,	_	,	17	_	_	_	_	_	_	_	I-Knowledge
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	I-Knowledge
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	I-Knowledge
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Knowledge
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	I-Knowledge
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	I-Knowledge
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	I-Knowledge
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	I-Knowledge
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	I-Knowledge
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	I-Knowledge
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	I-Knowledge
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	I-Knowledge
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	I-Knowledge
31	,	_	,	_	,	17	_	_	_	_	_	_	_	I-Knowledge
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	adult.n	People_by_age	S-Person
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	type.n	Type	S-Subtype
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	B-Category
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Category
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	family.n	Kinship	S-Relatives
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	S-Member
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	S-Group
42	members	_	member	_	NNS	17	_	_	_	_	_	member.n	Membership	S-Member
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	B-Donor
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	I-Donor
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	I-Donor
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Donor
45	(	_	(	_	(	17	_	_	_	_	_	_	_	I-Donor
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	I-Donor
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	I-Donor
48	)	_	)	_	)	17	_	_	_	_	_	_	_	I-Donor
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	contribute.v	Giving	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	B-Theme
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	I-Theme
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	I-Theme
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	I-Theme
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	I-Theme
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	I-Theme
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	I-Theme
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Theme
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	design.n	Coming_up_with	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	B-Idea
60	local	_	local	_	JJ	17	_	_	_	_	_	_	_	I-Idea
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	I-Idea
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	17	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	17	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	17	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	17	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	17	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	17	_	_	_	_	_	_	_	O
18	,	_	,	_	,	17	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	17	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	17	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	17	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	17	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	17	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	17	_	_	_	_	_	_	_	O
31	,	_	,	_	,	17	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	17	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	17	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	17	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	17	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	17	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	17	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	17	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
45	(	_	(	_	(	17	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	17	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	17	_	_	_	_	_	_	_	O
48	)	_	)	_	)	17	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	17	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	17	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	17	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	17	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	17	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	17	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	17	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	17	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	17	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	17	_	_	_	_	_	local.a	Political_locales	S-Locale
61	programmes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
62	.	_	.	_	.	17	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	18	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	18	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	18	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	18	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	18	_	_	_	_	_	_	_	O
6	:	_	:	_	:	18	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	18	_	_	_	_	_	_	_	O
8	(	_	(	_	(	18	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	18	_	_	_	_	_	_	_	O
10	)	_	)	_	)	18	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	18	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	18	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	18	_	_	_	_	_	_	_	O
14	)	_	)	_	)	18	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	18	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	18	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	18	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	18	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	18	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	18	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	18	_	_	_	_	_	_	_	O
8	(	_	(	_	(	18	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	18	_	_	_	_	_	_	_	O
10	)	_	)	_	)	18	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	18	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	18	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	18	_	_	_	_	_	_	_	O
14	)	_	)	_	)	18	_	_	_	_	_	_	_	O

1	emphasise	_	UNK	_	NNP	19	_	_	_	_	_	_	_	O
2	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	19	_	_	_	_	_	_	_	O
4	healthy	_	healthy	_	JJ	19	_	_	_	_	_	_	_	O
5	balanced	_	balance	_	VBN	19	_	_	_	_	_	_	_	O
6	eating	_	UNK	_	NN	19	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	19	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	19	_	_	_	_	_	_	_	O
9	applicable	_	applicable	_	JJ	19	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	19	_	_	_	_	_	_	_	O
12	general	_	general	_	JJ	19	_	_	_	_	_	_	_	S-Aggregate_property
13	population	_	population	_	NN	19	_	_	_	_	_	population.n	Aggregate	S-Aggregate
14	when	_	when	_	WRB	19	_	_	_	_	_	_	_	O
15	providing	_	provide	_	VBG	19	_	_	_	_	_	_	_	O
16	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	19	_	_	_	_	_	_	_	O
19	with	_	with	_	IN	19	_	_	_	_	_	_	_	O
20	type	_	type	_	JJ	19	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	19	_	_	_	_	_	_	_	O
22	diabetes	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O

1	emphasise	_	UNK	_	NNP	19	_	_	_	_	_	_	_	B-Supplier
2	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	I-Supplier
3	on	_	on	_	IN	19	_	_	_	_	_	_	_	I-Supplier
4	healthy	_	healthy	_	JJ	19	_	_	_	_	_	_	_	I-Supplier
5	balanced	_	balance	_	VBN	19	_	_	_	_	_	_	_	I-Supplier
6	eating	_	UNK	_	NN	19	_	_	_	_	_	_	_	I-Supplier
7	that	_	that	_	WDT	19	_	_	_	_	_	_	_	I-Supplier
8	is	_	be	_	VBZ	19	_	_	_	_	_	_	_	I-Supplier
9	applicable	_	applicable	_	JJ	19	_	_	_	_	_	_	_	I-Supplier
10	to	_	to	_	TO	19	_	_	_	_	_	_	_	I-Supplier
11	the	_	the	_	DT	19	_	_	_	_	_	_	_	I-Supplier
12	general	_	general	_	JJ	19	_	_	_	_	_	_	_	I-Supplier
13	population	_	population	_	NN	19	_	_	_	_	_	_	_	I-Supplier
14	when	_	when	_	WRB	19	_	_	_	_	_	_	_	O
15	providing	_	provide	_	VBG	19	_	_	_	_	_	provide.v	Supply	O
16	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	S-Theme
17	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	19	_	_	_	_	_	_	_	O
19	with	_	with	_	IN	19	_	_	_	_	_	_	_	O
20	type	_	type	_	JJ	19	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	19	_	_	_	_	_	_	_	O
22	diabetes	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O

1	emphasise	_	UNK	_	NNP	19	_	_	_	_	_	_	_	O
2	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	19	_	_	_	_	_	_	_	O
4	healthy	_	healthy	_	JJ	19	_	_	_	_	_	_	_	O
5	balanced	_	balance	_	VBN	19	_	_	_	_	_	_	_	O
6	eating	_	UNK	_	NN	19	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	19	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	19	_	_	_	_	_	_	_	O
9	applicable	_	applicable	_	JJ	19	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	19	_	_	_	_	_	_	_	O
12	general	_	general	_	JJ	19	_	_	_	_	_	_	_	O
13	population	_	population	_	NN	19	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	19	_	_	_	_	_	_	_	O
15	providing	_	provide	_	VBG	19	_	_	_	_	_	_	_	O
16	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	19	_	_	_	_	_	adult.n	People_by_age	S-Person
19	with	_	with	_	IN	19	_	_	_	_	_	_	_	O
20	type	_	type	_	JJ	19	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	19	_	_	_	_	_	_	_	O
22	diabetes	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O

1	emphasise	_	UNK	_	NNP	19	_	_	_	_	_	_	_	O
2	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	19	_	_	_	_	_	_	_	O
4	healthy	_	healthy	_	JJ	19	_	_	_	_	_	_	_	O
5	balanced	_	balance	_	VBN	19	_	_	_	_	_	_	_	O
6	eating	_	UNK	_	NN	19	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	19	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	19	_	_	_	_	_	_	_	O
9	applicable	_	applicable	_	JJ	19	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	19	_	_	_	_	_	_	_	O
12	general	_	general	_	JJ	19	_	_	_	_	_	_	_	O
13	population	_	population	_	NN	19	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	19	_	_	_	_	_	_	_	O
15	providing	_	provide	_	VBG	19	_	_	_	_	_	_	_	O
16	advice	_	advice	_	NN	19	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	19	_	_	_	_	_	_	_	O
19	with	_	with	_	IN	19	_	_	_	_	_	_	_	O
20	type	_	type	_	JJ	19	_	_	_	_	_	type.n	Type	S-Subtype
21	2	_	2	_	CD	19	_	_	_	_	_	_	_	O
22	diabetes	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	20	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	20	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	20	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	20	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	20	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	20	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	20	_	_	_	_	_	_	_	O
9	overweight	_	UNK	_	JJ	20	_	_	_	_	_	_	_	O
10	,	_	,	_	,	20	_	_	_	_	_	_	_	O
11	set	_	set	_	VBD	20	_	_	_	_	_	_	_	O
12	an	_	an	_	DT	20	_	_	_	_	_	_	_	O
13	initial	_	initial	_	JJ	20	_	_	_	_	_	_	_	O
14	body	_	body	_	NN	20	_	_	_	_	_	_	_	O
15	weight	_	weight	_	JJ	20	_	_	_	_	_	_	_	O
16	loss	_	loss	_	NN	20	_	_	_	_	_	_	_	O
17	target	_	target	_	NN	20	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	20	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	CD	20	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	20	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	20	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	20	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	20	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	20	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	20	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	20	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	20	_	_	_	_	_	_	_	O
9	overweight	_	UNK	_	JJ	20	_	_	_	_	_	_	_	O
10	,	_	,	_	,	20	_	_	_	_	_	_	_	O
11	set	_	set	_	VBD	20	_	_	_	_	_	_	_	O
12	an	_	an	_	DT	20	_	_	_	_	_	_	_	O
13	initial	_	initial	_	JJ	20	_	_	_	_	_	_	_	O
14	body	_	body	_	NN	20	_	_	_	_	_	_	_	O
15	weight	_	weight	_	JJ	20	_	_	_	_	_	_	_	O
16	loss	_	loss	_	NN	20	_	_	_	_	_	_	_	O
17	target	_	target	_	NN	20	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	20	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	CD	20	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	20	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	20	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	20	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	20	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	20	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	20	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	20	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	20	_	_	_	_	_	_	_	O
9	overweight	_	UNK	_	JJ	20	_	_	_	_	_	_	_	O
10	,	_	,	_	,	20	_	_	_	_	_	_	_	O
11	set	_	set	_	VBD	20	_	_	_	_	_	_	_	O
12	an	_	an	_	DT	20	_	_	_	_	_	_	_	O
13	initial	_	initial	_	JJ	20	_	_	_	_	_	_	_	S-Descriptor
14	body	_	body	_	NN	20	_	_	_	_	_	body.n	Body_parts	S-Body_part
15	weight	_	weight	_	JJ	20	_	_	_	_	_	_	_	O
16	loss	_	loss	_	NN	20	_	_	_	_	_	_	_	O
17	target	_	target	_	NN	20	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	20	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	CD	20	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	20	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	20	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	20	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	20	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	20	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	20	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	20	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	20	_	_	_	_	_	_	_	O
9	overweight	_	UNK	_	JJ	20	_	_	_	_	_	_	_	O
10	,	_	,	_	,	20	_	_	_	_	_	_	_	O
11	set	_	set	_	VBD	20	_	_	_	_	_	_	_	O
12	an	_	an	_	DT	20	_	_	_	_	_	_	_	O
13	initial	_	initial	_	JJ	20	_	_	_	_	_	_	_	O
14	body	_	body	_	NN	20	_	_	_	_	_	_	_	S-Object
15	weight	_	weight	_	JJ	20	_	_	_	_	_	weight.n	Dimension	S-Dimension
16	loss	_	loss	_	NN	20	_	_	_	_	_	_	_	O
17	target	_	target	_	NN	20	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	20	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	CD	20	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	20	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	NNP	21	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	21	_	_	_	_	_	_	_	O
4	carbohydrate	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	alcohol	_	alcohol	_	NN	21	_	_	_	_	_	alcohol.n	Intoxicants	S-Intoxicant
7	intake	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	meal	_	meal	_	NN	21	_	_	_	_	_	_	_	O
11	patterns	_	pattern	_	NNS	21	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	NNP	21	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	21	_	_	_	_	_	_	_	O
4	carbohydrate	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	alcohol	_	alcohol	_	NN	21	_	_	_	_	_	_	_	O
7	intake	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	meal	_	meal	_	NN	21	_	_	_	_	_	_	_	S-Entities
11	patterns	_	pattern	_	NNS	21	_	_	_	_	_	pattern.n	Pattern	O

1	reducing	_	UNK	_	VBG	22	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	22	_	_	_	_	_	_	_	O
3	risk	_	risk	_	NN	22	_	_	_	_	_	risk.n	Run_risk	O
4	of	_	of	_	IN	22	_	_	_	_	_	_	_	B-Asset
5	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	I-Asset
6	should	_	should	_	MD	22	_	_	_	_	_	_	_	O
7	be	_	be	_	VB	22	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	22	_	_	_	_	_	_	_	O
9	particular	_	particular	_	JJ	22	_	_	_	_	_	_	_	O
10	aim	_	aim	_	NN	22	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	22	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	22	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	22	_	_	_	_	_	_	_	O
14	using	_	use	_	VBG	22	_	_	_	_	_	_	_	O
15	insulin	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
16	or	_	or	_	CC	22	_	_	_	_	_	_	_	O
17	an	_	an	_	DT	22	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	JJ	22	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
20	.	_	.	_	.	22	_	_	_	_	_	_	_	O

1	reducing	_	UNK	_	VBG	22	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	22	_	_	_	_	_	_	_	O
3	risk	_	risk	_	NN	22	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	22	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	22	_	_	_	_	_	_	_	O
7	be	_	be	_	VB	22	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	22	_	_	_	_	_	_	_	O
9	particular	_	particular	_	JJ	22	_	_	_	_	_	_	_	O
10	aim	_	aim	_	NN	22	_	_	_	_	_	aim.n	Purpose	O
11	for	_	for	_	IN	22	_	_	_	_	_	_	_	B-Goal
12	a	_	a	_	DT	22	_	_	_	_	_	_	_	I-Goal
13	person	_	person	_	NN	22	_	_	_	_	_	_	_	I-Goal
14	using	_	use	_	VBG	22	_	_	_	_	_	_	_	I-Goal
15	insulin	_	UNK	_	NN	22	_	_	_	_	_	_	_	I-Goal
16	or	_	or	_	CC	22	_	_	_	_	_	_	_	I-Goal
17	an	_	an	_	DT	22	_	_	_	_	_	_	_	I-Goal
18	insulin	_	UNK	_	JJ	22	_	_	_	_	_	_	_	I-Goal
19	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	I-Goal
20	.	_	.	_	.	22	_	_	_	_	_	_	_	O

1	reducing	_	UNK	_	VBG	22	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	22	_	_	_	_	_	_	_	O
3	risk	_	risk	_	NN	22	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	22	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	22	_	_	_	_	_	_	_	O
7	be	_	be	_	VB	22	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	22	_	_	_	_	_	_	_	O
9	particular	_	particular	_	JJ	22	_	_	_	_	_	_	_	O
10	aim	_	aim	_	NN	22	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	22	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	22	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	22	_	_	_	_	_	person.n	People	S-Person
14	using	_	use	_	VBG	22	_	_	_	_	_	_	_	O
15	insulin	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
16	or	_	or	_	CC	22	_	_	_	_	_	_	_	O
17	an	_	an	_	DT	22	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	JJ	22	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
20	.	_	.	_	.	22	_	_	_	_	_	_	_	O

1	reducing	_	UNK	_	VBG	22	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	22	_	_	_	_	_	_	_	O
3	risk	_	risk	_	NN	22	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	22	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	22	_	_	_	_	_	_	_	O
7	be	_	be	_	VB	22	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	22	_	_	_	_	_	_	_	O
9	particular	_	particular	_	JJ	22	_	_	_	_	_	_	_	O
10	aim	_	aim	_	NN	22	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	22	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	22	_	_	_	_	_	_	_	B-Agent
13	person	_	person	_	NN	22	_	_	_	_	_	_	_	I-Agent
14	using	_	use	_	VBG	22	_	_	_	_	_	use.v	Using	O
15	insulin	_	UNK	_	NN	22	_	_	_	_	_	_	_	B-Instrument
16	or	_	or	_	CC	22	_	_	_	_	_	_	_	I-Instrument
17	an	_	an	_	DT	22	_	_	_	_	_	_	_	I-Instrument
18	insulin	_	UNK	_	JJ	22	_	_	_	_	_	_	_	I-Instrument
19	unk	_	UNK	_	NN	22	_	_	_	_	_	_	_	I-Instrument
20	.	_	.	_	.	22	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	23	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	23	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	23	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	23	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	23	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	23	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	S-Type
12	foods	_	food	_	NNS	23	_	_	_	_	_	food.n	Food	S-Food
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	23	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	23	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	23	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	other.a	Increment	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	S-Class
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	23	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	23	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	23	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	S-Goal
19	plan	_	plan	_	NN	23	_	_	_	_	_	plan.n	Purpose	S-Value
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	23	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	23	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	23	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	S-State_of_affairs
26	should	_	should	_	MD	23	_	_	_	_	_	should.v	Desirable_event	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	B-State_of_affairs
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	I-State_of_affairs
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	I-State_of_affairs
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	_	_	I-State_of_affairs
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	I-State_of_affairs
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	I-State_of_affairs
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	I-State_of_affairs
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	23	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	23	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	23	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	23	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	23	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	23	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	23	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	23	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	23	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	23	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	23	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	23	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	23	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	23	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	23	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	23	_	_	_	_	_	_	_	O
22	,	_	,	_	,	23	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	23	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	23	_	_	_	_	_	_	_	S-Agent
26	should	_	should	_	MD	23	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	23	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	23	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	23	_	_	_	_	_	avoid.v	Avoiding	O
31	excess	_	excess	_	JJ	23	_	_	_	_	_	_	_	B-Undesirable_situation
32	energy	_	energy	_	NN	23	_	_	_	_	_	_	_	I-Undesirable_situation
33	intake	_	UNK	_	NN	23	_	_	_	_	_	_	_	I-Undesirable_situation
34	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	24	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	24	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	24	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	24	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	24	_	_	_	_	_	_	_	O
6	:	_	:	_	:	24	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	24	_	_	_	_	_	_	_	O
8	(	_	(	_	(	24	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	24	_	_	_	_	_	_	_	O
10	)	_	)	_	)	24	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	24	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	24	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	24	_	_	_	_	_	_	_	O
14	)	_	)	_	)	24	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	24	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	24	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	24	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	24	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	24	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	24	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	24	_	_	_	_	_	_	_	O
8	(	_	(	_	(	24	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	24	_	_	_	_	_	_	_	O
10	)	_	)	_	)	24	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	24	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	24	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	24	_	_	_	_	_	_	_	O
14	)	_	)	_	)	24	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Category
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	B-Information
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	I-Information
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	I-Information
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	I-Information
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Information
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	admit.v	Reveal_secret	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	B-Information
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	I-Information
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	I-Information
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Information
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	I-Information
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	I-Information
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	I-Information
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	I-Information
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	I-Information
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	I-Information
19	,	_	,	_	,	25	_	_	_	_	_	_	_	I-Information
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	I-Information
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	I-Information
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	I-Information
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	I-Information
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	I-Information
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	I-Information
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	I-Information
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	I-Information
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	I-Information
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	hospital.n	Buildings	S-Building
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	other.a	Increment	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	S-Class
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	S-Theme
18	setting	_	set	_	VBG	25	_	_	_	_	_	set.v	Placing	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	implement.v	Execute_plan	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	B-Plan
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	I-Plan
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	I-Plan
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	I-Plan
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	I-Plan
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	I-Plan
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	I-Plan
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	I-Plan
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	I-Plan
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	I-Plan
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	I-Plan
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	I-Plan
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	I-Plan
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	I-Plan
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Plan
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	S-Component_entities
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	S-Function
24	system	_	system	_	NN	25	_	_	_	_	_	system.n	System	S-Complex
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	B-Supplier
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	I-Supplier
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	I-Supplier
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	I-Supplier
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	I-Supplier
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	provide.v	Supply	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	B-Theme
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	I-Theme
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	I-Theme
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	I-Theme
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	I-Theme
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	I-Theme
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	I-Theme
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	I-Theme
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Theme
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	weight.n	Dimension	S-Dimension
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	S-Place
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	S-Theme
53	gain	_	gain	_	NN	25	_	_	_	_	_	gain.n	Getting	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	weight.n	Dimension	S-Dimension
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	S-Object
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	activity.n	Intentionally_act	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	brief.a	Duration_description	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	B-Eventuality
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	I-Eventuality
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Eventuality
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	stop.v	Process_stop	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	B-Process
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	I-Process
73	,	_	,	_	,	25	_	_	_	_	_	_	_	I-Process
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	I-Process
75	:	_	:	_	:	25	_	_	_	_	_	_	_	I-Process
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	I-Process
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	I-Process
78	,	_	,	_	,	25	_	_	_	_	_	_	_	I-Process
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	I-Process
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	I-Process
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	S-Domain
72	services	_	service	_	NNS	25	_	_	_	_	_	service.n	Public_services	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	S-Item
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	reduction.n	Cause_change_of_position_on_a_scale	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	acute.a	Importance	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	B-Factor
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	I-Factor
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	I-Factor
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	I-Factor
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	I-Factor
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	S-Patient
87	health	_	health	_	NN	25	_	_	_	_	_	health.n	Medical_conditions	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	S-Domain
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	service.n	Public_services	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	people.n	People	S-Person
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	S-Type_property
100	type	_	type	_	NN	25	_	_	_	_	_	type.n	Type	S-Subtype
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	section.n	Part_whole	S-Part
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	B-Whole
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	I-Whole
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	I-Whole
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	people.n	People	S-Person
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
114	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	25	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	25	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	25	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	25	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	25	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	25	_	_	_	_	_	_	_	O
19	,	_	,	_	,	25	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	25	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	25	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	25	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	25	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	25	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	25	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	25	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	25	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	25	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
36	.	_	.	_	.	25	_	_	_	_	_	_	_	O
37	0	_	0	_	CD	25	_	_	_	_	_	_	_	O
38	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
39	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
40	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
41	lifestyle	_	lifestyle	_	JJ	25	_	_	_	_	_	_	_	O
42	advice	_	advice	_	NN	25	_	_	_	_	_	_	_	O
43	,	_	,	_	,	25	_	_	_	_	_	_	_	O
44	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
45	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
46	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
47	guidelines	_	guideline	_	NNS	25	_	_	_	_	_	_	_	O
48	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
49	:	_	:	_	:	25	_	_	_	_	_	_	_	O
50	preventing	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
51	excess	_	excess	_	JJ	25	_	_	_	_	_	_	_	O
52	weight	_	weight	_	NN	25	_	_	_	_	_	_	_	O
53	gain	_	gain	_	NN	25	_	_	_	_	_	_	_	O
54	,	_	,	_	,	25	_	_	_	_	_	_	_	O
55	weight	_	weight	_	JJ	25	_	_	_	_	_	_	_	O
56	management	_	management	_	NN	25	_	_	_	_	_	_	_	O
57	,	_	,	_	,	25	_	_	_	_	_	_	_	O
58	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
59	,	_	,	_	,	25	_	_	_	_	_	_	_	O
60	physical	_	physical	_	JJ	25	_	_	_	_	_	_	_	O
61	activity	_	activity	_	NN	25	_	_	_	_	_	_	_	O
62	,	_	,	_	,	25	_	_	_	_	_	_	_	O
63	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
64	:	_	:	_	:	25	_	_	_	_	_	_	_	O
65	brief	_	brief	_	JJ	25	_	_	_	_	_	_	_	O
66	interventions	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
67	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
68	referrals	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
69	,	_	,	_	,	25	_	_	_	_	_	_	_	O
70	stop	_	stop	_	VB	25	_	_	_	_	_	_	_	O
71	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
72	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
73	,	_	,	_	,	25	_	_	_	_	_	_	_	O
74	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
75	:	_	:	_	:	25	_	_	_	_	_	_	_	O
76	harm	_	harm	_	NN	25	_	_	_	_	_	_	_	O
77	reduction	_	reduction	_	NN	25	_	_	_	_	_	_	_	O
78	,	_	,	_	,	25	_	_	_	_	_	_	_	O
79	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
80	smoking	_	smoking	_	NN	25	_	_	_	_	_	_	_	O
81	:	_	:	_	:	25	_	_	_	_	_	_	_	O
82	acute	_	acute	_	NN	25	_	_	_	_	_	_	_	O
83	,	_	,	_	,	25	_	_	_	_	_	_	_	O
84	maternity	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
85	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
86	mental	_	mental	_	JJ	25	_	_	_	_	_	_	_	O
87	health	_	health	_	NN	25	_	_	_	_	_	_	_	O
88	services	_	service	_	NNS	25	_	_	_	_	_	_	_	O
89	.	_	.	_	.	25	_	_	_	_	_	_	_	O
90	1	_	1	_	CD	25	_	_	_	_	_	_	_	O
91	for	_	For	_	IN	25	_	_	_	_	_	_	_	O
92	recommendations	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
93	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
94	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
95	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
96	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
97	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
98	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
99	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
100	type	_	type	_	NN	25	_	_	_	_	_	_	_	O
101	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
102	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
103	,	_	,	_	,	25	_	_	_	_	_	_	_	O
104	see	_	see	_	VBP	25	_	_	_	_	_	_	_	O
105	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
106	section	_	section	_	NN	25	_	_	_	_	_	_	_	O
107	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
108	bariatric	_	UNK	_	JJ	25	_	_	_	_	_	_	_	O
109	surgery	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
110	for	_	for	_	IN	25	_	_	_	_	_	_	_	O
111	people	_	people	_	NNS	25	_	_	_	_	_	_	_	O
112	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	25	_	_	_	_	_	_	_	S-Type_property
114	type	_	type	_	NN	25	_	_	_	_	_	type.n	Type	S-Subtype
115	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
117	in	_	in	_	IN	25	_	_	_	_	_	_	_	O
118	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
119	nice	_	UNK	_	NNP	25	_	_	_	_	_	_	_	O
120	guideline	_	guideline	_	NN	25	_	_	_	_	_	_	_	O
121	on	_	on	_	IN	25	_	_	_	_	_	_	_	O
122	obesity	_	obesity	_	NN	25	_	_	_	_	_	_	_	O
123	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	measure	_	UNK	_	NN	26	_	_	_	_	_	_	_	B-Speaker
2	blood	_	blood	_	NN	26	_	_	_	_	_	_	_	I-Speaker
3	pressure	_	pressure	_	NN	26	_	_	_	_	_	pressure.n	Attempt_suasion	O
4	at	_	at	_	IN	26	_	_	_	_	_	_	_	O
5	least	_	least	_	JJS	26	_	_	_	_	_	_	_	O
6	annually	_	annually	_	RB	26	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	26	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	26	_	_	_	_	_	_	_	O
9	adult	_	adult	_	NN	26	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	26	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	26	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	26	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
14	without	_	without	_	IN	26	_	_	_	_	_	_	_	O
15	previously	_	previously	_	RB	26	_	_	_	_	_	_	_	O
16	diagnosed	_	UNK	_	VBN	26	_	_	_	_	_	_	_	O
17	hypertension	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	26	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	26	_	_	_	_	_	_	_	O
20	disease	_	disease	_	NN	26	_	_	_	_	_	_	_	O

1	measure	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	26	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	26	_	_	_	_	_	_	_	O
4	at	_	at	_	IN	26	_	_	_	_	_	_	_	O
5	least	_	least	_	JJS	26	_	_	_	_	_	_	_	O
6	annually	_	annually	_	RB	26	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	26	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	26	_	_	_	_	_	_	_	O
9	adult	_	adult	_	NN	26	_	_	_	_	_	adult.n	People_by_age	S-Person
10	with	_	with	_	IN	26	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	26	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	26	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
14	without	_	without	_	IN	26	_	_	_	_	_	_	_	O
15	previously	_	previously	_	RB	26	_	_	_	_	_	_	_	O
16	diagnosed	_	UNK	_	VBN	26	_	_	_	_	_	_	_	O
17	hypertension	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	26	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	26	_	_	_	_	_	_	_	O
20	disease	_	disease	_	NN	26	_	_	_	_	_	_	_	O

1	measure	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	26	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	26	_	_	_	_	_	_	_	O
4	at	_	at	_	IN	26	_	_	_	_	_	_	_	O
5	least	_	least	_	JJS	26	_	_	_	_	_	_	_	O
6	annually	_	annually	_	RB	26	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	26	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	26	_	_	_	_	_	_	_	O
9	adult	_	adult	_	NN	26	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	26	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	26	_	_	_	_	_	type.n	Type	S-Subtype
12	2	_	2	_	CD	26	_	_	_	_	_	_	_	B-Category
13	diabetes	_	UNK	_	NNS	26	_	_	_	_	_	_	_	I-Category
14	without	_	without	_	IN	26	_	_	_	_	_	_	_	O
15	previously	_	previously	_	RB	26	_	_	_	_	_	_	_	O
16	diagnosed	_	UNK	_	VBN	26	_	_	_	_	_	_	_	O
17	hypertension	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	26	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	26	_	_	_	_	_	_	_	O
20	disease	_	disease	_	NN	26	_	_	_	_	_	_	_	O

1	measure	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	26	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	26	_	_	_	_	_	_	_	O
4	at	_	at	_	IN	26	_	_	_	_	_	_	_	O
5	least	_	least	_	JJS	26	_	_	_	_	_	_	_	O
6	annually	_	annually	_	RB	26	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	26	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	26	_	_	_	_	_	_	_	O
9	adult	_	adult	_	NN	26	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	26	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	26	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	26	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
14	without	_	without	_	IN	26	_	_	_	_	_	_	_	O
15	previously	_	previously	_	RB	26	_	_	_	_	_	_	_	O
16	diagnosed	_	UNK	_	VBN	26	_	_	_	_	_	_	_	O
17	hypertension	_	UNK	_	NN	26	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	26	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	26	_	_	_	_	_	_	_	O
20	disease	_	disease	_	NN	26	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment

1	offer	_	UNK	_	NN	27	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	27	_	_	_	_	_	_	_	O
3	reinforce	_	reinforce	_	VB	27	_	_	_	_	_	reinforce.v	Cause_change_of_strength	O
4	preventive	_	UNK	_	JJ	27	_	_	_	_	_	_	_	B-Patient
5	lifestyle	_	lifestyle	_	JJ	27	_	_	_	_	_	_	_	I-Patient
6	advice	_	advice	_	NN	27	_	_	_	_	_	_	_	I-Patient
7	.	_	.	_	.	27	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	28	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	28	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	28	_	_	_	_	_	adult.n	People_by_age	S-Person
4	with	_	with	_	IN	28	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	28	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	28	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	28	_	_	_	_	_	_	_	O
8	on	_	on	_	IN	28	_	_	_	_	_	_	_	O
9	antihypertensive	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	28	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	28	_	_	_	_	_	_	_	O
12	when	_	when	_	WRB	28	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	VBZ	28	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	28	_	_	_	_	_	_	_	O
15	diagnosed	_	UNK	_	VBN	28	_	_	_	_	_	_	_	O
16	,	_	,	_	,	28	_	_	_	_	_	_	_	O
17	review	_	review	_	VB	28	_	_	_	_	_	_	_	O
18	blood	_	blood	_	NN	28	_	_	_	_	_	_	_	O
19	pressure	_	pressure	_	NN	28	_	_	_	_	_	_	_	O
20	control	_	control	_	NN	28	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
22	medications	_	medication	_	NNS	28	_	_	_	_	_	_	_	O
23	used	_	use	_	VBN	28	_	_	_	_	_	_	_	O
24	.	_	.	_	.	28	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	28	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	28	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	28	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	28	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	28	_	_	_	_	_	type.n	Type	S-Subtype
6	2	_	2	_	CD	28	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	28	_	_	_	_	_	_	_	O
8	on	_	on	_	IN	28	_	_	_	_	_	_	_	O
9	antihypertensive	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	28	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	28	_	_	_	_	_	_	_	O
12	when	_	when	_	WRB	28	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	VBZ	28	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	28	_	_	_	_	_	_	_	O
15	diagnosed	_	UNK	_	VBN	28	_	_	_	_	_	_	_	O
16	,	_	,	_	,	28	_	_	_	_	_	_	_	O
17	review	_	review	_	VB	28	_	_	_	_	_	_	_	O
18	blood	_	blood	_	NN	28	_	_	_	_	_	_	_	O
19	pressure	_	pressure	_	NN	28	_	_	_	_	_	_	_	O
20	control	_	control	_	NN	28	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
22	medications	_	medication	_	NNS	28	_	_	_	_	_	_	_	O
23	used	_	use	_	VBN	28	_	_	_	_	_	_	_	O
24	.	_	.	_	.	28	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	28	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	28	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	28	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	28	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	28	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	28	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	28	_	_	_	_	_	_	_	O
8	on	_	on	_	IN	28	_	_	_	_	_	_	_	O
9	antihypertensive	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	28	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	28	_	_	_	_	_	_	_	O
12	when	_	when	_	WRB	28	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	VBZ	28	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	28	_	_	_	_	_	_	_	O
15	diagnosed	_	UNK	_	VBN	28	_	_	_	_	_	_	_	O
16	,	_	,	_	,	28	_	_	_	_	_	_	_	O
17	review	_	review	_	VB	28	_	_	_	_	_	_	_	O
18	blood	_	blood	_	NN	28	_	_	_	_	_	_	_	S-Speaker
19	pressure	_	pressure	_	NN	28	_	_	_	_	_	pressure.n	Attempt_suasion	O
20	control	_	control	_	NN	28	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
22	medications	_	medication	_	NNS	28	_	_	_	_	_	_	_	O
23	used	_	use	_	VBN	28	_	_	_	_	_	_	_	O
24	.	_	.	_	.	28	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	28	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	28	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	28	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	28	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	28	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	28	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	28	_	_	_	_	_	_	_	O
8	on	_	on	_	IN	28	_	_	_	_	_	_	_	O
9	antihypertensive	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	28	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	28	_	_	_	_	_	_	_	O
12	when	_	when	_	WRB	28	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	VBZ	28	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	28	_	_	_	_	_	_	_	O
15	diagnosed	_	UNK	_	VBN	28	_	_	_	_	_	_	_	O
16	,	_	,	_	,	28	_	_	_	_	_	_	_	O
17	review	_	review	_	VB	28	_	_	_	_	_	_	_	O
18	blood	_	blood	_	NN	28	_	_	_	_	_	_	_	B-Instrument
19	pressure	_	pressure	_	NN	28	_	_	_	_	_	_	_	I-Instrument
20	control	_	control	_	NN	28	_	_	_	_	_	_	_	I-Instrument
21	and	_	and	_	CC	28	_	_	_	_	_	_	_	I-Instrument
22	medications	_	medication	_	NNS	28	_	_	_	_	_	_	_	I-Instrument
23	used	_	use	_	VBN	28	_	_	_	_	_	use.v	Using	O
24	.	_	.	_	.	28	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	29	_	_	_	_	_	pressure.n	Attempt_suasion	O
4	measurements	_	measurement	_	NNS	29	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	29	_	_	_	_	_	_	_	O
6	:	_	:	_	:	29	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	29	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	29	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	29	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	29	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
41	,	_	,	_	,	29	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	29	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	29	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	29	_	_	_	_	_	_	_	O
46	.	_	.	_	.	29	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	29	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	29	_	_	_	_	_	_	_	O
6	:	_	:	_	:	29	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	29	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	29	_	_	_	_	_	month.n	Calendric_unit	S-Unit
9	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	29	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	29	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
41	,	_	,	_	,	29	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	29	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	29	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	29	_	_	_	_	_	_	_	O
46	.	_	.	_	.	29	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	29	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	29	_	_	_	_	_	_	_	O
6	:	_	:	_	:	29	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	29	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	29	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	S-Speaker
11	pressure	_	pressure	_	NN	29	_	_	_	_	_	pressure.n	Attempt_suasion	O
12	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	29	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	29	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
41	,	_	,	_	,	29	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	29	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	29	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	29	_	_	_	_	_	_	_	O
46	.	_	.	_	.	29	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	29	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	29	_	_	_	_	_	_	_	O
6	:	_	:	_	:	29	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	29	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	29	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	B-Relative_time
16	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	I-Relative_time
17	2	_	2	_	CD	29	_	_	_	_	_	_	_	I-Relative_time
18	months	_	month	_	NNS	29	_	_	_	_	_	month.n	Calendric_unit	S-Unit
19	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	29	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	29	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
41	,	_	,	_	,	29	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	29	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	29	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	29	_	_	_	_	_	_	_	O
46	.	_	.	_	.	29	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	29	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	29	_	_	_	_	_	_	_	O
6	:	_	:	_	:	29	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	29	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	29	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	S-Speaker
21	pressure	_	pressure	_	NN	29	_	_	_	_	_	pressure.n	Attempt_suasion	O
22	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	29	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	29	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
41	,	_	,	_	,	29	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	29	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	29	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	29	_	_	_	_	_	_	_	O
46	.	_	.	_	.	29	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	29	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	29	_	_	_	_	_	_	_	O
6	:	_	:	_	:	29	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	29	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	29	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	B-Relative_time
26	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	I-Relative_time
27	2	_	2	_	CD	29	_	_	_	_	_	_	_	I-Relative_time
28	months	_	month	_	NNS	29	_	_	_	_	_	month.n	Calendric_unit	S-Unit
29	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	29	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	29	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
41	,	_	,	_	,	29	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	29	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	29	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	29	_	_	_	_	_	_	_	O
46	.	_	.	_	.	29	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	29	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	29	_	_	_	_	_	_	_	O
6	:	_	:	_	:	29	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	29	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	29	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	S-Speaker
31	pressure	_	pressure	_	NN	29	_	_	_	_	_	pressure.n	Attempt_suasion	O
32	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	29	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	29	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
41	,	_	,	_	,	29	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	29	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	29	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	29	_	_	_	_	_	_	_	O
46	.	_	.	_	.	29	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	29	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	29	_	_	_	_	_	_	_	O
6	:	_	:	_	:	29	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	29	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	29	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	29	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	29	_	_	_	_	_	there.adv	Locative_relation	S-Figure
39	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	B-Ground
40	kidney	_	UNK	_	NN	29	_	_	_	_	_	_	_	I-Ground
41	,	_	,	_	,	29	_	_	_	_	_	_	_	I-Ground
42	eye	_	eye	_	NN	29	_	_	_	_	_	_	_	I-Ground
43	or	_	or	_	CC	29	_	_	_	_	_	_	_	I-Ground
44	cerebrovascular	_	UNK	_	JJ	29	_	_	_	_	_	_	_	I-Ground
45	damage	_	damage	_	NN	29	_	_	_	_	_	_	_	I-Ground
46	.	_	.	_	.	29	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	29	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	29	_	_	_	_	_	_	_	O
6	:	_	:	_	:	29	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	29	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	29	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	29	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	29	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
41	,	_	,	_	,	29	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	29	_	_	_	_	_	eye.n	Body_parts	S-Body_part
43	or	_	or	_	CC	29	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	29	_	_	_	_	_	_	_	O
46	.	_	.	_	.	29	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	29	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	29	_	_	_	_	_	_	_	O
6	:	_	:	_	:	29	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	29	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	29	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	29	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	29	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	29	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	29	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	29	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	29	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	29	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	29	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	29	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	29	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
41	,	_	,	_	,	29	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	29	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	29	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	29	_	_	_	_	_	_	_	S-Patient
45	damage	_	damage	_	NN	29	_	_	_	_	_	damage.n	Damaging	O
46	.	_	.	_	.	29	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	30	_	_	_	_	_	provide.v	Supply	O
2	lifestyle	_	lifestyle	_	JJ	30	_	_	_	_	_	_	_	B-Theme
3	advice	_	advice	_	NN	30	_	_	_	_	_	_	_	I-Theme
4	(	_	(	_	(	30	_	_	_	_	_	_	_	O
5	see	_	see	_	VB	30	_	_	_	_	_	_	_	O
6	section	_	section	_	NN	30	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	30	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	30	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
12	lifestyle	_	lifestyle	_	JJ	30	_	_	_	_	_	_	_	O
13	interventions	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
14	section	_	section	_	NN	30	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
16	hypertension	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	30	_	_	_	_	_	_	_	O
19	[	_	[	_	JJ	30	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	30	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	30	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	30	_	_	_	_	_	_	_	O
23	]	_	]	_	NNP	30	_	_	_	_	_	_	_	O
24	)	_	)	_	)	30	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	30	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	30	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	30	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	30	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	30	_	_	_	_	_	_	_	O
4	(	_	(	_	(	30	_	_	_	_	_	_	_	O
5	see	_	see	_	VB	30	_	_	_	_	_	_	_	O
6	section	_	section	_	NN	30	_	_	_	_	_	section.n	Part_whole	S-Part
7	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	30	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	30	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
12	lifestyle	_	lifestyle	_	JJ	30	_	_	_	_	_	_	_	O
13	interventions	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
14	section	_	section	_	NN	30	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
16	hypertension	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	30	_	_	_	_	_	_	_	O
19	[	_	[	_	JJ	30	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	30	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	30	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	30	_	_	_	_	_	_	_	O
23	]	_	]	_	NNP	30	_	_	_	_	_	_	_	O
24	)	_	)	_	)	30	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	30	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	30	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	30	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	30	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	30	_	_	_	_	_	_	_	O
4	(	_	(	_	(	30	_	_	_	_	_	_	_	O
5	see	_	see	_	VB	30	_	_	_	_	_	_	_	O
6	section	_	section	_	NN	30	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	30	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	30	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
12	lifestyle	_	lifestyle	_	JJ	30	_	_	_	_	_	_	_	O
13	interventions	_	UNK	_	NNS	30	_	_	_	_	_	_	_	S-Whole
14	section	_	section	_	NN	30	_	_	_	_	_	section.n	Part_whole	S-Part
15	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
16	hypertension	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	30	_	_	_	_	_	_	_	O
19	[	_	[	_	JJ	30	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	30	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	30	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	30	_	_	_	_	_	_	_	O
23	]	_	]	_	NNP	30	_	_	_	_	_	_	_	O
24	)	_	)	_	)	30	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	30	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	30	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	30	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	30	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	30	_	_	_	_	_	_	_	O
4	(	_	(	_	(	30	_	_	_	_	_	_	_	O
5	see	_	see	_	VB	30	_	_	_	_	_	_	_	O
6	section	_	section	_	NN	30	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	30	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	30	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
12	lifestyle	_	lifestyle	_	JJ	30	_	_	_	_	_	_	_	O
13	interventions	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
14	section	_	section	_	NN	30	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
16	hypertension	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	30	_	_	_	_	_	adult.n	People_by_age	S-Person
19	[	_	[	_	JJ	30	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	30	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	30	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	30	_	_	_	_	_	_	_	O
23	]	_	]	_	NNP	30	_	_	_	_	_	_	_	O
24	)	_	)	_	)	30	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	30	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	30	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	31	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	31	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	31	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	31	_	_	_	_	_	_	_	O
6	:	_	:	_	:	31	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	31	_	_	_	_	_	_	_	O
8	(	_	(	_	(	31	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	31	_	_	_	_	_	_	_	O
10	)	_	)	_	)	31	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	31	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	31	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	31	_	_	_	_	_	_	_	O
14	)	_	)	_	)	31	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	31	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	31	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	31	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	31	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	31	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	31	_	_	_	_	_	_	_	O
8	(	_	(	_	(	31	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	31	_	_	_	_	_	_	_	O
10	)	_	)	_	)	31	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	31	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	31	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	31	_	_	_	_	_	_	_	O
14	)	_	)	_	)	31	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	33	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	33	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	33	_	_	_	_	_	family.n	Kinship	S-Relatives
5	origin	_	origin	_	NN	33	_	_	_	_	_	_	_	O
6	,	_	,	_	,	33	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	33	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	33	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	33	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	33	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	33	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	33	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	33	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	33	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	33	_	_	_	_	_	_	_	O
17	pregnant	_	pregnant	_	NN	33	_	_	_	_	_	_	_	O
18	.	_	.	_	.	33	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	33	_	_	_	_	_	_	_	B-Origin
2	or	_	or	_	CC	33	_	_	_	_	_	_	_	I-Origin
3	caribbean	_	Caribbean	_	JJ	33	_	_	_	_	_	_	_	I-Origin
4	family	_	family	_	NN	33	_	_	_	_	_	_	_	I-Origin
5	origin	_	origin	_	NN	33	_	_	_	_	_	origin.n	Origin	I-Origin
6	,	_	,	_	,	33	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	33	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	33	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	33	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	33	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	33	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	33	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	33	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	33	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	33	_	_	_	_	_	_	_	O
17	pregnant	_	pregnant	_	NN	33	_	_	_	_	_	_	_	O
18	.	_	.	_	.	33	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	33	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	33	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	33	_	_	_	_	_	_	_	O
5	origin	_	origin	_	NN	33	_	_	_	_	_	_	_	O
6	,	_	,	_	,	33	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	33	_	_	_	_	_	woman.n	People	S-Person
9	for	_	for	_	IN	33	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	33	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	33	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	33	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	33	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	33	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	33	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	33	_	_	_	_	_	_	_	O
17	pregnant	_	pregnant	_	NN	33	_	_	_	_	_	_	_	O
18	.	_	.	_	.	33	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	33	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	33	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	33	_	_	_	_	_	_	_	O
5	origin	_	origin	_	NN	33	_	_	_	_	_	_	_	O
6	,	_	,	_	,	33	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	33	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	33	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	33	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	33	_	_	_	_	_	there.adv	Locative_relation	S-Ground
12	is	_	be	_	VBZ	33	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	33	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	33	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	33	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	33	_	_	_	_	_	_	_	O
17	pregnant	_	pregnant	_	NN	33	_	_	_	_	_	_	_	O
18	.	_	.	_	.	33	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	33	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	33	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	33	_	_	_	_	_	_	_	O
5	origin	_	origin	_	NN	33	_	_	_	_	_	_	_	O
6	,	_	,	_	,	33	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	33	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	33	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	33	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	33	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	33	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	33	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	33	_	_	_	_	_	possibility.n	Alternatives	O
15	of	_	of	_	IN	33	_	_	_	_	_	_	_	B-Salient_entity
16	becoming	_	become	_	VBG	33	_	_	_	_	_	_	_	I-Salient_entity
17	pregnant	_	pregnant	_	NN	33	_	_	_	_	_	_	_	I-Salient_entity
18	.	_	.	_	.	33	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	33	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	33	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	33	_	_	_	_	_	_	_	O
5	origin	_	origin	_	NN	33	_	_	_	_	_	_	_	O
6	,	_	,	_	,	33	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	33	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	33	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	33	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	33	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	33	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	33	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	33	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	33	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	33	_	_	_	_	_	become.v	Becoming	O
17	pregnant	_	pregnant	_	NN	33	_	_	_	_	_	_	_	S-Final_category
18	.	_	.	_	.	33	_	_	_	_	_	_	_	O

1	caribbean	_	Caribbean	_	NNP	34	_	_	_	_	_	_	_	O
2	family	_	family	_	NN	34	_	_	_	_	_	family.n	Kinship	S-Alter
3	origin	_	origin	_	NN	34	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	34	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	34	_	_	_	_	_	_	_	O
6	an	_	an	_	DT	34	_	_	_	_	_	_	_	O
7	ace	_	UNK	_	NNP	34	_	_	_	_	_	_	_	O
8	inhibitor	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
9	plus	_	plus	_	CC	34	_	_	_	_	_	_	_	O
10	either	_	either	_	CC	34	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	34	_	_	_	_	_	_	_	O
12	diuretic	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	34	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	34	_	_	_	_	_	_	_	O
15	generic	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
17	blocker	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
18	.	_	.	_	.	34	_	_	_	_	_	_	_	O

1	caribbean	_	Caribbean	_	NNP	34	_	_	_	_	_	_	_	B-Entity
2	family	_	family	_	NN	34	_	_	_	_	_	_	_	I-Entity
3	origin	_	origin	_	NN	34	_	_	_	_	_	origin.n	Origin	S-Origin
4	should	_	should	_	MD	34	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	34	_	_	_	_	_	_	_	O
6	an	_	an	_	DT	34	_	_	_	_	_	_	_	O
7	ace	_	UNK	_	NNP	34	_	_	_	_	_	_	_	O
8	inhibitor	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
9	plus	_	plus	_	CC	34	_	_	_	_	_	_	_	O
10	either	_	either	_	CC	34	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	34	_	_	_	_	_	_	_	O
12	diuretic	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	34	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	34	_	_	_	_	_	_	_	O
15	generic	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
17	blocker	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
18	.	_	.	_	.	34	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	S-Patient
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	treatment.n	Cure	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	woman.n	People	S-Person
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	S-Depictive
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	discussion.n	Discussion	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	S-Party_1
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	agree.v	Make_agreement_on_action	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	B-Obligation
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	I-Obligation
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	I-Obligation
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	I-Obligation
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	I-Obligation
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	I-Obligation
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	I-Obligation
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	I-Obligation
33	.	_	.	_	.	35	_	_	_	_	_	_	_	I-Obligation
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	I-Obligation
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	I-Obligation
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	I-Obligation
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	I-Obligation
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	I-Obligation
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	I-Obligation
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Obligation
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	I-Obligation
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	I-Obligation
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	I-Obligation
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Obligation
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	there.adv	Locative_relation	S-Ground
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	possibility.n	Likelihood	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	B-Hypothetical_event
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	I-Hypothetical_event
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	B-Entity
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	I-Entity
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	I-Entity
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	I-Entity
31	becoming	_	become	_	VBG	35	_	_	_	_	_	become.v	Becoming	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	S-Final_quality
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	person.n	People	S-Person
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	continue.v	Process_continue	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	B-Event
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	I-Event
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	I-Event
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	I-Event
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Event
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	other.a	Increment	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	B-Class
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Class
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Class
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	I-Class
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Class
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	S-Agent
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	combine.v	Cause_to_amalgamate	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	B-Part_2
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	I-Part_2
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Part_2
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	I-Part_2
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	I-Part_2
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Part_2
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	I-Part_2
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Part_2
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	I-Part_2
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	I-Part_2
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Part_2
79	.	_	.	_	.	35	_	_	_	_	_	_	_	I-Part_2
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	I-Part_2
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	I-Part_2
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	I-Part_2
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	I-Part_2
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	I-Part_2
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	I-Part_2
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	I-Part_2
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	I-Part_2
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	treat.v	Medical_intervention	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	S-Patient
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	person.n	People	S-Person
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	B-Speaker
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	I-Speaker
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	I-Speaker
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	pressure.n	Attempt_suasion	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	B-Item
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	I-Item
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	I-Item
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	I-Item
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	I-Item
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	reduce.v	Cause_change_of_position_on_a_scale	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	B-Item
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	I-Item
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	I-Item
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	I-Item
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	I-Item
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	I-Item
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Item
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	I-Item
98	,	_	,	_	,	35	_	_	_	_	_	_	_	I-Item
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	I-Item
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	I-Item
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Item
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Item
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	I-Item
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	I-Item
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Item
106	(	_	(	_	(	35	_	_	_	_	_	_	_	I-Item
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	I-Item
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	I-Item
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Item
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	B-Party_1
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	I-Party_1
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	agree.v	Make_agreement_on_action	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	B-Obligation
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	I-Obligation
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Obligation
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	I-Obligation
98	,	_	,	_	,	35	_	_	_	_	_	_	_	I-Obligation
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	I-Obligation
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	I-Obligation
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Obligation
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Obligation
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	I-Obligation
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	I-Obligation
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Obligation
106	(	_	(	_	(	35	_	_	_	_	_	_	_	I-Obligation
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	I-Obligation
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	I-Obligation
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Obligation
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	I-Obligation
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Obligation
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Obligation
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	O
16	,	_	,	_	,	35	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	O
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
63	.	_	.	_	.	35	_	_	_	_	_	_	_	O
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	O
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	O
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	O
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	O
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
79	.	_	.	_	.	35	_	_	_	_	_	_	_	O
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	_	_	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	35	_	_	_	_	_	_	_	B-Message
2	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Message
3	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Message
4	should	_	should	_	MD	35	_	_	_	_	_	_	_	I-Message
5	be	_	be	_	VB	35	_	_	_	_	_	_	_	I-Message
6	the	_	the	_	DT	35	_	_	_	_	_	_	_	I-Message
7	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Message
8	antihypertensive	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Message
9	drug	_	drug	_	NN	35	_	_	_	_	_	_	_	I-Message
10	treatment	_	treatment	_	NN	35	_	_	_	_	_	_	_	I-Message
11	for	_	for	_	IN	35	_	_	_	_	_	_	_	I-Message
12	a	_	a	_	DT	35	_	_	_	_	_	_	_	I-Message
13	woman	_	woman	_	NN	35	_	_	_	_	_	_	_	I-Message
14	for	_	for	_	IN	35	_	_	_	_	_	_	_	I-Message
15	whom	_	whom	_	WP	35	_	_	_	_	_	_	_	I-Message
16	,	_	,	_	,	35	_	_	_	_	_	_	_	I-Message
17	after	_	after	_	IN	35	_	_	_	_	_	_	_	I-Message
18	an	_	an	_	DT	35	_	_	_	_	_	_	_	I-Message
19	informed	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Message
20	discussion	_	discussion	_	NN	35	_	_	_	_	_	_	_	I-Message
21	,	_	,	_	,	35	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	35	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	35	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	35	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	35	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	35	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	35	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	35	_	_	_	_	_	_	_	O
33	.	_	.	_	.	35	_	_	_	_	_	_	_	O
34	0	_	0	_	CD	35	_	_	_	_	_	_	_	O
35	for	_	For	_	IN	35	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
39	continuing	_	continue	_	VBG	35	_	_	_	_	_	_	_	O
40	intolerance	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
42	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
43	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
44	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
45	(	_	(	_	(	35	_	_	_	_	_	_	_	O
46	other	_	other	_	JJ	35	_	_	_	_	_	_	_	O
47	than	_	than	_	IN	35	_	_	_	_	_	_	_	O
48	renal	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
49	deterioration	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
50	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
52	)	_	)	_	)	35	_	_	_	_	_	_	_	O
53	,	_	,	_	,	35	_	_	_	_	_	_	_	O
54	substitute	_	UNK	_	VBP	35	_	_	_	_	_	_	_	O
55	an	_	an	_	DT	35	_	_	_	_	_	_	_	O
56	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
58	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	35	_	_	_	_	_	_	_	O
60	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
61	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	B-Message
62	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Message
63	.	_	.	_	.	35	_	_	_	_	_	_	_	I-Message
64	1	_	1	_	CD	35	_	_	_	_	_	_	_	I-Message
65	do	_	Do	_	NNP	35	_	_	_	_	_	_	_	I-Message
66	not	_	not	_	RB	35	_	_	_	_	_	_	_	I-Message
67	combine	_	combine	_	VB	35	_	_	_	_	_	_	_	I-Message
68	an	_	an	_	DT	35	_	_	_	_	_	_	_	I-Message
69	ace	_	UNK	_	NNP	35	_	_	_	_	_	_	_	I-Message
70	inhibitor	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Message
71	with	_	with	_	IN	35	_	_	_	_	_	_	_	I-Message
72	an	_	an	_	DT	35	_	_	_	_	_	_	_	I-Message
73	angiotensin	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Message
74	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	I-Message
75	antagonist	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Message
76	to	_	to	_	TO	35	_	_	_	_	_	_	_	I-Message
77	treat	_	treat	_	VB	35	_	_	_	_	_	_	_	I-Message
78	hypertension	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Message
79	.	_	.	_	.	35	_	_	_	_	_	_	_	I-Message
80	2	_	2	_	CD	35	_	_	_	_	_	_	_	I-Message
81	if	_	If	_	IN	35	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
83	person	_	person	_	NN	35	_	_	_	_	_	_	_	O
84	's	_	's	_	POS	35	_	_	_	_	_	_	_	O
85	blood	_	blood	_	NN	35	_	_	_	_	_	_	_	O
86	pressure	_	pressure	_	NN	35	_	_	_	_	_	_	_	O
87	is	_	be	_	VBZ	35	_	_	_	_	_	_	_	O
88	not	_	not	_	RB	35	_	_	_	_	_	_	_	O
89	reduced	_	reduce	_	VBN	35	_	_	_	_	_	_	_	O
90	to	_	to	_	TO	35	_	_	_	_	_	_	_	O
91	the	_	the	_	DT	35	_	_	_	_	_	_	_	O
92	individually	_	UNK	_	RB	35	_	_	_	_	_	_	_	O
93	agreed	_	agree	_	VBN	35	_	_	_	_	_	_	_	O
94	target	_	target	_	NN	35	_	_	_	_	_	_	_	O
95	with	_	with	_	IN	35	_	_	_	_	_	_	_	O
96	first-line	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
97	therapy	_	therapy	_	NN	35	_	_	_	_	_	_	_	O
98	,	_	,	_	,	35	_	_	_	_	_	_	_	O
99	add	_	add	_	VB	35	_	_	_	_	_	add.v	Statement	O
100	a	_	a	_	DT	35	_	_	_	_	_	_	_	B-Message
101	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Message
102	blocker	_	UNK	_	NN	35	_	_	_	_	_	_	_	I-Message
103	or	_	or	_	CC	35	_	_	_	_	_	_	_	I-Message
104	a	_	a	_	DT	35	_	_	_	_	_	_	_	I-Message
105	diuretic	_	UNK	_	JJ	35	_	_	_	_	_	_	_	I-Message
106	(	_	(	_	(	35	_	_	_	_	_	_	_	O
107	usually	_	usually	_	RB	35	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	35	_	_	_	_	_	_	_	O
109	thiazide	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	35	_	_	_	_	_	_	_	O
111	unk	_	UNK	_	JJ	35	_	_	_	_	_	_	_	O
112	diuretic	_	UNK	_	NN	35	_	_	_	_	_	_	_	O
113	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	36	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	36	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	36	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	36	_	_	_	_	_	_	_	O
6	:	_	:	_	:	36	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	36	_	_	_	_	_	_	_	O
8	(	_	(	_	(	36	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	36	_	_	_	_	_	_	_	O
10	)	_	)	_	)	36	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	36	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	36	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
14	)	_	)	_	)	36	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	36	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	36	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	36	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	36	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	36	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	36	_	_	_	_	_	_	_	O
8	(	_	(	_	(	36	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	36	_	_	_	_	_	_	_	O
10	)	_	)	_	)	36	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	36	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	36	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
14	)	_	)	_	)	36	_	_	_	_	_	_	_	O

1	do	_	Do	_	MD	37	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	37	_	_	_	_	_	_	_	O
3	offer	_	offer	_	VB	37	_	_	_	_	_	_	_	O
4	antiplatelet	_	UNK	_	NN	37	_	_	_	_	_	_	_	S-Type
5	therapy	_	therapy	_	NN	37	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
6	(	_	(	_	(	37	_	_	_	_	_	_	_	O
7	aspirin	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	37	_	_	_	_	_	_	_	O
9	clopidogrel	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
10	)	_	)	_	)	37	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	37	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	37	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	37	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	37	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
17	without	_	without	_	IN	37	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
19	disease	_	disease	_	NN	37	_	_	_	_	_	_	_	O
20	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	do	_	Do	_	MD	37	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	37	_	_	_	_	_	_	_	O
3	offer	_	offer	_	VB	37	_	_	_	_	_	_	_	O
4	antiplatelet	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
5	therapy	_	therapy	_	NN	37	_	_	_	_	_	_	_	O
6	(	_	(	_	(	37	_	_	_	_	_	_	_	O
7	aspirin	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	37	_	_	_	_	_	_	_	O
9	clopidogrel	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
10	)	_	)	_	)	37	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	37	_	_	_	_	_	adult.n	People_by_age	S-Person
13	with	_	with	_	IN	37	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	37	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	37	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
17	without	_	without	_	IN	37	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
19	disease	_	disease	_	NN	37	_	_	_	_	_	_	_	O
20	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	do	_	Do	_	MD	37	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	37	_	_	_	_	_	_	_	O
3	offer	_	offer	_	VB	37	_	_	_	_	_	_	_	O
4	antiplatelet	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
5	therapy	_	therapy	_	NN	37	_	_	_	_	_	_	_	O
6	(	_	(	_	(	37	_	_	_	_	_	_	_	O
7	aspirin	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	37	_	_	_	_	_	_	_	O
9	clopidogrel	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
10	)	_	)	_	)	37	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	37	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	37	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	37	_	_	_	_	_	type.n	Type	S-Subtype
15	2	_	2	_	CD	37	_	_	_	_	_	_	_	B-Category
16	diabetes	_	UNK	_	NNS	37	_	_	_	_	_	_	_	I-Category
17	without	_	without	_	IN	37	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
19	disease	_	disease	_	NN	37	_	_	_	_	_	_	_	O
20	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	do	_	Do	_	MD	37	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	37	_	_	_	_	_	_	_	O
3	offer	_	offer	_	VB	37	_	_	_	_	_	_	_	O
4	antiplatelet	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
5	therapy	_	therapy	_	NN	37	_	_	_	_	_	_	_	O
6	(	_	(	_	(	37	_	_	_	_	_	_	_	O
7	aspirin	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	37	_	_	_	_	_	_	_	O
9	clopidogrel	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
10	)	_	)	_	)	37	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	37	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	37	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	37	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	37	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	37	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
17	without	_	without	_	IN	37	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	JJ	37	_	_	_	_	_	_	_	O
19	disease	_	disease	_	NN	37	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
20	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	38	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	38	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	38	_	_	_	_	_	primary.a	First_rank	O
6	and	_	and	_	CC	38	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	38	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	38	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	38	_	_	_	_	_	_	_	B-Item
10	cardiovascular	_	UNK	_	JJ	38	_	_	_	_	_	_	_	I-Item
11	disease	_	disease	_	NN	38	_	_	_	_	_	_	_	I-Item
12	in	_	in	_	IN	38	_	_	_	_	_	_	_	I-Item
13	adults	_	adult	_	NNS	38	_	_	_	_	_	_	_	I-Item
14	with	_	with	_	IN	38	_	_	_	_	_	_	_	I-Item
15	type	_	type	_	JJ	38	_	_	_	_	_	_	_	I-Item
16	2	_	2	_	CD	38	_	_	_	_	_	_	_	I-Item
17	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	I-Item
18	,	_	,	_	,	38	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	38	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	38	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	38	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	38	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
29	.	_	.	_	.	38	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	38	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	38	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	38	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	38	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	38	_	_	_	_	_	_	_	S-Manner
8	prevention	_	prevention	_	NN	38	_	_	_	_	_	prevention.n	Preventing_or_letting	O
9	of	_	of	_	IN	38	_	_	_	_	_	_	_	B-Event
10	cardiovascular	_	UNK	_	JJ	38	_	_	_	_	_	_	_	I-Event
11	disease	_	disease	_	NN	38	_	_	_	_	_	_	_	I-Event
12	in	_	in	_	IN	38	_	_	_	_	_	_	_	I-Event
13	adults	_	adult	_	NNS	38	_	_	_	_	_	_	_	I-Event
14	with	_	with	_	IN	38	_	_	_	_	_	_	_	I-Event
15	type	_	type	_	JJ	38	_	_	_	_	_	_	_	I-Event
16	2	_	2	_	CD	38	_	_	_	_	_	_	_	I-Event
17	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	I-Event
18	,	_	,	_	,	38	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	38	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	38	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	38	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	38	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
29	.	_	.	_	.	38	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	38	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	38	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	38	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	38	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	38	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	38	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	38	_	_	_	_	_	_	_	O
10	cardiovascular	_	UNK	_	JJ	38	_	_	_	_	_	_	_	S-Patient
11	disease	_	disease	_	NN	38	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
12	in	_	in	_	IN	38	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	38	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	38	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
18	,	_	,	_	,	38	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	38	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	38	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	38	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	38	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
29	.	_	.	_	.	38	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	38	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	38	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	38	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	38	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	38	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	38	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	38	_	_	_	_	_	_	_	O
10	cardiovascular	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
11	disease	_	disease	_	NN	38	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	38	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	38	_	_	_	_	_	adult.n	People_by_age	S-Person
14	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	38	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
18	,	_	,	_	,	38	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	38	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	38	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	38	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	38	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
29	.	_	.	_	.	38	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	38	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	38	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	38	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	38	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	38	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	38	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	38	_	_	_	_	_	_	_	O
10	cardiovascular	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
11	disease	_	disease	_	NN	38	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	38	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	38	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	38	_	_	_	_	_	type.n	Type	S-Subtype
16	2	_	2	_	CD	38	_	_	_	_	_	_	_	B-Category
17	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	I-Category
18	,	_	,	_	,	38	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	38	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	38	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	38	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	38	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
29	.	_	.	_	.	38	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	38	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	38	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	38	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	38	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	38	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	38	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	38	_	_	_	_	_	_	_	O
10	cardiovascular	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
11	disease	_	disease	_	NN	38	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	38	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	38	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	38	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
18	,	_	,	_	,	38	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	38	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	38	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	38	_	_	_	_	_	_	_	S-Patient
25	disease	_	disease	_	NN	38	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
26	and	_	and	_	CC	38	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
29	.	_	.	_	.	38	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	40	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	40	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	40	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	40	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	O
7	,	_	,	_	,	40	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	40	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	40	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	40	_	_	_	_	_	_	_	O
12	:	_	:	_	:	40	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
15	(	_	(	_	(	40	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	40	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	40	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	40	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	40	_	_	_	_	_	_	_	O
20	)	_	)	_	)	40	_	_	_	_	_	_	_	O
21	,	_	,	_	,	40	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	40	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	40	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	40	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	40	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	40	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	40	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	40	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
43	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	40	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	40	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	40	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	40	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	40	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	40	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	40	_	_	_	_	_	_	_	O
12	:	_	:	_	:	40	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
15	(	_	(	_	(	40	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	40	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	40	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	40	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	40	_	_	_	_	_	_	_	O
20	)	_	)	_	)	40	_	_	_	_	_	_	_	O
21	,	_	,	_	,	40	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	40	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	40	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	40	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	40	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	40	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	40	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	40	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
43	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	40	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	40	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	40	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	O
7	,	_	,	_	,	40	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	40	_	_	_	_	_	_	_	S-Rank
9	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	S-Item
10	levels	_	level	_	NNS	40	_	_	_	_	_	level.n	Rank	O
11	at	_	at	_	IN	40	_	_	_	_	_	_	_	O
12	:	_	:	_	:	40	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
15	(	_	(	_	(	40	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	40	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	40	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	40	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	40	_	_	_	_	_	_	_	O
20	)	_	)	_	)	40	_	_	_	_	_	_	_	O
21	,	_	,	_	,	40	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	40	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	40	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	40	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	40	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	40	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	40	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	40	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
43	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	40	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	40	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	40	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	O
7	,	_	,	_	,	40	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	40	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	40	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	40	_	_	_	_	_	_	_	O
12	:	_	:	_	:	40	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	S-Time_span
14	intervals	_	interval	_	NNS	40	_	_	_	_	_	interval.n	Frequency	S-Interval
15	(	_	(	_	(	40	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	40	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	40	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	40	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	40	_	_	_	_	_	_	_	O
20	)	_	)	_	)	40	_	_	_	_	_	_	_	O
21	,	_	,	_	,	40	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	40	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	40	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	40	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	40	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	40	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	40	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	40	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
43	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	40	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	40	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	40	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	O
7	,	_	,	_	,	40	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	40	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	40	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	40	_	_	_	_	_	_	_	O
12	:	_	:	_	:	40	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
15	(	_	(	_	(	40	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	40	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	40	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	40	_	_	_	_	_	individual.n	People	O
19	needs	_	need	_	NNS	40	_	_	_	_	_	_	_	S-Person
20	)	_	)	_	)	40	_	_	_	_	_	_	_	O
21	,	_	,	_	,	40	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	40	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	40	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	40	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	40	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	40	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	40	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	40	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
43	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	40	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	40	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	40	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	O
7	,	_	,	_	,	40	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	40	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	40	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	40	_	_	_	_	_	_	_	O
12	:	_	:	_	:	40	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
15	(	_	(	_	(	40	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	40	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	40	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	40	_	_	_	_	_	_	_	S-Cognizer
19	needs	_	need	_	NNS	40	_	_	_	_	_	need.n	Needing	S-Requirement
20	)	_	)	_	)	40	_	_	_	_	_	_	_	O
21	,	_	,	_	,	40	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	40	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	40	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	40	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	40	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	40	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	40	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	40	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
43	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	40	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	40	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	40	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	O
7	,	_	,	_	,	40	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	40	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	40	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	40	_	_	_	_	_	_	_	O
12	:	_	:	_	:	40	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
15	(	_	(	_	(	40	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	40	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	40	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	40	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	40	_	_	_	_	_	_	_	O
20	)	_	)	_	)	40	_	_	_	_	_	_	_	O
21	,	_	,	_	,	40	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	40	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	40	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	40	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
30	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	40	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	40	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	40	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	40	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	40	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
43	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	40	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	40	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	40	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	O
7	,	_	,	_	,	40	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	40	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	40	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	40	_	_	_	_	_	_	_	O
12	:	_	:	_	:	40	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
15	(	_	(	_	(	40	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	40	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	40	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	40	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	40	_	_	_	_	_	_	_	O
20	)	_	)	_	)	40	_	_	_	_	_	_	_	O
21	,	_	,	_	,	40	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	40	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	40	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	40	_	_	_	_	_	interval.n	Frequency	S-Interval
32	once	_	once	_	IN	40	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	40	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	40	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	40	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	40	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
43	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	40	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	40	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	40	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	O
7	,	_	,	_	,	40	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	40	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	40	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	40	_	_	_	_	_	_	_	O
12	:	_	:	_	:	40	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
15	(	_	(	_	(	40	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	40	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	40	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	40	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	40	_	_	_	_	_	_	_	O
20	)	_	)	_	)	40	_	_	_	_	_	_	_	O
21	,	_	,	_	,	40	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	40	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	40	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	40	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	40	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	40	_	_	_	_	_	_	_	B-Item
38	glucose	_	UNK	_	NN	40	_	_	_	_	_	_	_	I-Item
39	lowering	_	lower	_	VBG	40	_	_	_	_	_	lower.v	Cause_change_of_position_on_a_scale	O
40	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	S-Item
41	are	_	be	_	VBP	40	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
43	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	40	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	40	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	40	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	40	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	40	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	40	_	_	_	_	_	_	_	O
7	,	_	,	_	,	40	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	40	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	40	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	40	_	_	_	_	_	_	_	O
12	:	_	:	_	:	40	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
15	(	_	(	_	(	40	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	40	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	40	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	40	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	40	_	_	_	_	_	_	_	O
20	)	_	)	_	)	40	_	_	_	_	_	_	_	O
21	,	_	,	_	,	40	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	40	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	40	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	40	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	40	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	40	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	40	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	40	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	40	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	40	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	40	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	40	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	40	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	40	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
41	are	_	be	_	VBP	40	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	40	_	_	_	_	_	_	_	O
43	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	use	_	UNK	_	NNP	41	_	_	_	_	_	_	_	S-Purpose
2	methods	_	method	_	NNS	41	_	_	_	_	_	method.n	Means	S-Means
3	to	_	to	_	TO	41	_	_	_	_	_	_	_	O
4	measure	_	measure	_	VB	41	_	_	_	_	_	_	_	O
5	hba1c	_	UNK	_	NNP	41	_	_	_	_	_	_	_	O
6	that	_	that	_	WDT	41	_	_	_	_	_	_	_	O
7	have	_	have	_	VBP	41	_	_	_	_	_	_	_	O
8	been	_	be	_	VBN	41	_	_	_	_	_	_	_	O
9	calibrated	_	UNK	_	VBN	41	_	_	_	_	_	_	_	O
10	according	_	accord	_	VBG	41	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	41	_	_	_	_	_	_	_	O

1	use	_	UNK	_	NNP	41	_	_	_	_	_	_	_	O
2	methods	_	method	_	NNS	41	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	41	_	_	_	_	_	_	_	O
4	measure	_	measure	_	VB	41	_	_	_	_	_	measure.v	Dimension	S-Dimension
5	hba1c	_	UNK	_	NNP	41	_	_	_	_	_	_	_	S-Object
6	that	_	that	_	WDT	41	_	_	_	_	_	_	_	O
7	have	_	have	_	VBP	41	_	_	_	_	_	_	_	O
8	been	_	be	_	VBN	41	_	_	_	_	_	_	_	O
9	calibrated	_	UNK	_	VBN	41	_	_	_	_	_	_	_	O
10	according	_	accord	_	VBG	41	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	41	_	_	_	_	_	_	_	O

1	use	_	UNK	_	NNP	41	_	_	_	_	_	_	_	B-Obligation
2	methods	_	method	_	NNS	41	_	_	_	_	_	_	_	I-Obligation
3	to	_	to	_	TO	41	_	_	_	_	_	_	_	I-Obligation
4	measure	_	measure	_	VB	41	_	_	_	_	_	_	_	I-Obligation
5	hba1c	_	UNK	_	NNP	41	_	_	_	_	_	_	_	I-Obligation
6	that	_	that	_	WDT	41	_	_	_	_	_	_	_	S-Party_1
7	have	_	have	_	VBP	41	_	_	_	_	_	_	_	O
8	been	_	be	_	VBN	41	_	_	_	_	_	_	_	O
9	calibrated	_	UNK	_	VBN	41	_	_	_	_	_	_	_	O
10	according	_	accord	_	VBG	41	_	_	_	_	_	accord.v	Be_in_agreement_on_action	O
11	to	_	to	_	TO	41	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	42	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	42	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	42	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	42	_	_	_	_	_	_	_	O
6	:	_	:	_	:	42	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	42	_	_	_	_	_	_	_	O
8	(	_	(	_	(	42	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
10	)	_	)	_	)	42	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	42	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	42	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
14	)	_	)	_	)	42	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	42	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	42	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	42	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	42	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	42	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	42	_	_	_	_	_	_	_	O
8	(	_	(	_	(	42	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
10	)	_	)	_	)	42	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	42	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	42	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
14	)	_	)	_	)	42	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
2	unexplained	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
3	discrepancies	_	UNK	_	NNS	43	_	_	_	_	_	_	_	O
4	between	_	between	_	IN	43	_	_	_	_	_	_	_	O
5	hba1c	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	43	_	_	_	_	_	_	_	O
7	other	_	other	_	JJ	43	_	_	_	_	_	other.a	Increment	O
8	glucose	_	UNK	_	NN	43	_	_	_	_	_	_	_	B-Class
9	measurements	_	measurement	_	NNS	43	_	_	_	_	_	_	_	I-Class

1	involve	_	UNK	_	NNP	44	_	_	_	_	_	_	_	S-Descriptor
2	adults	_	adult	_	NNS	44	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	44	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	44	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	44	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	44	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	44	_	_	_	_	_	_	_	O
8	decisions	_	decision	_	NNS	44	_	_	_	_	_	_	_	O
9	about	_	about	_	IN	44	_	_	_	_	_	_	_	O
10	their	_	their	_	PRP$	44	_	_	_	_	_	_	_	O
11	individual	_	individual	_	JJ	44	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	44	_	_	_	_	_	_	_	O
13	target	_	target	_	NN	44	_	_	_	_	_	_	_	O

1	involve	_	UNK	_	NNP	44	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	44	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	44	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	44	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	44	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	44	_	_	_	_	_	_	_	I-Category
7	in	_	in	_	IN	44	_	_	_	_	_	_	_	O
8	decisions	_	decision	_	NNS	44	_	_	_	_	_	_	_	O
9	about	_	about	_	IN	44	_	_	_	_	_	_	_	O
10	their	_	their	_	PRP$	44	_	_	_	_	_	_	_	O
11	individual	_	individual	_	JJ	44	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	44	_	_	_	_	_	_	_	O
13	target	_	target	_	NN	44	_	_	_	_	_	_	_	O

1	involve	_	UNK	_	NNP	44	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	44	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	44	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	44	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	44	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	44	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	44	_	_	_	_	_	_	_	O
8	decisions	_	decision	_	NNS	44	_	_	_	_	_	decision.n	Deciding	O
9	about	_	about	_	IN	44	_	_	_	_	_	_	_	O
10	their	_	their	_	PRP$	44	_	_	_	_	_	_	_	O
11	individual	_	individual	_	JJ	44	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	44	_	_	_	_	_	_	_	O
13	target	_	target	_	NN	44	_	_	_	_	_	_	_	O

1	involve	_	UNK	_	NNP	44	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	44	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	44	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	44	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	44	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	44	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	44	_	_	_	_	_	_	_	O
8	decisions	_	decision	_	NNS	44	_	_	_	_	_	_	_	O
9	about	_	about	_	IN	44	_	_	_	_	_	_	_	O
10	their	_	their	_	PRP$	44	_	_	_	_	_	_	_	O
11	individual	_	individual	_	JJ	44	_	_	_	_	_	individual.n	People	B-Person
12	hba1c	_	UNK	_	NNP	44	_	_	_	_	_	_	_	I-Person
13	target	_	target	_	NN	44	_	_	_	_	_	_	_	I-Person

1	offer	_	UNK	_	NN	45	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	45	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	45	_	_	_	_	_	_	_	S-Patient
6	treatment	_	treatment	_	NN	45	_	_	_	_	_	treatment.n	Cure	O
7	to	_	to	_	TO	45	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	45	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	45	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	45	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	45	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	45	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	45	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	45	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	45	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	45	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	45	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
20	target	_	target	_	NN	45	_	_	_	_	_	_	_	O
21	(	_	(	_	(	45	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	45	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	45	_	_	_	_	_	_	_	O
24	)	_	)	_	)	45	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	45	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	45	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	45	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	45	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	45	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	45	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	45	_	_	_	_	_	adult.n	People_by_age	S-Person
10	with	_	with	_	IN	45	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	45	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	45	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	45	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	45	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	45	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	45	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	45	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
20	target	_	target	_	NN	45	_	_	_	_	_	_	_	O
21	(	_	(	_	(	45	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	45	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	45	_	_	_	_	_	_	_	O
24	)	_	)	_	)	45	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	45	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	45	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	45	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	45	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	45	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	45	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	45	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	45	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	45	_	_	_	_	_	type.n	Type	S-Subtype
12	2	_	2	_	CD	45	_	_	_	_	_	_	_	B-Category
13	diabetes	_	UNK	_	NNS	45	_	_	_	_	_	_	_	I-Category
14	to	_	to	_	TO	45	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	45	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	45	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	45	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
20	target	_	target	_	NN	45	_	_	_	_	_	_	_	O
21	(	_	(	_	(	45	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	45	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	45	_	_	_	_	_	_	_	O
24	)	_	)	_	)	45	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	45	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	45	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	45	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	45	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	45	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	45	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	45	_	_	_	_	_	_	_	B-Agent
10	with	_	with	_	IN	45	_	_	_	_	_	_	_	I-Agent
11	type	_	type	_	JJ	45	_	_	_	_	_	_	_	I-Agent
12	2	_	2	_	CD	45	_	_	_	_	_	_	_	I-Agent
13	diabetes	_	UNK	_	NNS	45	_	_	_	_	_	_	_	I-Agent
14	to	_	to	_	TO	45	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	45	_	_	_	_	_	achieve.v	Accomplishment	O
16	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	45	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	45	_	_	_	_	_	_	_	B-Goal
19	hba1c	_	UNK	_	NNP	45	_	_	_	_	_	_	_	I-Goal
20	target	_	target	_	NN	45	_	_	_	_	_	_	_	I-Goal
21	(	_	(	_	(	45	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	45	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	45	_	_	_	_	_	_	_	O
24	)	_	)	_	)	45	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	45	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	45	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	45	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	45	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	45	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	45	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	45	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	45	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	45	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	45	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	45	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	45	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	45	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	45	_	_	_	_	_	maintain.v	Activity_ongoing	O
18	their	_	their	_	PRP$	45	_	_	_	_	_	_	_	B-Activity
19	hba1c	_	UNK	_	NNP	45	_	_	_	_	_	_	_	I-Activity
20	target	_	target	_	NN	45	_	_	_	_	_	_	_	I-Activity
21	(	_	(	_	(	45	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	45	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	45	_	_	_	_	_	_	_	O
24	)	_	)	_	)	45	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	45	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	45	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	45	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	45	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	45	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	45	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	45	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	45	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	45	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	45	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	45	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	45	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	45	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	45	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	45	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
20	target	_	target	_	NN	45	_	_	_	_	_	_	_	O
21	(	_	(	_	(	45	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	45	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	45	_	_	_	_	_	section.n	Part_whole	S-Part
24	)	_	)	_	)	45	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	46	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	46	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	46	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	46	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	46	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	46	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	46	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
13	,	_	,	_	,	46	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	46	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	46	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	46	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	46	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	46	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	46	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	46	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	46	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	46	_	_	_	_	_	_	_	O
28	,	_	,	_	,	46	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	46	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	46	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	46	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	46	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	46	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	46	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	46	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	46	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	46	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	46	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
41	(	_	(	_	(	46	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	46	_	_	_	_	_	_	_	O
43	)	_	)	_	)	46	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	46	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	46	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	46	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	46	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	46	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	46	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	46	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
13	,	_	,	_	,	46	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	46	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	46	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	46	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	46	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	46	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	46	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	46	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	46	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	46	_	_	_	_	_	_	_	O
28	,	_	,	_	,	46	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	46	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	46	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	46	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	46	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	46	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	46	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	46	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	46	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	46	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	46	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
41	(	_	(	_	(	46	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	46	_	_	_	_	_	_	_	O
43	)	_	)	_	)	46	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	46	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	46	_	_	_	_	_	_	_	B-Agent
3	with	_	with	_	IN	46	_	_	_	_	_	_	_	I-Agent
4	type	_	type	_	JJ	46	_	_	_	_	_	_	_	I-Agent
5	2	_	2	_	CD	46	_	_	_	_	_	_	_	I-Agent
6	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	I-Agent
7	managed	_	manage	_	VBD	46	_	_	_	_	_	manage.v	Success_or_failure	O
8	either	_	either	_	RB	46	_	_	_	_	_	_	_	B-Goal
9	by	_	by	_	IN	46	_	_	_	_	_	_	_	I-Goal
10	lifestyle	_	lifestyle	_	NN	46	_	_	_	_	_	_	_	I-Goal
11	and	_	and	_	CC	46	_	_	_	_	_	_	_	I-Goal
12	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	I-Goal
13	,	_	,	_	,	46	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	46	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	46	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	46	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	46	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	46	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	46	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	46	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	46	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	46	_	_	_	_	_	_	_	O
28	,	_	,	_	,	46	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	46	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	46	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	46	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	46	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	46	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	46	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	46	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	46	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	46	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	46	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
41	(	_	(	_	(	46	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	46	_	_	_	_	_	_	_	O
43	)	_	)	_	)	46	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	46	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	46	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	46	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	46	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	46	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	46	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	46	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
13	,	_	,	_	,	46	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	46	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	46	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	S-Part_1
19	combined	_	combine	_	VBN	46	_	_	_	_	_	combine.v	Cause_to_amalgamate	O
20	with	_	with	_	IN	46	_	_	_	_	_	_	_	B-Part_2
21	a	_	a	_	DT	46	_	_	_	_	_	_	_	I-Part_2
22	single	_	single	_	JJ	46	_	_	_	_	_	_	_	I-Part_2
23	drug	_	drug	_	NN	46	_	_	_	_	_	_	_	I-Part_2
24	not	_	not	_	RB	46	_	_	_	_	_	_	_	I-Part_2
25	associated	_	associate	_	VBN	46	_	_	_	_	_	_	_	I-Part_2
26	with	_	with	_	IN	46	_	_	_	_	_	_	_	I-Part_2
27	unk	_	UNK	_	NN	46	_	_	_	_	_	_	_	I-Part_2
28	,	_	,	_	,	46	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	46	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	46	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	46	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	46	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	46	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	46	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	46	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	46	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	46	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	46	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
41	(	_	(	_	(	46	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	46	_	_	_	_	_	_	_	O
43	)	_	)	_	)	46	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	46	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	46	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	46	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	46	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	46	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	46	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	46	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
13	,	_	,	_	,	46	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	46	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	46	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	46	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	46	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	46	_	_	_	_	_	single.a	Sole_instance	O
23	drug	_	drug	_	NN	46	_	_	_	_	_	_	_	S-Type
24	not	_	not	_	RB	46	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	46	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	46	_	_	_	_	_	_	_	O
28	,	_	,	_	,	46	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	46	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	46	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	46	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	46	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	46	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	46	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	46	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	46	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	46	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	46	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
41	(	_	(	_	(	46	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	46	_	_	_	_	_	_	_	O
43	)	_	)	_	)	46	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	46	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	46	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	46	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	46	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	46	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	46	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	46	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
13	,	_	,	_	,	46	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	46	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	46	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	46	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	46	_	_	_	_	_	_	_	B-Partner_1
22	single	_	single	_	JJ	46	_	_	_	_	_	_	_	I-Partner_1
23	drug	_	drug	_	NN	46	_	_	_	_	_	_	_	I-Partner_1
24	not	_	not	_	RB	46	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	46	_	_	_	_	_	associate.v	Collaboration	O
26	with	_	with	_	IN	46	_	_	_	_	_	_	_	B-Undertaking
27	unk	_	UNK	_	NN	46	_	_	_	_	_	_	_	I-Undertaking
28	,	_	,	_	,	46	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	46	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	46	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	46	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	46	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	46	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	46	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	46	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	46	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	46	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	46	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
41	(	_	(	_	(	46	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	46	_	_	_	_	_	_	_	O
43	)	_	)	_	)	46	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	46	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	46	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	46	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	46	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	46	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	46	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	46	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
13	,	_	,	_	,	46	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	46	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	46	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	46	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	46	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	46	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	46	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	46	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	46	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	46	_	_	_	_	_	_	_	O
28	,	_	,	_	,	46	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	46	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	46	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	46	_	_	_	_	_	person.n	People	S-Person
32	to	_	to	_	TO	46	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	46	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	46	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	46	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	46	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	46	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	46	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
41	(	_	(	_	(	46	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	46	_	_	_	_	_	_	_	O
43	)	_	)	_	)	46	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	46	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	46	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	46	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	46	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	46	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	46	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	46	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
13	,	_	,	_	,	46	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	46	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	46	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	46	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	46	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	46	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	46	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	46	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	46	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	46	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	46	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	46	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	46	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	46	_	_	_	_	_	_	_	O
28	,	_	,	_	,	46	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	46	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	46	_	_	_	_	_	_	_	B-Agent
31	person	_	person	_	NN	46	_	_	_	_	_	_	_	I-Agent
32	to	_	to	_	TO	46	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	46	_	_	_	_	_	aim.v	Purpose	O
34	for	_	for	_	IN	46	_	_	_	_	_	_	_	B-Goal
35	an	_	an	_	DT	46	_	_	_	_	_	_	_	I-Goal
36	hba1c	_	UNK	_	NNP	46	_	_	_	_	_	_	_	I-Goal
37	level	_	level	_	NN	46	_	_	_	_	_	_	_	I-Goal
38	of	_	of	_	IN	46	_	_	_	_	_	_	_	I-Goal
39	48	_	48	_	CD	46	_	_	_	_	_	_	_	I-Goal
40	unk	_	UNK	_	NNS	46	_	_	_	_	_	_	_	I-Goal
41	(	_	(	_	(	46	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	46	_	_	_	_	_	_	_	O
43	)	_	)	_	)	46	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	47	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	47	_	_	_	_	_	adult.n	People_by_age	S-Person
3	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	47	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
6	associated	_	associate	_	VBN	47	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	47	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
9	,	_	,	_	,	47	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	47	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	47	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
14	aim	_	aim	_	VB	47	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	47	_	_	_	_	_	_	_	O
16	an	_	an	_	DT	47	_	_	_	_	_	_	_	O
17	hba1c	_	UNK	_	NNP	47	_	_	_	_	_	_	_	O
18	level	_	level	_	NN	47	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	47	_	_	_	_	_	_	_	O
20	53	_	53	_	CD	47	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	NNS	47	_	_	_	_	_	_	_	O
22	(	_	(	_	(	47	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	47	_	_	_	_	_	_	_	O
24	)	_	)	_	)	47	_	_	_	_	_	_	_	O
25	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	47	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	47	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	47	_	_	_	_	_	_	_	B-Partner_1
5	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	I-Partner_1
6	associated	_	associate	_	VBN	47	_	_	_	_	_	associate.v	Collaboration	O
7	with	_	with	_	IN	47	_	_	_	_	_	_	_	B-Undertaking
8	unk	_	UNK	_	NN	47	_	_	_	_	_	_	_	I-Undertaking
9	,	_	,	_	,	47	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	47	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	47	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
14	aim	_	aim	_	VB	47	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	47	_	_	_	_	_	_	_	O
16	an	_	an	_	DT	47	_	_	_	_	_	_	_	O
17	hba1c	_	UNK	_	NNP	47	_	_	_	_	_	_	_	O
18	level	_	level	_	NN	47	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	47	_	_	_	_	_	_	_	O
20	53	_	53	_	CD	47	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	NNS	47	_	_	_	_	_	_	_	O
22	(	_	(	_	(	47	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	47	_	_	_	_	_	_	_	O
24	)	_	)	_	)	47	_	_	_	_	_	_	_	O
25	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	47	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	47	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	47	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
6	associated	_	associate	_	VBN	47	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	47	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
9	,	_	,	_	,	47	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	47	_	_	_	_	_	support.v	Supporting	O
11	the	_	the	_	DT	47	_	_	_	_	_	_	_	B-Supported
12	person	_	person	_	NN	47	_	_	_	_	_	_	_	I-Supported
13	to	_	to	_	TO	47	_	_	_	_	_	_	_	I-Supported
14	aim	_	aim	_	VB	47	_	_	_	_	_	_	_	I-Supported
15	for	_	for	_	IN	47	_	_	_	_	_	_	_	I-Supported
16	an	_	an	_	DT	47	_	_	_	_	_	_	_	I-Supported
17	hba1c	_	UNK	_	NNP	47	_	_	_	_	_	_	_	I-Supported
18	level	_	level	_	NN	47	_	_	_	_	_	_	_	I-Supported
19	of	_	of	_	IN	47	_	_	_	_	_	_	_	I-Supported
20	53	_	53	_	CD	47	_	_	_	_	_	_	_	I-Supported
21	unk	_	UNK	_	NNS	47	_	_	_	_	_	_	_	I-Supported
22	(	_	(	_	(	47	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	47	_	_	_	_	_	_	_	O
24	)	_	)	_	)	47	_	_	_	_	_	_	_	O
25	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	47	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	47	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	47	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
6	associated	_	associate	_	VBN	47	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	47	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
9	,	_	,	_	,	47	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	47	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	47	_	_	_	_	_	person.n	People	S-Person
13	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
14	aim	_	aim	_	VB	47	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	47	_	_	_	_	_	_	_	O
16	an	_	an	_	DT	47	_	_	_	_	_	_	_	O
17	hba1c	_	UNK	_	NNP	47	_	_	_	_	_	_	_	O
18	level	_	level	_	NN	47	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	47	_	_	_	_	_	_	_	O
20	53	_	53	_	CD	47	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	NNS	47	_	_	_	_	_	_	_	O
22	(	_	(	_	(	47	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	47	_	_	_	_	_	_	_	O
24	)	_	)	_	)	47	_	_	_	_	_	_	_	O
25	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	47	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	47	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	47	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
6	associated	_	associate	_	VBN	47	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	47	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
9	,	_	,	_	,	47	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	47	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	47	_	_	_	_	_	_	_	B-Agent
12	person	_	person	_	NN	47	_	_	_	_	_	_	_	I-Agent
13	to	_	to	_	TO	47	_	_	_	_	_	_	_	O
14	aim	_	aim	_	VB	47	_	_	_	_	_	aim.v	Purpose	O
15	for	_	for	_	IN	47	_	_	_	_	_	_	_	B-Goal
16	an	_	an	_	DT	47	_	_	_	_	_	_	_	I-Goal
17	hba1c	_	UNK	_	NNP	47	_	_	_	_	_	_	_	I-Goal
18	level	_	level	_	NN	47	_	_	_	_	_	_	_	I-Goal
19	of	_	of	_	IN	47	_	_	_	_	_	_	_	I-Goal
20	53	_	53	_	CD	47	_	_	_	_	_	_	_	I-Goal
21	unk	_	UNK	_	NNS	47	_	_	_	_	_	_	_	I-Goal
22	(	_	(	_	(	47	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	47	_	_	_	_	_	_	_	O
24	)	_	)	_	)	47	_	_	_	_	_	_	_	O
25	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	,	_	,	_	,	48	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	48	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	48	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	48	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	48	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	48	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	48	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
24	(	_	(	_	(	48	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
26	)	_	)	_	)	48	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	48	_	_	_	_	_	_	_	O
29	:	_	:	_	:	48	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	48	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	48	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	48	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
34	,	_	,	_	,	48	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	48	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
54	(	_	(	_	(	48	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
56	)	_	)	_	)	48	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	48	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
61	.	_	.	_	.	48	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	48	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	48	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	48	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	48	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	48	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	48	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	48	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
24	(	_	(	_	(	48	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
26	)	_	)	_	)	48	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	48	_	_	_	_	_	_	_	O
29	:	_	:	_	:	48	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	48	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	48	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	48	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
34	,	_	,	_	,	48	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	48	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
54	(	_	(	_	(	48	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
56	)	_	)	_	)	48	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	48	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
61	.	_	.	_	.	48	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	,	_	,	_	,	48	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	48	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	S-Rank
10	levels	_	level	_	NNS	48	_	_	_	_	_	level.n	Rank	O
11	are	_	be	_	VBP	48	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	48	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	48	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	48	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
24	(	_	(	_	(	48	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
26	)	_	)	_	)	48	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	48	_	_	_	_	_	_	_	O
29	:	_	:	_	:	48	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	48	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	48	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	48	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
34	,	_	,	_	,	48	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	48	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
54	(	_	(	_	(	48	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
56	)	_	)	_	)	48	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	48	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
61	.	_	.	_	.	48	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	,	_	,	_	,	48	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	48	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	48	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	48	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	48	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	48	_	_	_	_	_	single.a	Sole_instance	O
18	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	S-Type
19	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	48	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	48	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
24	(	_	(	_	(	48	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
26	)	_	)	_	)	48	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	48	_	_	_	_	_	_	_	O
29	:	_	:	_	:	48	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	48	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	48	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	48	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
34	,	_	,	_	,	48	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	48	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
54	(	_	(	_	(	48	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
56	)	_	)	_	)	48	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	48	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
61	.	_	.	_	.	48	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	,	_	,	_	,	48	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	48	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	48	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	48	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	48	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	48	_	_	_	_	_	rise.n	Change_position_on_a_scale	O
21	to	_	to	_	TO	48	_	_	_	_	_	_	_	B-Item
22	58	_	UNK	_	CD	48	_	_	_	_	_	_	_	I-Item
23	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	I-Item
24	(	_	(	_	(	48	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
26	)	_	)	_	)	48	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	48	_	_	_	_	_	_	_	O
29	:	_	:	_	:	48	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	48	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	48	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	48	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
34	,	_	,	_	,	48	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	48	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
54	(	_	(	_	(	48	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
56	)	_	)	_	)	48	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	48	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
61	.	_	.	_	.	48	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	,	_	,	_	,	48	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	48	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	48	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	48	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	48	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	48	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	48	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
24	(	_	(	_	(	48	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
26	)	_	)	_	)	48	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	48	_	_	_	_	_	_	_	O
29	:	_	:	_	:	48	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	48	_	_	_	_	_	reinforce.v	Cause_change_of_strength	O
31	advice	_	advice	_	NN	48	_	_	_	_	_	_	_	S-Patient
32	about	_	about	_	IN	48	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
34	,	_	,	_	,	48	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	48	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
54	(	_	(	_	(	48	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
56	)	_	)	_	)	48	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	48	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
61	.	_	.	_	.	48	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	,	_	,	_	,	48	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	48	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	48	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	48	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	48	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	48	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	48	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
24	(	_	(	_	(	48	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
26	)	_	)	_	)	48	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	48	_	_	_	_	_	_	_	O
29	:	_	:	_	:	48	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	48	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	48	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	48	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
34	,	_	,	_	,	48	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	S-Patient
40	treatment	_	treatment	_	NN	48	_	_	_	_	_	treatment.n	Cure	O
41	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	48	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
54	(	_	(	_	(	48	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
56	)	_	)	_	)	48	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	48	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
61	.	_	.	_	.	48	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	,	_	,	_	,	48	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	48	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	48	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	48	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	48	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	48	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	48	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
24	(	_	(	_	(	48	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
26	)	_	)	_	)	48	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	48	_	_	_	_	_	_	_	O
29	:	_	:	_	:	48	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	48	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	48	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	48	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
34	,	_	,	_	,	48	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	48	_	_	_	_	_	person.n	People	S-Person
45	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	48	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
54	(	_	(	_	(	48	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
56	)	_	)	_	)	48	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	48	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
61	.	_	.	_	.	48	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	,	_	,	_	,	48	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	48	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	48	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	48	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	48	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	48	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	48	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
24	(	_	(	_	(	48	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
26	)	_	)	_	)	48	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	48	_	_	_	_	_	_	_	O
29	:	_	:	_	:	48	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	48	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	48	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	48	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
34	,	_	,	_	,	48	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	48	_	_	_	_	_	_	_	B-Agent
44	person	_	person	_	NN	48	_	_	_	_	_	_	_	I-Agent
45	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	48	_	_	_	_	_	aim.v	Purpose	O
47	for	_	for	_	IN	48	_	_	_	_	_	_	_	B-Goal
48	an	_	an	_	DT	48	_	_	_	_	_	_	_	I-Goal
49	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	I-Goal
50	level	_	level	_	NN	48	_	_	_	_	_	_	_	I-Goal
51	of	_	of	_	IN	48	_	_	_	_	_	_	_	I-Goal
52	53	_	53	_	CD	48	_	_	_	_	_	_	_	I-Goal
53	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	I-Goal
54	(	_	(	_	(	48	_	_	_	_	_	_	_	I-Goal
55	%	_	%	_	NN	48	_	_	_	_	_	_	_	I-Goal
56	)	_	)	_	)	48	_	_	_	_	_	_	_	I-Goal
57	and	_	and	_	CC	48	_	_	_	_	_	_	_	I-Goal
58	intensify	_	intensify	_	JJ	48	_	_	_	_	_	_	_	I-Goal
59	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	I-Goal
60	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	I-Goal
61	.	_	.	_	.	48	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	48	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	48	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	48	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	48	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	48	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
7	,	_	,	_	,	48	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	48	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	48	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	48	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	48	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	48	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	48	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	48	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	48	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	48	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	48	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	48	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
24	(	_	(	_	(	48	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
26	)	_	)	_	)	48	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	48	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	48	_	_	_	_	_	_	_	O
29	:	_	:	_	:	48	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	48	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	48	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	48	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	48	_	_	_	_	_	_	_	O
34	,	_	,	_	,	48	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	48	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	48	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	48	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	48	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	48	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	48	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	48	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	48	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	48	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	48	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	48	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	48	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	48	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	48	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	48	_	_	_	_	_	_	_	O
54	(	_	(	_	(	48	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	48	_	_	_	_	_	_	_	O
56	)	_	)	_	)	48	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	48	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	48	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	48	_	_	_	_	_	_	_	S-Patient
60	treatment	_	treatment	_	NN	48	_	_	_	_	_	treatment.n	Cure	O
61	.	_	.	_	.	48	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	50	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	50	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	50	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	50	_	_	_	_	_	_	_	O
6	:	_	:	_	:	50	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	50	_	_	_	_	_	_	_	O
8	(	_	(	_	(	50	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
10	)	_	)	_	)	50	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	50	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	50	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
14	)	_	)	_	)	50	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	50	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	50	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	50	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	50	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	50	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	50	_	_	_	_	_	_	_	O
8	(	_	(	_	(	50	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	50	_	_	_	_	_	_	_	O
10	)	_	)	_	)	50	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	50	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	50	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	50	_	_	_	_	_	_	_	O
14	)	_	)	_	)	50	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	particular.a	Idiosyncrasy	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	B-Idiosyncrasy
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	I-Idiosyncrasy
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	I-Idiosyncrasy
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	I-Idiosyncrasy
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	I-Idiosyncrasy
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	I-Idiosyncrasy
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	I-Idiosyncrasy
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	I-Idiosyncrasy
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	consideration.n	Cogitation	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	B-Topic
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	I-Topic
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	I-Topic
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	I-Topic
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	I-Topic
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	I-Topic
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	I-Topic
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	people.n	People	S-Person
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	S-Resisting_entity
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	frail.a	Level_of_force_resistance	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	adult.n	People_by_age	S-Person
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	type.n	Type	S-Subtype
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	B-Category
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	I-Category
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	S-Hypothetical_event
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	unlikely.a	Likelihood	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	B-Hypothetical_event
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	I-Hypothetical_event
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	I-Hypothetical_event
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	I-Hypothetical_event
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	I-Hypothetical_event
36	,	_	,	_	,	51	_	_	_	_	_	_	_	I-Hypothetical_event
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	I-Hypothetical_event
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	I-Hypothetical_event
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	S-Agent
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	achieve.v	Accomplishment	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	B-Goal
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	I-Goal
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	I-Goal
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	example.n	Instance	S-Instance
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	people.n	People	S-Person
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	B-Simulated_entity
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	I-Simulated_entity
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	I-Simulated_entity
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	pose.v	Posing_as	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	B-Simulated_entity
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	I-Simulated_entity
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	I-Simulated_entity
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	I-Simulated_entity
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	I-Simulated_entity
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	I-Simulated_entity
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	I-Simulated_entity
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	I-Simulated_entity
61	,	_	,	_	,	51	_	_	_	_	_	_	_	I-Simulated_entity
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	I-Simulated_entity
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	I-Simulated_entity
64	,	_	,	_	,	51	_	_	_	_	_	_	_	I-Simulated_entity
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	I-Simulated_entity
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	I-Simulated_entity
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	I-Simulated_entity
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	I-Simulated_entity
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	I-Simulated_entity
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	I-Simulated_entity
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	I-Simulated_entity
72	,	_	,	_	,	51	_	_	_	_	_	_	_	I-Simulated_entity
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	high.a	Position_on_a_scale	S-Value
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	S-Item
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	S-Bad_outcome
55	risk	_	risk	_	NN	51	_	_	_	_	_	risk.n	Run_risk	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	B-Action
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	I-Action
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	I-Action
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	I-Action
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	I-Action
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	example.n	Instance	S-Instance
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	people.n	People	S-Person
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	B-Figure
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	I-Figure
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	at.prep	Locative_relation	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	B-Ground
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	I-Ground
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	I-Ground
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	B-Protagonist
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	I-Protagonist
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	risk.n	Run_risk	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	B-Asset
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	I-Asset
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	people.n	People	S-Person
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	people.n	People	S-Person
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	B-Agent
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	I-Agent
84	drive	_	drive	_	VBP	51	_	_	_	_	_	drive.v	Subjective_influence	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	B-Operator
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	I-Operator
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	operate.v	Operating_a_system	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	S-System
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	part.n	Part_whole	S-Part
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	B-Whole
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	I-Whole
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	I-Whole
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	S-Employee
92	job	_	job	_	NN	51	_	_	_	_	_	job.n	Being_employed	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	B-Evaluee
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	I-Evaluee
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	appropriate.a	Suitability	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	example.n	Instance	S-Instance
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	people.n	People	S-Person
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	B-Origin
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	I-Origin
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	I-Origin
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	significant.a	Importance	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	S-Factor
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	adult.n	People_by_age	S-Person
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	type.n	Type	S-Subtype
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	B-Category
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	I-Category
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	B-Agent
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	I-Agent
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	I-Agent
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	I-Agent
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	I-Agent
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	achieve.v	Accomplishment	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	B-Goal
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	I-Goal
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	I-Goal
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	I-Goal
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	I-Goal
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	I-Goal
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	I-Goal
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	I-Goal
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	I-Goal
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	I-Goal
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	I-Goal
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	I-Goal
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	I-Goal
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	I-Goal
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	I-Goal
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	S-Item
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	lower.v	Change_position_on_a_scale	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	B-Attribute
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	I-Attribute
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	I-Attribute
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	S-Experiencer
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	experience.v	Feeling	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	S-Emotional_state
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	O
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	S-Agent
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	encourage.v	Subjective_influence	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	S-Situation
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	_	_	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	51	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	51	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	51	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	51	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	51	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	51	_	_	_	_	_	_	_	O
9	,	_	,	_	,	51	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	51	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	51	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	51	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	51	_	_	_	_	_	_	_	O
20	,	_	,	_	,	51	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
27	:	_	:	_	:	51	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	51	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	51	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	51	_	_	_	_	_	_	_	O
36	,	_	,	_	,	51	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
39	,	_	,	_	,	51	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	51	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	51	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	51	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	51	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	51	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	51	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	51	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	51	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
61	,	_	,	_	,	51	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
64	,	_	,	_	,	51	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	51	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	51	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	51	_	_	_	_	_	_	_	O
72	,	_	,	_	,	51	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	51	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	51	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
80	,	_	,	_	,	51	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	51	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	51	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	51	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	51	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	51	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	51	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	51	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	51	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	51	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	51	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	51	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	51	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	51	_	_	_	_	_	_	_	O
101	,	_	,	_	,	51	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	51	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	51	_	_	_	_	_	_	_	O
104	,	_	,	_	,	51	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	51	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	51	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
109	.	_	.	_	.	51	_	_	_	_	_	_	_	O
110	0	_	0	_	CD	51	_	_	_	_	_	_	_	O
111	if	_	If	_	IN	51	_	_	_	_	_	_	_	O
112	adults	_	adult	_	NNS	51	_	_	_	_	_	_	_	O
113	with	_	with	_	IN	51	_	_	_	_	_	_	_	O
114	type	_	type	_	JJ	51	_	_	_	_	_	_	_	O
115	2	_	2	_	CD	51	_	_	_	_	_	_	_	O
116	diabetes	_	UNK	_	NNS	51	_	_	_	_	_	_	_	O
117	achieve	_	achieve	_	VBP	51	_	_	_	_	_	_	_	O
118	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
119	hba1c	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
120	level	_	level	_	NN	51	_	_	_	_	_	_	_	O
121	that	_	that	_	WDT	51	_	_	_	_	_	_	_	O
122	is	_	be	_	VBZ	51	_	_	_	_	_	_	_	O
123	lower	_	lower	_	JJR	51	_	_	_	_	_	_	_	O
124	than	_	than	_	IN	51	_	_	_	_	_	_	_	O
125	their	_	their	_	PRP$	51	_	_	_	_	_	_	_	O
126	target	_	target	_	NN	51	_	_	_	_	_	_	_	O
127	and	_	and	_	CC	51	_	_	_	_	_	_	_	O
128	they	_	they	_	PRP	51	_	_	_	_	_	_	_	O
129	are	_	be	_	VBP	51	_	_	_	_	_	_	_	O
130	not	_	not	_	RB	51	_	_	_	_	_	_	_	O
131	experiencing	_	experience	_	VBG	51	_	_	_	_	_	_	_	O
132	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
133	,	_	,	_	,	51	_	_	_	_	_	_	_	O
134	encourage	_	encourage	_	VB	51	_	_	_	_	_	_	_	O
135	them	_	them	_	PRP	51	_	_	_	_	_	_	_	S-Agent
136	to	_	to	_	TO	51	_	_	_	_	_	_	_	O
137	maintain	_	maintain	_	VB	51	_	_	_	_	_	maintain.v	Activity_ongoing	O
138	it	_	it	_	PRP	51	_	_	_	_	_	_	_	S-Activity

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	aware.a	Awareness	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	B-Content
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	I-Content
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	I-Content
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	I-Content
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	I-Content
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	I-Content
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	I-Content
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	I-Content
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	I-Content
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	I-Content
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	I-Content
14	,	_	,	_	,	52	_	_	_	_	_	_	_	I-Content
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	I-Content
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	I-Content
17	,	_	,	_	,	52	_	_	_	_	_	_	_	I-Content
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	I-Content
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	I-Content
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	I-Content
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	I-Content
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	I-Content
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	O
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	there.adv	Locative_relation	S-Ground
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	O
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	O
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	O
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	other.a	Increment	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	B-Class
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	I-Class
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	O
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	O
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	O
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	possible.a	Likelihood	O
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	S-Hypothetical_event
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	O
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	O
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	O
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	reason.n	Reason	O
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	O
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	O
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	O
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	low.a	Position_on_a_scale	S-Value
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	B-Item
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	I-Item
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	O
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	O
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	O
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	example.n	Instance	S-Instance
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	O
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	O
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	O
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	deteriorate.v	Improvement_or_decline	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	B-Entity
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	I-Entity
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	I-Entity
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	I-Entity
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	I-Entity
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	I-Entity
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	O
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	O
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	O
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	B-Determinant
20	function	_	function	_	NN	52	_	_	_	_	_	function.n	Contingency	I-Determinant
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	O
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	O
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	O
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	52	_	_	_	_	_	weight.n	Dimension	S-Dimension
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	O
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	O
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	O
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	woman.n	People	S-Person
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	O
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	O
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	O
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	type.n	Type	S-Subtype
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	O
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	O
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	O
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	S-Agent
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	plan.v	Making_arrangements	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	B-Event
44	become	_	become	_	VB	52	_	_	_	_	_	_	_	I-Event
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	I-Event
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	52	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	52	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	52	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	52	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	52	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	52	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	52	_	_	_	_	_	_	_	O
14	,	_	,	_	,	52	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	52	_	_	_	_	_	_	_	O
17	,	_	,	_	,	52	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	52	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	52	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	52	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	52	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	52	_	_	_	_	_	_	_	O
25	.	_	.	_	.	52	_	_	_	_	_	_	_	O
26	1	_	1	_	CD	52	_	_	_	_	_	_	_	O
27	for	_	For	_	IN	52	_	_	_	_	_	_	_	O
28	guidance	_	guidance	_	NN	52	_	_	_	_	_	_	_	O
29	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
30	hba1c	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
31	targets	_	target	_	NNS	52	_	_	_	_	_	_	_	O
32	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
33	women	_	woman	_	NNS	52	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	52	_	_	_	_	_	_	_	O
35	type	_	type	_	JJ	52	_	_	_	_	_	_	_	O
36	2	_	2	_	CD	52	_	_	_	_	_	_	_	O
37	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
38	who	_	who	_	WP	52	_	_	_	_	_	_	_	S-Entity
39	are	_	be	_	VBP	52	_	_	_	_	_	_	_	O
40	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	52	_	_	_	_	_	_	_	O
42	planning	_	plan	_	VBG	52	_	_	_	_	_	_	_	O
43	to	_	to	_	TO	52	_	_	_	_	_	_	_	O
44	become	_	become	_	VB	52	_	_	_	_	_	become.v	Becoming	O
45	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	S-Final_category
46	,	_	,	_	,	52	_	_	_	_	_	_	_	O
47	see	_	see	_	VB	52	_	_	_	_	_	_	_	O
48	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
49	nice	_	UNK	_	NNP	52	_	_	_	_	_	_	_	O
50	guideline	_	guideline	_	NN	52	_	_	_	_	_	_	_	O
51	on	_	on	_	IN	52	_	_	_	_	_	_	_	O
52	diabetes	_	UNK	_	NNS	52	_	_	_	_	_	_	_	O
53	in	_	in	_	IN	52	_	_	_	_	_	_	_	O
54	pregnancy	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
55	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	vehicle.n	Vehicle	S-Vehicle
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	B-Figure
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	I-Figure
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	I-Figure
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	I-Figure
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	I-Figure
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	I-Figure
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	I-Figure
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	I-Figure
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	I-Figure
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	I-Figure
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	I-Figure
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	I-Figure
13	(	_	(	_	(	53	_	_	_	_	_	_	_	I-Figure
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	I-Figure
15	)	_	)	_	)	53	_	_	_	_	_	_	_	I-Figure
16	at	_	At	_	IN	53	_	_	_	_	_	at.prep	Locative_relation	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	B-Ground
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	I-Ground
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	I-Ground
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	glance.n	Perception_active	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	S-Phenomenon
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	current.a	Temporal_collocation	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	B-Driver
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	I-Driver
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	I-Driver
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	I-Driver
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	I-Driver
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	I-Driver
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	drive.v	Operate_vehicle	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	account.n	Text	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	offer.v	Offering	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	B-Theme
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	I-Theme
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	I-Theme
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	I-Theme
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	I-Theme
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	I-Theme
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	I-Theme
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	I-Theme
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	I-Theme
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	I-Theme
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	I-Theme
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	adult.n	People_by_age	S-Person
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	type.n	Type	S-Subtype
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	B-Category
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	I-Category
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	adult.n	People_by_age	S-Person
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	type.n	Type	S-Subtype
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	B-Category
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	I-Category
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	person.n	People	S-Person
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	there.adv	Locative_relation	S-Ground
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	evidence.n	Evidence	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	B-Proposition
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	I-Proposition
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	I-Proposition
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	I-Proposition
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	I-Proposition
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	I-Proposition
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	I-Proposition
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	I-Proposition
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	I-Proposition
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	I-Proposition
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	I-Proposition
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	I-Proposition
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	I-Proposition
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	I-Proposition
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	I-Proposition
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	I-Proposition
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	I-Proposition
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	I-Proposition
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	I-Proposition
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	I-Proposition
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	person.n	People	S-Person
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	B-Item
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	I-Item
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	I-Item
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	I-Item
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	S-Protagonist
86	risk	_	risk	_	NN	53	_	_	_	_	_	risk.n	Run_risk	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	B-Action
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	I-Action
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	O
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	drive.v	Operate_vehicle	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	_	_	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	S-Vehicle
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
6	take	_	UNK	_	VBP	53	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
8	driver	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	53	_	_	_	_	_	_	_	O
10	vehicle	_	Vehicle	_	NNP	53	_	_	_	_	_	_	_	O
11	licensing	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
12	agency	_	Agency	_	NNP	53	_	_	_	_	_	_	_	O
13	(	_	(	_	(	53	_	_	_	_	_	_	_	O
14	dvla	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
15	)	_	)	_	)	53	_	_	_	_	_	_	_	O
16	at	_	At	_	IN	53	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	53	_	_	_	_	_	_	_	O
18	glance	_	glance	_	NN	53	_	_	_	_	_	_	_	O
19	guide	_	guide	_	NN	53	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
22	current	_	current	_	JJ	53	_	_	_	_	_	_	_	O
23	medical	_	medical	_	JJ	53	_	_	_	_	_	_	_	O
24	standards	_	standard	_	NNS	53	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
26	fitness	_	fitness	_	NN	53	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
28	drive	_	drive	_	VB	53	_	_	_	_	_	_	_	O
29	into	_	into	_	IN	53	_	_	_	_	_	_	_	O
30	account	_	account	_	NN	53	_	_	_	_	_	_	_	O
31	when	_	when	_	WRB	53	_	_	_	_	_	_	_	O
32	offering	_	offer	_	VBG	53	_	_	_	_	_	_	_	O
33	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
35	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
36	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
37	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
38	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
44	.	_	.	_	.	53	_	_	_	_	_	_	_	O
45	3	_	3	_	CD	53	_	_	_	_	_	_	_	O
46	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
47	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
48	routinely	_	routinely	_	RB	53	_	_	_	_	_	_	_	O
49	offer	_	offer	_	VBP	53	_	_	_	_	_	_	_	O
50	self-monitoring	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
52	blood	_	blood	_	NN	53	_	_	_	_	_	_	_	O
53	glucose	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
54	levels	_	level	_	NNS	53	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	53	_	_	_	_	_	_	_	O
56	adults	_	adult	_	NNS	53	_	_	_	_	_	_	_	O
57	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
58	type	_	type	_	JJ	53	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	53	_	_	_	_	_	_	_	O
60	diabetes	_	UNK	_	NNS	53	_	_	_	_	_	_	_	O
61	unless	_	unless	_	IN	53	_	_	_	_	_	_	_	O
62	:	_	:	_	:	53	_	_	_	_	_	_	_	O
63	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
64	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
65	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
66	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
67	insulin	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
68	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
69	there	_	there	_	EX	53	_	_	_	_	_	_	_	O
70	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
71	evidence	_	evidence	_	NN	53	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
73	unk	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
74	episodes	_	episode	_	NNS	53	_	_	_	_	_	_	_	O
75	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	53	_	_	_	_	_	_	_	O
77	person	_	person	_	NN	53	_	_	_	_	_	_	_	O
78	is	_	be	_	VBZ	53	_	_	_	_	_	_	_	O
79	on	_	on	_	IN	53	_	_	_	_	_	_	_	O
80	oral	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
81	medication	_	medication	_	NN	53	_	_	_	_	_	_	_	O
82	that	_	that	_	WDT	53	_	_	_	_	_	_	_	O
83	may	_	may	_	MD	53	_	_	_	_	_	_	_	O
84	increase	_	increase	_	VB	53	_	_	_	_	_	_	_	O
85	their	_	their	_	PRP$	53	_	_	_	_	_	_	_	O
86	risk	_	risk	_	NN	53	_	_	_	_	_	_	_	O
87	of	_	of	_	IN	53	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
89	while	_	while	_	IN	53	_	_	_	_	_	_	_	O
90	driving	_	drive	_	VBG	53	_	_	_	_	_	_	_	O
91	or	_	or	_	CC	53	_	_	_	_	_	_	_	O
92	operating	_	operate	_	VBG	53	_	_	_	_	_	operate.v	Operating_a_system	O
93	machinery	_	machinery	_	NN	53	_	_	_	_	_	_	_	S-System
94	or	_	or	_	CC	53	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	54	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	54	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	54	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	54	_	_	_	_	_	_	_	O
6	:	_	:	_	:	54	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	54	_	_	_	_	_	_	_	O
8	(	_	(	_	(	54	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	54	_	_	_	_	_	_	_	O
10	)	_	)	_	)	54	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	54	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	54	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
14	)	_	)	_	)	54	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	54	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	54	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	54	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	54	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	54	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	54	_	_	_	_	_	_	_	O
8	(	_	(	_	(	54	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	54	_	_	_	_	_	_	_	O
10	)	_	)	_	)	54	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	54	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	54	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
14	)	_	)	_	)	54	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	55	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	55	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	55	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	55	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	55	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	55	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	55	_	_	_	_	_	_	_	O
8	pregnant	_	pregnant	_	JJ	55	_	_	_	_	_	_	_	O
9	,	_	,	_	,	55	_	_	_	_	_	_	_	O
10	or	_	or	_	CC	55	_	_	_	_	_	_	_	O
11	is	_	be	_	VBZ	55	_	_	_	_	_	_	_	O
12	planning	_	plan	_	VBG	55	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	55	_	_	_	_	_	_	_	O
14	become	_	become	_	VB	55	_	_	_	_	_	_	_	O
15	pregnant	_	pregnant	_	JJ	55	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	55	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	55	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	55	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	55	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	55	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	55	_	_	_	_	_	person.n	People	S-Person
7	is	_	be	_	VBZ	55	_	_	_	_	_	_	_	O
8	pregnant	_	pregnant	_	JJ	55	_	_	_	_	_	_	_	O
9	,	_	,	_	,	55	_	_	_	_	_	_	_	O
10	or	_	or	_	CC	55	_	_	_	_	_	_	_	O
11	is	_	be	_	VBZ	55	_	_	_	_	_	_	_	O
12	planning	_	plan	_	VBG	55	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	55	_	_	_	_	_	_	_	O
14	become	_	become	_	VB	55	_	_	_	_	_	_	_	O
15	pregnant	_	pregnant	_	JJ	55	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	55	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	55	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	55	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	55	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	55	_	_	_	_	_	_	_	B-Agent
6	person	_	person	_	NN	55	_	_	_	_	_	_	_	I-Agent
7	is	_	be	_	VBZ	55	_	_	_	_	_	_	_	O
8	pregnant	_	pregnant	_	JJ	55	_	_	_	_	_	_	_	O
9	,	_	,	_	,	55	_	_	_	_	_	_	_	O
10	or	_	or	_	CC	55	_	_	_	_	_	_	_	O
11	is	_	be	_	VBZ	55	_	_	_	_	_	_	_	O
12	planning	_	plan	_	VBG	55	_	_	_	_	_	plan.v	Purpose	O
13	to	_	to	_	TO	55	_	_	_	_	_	_	_	O
14	become	_	become	_	VB	55	_	_	_	_	_	_	_	O
15	pregnant	_	pregnant	_	JJ	55	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	55	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	55	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	55	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	55	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	55	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	55	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	55	_	_	_	_	_	_	_	O
8	pregnant	_	pregnant	_	JJ	55	_	_	_	_	_	_	_	O
9	,	_	,	_	,	55	_	_	_	_	_	_	_	O
10	or	_	or	_	CC	55	_	_	_	_	_	_	_	O
11	is	_	be	_	VBZ	55	_	_	_	_	_	_	_	O
12	planning	_	plan	_	VBG	55	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	55	_	_	_	_	_	_	_	O
14	become	_	become	_	VB	55	_	_	_	_	_	become.v	Becoming	O
15	pregnant	_	pregnant	_	JJ	55	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	information.n	Information	S-Information
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	O
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	adult.n	People_by_age	S-Person
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	O
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	type.n	Type	S-Subtype
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	B-Category
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	I-Category
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	O
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	B-Requirement
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	I-Requirement
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	necessary.a	Being_necessary	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	O
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	start.v	Process_start	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	B-Event
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	I-Event
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	I-Event
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	I-Event
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	I-Event
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	I-Event
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	I-Event
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	I-Event
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	I-Event
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	I-Event
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	I-Event
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	O
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	treatment.n	Cure	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	O
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	confirm.v	Evidence	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	B-Proposition
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	I-Proposition
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	O
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	suspected.a	Awareness_status	O
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	S-Content
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	O
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	aware.a	Awareness	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	B-Content
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	I-Content
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	I-Content
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	I-Content
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	I-Content
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	I-Content
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	I-Content
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	I-Content
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	I-Content
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	I-Content
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	I-Content
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	adult.n	People_by_age	S-Person
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	O
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
56	type	_	type	_	JJ	56	_	_	_	_	_	type.n	Type	S-Subtype
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	O
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	B-Factor
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	I-Factor
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	I-Factor
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	I-Factor
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	I-Factor
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	I-Factor
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	acute.a	Importance	O
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	B-Factor
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	I-Factor
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	S-Cause
63	illness	_	illness	_	NN	56	_	_	_	_	_	illness.n	Medical_conditions	S-Ailment
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	_	_	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	56	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	56	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	56	_	_	_	_	_	_	_	O
4	,	_	,	_	,	56	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	56	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	56	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	56	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	56	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
13	.	_	.	_	.	56	_	_	_	_	_	_	_	O
14	4	_	4	_	CD	56	_	_	_	_	_	_	_	O
15	consider	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
16	short-term	_	short-term	_	JJ	56	_	_	_	_	_	_	_	O
17	self-monitoring	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
19	blood	_	blood	_	NN	56	_	_	_	_	_	_	_	O
20	glucose	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
21	levels	_	level	_	NNS	56	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	56	_	_	_	_	_	_	_	O
23	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
25	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
26	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
27	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
28	(	_	(	_	(	56	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	56	_	_	_	_	_	_	_	O
30	review	_	review	_	VB	56	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	56	_	_	_	_	_	_	_	O
33	necessary	_	necessary	_	JJ	56	_	_	_	_	_	_	_	O
34	)	_	)	_	)	56	_	_	_	_	_	_	_	O
35	:	_	:	_	:	56	_	_	_	_	_	_	_	O
36	when	_	when	_	WRB	56	_	_	_	_	_	_	_	O
37	starting	_	start	_	VBG	56	_	_	_	_	_	_	_	O
38	treatment	_	treatment	_	NN	56	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
40	oral	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
42	intravenous	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
43	corticosteroids	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
44	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	56	_	_	_	_	_	_	_	O
46	confirm	_	confirm	_	VB	56	_	_	_	_	_	_	_	O
47	suspected	_	suspected	_	JJ	56	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
49	.	_	.	_	.	56	_	_	_	_	_	_	_	O
50	5	_	5	_	CD	56	_	_	_	_	_	_	_	O
51	be	_	UNK	_	NNP	56	_	_	_	_	_	_	_	O
52	aware	_	aware	_	JJ	56	_	_	_	_	_	_	_	O
53	that	_	that	_	IN	56	_	_	_	_	_	_	_	O
54	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
55	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
56	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
57	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
58	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
59	who	_	who	_	WP	56	_	_	_	_	_	_	_	O
60	have	_	have	_	VBP	56	_	_	_	_	_	_	_	O
61	acute	_	acute	_	VBN	56	_	_	_	_	_	_	_	B-Protagonist
62	unk	_	UNK	_	JJ	56	_	_	_	_	_	_	_	I-Protagonist
63	illness	_	illness	_	NN	56	_	_	_	_	_	_	_	I-Protagonist
64	are	_	be	_	VBP	56	_	_	_	_	_	_	_	O
65	at	_	at	_	IN	56	_	_	_	_	_	_	_	O
66	risk	_	risk	_	NN	56	_	_	_	_	_	risk.n	Run_risk	O
67	of	_	of	_	IN	56	_	_	_	_	_	_	_	O
68	worsening	_	UNK	_	VBG	56	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	NN	56	_	_	_	_	_	_	_	O

1	review	_	Review	_	NNP	57	_	_	_	_	_	_	_	S-Treatment
2	treatment	_	treatment	_	NN	57	_	_	_	_	_	treatment.n	Cure	O
3	as	_	a	_	IN	57	_	_	_	_	_	_	_	O
4	necessary	_	necessary	_	JJ	57	_	_	_	_	_	_	_	O
5	.	_	.	_	.	57	_	_	_	_	_	_	_	O
6	6	_	6	_	CD	57	_	_	_	_	_	_	_	O
7	if	_	If	_	IN	57	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	57	_	_	_	_	_	_	_	O
14	self-monitoring	_	UNK	_	VBG	57	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	57	_	_	_	_	_	_	_	O
16	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	O
17	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
18	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	O
19	,	_	,	_	,	57	_	_	_	_	_	_	_	O
20	carry	_	carry	_	VBP	57	_	_	_	_	_	_	_	O
21	out	_	out	_	RP	57	_	_	_	_	_	_	_	O
22	a	_	a	_	DT	57	_	_	_	_	_	_	_	O
23	structured	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
24	assessment	_	assessment	_	NN	57	_	_	_	_	_	_	_	O
25	at	_	at	_	IN	57	_	_	_	_	_	_	_	O
26	least	_	least	_	JJS	57	_	_	_	_	_	_	_	O
27	annually	_	annually	_	RB	57	_	_	_	_	_	_	_	O

1	review	_	Review	_	NNP	57	_	_	_	_	_	_	_	B-Requirement
2	treatment	_	treatment	_	NN	57	_	_	_	_	_	_	_	I-Requirement
3	as	_	a	_	IN	57	_	_	_	_	_	_	_	O
4	necessary	_	necessary	_	JJ	57	_	_	_	_	_	necessary.a	Being_necessary	O
5	.	_	.	_	.	57	_	_	_	_	_	_	_	O
6	6	_	6	_	CD	57	_	_	_	_	_	_	_	O
7	if	_	If	_	IN	57	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	57	_	_	_	_	_	_	_	O
14	self-monitoring	_	UNK	_	VBG	57	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	57	_	_	_	_	_	_	_	O
16	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	O
17	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
18	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	O
19	,	_	,	_	,	57	_	_	_	_	_	_	_	O
20	carry	_	carry	_	VBP	57	_	_	_	_	_	_	_	O
21	out	_	out	_	RP	57	_	_	_	_	_	_	_	O
22	a	_	a	_	DT	57	_	_	_	_	_	_	_	O
23	structured	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
24	assessment	_	assessment	_	NN	57	_	_	_	_	_	_	_	O
25	at	_	at	_	IN	57	_	_	_	_	_	_	_	O
26	least	_	least	_	JJS	57	_	_	_	_	_	_	_	O
27	annually	_	annually	_	RB	57	_	_	_	_	_	_	_	O

1	review	_	Review	_	NNP	57	_	_	_	_	_	_	_	O
2	treatment	_	treatment	_	NN	57	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	57	_	_	_	_	_	_	_	O
4	necessary	_	necessary	_	JJ	57	_	_	_	_	_	_	_	O
5	.	_	.	_	.	57	_	_	_	_	_	_	_	O
6	6	_	6	_	CD	57	_	_	_	_	_	_	_	O
7	if	_	If	_	IN	57	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	57	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	57	_	_	_	_	_	_	_	O
14	self-monitoring	_	UNK	_	VBG	57	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	57	_	_	_	_	_	_	_	O
16	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	O
17	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
18	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	O
19	,	_	,	_	,	57	_	_	_	_	_	_	_	O
20	carry	_	carry	_	VBP	57	_	_	_	_	_	_	_	O
21	out	_	out	_	RP	57	_	_	_	_	_	_	_	O
22	a	_	a	_	DT	57	_	_	_	_	_	_	_	O
23	structured	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
24	assessment	_	assessment	_	NN	57	_	_	_	_	_	_	_	O
25	at	_	at	_	IN	57	_	_	_	_	_	_	_	O
26	least	_	least	_	JJS	57	_	_	_	_	_	_	_	O
27	annually	_	annually	_	RB	57	_	_	_	_	_	_	_	O

1	review	_	Review	_	NNP	57	_	_	_	_	_	_	_	O
2	treatment	_	treatment	_	NN	57	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	57	_	_	_	_	_	_	_	O
4	necessary	_	necessary	_	JJ	57	_	_	_	_	_	_	_	O
5	.	_	.	_	.	57	_	_	_	_	_	_	_	O
6	6	_	6	_	CD	57	_	_	_	_	_	_	_	O
7	if	_	If	_	IN	57	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	57	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	57	_	_	_	_	_	_	_	B-Category
12	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	I-Category
13	are	_	be	_	VBP	57	_	_	_	_	_	_	_	O
14	self-monitoring	_	UNK	_	VBG	57	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	57	_	_	_	_	_	_	_	O
16	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	O
17	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
18	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	O
19	,	_	,	_	,	57	_	_	_	_	_	_	_	O
20	carry	_	carry	_	VBP	57	_	_	_	_	_	_	_	O
21	out	_	out	_	RP	57	_	_	_	_	_	_	_	O
22	a	_	a	_	DT	57	_	_	_	_	_	_	_	O
23	structured	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
24	assessment	_	assessment	_	NN	57	_	_	_	_	_	_	_	O
25	at	_	at	_	IN	57	_	_	_	_	_	_	_	O
26	least	_	least	_	JJS	57	_	_	_	_	_	_	_	O
27	annually	_	annually	_	RB	57	_	_	_	_	_	_	_	O

1	review	_	Review	_	NNP	57	_	_	_	_	_	_	_	O
2	treatment	_	treatment	_	NN	57	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	57	_	_	_	_	_	_	_	O
4	necessary	_	necessary	_	JJ	57	_	_	_	_	_	_	_	O
5	.	_	.	_	.	57	_	_	_	_	_	_	_	O
6	6	_	6	_	CD	57	_	_	_	_	_	_	_	O
7	if	_	If	_	IN	57	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	57	_	_	_	_	_	_	_	O
14	self-monitoring	_	UNK	_	VBG	57	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	57	_	_	_	_	_	_	_	B-Theme
16	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	I-Theme
17	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	I-Theme
18	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	I-Theme
19	,	_	,	_	,	57	_	_	_	_	_	_	_	O
20	carry	_	carry	_	VBP	57	_	_	_	_	_	carry.v	Bringing	O
21	out	_	out	_	RP	57	_	_	_	_	_	_	_	O
22	a	_	a	_	DT	57	_	_	_	_	_	_	_	B-Goal
23	structured	_	UNK	_	JJ	57	_	_	_	_	_	_	_	I-Goal
24	assessment	_	assessment	_	NN	57	_	_	_	_	_	_	_	I-Goal
25	at	_	at	_	IN	57	_	_	_	_	_	_	_	O
26	least	_	least	_	JJS	57	_	_	_	_	_	_	_	O
27	annually	_	annually	_	RB	57	_	_	_	_	_	_	_	O

1	review	_	Review	_	NNP	57	_	_	_	_	_	_	_	O
2	treatment	_	treatment	_	NN	57	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	57	_	_	_	_	_	_	_	O
4	necessary	_	necessary	_	JJ	57	_	_	_	_	_	_	_	O
5	.	_	.	_	.	57	_	_	_	_	_	_	_	O
6	6	_	6	_	CD	57	_	_	_	_	_	_	_	O
7	if	_	If	_	IN	57	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	57	_	_	_	_	_	_	_	O
14	self-monitoring	_	UNK	_	VBG	57	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	57	_	_	_	_	_	_	_	O
16	blood	_	blood	_	NN	57	_	_	_	_	_	_	_	O
17	glucose	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
18	levels	_	level	_	NNS	57	_	_	_	_	_	_	_	O
19	,	_	,	_	,	57	_	_	_	_	_	_	_	O
20	carry	_	carry	_	VBP	57	_	_	_	_	_	_	_	O
21	out	_	out	_	RP	57	_	_	_	_	_	_	_	O
22	a	_	a	_	DT	57	_	_	_	_	_	_	_	O
23	structured	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
24	assessment	_	assessment	_	NN	57	_	_	_	_	_	assessment.n	Assessing	S-Assessor
25	at	_	at	_	IN	57	_	_	_	_	_	_	_	O
26	least	_	least	_	JJS	57	_	_	_	_	_	_	_	O
27	annually	_	annually	_	RB	57	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	assessment.n	Assessing	S-Assessor
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	B-Total
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	I-Total
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	include.v	Inclusion	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	B-Part
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	I-Part
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	I-Part
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	I-Part
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	I-Part
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Part
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	I-Part
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	I-Part
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	I-Part
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	I-Part
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	I-Part
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	I-Part
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	I-Part
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Part
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	I-Part
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	I-Part
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	I-Part
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	I-Part
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	I-Part
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Part
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	person.n	People	S-Person
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	S-Knowledge
10	skills	_	skill	_	NNS	58	_	_	_	_	_	skill.n	Expertise	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	frequency.n	Frequency	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	B-Event
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	I-Event
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	I-Event
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	I-Event
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Event
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	I-Event
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	I-Event
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	I-Event
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	I-Event
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	I-Event
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Event
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	I-Event
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	I-Event
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	I-Event
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	I-Event
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	I-Event
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	I-Event
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	I-Event
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	I-Event
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Event
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	B-Tester
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	I-Tester
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	I-Tester
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	test.v	Operational_testing	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	check.v	Inspecting	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	58	_	_	_	_	_	person.n	People	S-Person
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	B-Cognizer
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	I-Cognizer
21	knows	_	know	_	VBZ	58	_	_	_	_	_	know.v	Awareness	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	B-Content
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	I-Content
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	I-Content
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Content
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	I-Content
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	I-Content
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	I-Content
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	I-Content
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	I-Content
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	I-Content
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	I-Content
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	I-Content
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Content
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	I-Content
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	I-Content
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Content
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	I-Content
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	I-Content
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	I-Content
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	I-Content
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	action.n	Intentionally_act	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	B-Act
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	I-Act
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Act
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	I-Act
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	I-Act
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Act
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	I-Act
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	I-Act
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	I-Act
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	I-Act
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	I-Act
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Act
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	I-Act
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	I-Act
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	I-Act
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Act
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	I-Act
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Act
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	I-Act
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	I-Act
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	58	_	_	_	_	_	impact.n	Objective_influence	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	B-Dependent_entity
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Dependent_entity
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	I-Dependent_entity
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	I-Dependent_entity
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	I-Dependent_entity
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	I-Dependent_entity
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	I-Dependent_entity
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Dependent_entity
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	I-Dependent_entity
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	I-Dependent_entity
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	I-Dependent_entity
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Dependent_entity
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	I-Dependent_entity
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	I-Dependent_entity
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	I-Dependent_entity
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	I-Dependent_entity
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	58	_	_	_	_	_	person.n	People	S-Person
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	person.n	People	S-Person
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	equipment.n	Gizmo	S-Gizmo
51	used	_	use	_	VBN	58	_	_	_	_	_	_	_	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	58	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	58	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	58	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	58	_	_	_	_	_	_	_	O
5	:	_	:	_	:	58	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	58	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	58	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	58	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	58	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	58	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	58	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	58	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	58	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	58	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	58	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	58	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	58	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	58	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	58	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	58	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	58	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	58	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	58	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	58	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	58	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	58	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	58	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	58	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	58	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	58	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	58	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	58	_	_	_	_	_	_	_	S-Instrument
51	used	_	use	_	VBN	58	_	_	_	_	_	use.v	Using	O
52	.	_	.	_	.	58	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	59	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	59	_	_	_	_	_	section.n	Part_whole	S-Part
5	that	_	that	_	IN	59	_	_	_	_	_	_	_	B-Whole
6	cover	_	cover	_	NN	59	_	_	_	_	_	_	_	I-Whole
7	dipeptidyl	_	UNK	_	NN	59	_	_	_	_	_	_	_	I-Whole
8	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	I-Whole
9	(	_	(	_	(	59	_	_	_	_	_	_	_	I-Whole
10	dpp-4	_	UNK	_	NNP	59	_	_	_	_	_	_	_	I-Whole
11	)	_	)	_	)	59	_	_	_	_	_	_	_	I-Whole
12	inhibitors	_	UNK	_	NNS	59	_	_	_	_	_	_	_	I-Whole
13	,	_	,	_	,	59	_	_	_	_	_	_	_	I-Whole
14	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	I-Whole
15	unk	_	UNK	_	NN	59	_	_	_	_	_	_	_	I-Whole
16	(	_	(	_	(	59	_	_	_	_	_	_	_	I-Whole
17	glp-1	_	UNK	_	NNP	59	_	_	_	_	_	_	_	I-Whole
18	)	_	)	_	)	59	_	_	_	_	_	_	_	I-Whole
19	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	I-Whole
20	and	_	and	_	CC	59	_	_	_	_	_	_	_	I-Whole
21	sulfonylureas	_	UNK	_	NNS	59	_	_	_	_	_	_	_	I-Whole
22	refer	_	refer	_	VBP	59	_	_	_	_	_	_	_	I-Whole
23	to	_	to	_	TO	59	_	_	_	_	_	_	_	I-Whole
24	each	_	each	_	DT	59	_	_	_	_	_	_	_	I-Whole
25	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	59	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	59	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	59	_	_	_	_	_	_	_	O
30	at	_	at	_	IN	59	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	59	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	59	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	59	_	_	_	_	_	_	_	O
34	.	_	.	_	.	59	_	_	_	_	_	_	_	O
35	7	_	7	_	CD	59	_	_	_	_	_	_	_	O
36	for	_	For	_	IN	59	_	_	_	_	_	_	_	O
37	adults	_	adult	_	NNS	59	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	59	_	_	_	_	_	_	_	O
39	type	_	type	_	JJ	59	_	_	_	_	_	_	_	O
40	2	_	2	_	CD	59	_	_	_	_	_	_	_	O
41	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
42	,	_	,	_	,	59	_	_	_	_	_	_	_	O
43	discuss	_	discuss	_	VBP	59	_	_	_	_	_	_	_	O
44	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
45	benefits	_	benefit	_	NNS	59	_	_	_	_	_	_	_	O
46	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
47	risks	_	risk	_	NNS	59	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
49	drug	_	drug	_	NN	59	_	_	_	_	_	_	_	O
50	treatment	_	treatment	_	NN	59	_	_	_	_	_	_	_	O
51	,	_	,	_	,	59	_	_	_	_	_	_	_	O
52	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
53	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
54	options	_	option	_	NNS	59	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	59	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	59	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	59	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	59	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	59	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
9	(	_	(	_	(	59	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
11	)	_	)	_	)	59	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
13	,	_	,	_	,	59	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	B-Entity
15	unk	_	UNK	_	NN	59	_	_	_	_	_	_	_	I-Entity
16	(	_	(	_	(	59	_	_	_	_	_	_	_	I-Entity
17	glp-1	_	UNK	_	NNP	59	_	_	_	_	_	_	_	I-Entity
18	)	_	)	_	)	59	_	_	_	_	_	_	_	I-Entity
19	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	I-Entity
20	and	_	and	_	CC	59	_	_	_	_	_	_	_	I-Entity
21	sulfonylureas	_	UNK	_	NNS	59	_	_	_	_	_	_	_	I-Entity
22	refer	_	refer	_	VBP	59	_	_	_	_	_	refer.v	Referring_by_name	O
23	to	_	to	_	TO	59	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	59	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	59	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	59	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	59	_	_	_	_	_	_	_	O
30	at	_	at	_	IN	59	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	59	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	59	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	59	_	_	_	_	_	_	_	O
34	.	_	.	_	.	59	_	_	_	_	_	_	_	O
35	7	_	7	_	CD	59	_	_	_	_	_	_	_	O
36	for	_	For	_	IN	59	_	_	_	_	_	_	_	O
37	adults	_	adult	_	NNS	59	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	59	_	_	_	_	_	_	_	O
39	type	_	type	_	JJ	59	_	_	_	_	_	_	_	O
40	2	_	2	_	CD	59	_	_	_	_	_	_	_	O
41	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
42	,	_	,	_	,	59	_	_	_	_	_	_	_	O
43	discuss	_	discuss	_	VBP	59	_	_	_	_	_	_	_	O
44	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
45	benefits	_	benefit	_	NNS	59	_	_	_	_	_	_	_	O
46	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
47	risks	_	risk	_	NNS	59	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
49	drug	_	drug	_	NN	59	_	_	_	_	_	_	_	O
50	treatment	_	treatment	_	NN	59	_	_	_	_	_	_	_	O
51	,	_	,	_	,	59	_	_	_	_	_	_	_	O
52	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
53	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
54	options	_	option	_	NNS	59	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	59	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	59	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	59	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	59	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	59	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
9	(	_	(	_	(	59	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
11	)	_	)	_	)	59	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
13	,	_	,	_	,	59	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
16	(	_	(	_	(	59	_	_	_	_	_	_	_	O
17	glp-1	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
18	)	_	)	_	)	59	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
21	sulfonylureas	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
22	refer	_	refer	_	VBP	59	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	59	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	59	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	59	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	59	_	_	_	_	_	group.n	Aggregate	S-Aggregate
28	of	_	of	_	IN	59	_	_	_	_	_	_	_	B-Individuals
29	drugs	_	drug	_	NNS	59	_	_	_	_	_	_	_	I-Individuals
30	at	_	at	_	IN	59	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	59	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	59	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	59	_	_	_	_	_	_	_	O
34	.	_	.	_	.	59	_	_	_	_	_	_	_	O
35	7	_	7	_	CD	59	_	_	_	_	_	_	_	O
36	for	_	For	_	IN	59	_	_	_	_	_	_	_	O
37	adults	_	adult	_	NNS	59	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	59	_	_	_	_	_	_	_	O
39	type	_	type	_	JJ	59	_	_	_	_	_	_	_	O
40	2	_	2	_	CD	59	_	_	_	_	_	_	_	O
41	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
42	,	_	,	_	,	59	_	_	_	_	_	_	_	O
43	discuss	_	discuss	_	VBP	59	_	_	_	_	_	_	_	O
44	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
45	benefits	_	benefit	_	NNS	59	_	_	_	_	_	_	_	O
46	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
47	risks	_	risk	_	NNS	59	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
49	drug	_	drug	_	NN	59	_	_	_	_	_	_	_	O
50	treatment	_	treatment	_	NN	59	_	_	_	_	_	_	_	O
51	,	_	,	_	,	59	_	_	_	_	_	_	_	O
52	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
53	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
54	options	_	option	_	NNS	59	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	59	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	59	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	59	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	59	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	59	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
9	(	_	(	_	(	59	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
11	)	_	)	_	)	59	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
13	,	_	,	_	,	59	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
16	(	_	(	_	(	59	_	_	_	_	_	_	_	O
17	glp-1	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
18	)	_	)	_	)	59	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
21	sulfonylureas	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
22	refer	_	refer	_	VBP	59	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	59	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	59	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	59	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	59	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	59	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
30	at	_	at	_	IN	59	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	59	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	59	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	59	_	_	_	_	_	_	_	O
34	.	_	.	_	.	59	_	_	_	_	_	_	_	O
35	7	_	7	_	CD	59	_	_	_	_	_	_	_	O
36	for	_	For	_	IN	59	_	_	_	_	_	_	_	O
37	adults	_	adult	_	NNS	59	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	59	_	_	_	_	_	_	_	O
39	type	_	type	_	JJ	59	_	_	_	_	_	_	_	O
40	2	_	2	_	CD	59	_	_	_	_	_	_	_	O
41	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
42	,	_	,	_	,	59	_	_	_	_	_	_	_	O
43	discuss	_	discuss	_	VBP	59	_	_	_	_	_	_	_	O
44	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
45	benefits	_	benefit	_	NNS	59	_	_	_	_	_	_	_	O
46	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
47	risks	_	risk	_	NNS	59	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
49	drug	_	drug	_	NN	59	_	_	_	_	_	_	_	O
50	treatment	_	treatment	_	NN	59	_	_	_	_	_	_	_	O
51	,	_	,	_	,	59	_	_	_	_	_	_	_	O
52	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
53	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
54	options	_	option	_	NNS	59	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	59	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	59	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	59	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	59	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	59	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
9	(	_	(	_	(	59	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
11	)	_	)	_	)	59	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
13	,	_	,	_	,	59	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
16	(	_	(	_	(	59	_	_	_	_	_	_	_	O
17	glp-1	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
18	)	_	)	_	)	59	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
21	sulfonylureas	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
22	refer	_	refer	_	VBP	59	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	59	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	59	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	59	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	59	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	59	_	_	_	_	_	_	_	O
30	at	_	at	_	IN	59	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	59	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	59	_	_	_	_	_	class.n	Type	S-Subtype
33	level	_	level	_	NN	59	_	_	_	_	_	_	_	O
34	.	_	.	_	.	59	_	_	_	_	_	_	_	O
35	7	_	7	_	CD	59	_	_	_	_	_	_	_	O
36	for	_	For	_	IN	59	_	_	_	_	_	_	_	O
37	adults	_	adult	_	NNS	59	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	59	_	_	_	_	_	_	_	O
39	type	_	type	_	JJ	59	_	_	_	_	_	_	_	O
40	2	_	2	_	CD	59	_	_	_	_	_	_	_	O
41	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
42	,	_	,	_	,	59	_	_	_	_	_	_	_	O
43	discuss	_	discuss	_	VBP	59	_	_	_	_	_	_	_	O
44	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
45	benefits	_	benefit	_	NNS	59	_	_	_	_	_	_	_	O
46	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
47	risks	_	risk	_	NNS	59	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
49	drug	_	drug	_	NN	59	_	_	_	_	_	_	_	O
50	treatment	_	treatment	_	NN	59	_	_	_	_	_	_	_	O
51	,	_	,	_	,	59	_	_	_	_	_	_	_	O
52	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
53	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
54	options	_	option	_	NNS	59	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	59	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	59	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	59	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	59	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	59	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
9	(	_	(	_	(	59	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
11	)	_	)	_	)	59	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
13	,	_	,	_	,	59	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
16	(	_	(	_	(	59	_	_	_	_	_	_	_	O
17	glp-1	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
18	)	_	)	_	)	59	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
21	sulfonylureas	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
22	refer	_	refer	_	VBP	59	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	59	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	59	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	59	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	59	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	59	_	_	_	_	_	_	_	O
30	at	_	at	_	IN	59	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	59	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	59	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	59	_	_	_	_	_	_	_	O
34	.	_	.	_	.	59	_	_	_	_	_	_	_	O
35	7	_	7	_	CD	59	_	_	_	_	_	_	_	O
36	for	_	For	_	IN	59	_	_	_	_	_	_	_	O
37	adults	_	adult	_	NNS	59	_	_	_	_	_	adult.n	People_by_age	S-Person
38	with	_	with	_	IN	59	_	_	_	_	_	_	_	O
39	type	_	type	_	JJ	59	_	_	_	_	_	_	_	O
40	2	_	2	_	CD	59	_	_	_	_	_	_	_	O
41	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
42	,	_	,	_	,	59	_	_	_	_	_	_	_	O
43	discuss	_	discuss	_	VBP	59	_	_	_	_	_	_	_	O
44	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
45	benefits	_	benefit	_	NNS	59	_	_	_	_	_	_	_	O
46	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
47	risks	_	risk	_	NNS	59	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
49	drug	_	drug	_	NN	59	_	_	_	_	_	_	_	O
50	treatment	_	treatment	_	NN	59	_	_	_	_	_	_	_	O
51	,	_	,	_	,	59	_	_	_	_	_	_	_	O
52	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
53	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
54	options	_	option	_	NNS	59	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	59	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	59	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	59	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	59	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	59	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
9	(	_	(	_	(	59	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
11	)	_	)	_	)	59	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
13	,	_	,	_	,	59	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
16	(	_	(	_	(	59	_	_	_	_	_	_	_	O
17	glp-1	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
18	)	_	)	_	)	59	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
21	sulfonylureas	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
22	refer	_	refer	_	VBP	59	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	59	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	59	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	59	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	59	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	59	_	_	_	_	_	_	_	O
30	at	_	at	_	IN	59	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	59	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	59	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	59	_	_	_	_	_	_	_	O
34	.	_	.	_	.	59	_	_	_	_	_	_	_	O
35	7	_	7	_	CD	59	_	_	_	_	_	_	_	O
36	for	_	For	_	IN	59	_	_	_	_	_	_	_	O
37	adults	_	adult	_	NNS	59	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	59	_	_	_	_	_	_	_	O
39	type	_	type	_	JJ	59	_	_	_	_	_	type.n	Type	S-Subtype
40	2	_	2	_	CD	59	_	_	_	_	_	_	_	B-Category
41	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	I-Category
42	,	_	,	_	,	59	_	_	_	_	_	_	_	O
43	discuss	_	discuss	_	VBP	59	_	_	_	_	_	_	_	O
44	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
45	benefits	_	benefit	_	NNS	59	_	_	_	_	_	_	_	O
46	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
47	risks	_	risk	_	NNS	59	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
49	drug	_	drug	_	NN	59	_	_	_	_	_	_	_	O
50	treatment	_	treatment	_	NN	59	_	_	_	_	_	_	_	O
51	,	_	,	_	,	59	_	_	_	_	_	_	_	O
52	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
53	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
54	options	_	option	_	NNS	59	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	59	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	59	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	59	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	59	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	59	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
9	(	_	(	_	(	59	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
11	)	_	)	_	)	59	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
13	,	_	,	_	,	59	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
16	(	_	(	_	(	59	_	_	_	_	_	_	_	O
17	glp-1	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
18	)	_	)	_	)	59	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
21	sulfonylureas	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
22	refer	_	refer	_	VBP	59	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	59	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	59	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	59	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	59	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	59	_	_	_	_	_	_	_	O
30	at	_	at	_	IN	59	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	59	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	59	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	59	_	_	_	_	_	_	_	O
34	.	_	.	_	.	59	_	_	_	_	_	_	_	O
35	7	_	7	_	CD	59	_	_	_	_	_	_	_	O
36	for	_	For	_	IN	59	_	_	_	_	_	_	_	O
37	adults	_	adult	_	NNS	59	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	59	_	_	_	_	_	_	_	O
39	type	_	type	_	JJ	59	_	_	_	_	_	_	_	O
40	2	_	2	_	CD	59	_	_	_	_	_	_	_	O
41	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
42	,	_	,	_	,	59	_	_	_	_	_	_	_	O
43	discuss	_	discuss	_	VBP	59	_	_	_	_	_	discuss.v	Discussion	O
44	the	_	the	_	DT	59	_	_	_	_	_	_	_	B-Topic
45	benefits	_	benefit	_	NNS	59	_	_	_	_	_	_	_	I-Topic
46	and	_	and	_	CC	59	_	_	_	_	_	_	_	I-Topic
47	risks	_	risk	_	NNS	59	_	_	_	_	_	_	_	I-Topic
48	of	_	of	_	IN	59	_	_	_	_	_	_	_	I-Topic
49	drug	_	drug	_	NN	59	_	_	_	_	_	_	_	I-Topic
50	treatment	_	treatment	_	NN	59	_	_	_	_	_	_	_	I-Topic
51	,	_	,	_	,	59	_	_	_	_	_	_	_	O
52	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
53	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
54	options	_	option	_	NNS	59	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	59	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	59	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	59	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	59	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	59	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
9	(	_	(	_	(	59	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
11	)	_	)	_	)	59	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
13	,	_	,	_	,	59	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
16	(	_	(	_	(	59	_	_	_	_	_	_	_	O
17	glp-1	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
18	)	_	)	_	)	59	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
21	sulfonylureas	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
22	refer	_	refer	_	VBP	59	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	59	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	59	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	59	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	59	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	59	_	_	_	_	_	_	_	O
30	at	_	at	_	IN	59	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	59	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	59	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	59	_	_	_	_	_	_	_	O
34	.	_	.	_	.	59	_	_	_	_	_	_	_	O
35	7	_	7	_	CD	59	_	_	_	_	_	_	_	O
36	for	_	For	_	IN	59	_	_	_	_	_	_	_	O
37	adults	_	adult	_	NNS	59	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	59	_	_	_	_	_	_	_	O
39	type	_	type	_	JJ	59	_	_	_	_	_	_	_	O
40	2	_	2	_	CD	59	_	_	_	_	_	_	_	O
41	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
42	,	_	,	_	,	59	_	_	_	_	_	_	_	O
43	discuss	_	discuss	_	VBP	59	_	_	_	_	_	_	_	O
44	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
45	benefits	_	benefit	_	NNS	59	_	_	_	_	_	_	_	O
46	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
47	risks	_	risk	_	NNS	59	_	_	_	_	_	risk.n	Run_risk	O
48	of	_	of	_	IN	59	_	_	_	_	_	_	_	B-Asset
49	drug	_	drug	_	NN	59	_	_	_	_	_	_	_	I-Asset
50	treatment	_	treatment	_	NN	59	_	_	_	_	_	_	_	I-Asset
51	,	_	,	_	,	59	_	_	_	_	_	_	_	O
52	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
53	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
54	options	_	option	_	NNS	59	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	59	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	59	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	59	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	59	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	59	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
9	(	_	(	_	(	59	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
11	)	_	)	_	)	59	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
13	,	_	,	_	,	59	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
16	(	_	(	_	(	59	_	_	_	_	_	_	_	O
17	glp-1	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
18	)	_	)	_	)	59	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
21	sulfonylureas	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
22	refer	_	refer	_	VBP	59	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	59	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	59	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	59	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	59	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	59	_	_	_	_	_	_	_	O
30	at	_	at	_	IN	59	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	59	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	59	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	59	_	_	_	_	_	_	_	O
34	.	_	.	_	.	59	_	_	_	_	_	_	_	O
35	7	_	7	_	CD	59	_	_	_	_	_	_	_	O
36	for	_	For	_	IN	59	_	_	_	_	_	_	_	O
37	adults	_	adult	_	NNS	59	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	59	_	_	_	_	_	_	_	O
39	type	_	type	_	JJ	59	_	_	_	_	_	_	_	O
40	2	_	2	_	CD	59	_	_	_	_	_	_	_	O
41	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
42	,	_	,	_	,	59	_	_	_	_	_	_	_	O
43	discuss	_	discuss	_	VBP	59	_	_	_	_	_	_	_	O
44	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
45	benefits	_	benefit	_	NNS	59	_	_	_	_	_	_	_	O
46	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
47	risks	_	risk	_	NNS	59	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
49	drug	_	drug	_	NN	59	_	_	_	_	_	_	_	S-Patient
50	treatment	_	treatment	_	NN	59	_	_	_	_	_	treatment.n	Cure	O
51	,	_	,	_	,	59	_	_	_	_	_	_	_	O
52	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
53	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
54	options	_	option	_	NNS	59	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	59	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	59	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	59	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	59	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	59	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	59	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
9	(	_	(	_	(	59	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
11	)	_	)	_	)	59	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
13	,	_	,	_	,	59	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	59	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	59	_	_	_	_	_	_	_	O
16	(	_	(	_	(	59	_	_	_	_	_	_	_	O
17	glp-1	_	UNK	_	NNP	59	_	_	_	_	_	_	_	O
18	)	_	)	_	)	59	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
21	sulfonylureas	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
22	refer	_	refer	_	VBP	59	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	59	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	59	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	59	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	59	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	59	_	_	_	_	_	_	_	O
30	at	_	at	_	IN	59	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	59	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	59	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	59	_	_	_	_	_	_	_	O
34	.	_	.	_	.	59	_	_	_	_	_	_	_	O
35	7	_	7	_	CD	59	_	_	_	_	_	_	_	O
36	for	_	For	_	IN	59	_	_	_	_	_	_	_	O
37	adults	_	adult	_	NNS	59	_	_	_	_	_	_	_	O
38	with	_	with	_	IN	59	_	_	_	_	_	_	_	O
39	type	_	type	_	JJ	59	_	_	_	_	_	_	_	O
40	2	_	2	_	CD	59	_	_	_	_	_	_	_	O
41	diabetes	_	UNK	_	NNS	59	_	_	_	_	_	_	_	O
42	,	_	,	_	,	59	_	_	_	_	_	_	_	O
43	discuss	_	discuss	_	VBP	59	_	_	_	_	_	_	_	O
44	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
45	benefits	_	benefit	_	NNS	59	_	_	_	_	_	_	_	O
46	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
47	risks	_	risk	_	NNS	59	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	59	_	_	_	_	_	_	_	O
49	drug	_	drug	_	NN	59	_	_	_	_	_	_	_	O
50	treatment	_	treatment	_	NN	59	_	_	_	_	_	_	_	O
51	,	_	,	_	,	59	_	_	_	_	_	_	_	O
52	and	_	and	_	CC	59	_	_	_	_	_	_	_	O
53	the	_	the	_	DT	59	_	_	_	_	_	_	_	O
54	options	_	option	_	NNS	59	_	_	_	_	_	option.n	Alternatives	O
55	available	_	available	_	JJ	59	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	60	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	60	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	60	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	60	_	_	_	_	_	_	_	O
6	:	_	:	_	:	60	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	60	_	_	_	_	_	_	_	O
8	(	_	(	_	(	60	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
10	)	_	)	_	)	60	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	60	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	60	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
14	)	_	)	_	)	60	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	60	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	60	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	60	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	60	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	60	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	60	_	_	_	_	_	_	_	O
8	(	_	(	_	(	60	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
10	)	_	)	_	)	60	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	60	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	60	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
14	)	_	)	_	)	60	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	S-Patient
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	treatment.n	Cure	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	person.n	People	S-Person
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	individual.n	People	B-Person
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	I-Person
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	I-Person
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	example.n	Instance	S-Instance
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	risk.n	Run_risk	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	B-Action
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	I-Action
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	person.n	People	S-Person
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	individual.n	People	S-Person
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	need.v	Needing	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	B-Requirement
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	I-Requirement
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	I-Requirement
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	I-Requirement
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	I-Requirement
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	I-Requirement
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	I-Requirement
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	S-Descriptor
52	indications	_	indication	_	NNS	61	_	_	_	_	_	indication.n	Sign	S-Indicator
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	cost.n	Expensiveness	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	same.a	Identicality	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	S-Type
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	S-Type_property
64	class	_	class	_	NN	61	_	_	_	_	_	class.n	Type	S-Subtype
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	B-Evaluee
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	I-Evaluee
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	I-Evaluee
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	appropriate.a	Suitability	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	B-Chosen
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	I-Chosen
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	I-Chosen
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	I-Chosen
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	I-Chosen
6	(	_	(	_	(	61	_	_	_	_	_	_	_	I-Chosen
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	I-Chosen
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	I-Chosen
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	I-Chosen
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	I-Chosen
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	I-Chosen
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	I-Chosen
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	I-Chosen
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	I-Chosen
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	I-Chosen
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	I-Chosen
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	I-Chosen
18	)	_	)	_	)	61	_	_	_	_	_	_	_	I-Chosen
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	I-Chosen
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	I-Chosen
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	I-Chosen
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	I-Chosen
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	I-Chosen
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	I-Chosen
25	(	_	(	_	(	61	_	_	_	_	_	_	_	I-Chosen
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	I-Chosen
27	)	_	)	_	)	61	_	_	_	_	_	_	_	I-Chosen
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	I-Chosen
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	I-Chosen
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	I-Chosen
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	I-Chosen
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	I-Chosen
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	I-Chosen
34	,	_	,	_	,	61	_	_	_	_	_	_	_	I-Chosen
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	I-Chosen
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	I-Chosen
37	,	_	,	_	,	61	_	_	_	_	_	_	_	I-Chosen
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	I-Chosen
39	,	_	,	_	,	61	_	_	_	_	_	_	_	I-Chosen
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	I-Chosen
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	choose.v	Choosing	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	B-Chosen
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	I-Chosen
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	I-Chosen
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	I-Chosen
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	I-Chosen
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	I-Chosen
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	I-Chosen
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	option.n	Alternatives	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	B-Situation
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	I-Situation
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	I-Situation
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	I-Situation
75	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	I-Situation
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	61	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	61	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	61	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	61	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	61	_	_	_	_	_	_	_	O
6	(	_	(	_	(	61	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	61	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	61	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	61	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	61	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	61	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	61	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	61	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	61	_	_	_	_	_	_	_	O
18	)	_	)	_	)	61	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	61	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	61	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	61	_	_	_	_	_	_	_	O
25	(	_	(	_	(	61	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	61	_	_	_	_	_	_	_	O
27	)	_	)	_	)	61	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	61	_	_	_	_	_	_	_	O
34	,	_	,	_	,	61	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	61	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	61	_	_	_	_	_	_	_	O
37	,	_	,	_	,	61	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
39	,	_	,	_	,	61	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	61	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	61	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	61	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	61	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	61	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	61	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	61	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	61	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	61	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	61	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	61	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	61	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	61	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	61	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	61	_	_	_	_	_	_	_	O
57	(	_	(	_	(	61	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	61	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	61	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	61	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	61	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	61	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	61	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	61	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	61	_	_	_	_	_	_	_	O
67	,	_	,	_	,	61	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	61	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	61	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	61	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	61	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	61	_	_	_	_	_	_	_	B-Asset
74	acquisition	_	acquisition	_	NN	61	_	_	_	_	_	_	_	I-Asset
75	cost	_	cost	_	NN	61	_	_	_	_	_	cost.n	Expensiveness	O
76	)	_	)	_	)	61	_	_	_	_	_	_	_	O
77	.	_	.	_	.	61	_	_	_	_	_	_	_	O

1	rescue	_	Rescue	_	NNP	62	_	_	_	_	_	_	_	O
2	therapy	_	therapy	_	NN	62	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
3	at	_	at	_	IN	62	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	62	_	_	_	_	_	_	_	O
5	phase	_	phase	_	NN	62	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
7	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
8	8	_	8	_	CD	62	_	_	_	_	_	_	_	O
9	if	_	If	_	IN	62	_	_	_	_	_	_	_	O
10	an	_	an	_	DT	62	_	_	_	_	_	_	_	O
11	adult	_	adult	_	NN	62	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	62	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	62	_	_	_	_	_	_	_	O
17	symptomatically	_	UNK	_	RB	62	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
19	,	_	,	_	,	62	_	_	_	_	_	_	_	O
20	consider	_	consider	_	VB	62	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
22	(	_	(	_	(	62	_	_	_	_	_	_	_	O
23	see	_	see	_	VB	62	_	_	_	_	_	_	_	O
24	recommendations	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	62	_	_	_	_	_	_	_	O
26	4	_	4	_	CD	62	_	_	_	_	_	_	_	O
27	)	_	)	_	)	62	_	_	_	_	_	_	_	O
28	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	62	_	_	_	_	_	_	_	O
30	sulfonylurea	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
31	,	_	,	_	,	62	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
33	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
35	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
36	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	O
37	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
38	control	_	control	_	NN	62	_	_	_	_	_	_	_	O
39	has	_	have	_	VBZ	62	_	_	_	_	_	_	_	O
40	been	_	be	_	VBN	62	_	_	_	_	_	_	_	O
41	achieved	_	achieve	_	VBN	62	_	_	_	_	_	_	_	O
42	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	rescue	_	Rescue	_	NNP	62	_	_	_	_	_	_	_	O
2	therapy	_	therapy	_	NN	62	_	_	_	_	_	_	_	O
3	at	_	at	_	IN	62	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	62	_	_	_	_	_	_	_	O
5	phase	_	phase	_	NN	62	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
7	treatment	_	treatment	_	NN	62	_	_	_	_	_	treatment.n	Cure	S-Patient
8	8	_	8	_	CD	62	_	_	_	_	_	_	_	O
9	if	_	If	_	IN	62	_	_	_	_	_	_	_	O
10	an	_	an	_	DT	62	_	_	_	_	_	_	_	O
11	adult	_	adult	_	NN	62	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	62	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	62	_	_	_	_	_	_	_	O
17	symptomatically	_	UNK	_	RB	62	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
19	,	_	,	_	,	62	_	_	_	_	_	_	_	O
20	consider	_	consider	_	VB	62	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
22	(	_	(	_	(	62	_	_	_	_	_	_	_	O
23	see	_	see	_	VB	62	_	_	_	_	_	_	_	O
24	recommendations	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	62	_	_	_	_	_	_	_	O
26	4	_	4	_	CD	62	_	_	_	_	_	_	_	O
27	)	_	)	_	)	62	_	_	_	_	_	_	_	O
28	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	62	_	_	_	_	_	_	_	O
30	sulfonylurea	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
31	,	_	,	_	,	62	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
33	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
35	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
36	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	O
37	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
38	control	_	control	_	NN	62	_	_	_	_	_	_	_	O
39	has	_	have	_	VBZ	62	_	_	_	_	_	_	_	O
40	been	_	be	_	VBN	62	_	_	_	_	_	_	_	O
41	achieved	_	achieve	_	VBN	62	_	_	_	_	_	_	_	O
42	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	rescue	_	Rescue	_	NNP	62	_	_	_	_	_	_	_	O
2	therapy	_	therapy	_	NN	62	_	_	_	_	_	_	_	O
3	at	_	at	_	IN	62	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	62	_	_	_	_	_	_	_	O
5	phase	_	phase	_	NN	62	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
7	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
8	8	_	8	_	CD	62	_	_	_	_	_	_	_	O
9	if	_	If	_	IN	62	_	_	_	_	_	_	_	O
10	an	_	an	_	DT	62	_	_	_	_	_	_	_	O
11	adult	_	adult	_	NN	62	_	_	_	_	_	adult.n	People_by_age	S-Person
12	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	62	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	62	_	_	_	_	_	_	_	O
17	symptomatically	_	UNK	_	RB	62	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
19	,	_	,	_	,	62	_	_	_	_	_	_	_	O
20	consider	_	consider	_	VB	62	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
22	(	_	(	_	(	62	_	_	_	_	_	_	_	O
23	see	_	see	_	VB	62	_	_	_	_	_	_	_	O
24	recommendations	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	62	_	_	_	_	_	_	_	O
26	4	_	4	_	CD	62	_	_	_	_	_	_	_	O
27	)	_	)	_	)	62	_	_	_	_	_	_	_	O
28	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	62	_	_	_	_	_	_	_	O
30	sulfonylurea	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
31	,	_	,	_	,	62	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
33	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
35	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
36	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	O
37	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
38	control	_	control	_	NN	62	_	_	_	_	_	_	_	O
39	has	_	have	_	VBZ	62	_	_	_	_	_	_	_	O
40	been	_	be	_	VBN	62	_	_	_	_	_	_	_	O
41	achieved	_	achieve	_	VBN	62	_	_	_	_	_	_	_	O
42	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	rescue	_	Rescue	_	NNP	62	_	_	_	_	_	_	_	O
2	therapy	_	therapy	_	NN	62	_	_	_	_	_	_	_	O
3	at	_	at	_	IN	62	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	62	_	_	_	_	_	_	_	O
5	phase	_	phase	_	NN	62	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
7	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
8	8	_	8	_	CD	62	_	_	_	_	_	_	_	O
9	if	_	If	_	IN	62	_	_	_	_	_	_	_	O
10	an	_	an	_	DT	62	_	_	_	_	_	_	_	O
11	adult	_	adult	_	NN	62	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	62	_	_	_	_	_	type.n	Type	S-Subtype
14	2	_	2	_	CD	62	_	_	_	_	_	_	_	B-Category
15	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	I-Category
16	is	_	be	_	VBZ	62	_	_	_	_	_	_	_	O
17	symptomatically	_	UNK	_	RB	62	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
19	,	_	,	_	,	62	_	_	_	_	_	_	_	O
20	consider	_	consider	_	VB	62	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
22	(	_	(	_	(	62	_	_	_	_	_	_	_	O
23	see	_	see	_	VB	62	_	_	_	_	_	_	_	O
24	recommendations	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	62	_	_	_	_	_	_	_	O
26	4	_	4	_	CD	62	_	_	_	_	_	_	_	O
27	)	_	)	_	)	62	_	_	_	_	_	_	_	O
28	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	62	_	_	_	_	_	_	_	O
30	sulfonylurea	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
31	,	_	,	_	,	62	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
33	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
35	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
36	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	O
37	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
38	control	_	control	_	NN	62	_	_	_	_	_	_	_	O
39	has	_	have	_	VBZ	62	_	_	_	_	_	_	_	O
40	been	_	be	_	VBN	62	_	_	_	_	_	_	_	O
41	achieved	_	achieve	_	VBN	62	_	_	_	_	_	_	_	O
42	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	rescue	_	Rescue	_	NNP	62	_	_	_	_	_	_	_	O
2	therapy	_	therapy	_	NN	62	_	_	_	_	_	_	_	O
3	at	_	at	_	IN	62	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	62	_	_	_	_	_	_	_	O
5	phase	_	phase	_	NN	62	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
7	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
8	8	_	8	_	CD	62	_	_	_	_	_	_	_	O
9	if	_	If	_	IN	62	_	_	_	_	_	_	_	O
10	an	_	an	_	DT	62	_	_	_	_	_	_	_	O
11	adult	_	adult	_	NN	62	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	62	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	62	_	_	_	_	_	_	_	O
17	symptomatically	_	UNK	_	RB	62	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
19	,	_	,	_	,	62	_	_	_	_	_	_	_	O
20	consider	_	consider	_	VB	62	_	_	_	_	_	consider.v	Categorization	O
21	insulin	_	UNK	_	NN	62	_	_	_	_	_	_	_	S-Item
22	(	_	(	_	(	62	_	_	_	_	_	_	_	O
23	see	_	see	_	VB	62	_	_	_	_	_	_	_	O
24	recommendations	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	62	_	_	_	_	_	_	_	O
26	4	_	4	_	CD	62	_	_	_	_	_	_	_	O
27	)	_	)	_	)	62	_	_	_	_	_	_	_	O
28	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	62	_	_	_	_	_	_	_	O
30	sulfonylurea	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
31	,	_	,	_	,	62	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
33	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
35	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
36	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	O
37	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
38	control	_	control	_	NN	62	_	_	_	_	_	_	_	O
39	has	_	have	_	VBZ	62	_	_	_	_	_	_	_	O
40	been	_	be	_	VBN	62	_	_	_	_	_	_	_	O
41	achieved	_	achieve	_	VBN	62	_	_	_	_	_	_	_	O
42	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	rescue	_	Rescue	_	NNP	62	_	_	_	_	_	_	_	O
2	therapy	_	therapy	_	NN	62	_	_	_	_	_	_	_	O
3	at	_	at	_	IN	62	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	62	_	_	_	_	_	_	_	O
5	phase	_	phase	_	NN	62	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	62	_	_	_	_	_	_	_	O
7	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
8	8	_	8	_	CD	62	_	_	_	_	_	_	_	O
9	if	_	If	_	IN	62	_	_	_	_	_	_	_	O
10	an	_	an	_	DT	62	_	_	_	_	_	_	_	O
11	adult	_	adult	_	NN	62	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	62	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	62	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	62	_	_	_	_	_	_	_	O
17	symptomatically	_	UNK	_	RB	62	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	62	_	_	_	_	_	_	_	O
19	,	_	,	_	,	62	_	_	_	_	_	_	_	O
20	consider	_	consider	_	VB	62	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
22	(	_	(	_	(	62	_	_	_	_	_	_	_	O
23	see	_	see	_	VB	62	_	_	_	_	_	_	_	O
24	recommendations	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	62	_	_	_	_	_	_	_	O
26	4	_	4	_	CD	62	_	_	_	_	_	_	_	O
27	)	_	)	_	)	62	_	_	_	_	_	_	_	O
28	or	_	or	_	CC	62	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	62	_	_	_	_	_	_	_	O
30	sulfonylurea	_	UNK	_	NN	62	_	_	_	_	_	_	_	O
31	,	_	,	_	,	62	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	62	_	_	_	_	_	_	_	O
33	review	_	review	_	VB	62	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	62	_	_	_	_	_	_	_	O
35	when	_	when	_	WRB	62	_	_	_	_	_	_	_	O
36	blood	_	blood	_	NN	62	_	_	_	_	_	_	_	B-Goal
37	glucose	_	UNK	_	NN	62	_	_	_	_	_	_	_	I-Goal
38	control	_	control	_	NN	62	_	_	_	_	_	_	_	I-Goal
39	has	_	have	_	VBZ	62	_	_	_	_	_	_	_	O
40	been	_	be	_	VBN	62	_	_	_	_	_	_	_	O
41	achieved	_	achieve	_	VBN	62	_	_	_	_	_	achieve.v	Accomplishment	O
42	.	_	.	_	.	62	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	initial.a	Version_sequence	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	B-Item
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	I-Item
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	S-Patient
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	treatment.n	Cure	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	S-Patient
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	treatment.n	Cure	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	adult.n	People_by_age	S-Person
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	type.n	Type	S-Subtype
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	B-Category
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	I-Category
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	increase.v	Cause_change_of_position_on_a_scale	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	dose.n	Quantified_mass	S-Quantity
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	B-Individuals
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	I-Individuals
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	I-Individuals
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	several.a	Quantified_mass	S-Quantity
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	S-Individuals
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	S-Count
30	weeks	_	week	_	NNS	63	_	_	_	_	_	week.n	Calendric_unit	S-Unit
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	risk.n	Run_risk	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	B-Asset
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	I-Asset
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	I-Asset
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	I-Asset
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	I-Asset
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	I-Asset
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	I-Asset
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	I-Asset
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	I-Asset
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	I-Asset
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	B-Dependent_entity
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	I-Dependent_entity
38	effects	_	effect	_	NNS	63	_	_	_	_	_	effect.n	Objective_influence	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	adult.n	People_by_age	S-Person
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	type.n	Type	S-Subtype
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	B-Category
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	I-Category
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	adult.n	People_by_age	S-Person
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	type.n	Type	S-Subtype
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	S-Phenomenon
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	experience.n	Perception_experience	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	B-Phenomenon
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	I-Phenomenon
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	I-Phenomenon
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	I-Phenomenon
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	I-Phenomenon
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	I-Phenomenon
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	side.n	Taking_sides	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	B-Dependent_entity
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	I-Dependent_entity
57	effects	_	effect	_	NNS	63	_	_	_	_	_	effect.n	Objective_influence	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	B-Dependent_entity
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	I-Dependent_entity
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	I-Dependent_entity
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	consider.v	Categorization	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	B-Category
64	trial	_	trial	_	NN	63	_	_	_	_	_	_	_	I-Category
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	I-Category
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	I-Category
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	I-Category
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	63	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
3	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
4	9	_	9	_	CD	63	_	_	_	_	_	_	_	O
5	offer	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	63	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
10	initial	_	initial	_	JJ	63	_	_	_	_	_	_	_	O
11	drug	_	drug	_	NN	63	_	_	_	_	_	_	_	O
12	treatment	_	treatment	_	NN	63	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	63	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
19	.	_	.	_	.	63	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	63	_	_	_	_	_	_	_	O
21	gradually	_	Gradually	_	NNP	63	_	_	_	_	_	_	_	O
22	increase	_	increase	_	VB	63	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
24	dose	_	dose	_	NN	63	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
27	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
28	over	_	over	_	IN	63	_	_	_	_	_	_	_	O
29	several	_	several	_	JJ	63	_	_	_	_	_	_	_	O
30	weeks	_	week	_	NNS	63	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	63	_	_	_	_	_	_	_	O
32	minimise	_	UNK	_	VB	63	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	63	_	_	_	_	_	_	_	O
34	risk	_	risk	_	NN	63	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	63	_	_	_	_	_	_	_	O
36	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
37	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
38	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
39	in	_	in	_	IN	63	_	_	_	_	_	_	_	O
40	adults	_	adult	_	NNS	63	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
42	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
45	.	_	.	_	.	63	_	_	_	_	_	_	_	O
46	1	_	1	_	CD	63	_	_	_	_	_	_	_	O
47	if	_	If	_	IN	63	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	63	_	_	_	_	_	_	_	O
49	adult	_	adult	_	NN	63	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
51	type	_	type	_	JJ	63	_	_	_	_	_	_	_	O
52	2	_	2	_	CD	63	_	_	_	_	_	_	_	O
53	diabetes	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
54	experiences	_	experience	_	NNS	63	_	_	_	_	_	_	_	O
55	gastrointestinal	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
56	side	_	side	_	NN	63	_	_	_	_	_	_	_	O
57	effects	_	effect	_	NNS	63	_	_	_	_	_	_	_	O
58	with	_	with	_	IN	63	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
60	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	O
61	,	_	,	_	,	63	_	_	_	_	_	_	_	O
62	consider	_	consider	_	VB	63	_	_	_	_	_	_	_	O
63	a	_	a	_	DT	63	_	_	_	_	_	_	_	O
64	trial	_	trial	_	NN	63	_	_	_	_	_	trial.n	Trial	O
65	of	_	of	_	IN	63	_	_	_	_	_	_	_	B-Defendant
66	unk	_	UNK	_	JJ	63	_	_	_	_	_	_	_	I-Defendant
67	metformin	_	UNK	_	NN	63	_	_	_	_	_	_	_	I-Defendant
68	.	_	.	_	.	63	_	_	_	_	_	_	_	O

1	algorithm	_	UNK	_	NNP	64	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	64	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	64	_	_	_	_	_	_	_	B-Item
4	glucose	_	UNK	_	NN	64	_	_	_	_	_	_	_	I-Item
5	lowering	_	lower	_	VBG	64	_	_	_	_	_	lower.v	Cause_change_of_position_on_a_scale	O
6	therapy	_	therapy	_	NN	64	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	64	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	64	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	64	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	64	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	64	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	64	_	_	_	_	_	_	_	O

1	algorithm	_	UNK	_	NNP	64	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	64	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	64	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	NN	64	_	_	_	_	_	_	_	O
5	lowering	_	lower	_	VBG	64	_	_	_	_	_	_	_	O
6	therapy	_	therapy	_	NN	64	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	64	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	64	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	64	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	64	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	64	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	64	_	_	_	_	_	_	_	O

1	algorithm	_	UNK	_	NNP	64	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	64	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	64	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	NN	64	_	_	_	_	_	_	_	O
5	lowering	_	lower	_	VBG	64	_	_	_	_	_	_	_	O
6	therapy	_	therapy	_	NN	64	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	64	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	64	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	64	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	64	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	64	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	64	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	65	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	65	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	65	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	65	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	65	_	_	_	_	_	_	_	O
6	:	_	:	_	:	65	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	65	_	_	_	_	_	_	_	O
8	(	_	(	_	(	65	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	65	_	_	_	_	_	_	_	O
10	)	_	)	_	)	65	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	65	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	65	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	65	_	_	_	_	_	_	_	O
14	)	_	)	_	)	65	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	65	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	65	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	65	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	65	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	65	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	65	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	65	_	_	_	_	_	_	_	O
8	(	_	(	_	(	65	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	65	_	_	_	_	_	_	_	O
10	)	_	)	_	)	65	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	65	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	65	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	65	_	_	_	_	_	_	_	O
14	)	_	)	_	)	65	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	66	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	66	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	66	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	66	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
12	,	_	,	_	,	66	_	_	_	_	_	_	_	O
13	review	_	review	_	VBP	66	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
15	dose	_	dose	_	NN	66	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	66	_	_	_	_	_	_	_	O
17	metformin	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
18	if	_	if	_	IN	66	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
20	estimated	_	estimate	_	VBN	66	_	_	_	_	_	_	_	O
21	glomerular	_	UNK	_	JJ	66	_	_	_	_	_	_	_	O
22	filtration	_	filtration	_	NN	66	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	66	_	_	_	_	_	_	_	O
24	(	_	(	_	(	66	_	_	_	_	_	_	_	O
25	egfr	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
26	)	_	)	_	)	66	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	66	_	_	_	_	_	_	_	O
28	below	_	below	_	IN	66	_	_	_	_	_	_	_	O
29	45	_	45	_	CD	66	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
32	:	_	:	_	:	66	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	66	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	66	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	66	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	66	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	66	_	_	_	_	_	adult.n	People_by_age	S-Person
8	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
12	,	_	,	_	,	66	_	_	_	_	_	_	_	O
13	review	_	review	_	VBP	66	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
15	dose	_	dose	_	NN	66	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	66	_	_	_	_	_	_	_	O
17	metformin	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
18	if	_	if	_	IN	66	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
20	estimated	_	estimate	_	VBN	66	_	_	_	_	_	_	_	O
21	glomerular	_	UNK	_	JJ	66	_	_	_	_	_	_	_	O
22	filtration	_	filtration	_	NN	66	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	66	_	_	_	_	_	_	_	O
24	(	_	(	_	(	66	_	_	_	_	_	_	_	O
25	egfr	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
26	)	_	)	_	)	66	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	66	_	_	_	_	_	_	_	O
28	below	_	below	_	IN	66	_	_	_	_	_	_	_	O
29	45	_	45	_	CD	66	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
32	:	_	:	_	:	66	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	66	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	66	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	66	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	66	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	66	_	_	_	_	_	type.n	Type	S-Subtype
10	2	_	2	_	CD	66	_	_	_	_	_	_	_	B-Category
11	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	I-Category
12	,	_	,	_	,	66	_	_	_	_	_	_	_	O
13	review	_	review	_	VBP	66	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
15	dose	_	dose	_	NN	66	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	66	_	_	_	_	_	_	_	O
17	metformin	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
18	if	_	if	_	IN	66	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
20	estimated	_	estimate	_	VBN	66	_	_	_	_	_	_	_	O
21	glomerular	_	UNK	_	JJ	66	_	_	_	_	_	_	_	O
22	filtration	_	filtration	_	NN	66	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	66	_	_	_	_	_	_	_	O
24	(	_	(	_	(	66	_	_	_	_	_	_	_	O
25	egfr	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
26	)	_	)	_	)	66	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	66	_	_	_	_	_	_	_	O
28	below	_	below	_	IN	66	_	_	_	_	_	_	_	O
29	45	_	45	_	CD	66	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
32	:	_	:	_	:	66	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	66	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	66	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	66	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	66	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
12	,	_	,	_	,	66	_	_	_	_	_	_	_	O
13	review	_	review	_	VBP	66	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
15	dose	_	dose	_	NN	66	_	_	_	_	_	dose.n	Quantified_mass	S-Quantity
16	of	_	of	_	IN	66	_	_	_	_	_	_	_	B-Individuals
17	metformin	_	UNK	_	NN	66	_	_	_	_	_	_	_	I-Individuals
18	if	_	if	_	IN	66	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
20	estimated	_	estimate	_	VBN	66	_	_	_	_	_	_	_	O
21	glomerular	_	UNK	_	JJ	66	_	_	_	_	_	_	_	O
22	filtration	_	filtration	_	NN	66	_	_	_	_	_	_	_	O
23	rate	_	rate	_	NN	66	_	_	_	_	_	_	_	O
24	(	_	(	_	(	66	_	_	_	_	_	_	_	O
25	egfr	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
26	)	_	)	_	)	66	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	66	_	_	_	_	_	_	_	O
28	below	_	below	_	IN	66	_	_	_	_	_	_	_	O
29	45	_	45	_	CD	66	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
32	:	_	:	_	:	66	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	66	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	66	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	66	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	66	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
12	,	_	,	_	,	66	_	_	_	_	_	_	_	O
13	review	_	review	_	VBP	66	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
15	dose	_	dose	_	NN	66	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	66	_	_	_	_	_	_	_	O
17	metformin	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
18	if	_	if	_	IN	66	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
20	estimated	_	estimate	_	VBN	66	_	_	_	_	_	estimate.v	Estimating	O
21	glomerular	_	UNK	_	JJ	66	_	_	_	_	_	_	_	B-Estimation
22	filtration	_	filtration	_	NN	66	_	_	_	_	_	_	_	I-Estimation
23	rate	_	rate	_	NN	66	_	_	_	_	_	_	_	I-Estimation
24	(	_	(	_	(	66	_	_	_	_	_	_	_	O
25	egfr	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
26	)	_	)	_	)	66	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	66	_	_	_	_	_	_	_	O
28	below	_	below	_	IN	66	_	_	_	_	_	_	_	O
29	45	_	45	_	CD	66	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
32	:	_	:	_	:	66	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	66	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	66	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	66	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	66	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
12	,	_	,	_	,	66	_	_	_	_	_	_	_	O
13	review	_	review	_	VBP	66	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
15	dose	_	dose	_	NN	66	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	66	_	_	_	_	_	_	_	O
17	metformin	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
18	if	_	if	_	IN	66	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
20	estimated	_	estimate	_	VBN	66	_	_	_	_	_	_	_	O
21	glomerular	_	UNK	_	JJ	66	_	_	_	_	_	_	_	B-Entity
22	filtration	_	filtration	_	NN	66	_	_	_	_	_	_	_	I-Entity
23	rate	_	rate	_	NN	66	_	_	_	_	_	rate.n	Speed_description	S-Attribute
24	(	_	(	_	(	66	_	_	_	_	_	_	_	O
25	egfr	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
26	)	_	)	_	)	66	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	66	_	_	_	_	_	_	_	O
28	below	_	below	_	IN	66	_	_	_	_	_	_	_	O
29	45	_	45	_	CD	66	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
32	:	_	:	_	:	66	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	66	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	66	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	66	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	66	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	66	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
12	,	_	,	_	,	66	_	_	_	_	_	_	_	O
13	review	_	review	_	VBP	66	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
15	dose	_	dose	_	NN	66	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	66	_	_	_	_	_	_	_	O
17	metformin	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
18	if	_	if	_	IN	66	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	66	_	_	_	_	_	_	_	O
20	estimated	_	estimate	_	VBN	66	_	_	_	_	_	_	_	O
21	glomerular	_	UNK	_	JJ	66	_	_	_	_	_	_	_	B-Figure
22	filtration	_	filtration	_	NN	66	_	_	_	_	_	_	_	I-Figure
23	rate	_	rate	_	NN	66	_	_	_	_	_	_	_	I-Figure
24	(	_	(	_	(	66	_	_	_	_	_	_	_	I-Figure
25	egfr	_	UNK	_	NN	66	_	_	_	_	_	_	_	I-Figure
26	)	_	)	_	)	66	_	_	_	_	_	_	_	I-Figure
27	is	_	be	_	VBZ	66	_	_	_	_	_	_	_	O
28	below	_	below	_	IN	66	_	_	_	_	_	below.prep	Directional_locative_relation	O
29	45	_	45	_	CD	66	_	_	_	_	_	_	_	B-Ground
30	unk	_	UNK	_	NNS	66	_	_	_	_	_	_	_	I-Ground
31	unk	_	UNK	_	CD	66	_	_	_	_	_	_	_	I-Ground
32	:	_	:	_	:	66	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	caution.n	Statement	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	S-Protagonist
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	risk.n	Run_risk	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	B-Asset
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	I-Asset
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	I-Asset
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	I-Asset
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	I-Asset
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	I-Asset
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	I-Asset
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	S-Determinant
15	function	_	function	_	NN	67	_	_	_	_	_	function.n	Contingency	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	S-Protagonist
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	risk.n	Run_risk	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	B-Asset
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	I-Asset
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	S-Figure
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	below.prep	Directional_locative_relation	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	B-Ground
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	I-Ground
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	I-Ground
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	adult.n	People_by_age	S-Person
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	type.n	Type	S-Subtype
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	B-Category
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	I-Category
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	consider.v	Categorization	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	B-Item
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	I-Item
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	I-Item
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	S-Category
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	S-Patient
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	treatment.n	Cure	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	adult.n	People_by_age	S-Person
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	type.n	Type	S-Subtype
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	B-Category
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	I-Category
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	continue.v	Process_continue	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	S-Event
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	S-Agent
86	failure	_	failure	_	NN	67	_	_	_	_	_	failure.n	Success_or_failure	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	S-Participant
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	history.n	Individual_history	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	B-Participant
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	I-Participant
91	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	67	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	67	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	67	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	67	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	67	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	67	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	67	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	67	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	67	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	67	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	CD	67	_	_	_	_	_	_	_	O
27	.	_	.	_	.	67	_	_	_	_	_	_	_	O
28	3	_	3	_	CD	67	_	_	_	_	_	_	_	O
29	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
30	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
31	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
32	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
35	,	_	,	_	,	67	_	_	_	_	_	_	_	O
36	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
37	metformin	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
38	is	_	be	_	VBZ	67	_	_	_	_	_	_	_	O
39	contraindicated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
41	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
42	tolerated	_	UNK	_	VBN	67	_	_	_	_	_	_	_	O
43	,	_	,	_	,	67	_	_	_	_	_	_	_	O
44	consider	_	consider	_	VB	67	_	_	_	_	_	_	_	O
45	initial	_	initial	_	JJ	67	_	_	_	_	_	_	_	O
46	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	67	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
49	:	_	:	_	:	67	_	_	_	_	_	_	_	O
50	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
51	dipeptidyl	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
52	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
53	(	_	(	_	(	67	_	_	_	_	_	_	_	O
54	dpp-4	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
55	)	_	)	_	)	67	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
58	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
60	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
61	sulfonylurea	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
62	.	_	.	_	.	67	_	_	_	_	_	_	_	O
63	4	_	4	_	CD	67	_	_	_	_	_	_	_	O
64	in	_	In	_	IN	67	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
70	,	_	,	_	,	67	_	_	_	_	_	_	_	O
71	do	_	do	_	VBP	67	_	_	_	_	_	_	_	O
72	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
73	offer	_	offer	_	VB	67	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
75	continue	_	continue	_	VB	67	_	_	_	_	_	_	_	O
76	pioglitazone	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
77	if	_	if	_	IN	67	_	_	_	_	_	_	_	O
78	they	_	they	_	PRP	67	_	_	_	_	_	_	_	O
79	have	_	have	_	VBP	67	_	_	_	_	_	_	_	O
80	any	_	any	_	DT	67	_	_	_	_	_	_	_	O
81	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
82	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
83	following	_	following	_	NN	67	_	_	_	_	_	_	_	O
84	:	_	:	_	:	67	_	_	_	_	_	_	_	O
85	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	O
86	failure	_	failure	_	NN	67	_	_	_	_	_	_	_	O
87	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
88	history	_	history	_	NN	67	_	_	_	_	_	_	_	O
89	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
90	heart	_	heart	_	NN	67	_	_	_	_	_	_	_	S-Agent
91	failure	_	failure	_	NN	67	_	_	_	_	_	failure.n	Success_or_failure	O

1	type	_	Type	_	$	68	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	68	_	_	_	_	_	_	_	O
6	:	_	:	_	:	68	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	68	_	_	_	_	_	_	_	O
8	(	_	(	_	(	68	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
10	)	_	)	_	)	68	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	68	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	68	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
14	)	_	)	_	)	68	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	68	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	68	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	68	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	68	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	68	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	68	_	_	_	_	_	_	_	O
8	(	_	(	_	(	68	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
10	)	_	)	_	)	68	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	68	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	68	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
14	)	_	)	_	)	68	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
4	cotransporter	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	(	_	(	_	(	69	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
8	)	_	)	_	)	69	_	_	_	_	_	_	_	O
9	inhibitors	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
10	,	_	,	_	,	69	_	_	_	_	_	_	_	O
11	may	_	may	_	MD	69	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	69	_	_	_	_	_	_	_	O
13	appropriate	_	appropriate	_	JJ	69	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
15	some	_	some	_	DT	69	_	_	_	_	_	_	_	O
16	adults	_	adult	_	NNS	69	_	_	_	_	_	adult.n	People_by_age	S-Person
17	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
18	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
19	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
20	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
21	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
22	metformin	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	69	_	_	_	_	_	_	_	O
24	contraindicated	_	UNK	_	VBN	69	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
26	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
27	tolerated	_	UNK	_	VBN	69	_	_	_	_	_	_	_	O
28	(	_	(	_	(	69	_	_	_	_	_	_	_	O
29	see	_	see	_	VB	69	_	_	_	_	_	_	_	O
30	nice	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	69	_	_	_	_	_	_	_	O
32	guidance	_	guidance	_	NN	69	_	_	_	_	_	_	_	O
33	on	_	on	_	IN	69	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
35	,	_	,	_	,	69	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
38	unk	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
39	as	_	a	_	IN	69	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
41	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
42	treating	_	treat	_	VBG	69	_	_	_	_	_	_	_	O
43	type	_	type	_	NN	69	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
46	)	_	)	_	)	69	_	_	_	_	_	_	_	O
47	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
4	cotransporter	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	(	_	(	_	(	69	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
8	)	_	)	_	)	69	_	_	_	_	_	_	_	O
9	inhibitors	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
10	,	_	,	_	,	69	_	_	_	_	_	_	_	O
11	may	_	may	_	MD	69	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	69	_	_	_	_	_	_	_	O
13	appropriate	_	appropriate	_	JJ	69	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
15	some	_	some	_	DT	69	_	_	_	_	_	_	_	O
16	adults	_	adult	_	NNS	69	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
18	type	_	type	_	JJ	69	_	_	_	_	_	type.n	Type	S-Subtype
19	2	_	2	_	CD	69	_	_	_	_	_	_	_	B-Category
20	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	I-Category
21	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
22	metformin	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	69	_	_	_	_	_	_	_	O
24	contraindicated	_	UNK	_	VBN	69	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
26	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
27	tolerated	_	UNK	_	VBN	69	_	_	_	_	_	_	_	O
28	(	_	(	_	(	69	_	_	_	_	_	_	_	O
29	see	_	see	_	VB	69	_	_	_	_	_	_	_	O
30	nice	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	69	_	_	_	_	_	_	_	O
32	guidance	_	guidance	_	NN	69	_	_	_	_	_	_	_	O
33	on	_	on	_	IN	69	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
35	,	_	,	_	,	69	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
38	unk	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
39	as	_	a	_	IN	69	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
41	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
42	treating	_	treat	_	VBG	69	_	_	_	_	_	_	_	O
43	type	_	type	_	NN	69	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
46	)	_	)	_	)	69	_	_	_	_	_	_	_	O
47	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
4	cotransporter	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	(	_	(	_	(	69	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
8	)	_	)	_	)	69	_	_	_	_	_	_	_	O
9	inhibitors	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
10	,	_	,	_	,	69	_	_	_	_	_	_	_	O
11	may	_	may	_	MD	69	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	69	_	_	_	_	_	_	_	O
13	appropriate	_	appropriate	_	JJ	69	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
15	some	_	some	_	DT	69	_	_	_	_	_	_	_	O
16	adults	_	adult	_	NNS	69	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
18	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
19	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
20	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
21	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
22	metformin	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	69	_	_	_	_	_	_	_	O
24	contraindicated	_	UNK	_	VBN	69	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
26	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
27	tolerated	_	UNK	_	VBN	69	_	_	_	_	_	_	_	O
28	(	_	(	_	(	69	_	_	_	_	_	_	_	O
29	see	_	see	_	VB	69	_	_	_	_	_	_	_	O
30	nice	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	69	_	_	_	_	_	_	_	O
32	guidance	_	guidance	_	NN	69	_	_	_	_	_	_	_	O
33	on	_	on	_	IN	69	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
35	,	_	,	_	,	69	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
38	unk	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
39	as	_	a	_	IN	69	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
41	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
42	treating	_	treat	_	VBG	69	_	_	_	_	_	treat.v	Medical_intervention	O
43	type	_	type	_	NN	69	_	_	_	_	_	_	_	B-Patient
44	2	_	2	_	CD	69	_	_	_	_	_	_	_	I-Patient
45	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	I-Patient
46	)	_	)	_	)	69	_	_	_	_	_	_	_	O
47	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
4	cotransporter	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	(	_	(	_	(	69	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
8	)	_	)	_	)	69	_	_	_	_	_	_	_	O
9	inhibitors	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
10	,	_	,	_	,	69	_	_	_	_	_	_	_	O
11	may	_	may	_	MD	69	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	69	_	_	_	_	_	_	_	O
13	appropriate	_	appropriate	_	JJ	69	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
15	some	_	some	_	DT	69	_	_	_	_	_	_	_	O
16	adults	_	adult	_	NNS	69	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
18	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
19	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
20	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
21	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
22	metformin	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	69	_	_	_	_	_	_	_	O
24	contraindicated	_	UNK	_	VBN	69	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
26	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
27	tolerated	_	UNK	_	VBN	69	_	_	_	_	_	_	_	O
28	(	_	(	_	(	69	_	_	_	_	_	_	_	O
29	see	_	see	_	VB	69	_	_	_	_	_	_	_	O
30	nice	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	69	_	_	_	_	_	_	_	O
32	guidance	_	guidance	_	NN	69	_	_	_	_	_	_	_	O
33	on	_	on	_	IN	69	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
35	,	_	,	_	,	69	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
38	unk	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
39	as	_	a	_	IN	69	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
41	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
42	treating	_	treat	_	VBG	69	_	_	_	_	_	_	_	O
43	type	_	type	_	NN	69	_	_	_	_	_	type.n	Type	S-Subtype
44	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
46	)	_	)	_	)	69	_	_	_	_	_	_	_	O
47	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	B-Category
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	I-Category
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	S-Patient
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	treatment.n	Cure	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	B-Event
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	I-Event
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	I-Event
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	I-Event
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Event
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	continue.v	Process_continue	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	B-Event
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	I-Event
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	I-Event
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	I-Event
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	I-Event
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	I-Event
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	I-Event
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	I-Event
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	I-Event
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	I-Event
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Event
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	I-Event
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Event
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	B-Controlling_entity
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	I-Controlling_entity
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	I-Controlling_entity
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	I-Controlling_entity
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Controlling_entity
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	control.v	Being_in_control	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	B-Dependent_entity
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	I-Dependent_entity
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	I-Dependent_entity
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	I-Dependent_entity
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	I-Dependent_entity
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	I-Dependent_entity
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	I-Dependent_entity
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	I-Dependent_entity
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Dependent_entity
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	I-Dependent_entity
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Dependent_entity
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	below.prep	Directional_locative_relation	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	B-Ground
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	I-Ground
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	I-Ground
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	I-Ground
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	I-Ground
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Ground
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	I-Ground
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Ground
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	person.n	People	S-Person
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	B-Party_1
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	I-Party_1
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	I-Party_1
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	S-Parties
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	agree.v	Make_agreement_on_action	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	B-Obligation
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	I-Obligation
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Obligation
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	consider.v	Categorization	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	B-Item
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	I-Item
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	S-Category
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	S-Entity
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	adult.n	People_by_age	S-Person
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	type.n	Type	S-Subtype
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	B-Category
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	I-Category
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	B-Activity
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	I-Activity
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	I-Activity
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	continue.v	Activity_ongoing	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	B-Activity
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	I-Activity
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	I-Activity
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	I-Activity
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	I-Activity
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	I-Activity
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	I-Activity
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	I-Activity
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	I-Activity
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	I-Activity
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Activity
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	I-Activity
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Activity
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	control.v	Being_in_control	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	B-Dependent_entity
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	I-Dependent_entity
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	I-Dependent_entity
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	I-Dependent_entity
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	I-Dependent_entity
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	I-Dependent_entity
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	I-Dependent_entity
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	I-Dependent_entity
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Dependent_entity
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	I-Dependent_entity
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Dependent_entity
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	person.n	People	S-Person
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	B-Party_1
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	I-Party_1
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	I-Party_1
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	S-Parties
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	agree.v	Make_agreement_on_action	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	B-Obligation
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	I-Obligation
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Obligation
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	consider.v	Categorization	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	B-Item
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	I-Item
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	S-Category
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	B-Category
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	I-Category
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Category
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	I-Category
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Category
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	I-Category
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	I-Category
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	I-Category
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Category
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	I-Category
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	I-Category
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Category
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	I-Category
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Category
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	I-Category
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	I-Category
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	I-Category
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	S-Entity
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	70	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	70	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
6	5	_	5	_	CD	70	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
13	,	_	,	_	,	70	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
15	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
19	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
20	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
22	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
24	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
27	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
31	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
32	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
33	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
35	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
36	,	_	,	_	,	70	_	_	_	_	_	_	_	O
37	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	70	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
41	:	_	:	_	:	70	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
44	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
45	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
46	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
47	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
48	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
49	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
50	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
53	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
55	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
56	.	_	.	_	.	70	_	_	_	_	_	_	_	O
57	6	_	6	_	CD	70	_	_	_	_	_	_	_	O
58	in	_	In	_	IN	70	_	_	_	_	_	_	_	O
59	adults	_	adult	_	NNS	70	_	_	_	_	_	_	_	O
60	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
61	type	_	type	_	JJ	70	_	_	_	_	_	_	_	O
62	2	_	2	_	CD	70	_	_	_	_	_	_	_	O
63	diabetes	_	UNK	_	NNS	70	_	_	_	_	_	_	_	O
64	,	_	,	_	,	70	_	_	_	_	_	_	_	O
65	if	_	if	_	IN	70	_	_	_	_	_	_	_	O
66	metformin	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
67	is	_	be	_	VBZ	70	_	_	_	_	_	_	_	O
68	contraindicated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
69	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
70	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
71	tolerated	_	UNK	_	VBN	70	_	_	_	_	_	_	_	O
72	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
73	initial	_	initial	_	JJ	70	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	70	_	_	_	_	_	_	_	O
75	treatment	_	treatment	_	NN	70	_	_	_	_	_	_	_	O
76	has	_	have	_	VBZ	70	_	_	_	_	_	_	_	O
77	not	_	not	_	RB	70	_	_	_	_	_	_	_	O
78	continued	_	continue	_	VBN	70	_	_	_	_	_	_	_	O
79	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
80	control	_	control	_	VB	70	_	_	_	_	_	_	_	O
81	hba1c	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
82	to	_	to	_	TO	70	_	_	_	_	_	_	_	O
83	below	_	below	_	VB	70	_	_	_	_	_	_	_	O
84	the	_	the	_	DT	70	_	_	_	_	_	_	_	O
85	person	_	person	_	NN	70	_	_	_	_	_	_	_	O
86	's	_	's	_	POS	70	_	_	_	_	_	_	_	O
87	individually	_	UNK	_	RB	70	_	_	_	_	_	_	_	O
88	agreed	_	agree	_	VBN	70	_	_	_	_	_	_	_	O
89	threshold	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	70	_	_	_	_	_	_	_	O
91	intensification	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
92	,	_	,	_	,	70	_	_	_	_	_	_	_	O
93	consider	_	consider	_	VB	70	_	_	_	_	_	_	_	O
94	dual	_	dual	_	JJ	70	_	_	_	_	_	_	_	O
95	therapy	_	therapy	_	NN	70	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
96	with	_	with	_	IN	70	_	_	_	_	_	_	_	O
97	:	_	:	_	:	70	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
99	dpp-4	_	UNK	_	NNP	70	_	_	_	_	_	_	_	O
100	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
101	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
102	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
103	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
104	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
105	dpp-4	_	UNK	_	JJ	70	_	_	_	_	_	_	_	O
106	inhibitor	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
107	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
108	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
109	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
110	or	_	or	_	CC	70	_	_	_	_	_	_	_	O
111	pioglitazone	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
112	and	_	and	_	CC	70	_	_	_	_	_	_	_	O
113	a	_	a	_	DT	70	_	_	_	_	_	_	_	O
114	sulfonylurea	_	UNK	_	NN	70	_	_	_	_	_	_	_	O
115	.	_	.	_	.	70	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	71	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	71	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	71	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	71	_	_	_	_	_	_	_	O
6	:	_	:	_	:	71	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	71	_	_	_	_	_	_	_	O
8	(	_	(	_	(	71	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	71	_	_	_	_	_	_	_	O
10	)	_	)	_	)	71	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	71	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	71	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
14	)	_	)	_	)	71	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	71	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	71	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	71	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	71	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	71	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	71	_	_	_	_	_	_	_	O
8	(	_	(	_	(	71	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	71	_	_	_	_	_	_	_	O
10	)	_	)	_	)	71	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	71	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	71	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
14	)	_	)	_	)	71	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	S-Patient
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	treatment.n	Cure	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	B-Category
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	I-Category
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	S-Entity
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	S-Type
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	another.n	Increment	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	B-Class
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	I-Class
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	B-Agent
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	I-Agent
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	I-Agent
23	(	_	(	_	(	72	_	_	_	_	_	_	_	I-Agent
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	I-Agent
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Agent
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	I-Agent
27	)	_	)	_	)	72	_	_	_	_	_	_	_	I-Agent
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	continue.v	Activity_ongoing	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	B-Activity
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	I-Activity
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	I-Activity
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	I-Activity
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	I-Activity
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	I-Activity
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	I-Activity
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	I-Activity
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	I-Activity
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	I-Activity
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Activity
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	I-Activity
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Activity
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	B-Controlling_entity
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	I-Controlling_entity
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	I-Controlling_entity
23	(	_	(	_	(	72	_	_	_	_	_	_	_	I-Controlling_entity
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	I-Controlling_entity
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Controlling_entity
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	I-Controlling_entity
27	)	_	)	_	)	72	_	_	_	_	_	_	_	I-Controlling_entity
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	control.v	Being_in_control	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	B-Dependent_entity
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	I-Dependent_entity
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	I-Dependent_entity
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	I-Dependent_entity
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	I-Dependent_entity
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	I-Dependent_entity
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	I-Dependent_entity
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	I-Dependent_entity
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Dependent_entity
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	I-Dependent_entity
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Dependent_entity
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	B-Figure
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	I-Figure
23	(	_	(	_	(	72	_	_	_	_	_	_	_	I-Figure
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	I-Figure
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Figure
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	I-Figure
27	)	_	)	_	)	72	_	_	_	_	_	_	_	I-Figure
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	below.prep	Directional_locative_relation	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	B-Ground
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	I-Ground
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	person.n	People	S-Person
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	B-Party_1
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	I-Party_1
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	I-Party_1
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	S-Parties
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	agree.v	Make_agreement_on_action	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	B-Obligation
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	I-Obligation
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Obligation
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	consider.v	Categorization	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	S-Category
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	B-Agent
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	I-Agent
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Agent
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	I-Agent
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	I-Agent
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Agent
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	I-Agent
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Agent
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	start.v	Activity_start	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	B-Activity
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	I-Activity
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	treatment.n	Cure	S-Patient
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	other.a	Increment	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	B-Class
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	I-Class
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	S-Descriptor
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	B-Entity
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	I-Entity
93	)	_	)	_	)	72	_	_	_	_	_	_	_	I-Entity
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	effective.a	Usefulness	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	consider.v	Categorization	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	B-Category
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	I-Category
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	I-Category
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Category
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	adult.n	People_by_age	S-Person
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	type.n	Type	S-Subtype
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	people.n	People	S-Person
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	S-Entity
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	black.a	Color	S-Color
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	other.a	Increment	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	B-Class
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	I-Class
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	I-Class
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	B-Aggregate_property
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	I-Aggregate_property
148	groups	_	group	_	NNS	72	_	_	_	_	_	group.n	Aggregate	S-Aggregate
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	other.a	Increment	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	B-Class
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	I-Class
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	S-Experiencer
156	problems	_	problem	_	NNS	72	_	_	_	_	_	problem.n	Predicament	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	B-Partner_1
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	I-Partner_1
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	I-Partner_1
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	I-Partner_1
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	I-Partner_1
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	I-Partner_1
149	)	_	)	_	)	72	_	_	_	_	_	_	_	I-Partner_1
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	I-Partner_1
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	I-Partner_1
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	I-Partner_1
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	I-Partner_1
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	I-Partner_1
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	I-Partner_1
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	I-Partner_1
157	associated	_	associate	_	VBN	72	_	_	_	_	_	associate.v	Collaboration	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	B-Partner_2
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	I-Partner_2
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	I-Partner_2
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	I-Partner_2
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	I-Partner_2
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	I-Partner_2
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	I-Partner_2
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	I-Partner_2
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	I-Partner_2
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Partner_2
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	significant.a	Importance	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	B-Factor
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	I-Factor
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	weight.n	Dimension	S-Dimension
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	other.a	Increment	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	B-Class
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	I-Class
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	I-Class
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	significant.a	Importance	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	B-Factor
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	I-Factor
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	S-Agent
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	continue.v	Activity_ongoing	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	B-Activity
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	I-Activity
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	I-Activity
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	person.n	People	S-Person
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	type.n	Type	S-Subtype
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	S-Trigger
206	response	_	response	_	NN	72	_	_	_	_	_	response.n	Response	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	_	_	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	72	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
6	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
7	in	_	In	_	IN	72	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
13	,	_	,	_	,	72	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
15	dual	_	dual	_	JJ	72	_	_	_	_	_	_	_	O
16	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
18	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
20	another	_	another	_	DT	72	_	_	_	_	_	_	_	O
21	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
22	drug	_	drug	_	NN	72	_	_	_	_	_	_	_	O
23	(	_	(	_	(	72	_	_	_	_	_	_	_	O
24	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
25	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
26	5	_	5	_	CD	72	_	_	_	_	_	_	_	O
27	)	_	)	_	)	72	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	72	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	72	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	72	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	72	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	72	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
44	,	_	,	_	,	72	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
46	either	_	either	_	DT	72	_	_	_	_	_	_	_	O
47	:	_	:	_	:	72	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
50	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
51	:	_	:	_	:	72	_	_	_	_	_	_	_	O
52	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
53	,	_	,	_	,	72	_	_	_	_	_	_	_	O
54	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
55	dpp-4	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
56	inhibitor	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
61	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
62	,	_	,	_	,	72	_	_	_	_	_	_	_	O
63	pioglitazone	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
64	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
65	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
66	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
67	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
68	starting	_	start	_	VBG	72	_	_	_	_	_	_	_	O
69	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
70	treatment	_	treatment	_	NN	72	_	_	_	_	_	_	_	O
71	(	_	(	_	(	72	_	_	_	_	_	_	_	O
72	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
73	recommendations	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
75	4	_	4	_	CD	72	_	_	_	_	_	_	_	O
76	)	_	)	_	)	72	_	_	_	_	_	_	_	O
77	.	_	.	_	.	72	_	_	_	_	_	_	_	O
78	8	_	8	_	CD	72	_	_	_	_	_	_	_	O
79	if	_	If	_	IN	72	_	_	_	_	_	_	_	O
80	triple	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
81	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
82	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
83	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
84	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
86	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
87	oral	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
88	drugs	_	drug	_	NNS	72	_	_	_	_	_	_	_	O
89	(	_	(	_	(	72	_	_	_	_	_	_	_	O
90	see	_	see	_	VB	72	_	_	_	_	_	_	_	O
91	recommendation	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
92	7	_	7	_	CD	72	_	_	_	_	_	_	_	O
93	)	_	)	_	)	72	_	_	_	_	_	_	_	O
94	is	_	be	_	VBZ	72	_	_	_	_	_	_	_	O
95	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
96	effective	_	effective	_	JJ	72	_	_	_	_	_	_	_	O
97	,	_	,	_	,	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	tolerated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
100	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
101	contraindicated	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
102	,	_	,	_	,	72	_	_	_	_	_	_	_	O
103	consider	_	consider	_	VB	72	_	_	_	_	_	_	_	O
104	combination	_	combination	_	NN	72	_	_	_	_	_	_	_	O
105	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	metformin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
108	,	_	,	_	,	72	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
110	sulfonylurea	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
111	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
113	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
114	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
115	(	_	(	_	(	72	_	_	_	_	_	_	_	O
116	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
117	)	_	)	_	)	72	_	_	_	_	_	_	_	O
118	mimetic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
119	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
120	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
121	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
122	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
123	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
124	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
125	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
126	:	_	:	_	:	72	_	_	_	_	_	_	_	O
127	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
128	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
129	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
130	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
131	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
132	kg/m2	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
133	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
134	higher	_	higher	_	JJR	72	_	_	_	_	_	_	_	O
135	(	_	(	_	(	72	_	_	_	_	_	_	_	O
136	adjust	_	UNK	_	VBP	72	_	_	_	_	_	_	_	O
137	accordingly	_	accordingly	_	RB	72	_	_	_	_	_	_	_	O
138	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
139	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
140	from	_	from	_	IN	72	_	_	_	_	_	_	_	O
141	black	_	black	_	JJ	72	_	_	_	_	_	_	_	O
142	,	_	,	_	,	72	_	_	_	_	_	_	_	O
143	asian	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
144	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
145	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
146	minority	_	minority	_	NN	72	_	_	_	_	_	_	_	O
147	ethnic	_	ethnic	_	JJ	72	_	_	_	_	_	_	_	O
148	groups	_	group	_	NNS	72	_	_	_	_	_	_	_	O
149	)	_	)	_	)	72	_	_	_	_	_	_	_	O
150	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
151	specific	_	specific	_	JJ	72	_	_	_	_	_	_	_	O
152	psychological	_	psychological	_	JJ	72	_	_	_	_	_	_	_	O
153	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
154	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
155	medical	_	medical	_	JJ	72	_	_	_	_	_	_	_	O
156	problems	_	problem	_	NNS	72	_	_	_	_	_	_	_	O
157	associated	_	associate	_	VBN	72	_	_	_	_	_	_	_	O
158	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
159	obesity	_	obesity	_	NN	72	_	_	_	_	_	_	_	O
160	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
161	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
162	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
163	bmi	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
164	lower	_	lower	_	JJR	72	_	_	_	_	_	_	_	O
165	than	_	than	_	IN	72	_	_	_	_	_	_	_	O
166	35	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
167	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
168	:	_	:	_	:	72	_	_	_	_	_	_	_	O
169	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
170	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
171	insulin	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
172	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
173	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
174	have	_	have	_	VB	72	_	_	_	_	_	_	_	O
175	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
176	occupational	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
177	implications	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
178	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
179	weight	_	weight	_	JJ	72	_	_	_	_	_	_	_	O
180	loss	_	loss	_	NN	72	_	_	_	_	_	_	_	O
181	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
182	benefit	_	benefit	_	VB	72	_	_	_	_	_	_	_	O
183	other	_	other	_	JJ	72	_	_	_	_	_	_	_	O
184	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
185	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
186	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
187	.	_	.	_	.	72	_	_	_	_	_	_	_	O
188	9	_	9	_	CD	72	_	_	_	_	_	_	_	O
189	only	_	Only	_	RB	72	_	_	_	_	_	_	_	O
190	continue	_	continue	_	VB	72	_	_	_	_	_	_	_	O
191	glp-1	_	UNK	_	NNP	72	_	_	_	_	_	_	_	O
192	mimetic	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
193	therapy	_	therapy	_	NN	72	_	_	_	_	_	_	_	O
194	if	_	if	_	IN	72	_	_	_	_	_	_	_	O
195	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
196	person	_	person	_	NN	72	_	_	_	_	_	_	_	O
197	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
198	type	_	type	_	NN	72	_	_	_	_	_	_	_	O
199	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
200	diabetes	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
201	has	_	have	_	VBZ	72	_	_	_	_	_	_	_	O
202	had	_	have	_	VBN	72	_	_	_	_	_	_	_	O
203	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
204	beneficial	_	beneficial	_	JJ	72	_	_	_	_	_	_	_	O
205	metabolic	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
206	response	_	response	_	NN	72	_	_	_	_	_	_	_	O
207	(	_	(	_	(	72	_	_	_	_	_	_	_	O
208	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
209	reduction	_	reduction	_	NN	72	_	_	_	_	_	reduction.n	Cause_change_of_position_on_a_scale	O
210	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
211	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
212	least	_	least	_	JJS	72	_	_	_	_	_	_	_	O
213	11	_	11	_	CD	72	_	_	_	_	_	_	_	O
214	unk	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
215	[	_	[	_	CD	72	_	_	_	_	_	_	_	O
216	%	_	%	_	NN	72	_	_	_	_	_	_	_	O
217	]	_	]	_	NN	72	_	_	_	_	_	_	_	O
218	in	_	in	_	IN	72	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	weight.n	Dimension	S-Dimension
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	S-Competition
5	loss	_	loss	_	NN	73	_	_	_	_	_	loss.n	Finish_competition	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	at.prep	Temporal_collocation	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	initial.a	Version_sequence	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	S-Item
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	S-Aggregate_property
13	body	_	body	_	NN	73	_	_	_	_	_	body.n	Aggregate	S-Aggregate
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	S-Object
14	weight	_	weight	_	VBD	73	_	_	_	_	_	weight.n	Dimension	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	B-Measurement
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	I-Measurement
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	I-Measurement
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	S-Count
17	months	_	month	_	NNS	73	_	_	_	_	_	month.n	Calendric_unit	S-Unit
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	adult.n	People_by_age	S-Person
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	type.n	Type	S-Subtype
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	B-Category
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	I-Category
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	S-Entity
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	B-Descriptor
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	I-Descriptor
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	B-Agent
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	I-Agent
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	I-Agent
44	(	_	(	_	(	73	_	_	_	_	_	_	_	I-Agent
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	I-Agent
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	I-Agent
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	I-Agent
48	)	_	)	_	)	73	_	_	_	_	_	_	_	I-Agent
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	continue.v	Activity_ongoing	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	B-Activity
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	I-Activity
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	I-Activity
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	I-Activity
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	I-Activity
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	I-Activity
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	I-Activity
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	I-Activity
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	I-Activity
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	I-Activity
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	I-Activity
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	I-Activity
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	I-Activity
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	B-Controlling_entity
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	I-Controlling_entity
48	)	_	)	_	)	73	_	_	_	_	_	_	_	I-Controlling_entity
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	control.v	Being_in_control	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	B-Dependent_entity
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	I-Dependent_entity
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	I-Dependent_entity
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	I-Dependent_entity
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	I-Dependent_entity
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	I-Dependent_entity
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	I-Dependent_entity
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	I-Dependent_entity
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	I-Dependent_entity
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	I-Dependent_entity
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	I-Dependent_entity
65	,	_	,	_	,	73	_	_	_	_	_	_	_	I-Dependent_entity
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	I-Dependent_entity
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	I-Dependent_entity
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	I-Dependent_entity
69	(	_	(	_	(	73	_	_	_	_	_	_	_	I-Dependent_entity
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	I-Dependent_entity
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	I-Dependent_entity
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	I-Dependent_entity
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	I-Dependent_entity
74	)	_	)	_	)	73	_	_	_	_	_	_	_	I-Dependent_entity
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	B-Figure
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	I-Figure
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	I-Figure
44	(	_	(	_	(	73	_	_	_	_	_	_	_	I-Figure
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	I-Figure
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	I-Figure
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	I-Figure
48	)	_	)	_	)	73	_	_	_	_	_	_	_	I-Figure
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	below.prep	Directional_locative_relation	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	B-Ground
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	I-Ground
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	I-Ground
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	I-Ground
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	I-Ground
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	I-Ground
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	I-Ground
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	I-Ground
65	,	_	,	_	,	73	_	_	_	_	_	_	_	I-Ground
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	I-Ground
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	I-Ground
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	I-Ground
69	(	_	(	_	(	73	_	_	_	_	_	_	_	I-Ground
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	I-Ground
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	I-Ground
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	I-Ground
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	I-Ground
74	)	_	)	_	)	73	_	_	_	_	_	_	_	I-Ground
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	person.n	People	S-Person
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	B-Party_1
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	I-Party_1
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	I-Party_1
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	S-Parties
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	agree.v	Make_agreement_on_action	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	B-Obligation
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	I-Obligation
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	I-Obligation
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	O
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	73	_	_	_	_	_	_	_	O
4	weight	_	weight	_	JJ	73	_	_	_	_	_	_	_	O
5	loss	_	loss	_	NN	73	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	73	_	_	_	_	_	_	_	O
8	least	_	least	_	JJS	73	_	_	_	_	_	_	_	O
9	3	_	3	_	CD	73	_	_	_	_	_	_	_	O
10	%	_	%	_	NN	73	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	73	_	_	_	_	_	_	_	O
12	initial	_	initial	_	JJ	73	_	_	_	_	_	_	_	O
13	body	_	body	_	NN	73	_	_	_	_	_	_	_	O
14	weight	_	weight	_	VBD	73	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	73	_	_	_	_	_	_	_	O
16	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
17	months	_	month	_	NNS	73	_	_	_	_	_	_	_	O
18	)	_	)	_	)	73	_	_	_	_	_	_	_	O
19	.	_	.	_	.	73	_	_	_	_	_	_	_	O
20	0	_	0	_	CD	73	_	_	_	_	_	_	_	O
21	in	_	In	_	IN	73	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
27	,	_	,	_	,	73	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
29	metformin	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
31	contraindicated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
32	or	_	or	_	CC	73	_	_	_	_	_	_	_	O
33	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
34	tolerated	_	UNK	_	VBN	73	_	_	_	_	_	_	_	O
35	,	_	,	_	,	73	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
37	if	_	if	_	IN	73	_	_	_	_	_	_	_	O
38	dual	_	dual	_	JJ	73	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	73	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
41	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
42	oral	_	UNK	_	JJ	73	_	_	_	_	_	_	_	O
43	drugs	_	drug	_	NNS	73	_	_	_	_	_	_	_	O
44	(	_	(	_	(	73	_	_	_	_	_	_	_	O
45	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
46	recommendation	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
47	6	_	6	_	CD	73	_	_	_	_	_	_	_	O
48	)	_	)	_	)	73	_	_	_	_	_	_	_	O
49	has	_	have	_	VBZ	73	_	_	_	_	_	_	_	O
50	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
51	continued	_	continue	_	VBN	73	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
53	control	_	control	_	VB	73	_	_	_	_	_	_	_	O
54	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
56	below	_	below	_	VB	73	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	73	_	_	_	_	_	_	_	O
58	person	_	person	_	NN	73	_	_	_	_	_	_	_	O
59	's	_	's	_	POS	73	_	_	_	_	_	_	_	O
60	individually	_	UNK	_	RB	73	_	_	_	_	_	_	_	O
61	agreed	_	agree	_	VBN	73	_	_	_	_	_	_	_	O
62	threshold	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
63	for	_	for	_	IN	73	_	_	_	_	_	_	_	O
64	intensification	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
65	,	_	,	_	,	73	_	_	_	_	_	_	_	O
66	consider	_	consider	_	VB	73	_	_	_	_	_	consider.v	Categorization	O
67	unk	_	UNK	_	JJ	73	_	_	_	_	_	_	_	B-Item
68	treatment	_	treatment	_	NN	73	_	_	_	_	_	_	_	I-Item
69	(	_	(	_	(	73	_	_	_	_	_	_	_	O
70	see	_	see	_	VB	73	_	_	_	_	_	_	_	O
71	recommendations	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
72	unk	_	UNK	_	CD	73	_	_	_	_	_	_	_	O
73	4	_	4	_	CD	73	_	_	_	_	_	_	_	O
74	)	_	)	_	)	73	_	_	_	_	_	_	_	O
75	.	_	.	_	.	73	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	74	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	74	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	74	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	74	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	74	_	_	_	_	_	_	_	O
6	:	_	:	_	:	74	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	74	_	_	_	_	_	_	_	O
8	(	_	(	_	(	74	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
10	)	_	)	_	)	74	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	74	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	74	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	74	_	_	_	_	_	_	_	O
14	)	_	)	_	)	74	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	74	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	74	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	74	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	74	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	74	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	74	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	74	_	_	_	_	_	_	_	O
8	(	_	(	_	(	74	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
10	)	_	)	_	)	74	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	74	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	74	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	74	_	_	_	_	_	_	_	O
14	)	_	)	_	)	74	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	75	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	75	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	75	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	75	_	_	_	_	_	_	_	O
5	1	_	1	_	CD	75	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	75	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	75	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	75	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
12	,	_	,	_	,	75	_	_	_	_	_	_	_	O
13	only	_	only	_	RB	75	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VBP	75	_	_	_	_	_	_	_	O
15	a	_	a	_	DT	75	_	_	_	_	_	_	_	O
16	glp-1	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
17	mimetic	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	75	_	_	_	_	_	_	_	O
19	combination	_	combination	_	NN	75	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
23	specialist	_	specialist	_	NN	75	_	_	_	_	_	_	_	O
24	care	_	care	_	NN	75	_	_	_	_	_	_	_	O
25	advice	_	advice	_	NN	75	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	75	_	_	_	_	_	_	_	O
27	ongoing	_	ongoing	_	VBG	75	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	75	_	_	_	_	_	_	_	O
29	from	_	from	_	IN	75	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	75	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	JJ	75	_	_	_	_	_	_	_	O
32	multidisciplinary	_	UNK	_	JJ	75	_	_	_	_	_	_	_	O
33	team	_	team	_	NN	75	_	_	_	_	_	_	_	O
34	.	_	.	_	.	75	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	75	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	75	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	75	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	75	_	_	_	_	_	_	_	O
5	1	_	1	_	CD	75	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	75	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	75	_	_	_	_	_	adult.n	People_by_age	S-Person
8	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	75	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
12	,	_	,	_	,	75	_	_	_	_	_	_	_	O
13	only	_	only	_	RB	75	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VBP	75	_	_	_	_	_	_	_	O
15	a	_	a	_	DT	75	_	_	_	_	_	_	_	O
16	glp-1	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
17	mimetic	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	75	_	_	_	_	_	_	_	O
19	combination	_	combination	_	NN	75	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
23	specialist	_	specialist	_	NN	75	_	_	_	_	_	_	_	O
24	care	_	care	_	NN	75	_	_	_	_	_	_	_	O
25	advice	_	advice	_	NN	75	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	75	_	_	_	_	_	_	_	O
27	ongoing	_	ongoing	_	VBG	75	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	75	_	_	_	_	_	_	_	O
29	from	_	from	_	IN	75	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	75	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	JJ	75	_	_	_	_	_	_	_	O
32	multidisciplinary	_	UNK	_	JJ	75	_	_	_	_	_	_	_	O
33	team	_	team	_	NN	75	_	_	_	_	_	_	_	O
34	.	_	.	_	.	75	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	75	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	75	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	75	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	75	_	_	_	_	_	_	_	O
5	1	_	1	_	CD	75	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	75	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	75	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	75	_	_	_	_	_	type.n	Type	S-Subtype
10	2	_	2	_	CD	75	_	_	_	_	_	_	_	B-Category
11	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	I-Category
12	,	_	,	_	,	75	_	_	_	_	_	_	_	O
13	only	_	only	_	RB	75	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VBP	75	_	_	_	_	_	_	_	O
15	a	_	a	_	DT	75	_	_	_	_	_	_	_	O
16	glp-1	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
17	mimetic	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	75	_	_	_	_	_	_	_	O
19	combination	_	combination	_	NN	75	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
23	specialist	_	specialist	_	NN	75	_	_	_	_	_	_	_	O
24	care	_	care	_	NN	75	_	_	_	_	_	_	_	O
25	advice	_	advice	_	NN	75	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	75	_	_	_	_	_	_	_	O
27	ongoing	_	ongoing	_	VBG	75	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	75	_	_	_	_	_	_	_	O
29	from	_	from	_	IN	75	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	75	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	JJ	75	_	_	_	_	_	_	_	O
32	multidisciplinary	_	UNK	_	JJ	75	_	_	_	_	_	_	_	O
33	team	_	team	_	NN	75	_	_	_	_	_	_	_	O
34	.	_	.	_	.	75	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	75	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	75	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	75	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	75	_	_	_	_	_	_	_	O
5	1	_	1	_	CD	75	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	75	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	75	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	75	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
12	,	_	,	_	,	75	_	_	_	_	_	_	_	O
13	only	_	only	_	RB	75	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VBP	75	_	_	_	_	_	_	_	O
15	a	_	a	_	DT	75	_	_	_	_	_	_	_	O
16	glp-1	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
17	mimetic	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	75	_	_	_	_	_	_	_	O
19	combination	_	combination	_	NN	75	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
23	specialist	_	specialist	_	NN	75	_	_	_	_	_	_	_	O
24	care	_	care	_	NN	75	_	_	_	_	_	_	_	O
25	advice	_	advice	_	NN	75	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	75	_	_	_	_	_	_	_	O
27	ongoing	_	ongoing	_	VBG	75	_	_	_	_	_	ongoing.a	Process_continue	O
28	support	_	support	_	NN	75	_	_	_	_	_	_	_	S-Event
29	from	_	from	_	IN	75	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	75	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	JJ	75	_	_	_	_	_	_	_	O
32	multidisciplinary	_	UNK	_	JJ	75	_	_	_	_	_	_	_	O
33	team	_	team	_	NN	75	_	_	_	_	_	_	_	O
34	.	_	.	_	.	75	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	75	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	75	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	75	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	75	_	_	_	_	_	_	_	O
5	1	_	1	_	CD	75	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	75	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	75	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	75	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
12	,	_	,	_	,	75	_	_	_	_	_	_	_	O
13	only	_	only	_	RB	75	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VBP	75	_	_	_	_	_	_	_	O
15	a	_	a	_	DT	75	_	_	_	_	_	_	_	O
16	glp-1	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
17	mimetic	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	75	_	_	_	_	_	_	_	O
19	combination	_	combination	_	NN	75	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
23	specialist	_	specialist	_	NN	75	_	_	_	_	_	_	_	O
24	care	_	care	_	NN	75	_	_	_	_	_	_	_	O
25	advice	_	advice	_	NN	75	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	75	_	_	_	_	_	_	_	O
27	ongoing	_	ongoing	_	VBG	75	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	75	_	_	_	_	_	_	_	O
29	from	_	from	_	IN	75	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	75	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	JJ	75	_	_	_	_	_	_	_	B-Aggregate_property
32	multidisciplinary	_	UNK	_	JJ	75	_	_	_	_	_	_	_	I-Aggregate_property
33	team	_	team	_	NN	75	_	_	_	_	_	team.n	Aggregate	S-Aggregate
34	.	_	.	_	.	75	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	B-Agent
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	I-Agent
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	I-Agent
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	start.v	Activity_start	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	B-Activity
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	I-Activity
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	I-Activity
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	I-Activity
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	I-Activity
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	I-Activity
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	I-Activity
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	I-Activity
14	,	_	,	_	,	76	_	_	_	_	_	_	_	I-Activity
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	I-Activity
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	I-Activity
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	I-Activity
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Activity
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	I-Activity
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	I-Activity
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Activity
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	I-Activity
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Activity
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	I-Activity
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	I-Activity
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	adult.n	People_by_age	S-Person
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	O
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	O
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	type.n	Type	S-Subtype
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	B-Category
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	I-Category
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	O
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	O
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	use.v	Using	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	B-Instrument
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	I-Instrument
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Instrument
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	I-Instrument
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	I-Instrument
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Instrument
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	I-Instrument
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Instrument
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	I-Instrument
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	I-Instrument
26	:	_	:	_	:	76	_	_	_	_	_	_	_	I-Instrument
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	I-Instrument
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	I-Instrument
29	,	_	,	_	,	76	_	_	_	_	_	_	_	I-Instrument
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	I-Instrument
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	I-Instrument
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	I-Instrument
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	I-Instrument
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	I-Instrument
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	I-Instrument
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	B-Agent
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	I-Agent
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Agent
19	employing	_	employ	_	VBG	76	_	_	_	_	_	employ.v	Using	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	B-Instrument
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Instrument
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	I-Instrument
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Instrument
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	I-Instrument
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	I-Instrument
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	active.a	Being_active	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	B-Agent
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	I-Agent
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	I-Agent
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	I-Agent
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	I-Agent
26	:	_	:	_	:	76	_	_	_	_	_	_	_	I-Agent
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	I-Agent
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	I-Agent
29	,	_	,	_	,	76	_	_	_	_	_	_	_	I-Agent
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	I-Agent
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	I-Agent
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	I-Agent
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	I-Agent
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	I-Agent
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	I-Agent
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	I-Agent
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	I-Agent
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	I-Agent
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	I-Agent
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	I-Agent
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	S-Mass
22	dose	_	dose	_	JJ	76	_	_	_	_	_	dose.n	Quantified_mass	S-Quantity
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	O
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	O
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	O
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	O
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	S-Purpose
28	technique	_	technique	_	NN	76	_	_	_	_	_	technique.n	Means	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	O
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	O
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	B-Total
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	I-Total
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	include.v	Inclusion	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	B-Part
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	I-Part
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	I-Part
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	O
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	O
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	S-Use
33	sites	_	site	_	NNS	76	_	_	_	_	_	site.n	Locale_by_use	S-Locale
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	O
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	O
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	avoid.v	Avoiding	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	B-Undesirable_situation
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	I-Undesirable_situation
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	O
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	O
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	same.a	Identicality	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	B-Type
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	I-Type
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	I-Type
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	O
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	O
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	site.n	Locale_by_use	S-Locale
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	O
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	O
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	S-Activity
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	continue.v	Activity_ongoing	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	O
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	O
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	S-Mass
48	dose	_	dose	_	JJ	76	_	_	_	_	_	dose.n	Quantified_mass	S-Quantity
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	O
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
2	treatments	_	treatment	_	NNS	76	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
4	when	_	When	_	WRB	76	_	_	_	_	_	_	_	O
5	starting	_	start	_	VBG	76	_	_	_	_	_	_	_	O
6	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
7	therapy	_	therapy	_	NN	76	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	76	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	76	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	76	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	76	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	76	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	76	_	_	_	_	_	_	_	O
14	,	_	,	_	,	76	_	_	_	_	_	_	_	O
15	use	_	use	_	VBP	76	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	76	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	76	_	_	_	_	_	_	_	O
18	programme	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
19	employing	_	employ	_	VBG	76	_	_	_	_	_	_	_	O
20	active	_	active	_	JJ	76	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
22	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
23	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
24	that	_	that	_	WDT	76	_	_	_	_	_	_	_	O
25	encompasses	_	encompass	_	VBZ	76	_	_	_	_	_	_	_	O
26	:	_	:	_	:	76	_	_	_	_	_	_	_	O
27	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
28	technique	_	technique	_	NN	76	_	_	_	_	_	_	_	O
29	,	_	,	_	,	76	_	_	_	_	_	_	_	O
30	including	_	include	_	VBG	76	_	_	_	_	_	_	_	O
31	rotating	_	UNK	_	VBG	76	_	_	_	_	_	_	_	O
32	injection	_	injection	_	NN	76	_	_	_	_	_	_	_	O
33	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	76	_	_	_	_	_	_	_	O
35	avoiding	_	avoid	_	VBG	76	_	_	_	_	_	_	_	O
36	repeated	_	repeat	_	VBN	76	_	_	_	_	_	_	_	O
37	injections	_	injection	_	NNS	76	_	_	_	_	_	_	_	O
38	at	_	at	_	IN	76	_	_	_	_	_	_	_	O
39	the	_	the	_	DT	76	_	_	_	_	_	_	_	O
40	same	_	same	_	JJ	76	_	_	_	_	_	_	_	O
41	point	_	point	_	NN	76	_	_	_	_	_	_	_	O
42	within	_	within	_	IN	76	_	_	_	_	_	_	_	O
43	sites	_	site	_	NNS	76	_	_	_	_	_	_	_	O
44	continuing	_	continue	_	VBG	76	_	_	_	_	_	_	_	O
45	telephone	_	telephone	_	NN	76	_	_	_	_	_	_	_	O
46	support	_	support	_	NN	76	_	_	_	_	_	_	_	O
47	self-monitoring	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
48	dose	_	dose	_	JJ	76	_	_	_	_	_	_	_	O
49	titration	_	UNK	_	NN	76	_	_	_	_	_	_	_	O
50	to	_	to	_	TO	76	_	_	_	_	_	_	_	O
51	target	_	target	_	NN	76	_	_	_	_	_	_	_	O
52	levels	_	level	_	NNS	76	_	_	_	_	_	_	_	B-Content
53	dietary	_	UNK	_	JJ	76	_	_	_	_	_	_	_	I-Content
54	understanding	_	understanding	_	NN	76	_	_	_	_	_	understanding.n	Awareness	O

1	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	77	_	_	_	_	_	_	_	O
3	(	_	(	_	(	77	_	_	_	_	_	_	_	O
4	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
6	glance	_	glance	_	NN	77	_	_	_	_	_	glance.n	Perception_active	O
7	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	S-Phenomenon
8	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
11	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
12	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
14	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
17	)	_	)	_	)	77	_	_	_	_	_	_	_	O
18	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
21	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
23	acute	_	acute	_	NN	77	_	_	_	_	_	_	_	O
24	changes	_	change	_	NNS	77	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
26	plasma	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
28	control	_	control	_	NN	77	_	_	_	_	_	_	_	O
29	support	_	support	_	NN	77	_	_	_	_	_	_	_	O
30	from	_	from	_	IN	77	_	_	_	_	_	_	_	O
31	an	_	an	_	DT	77	_	_	_	_	_	_	_	O
32	appropriately	_	UNK	_	RB	77	_	_	_	_	_	_	_	O
33	trained	_	trained	_	JJ	77	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
35	experienced	_	experience	_	VBD	77	_	_	_	_	_	_	_	O
36	healthcare	_	healthcare	_	JJ	77	_	_	_	_	_	_	_	O
37	professional	_	professional	_	JJ	77	_	_	_	_	_	_	_	O
38	.	_	.	_	.	77	_	_	_	_	_	_	_	O
39	3	_	3	_	CD	77	_	_	_	_	_	_	_	O
40	when	_	When	_	WRB	77	_	_	_	_	_	_	_	O
41	starting	_	start	_	VBG	77	_	_	_	_	_	_	_	O
42	insulin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
43	therapy	_	therapy	_	NN	77	_	_	_	_	_	_	_	O
44	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
45	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
46	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
47	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
50	,	_	,	_	,	77	_	_	_	_	_	_	_	O
51	continue	_	continue	_	VBP	77	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
53	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
56	people	_	people	_	NNS	77	_	_	_	_	_	_	_	O
57	without	_	without	_	IN	77	_	_	_	_	_	_	_	O
58	contraindications	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
60	intolerance	_	UNK	_	NN	77	_	_	_	_	_	_	_	O

1	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	77	_	_	_	_	_	_	_	O
3	(	_	(	_	(	77	_	_	_	_	_	_	_	O
4	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
6	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
7	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	77	_	_	_	_	_	current.a	Temporal_collocation	O
11	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	B-Trajector_entity
12	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	I-Trajector_entity
13	of	_	of	_	IN	77	_	_	_	_	_	_	_	B-Trajector_event
14	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	I-Trajector_event
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	I-Trajector_event
16	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	I-Trajector_event
17	)	_	)	_	)	77	_	_	_	_	_	_	_	I-Trajector_event
18	management	_	management	_	NN	77	_	_	_	_	_	_	_	I-Trajector_event
19	of	_	of	_	IN	77	_	_	_	_	_	_	_	I-Trajector_event
20	unk	_	UNK	_	NN	77	_	_	_	_	_	_	_	I-Trajector_event
21	management	_	management	_	NN	77	_	_	_	_	_	_	_	I-Trajector_event
22	of	_	of	_	IN	77	_	_	_	_	_	_	_	I-Trajector_event
23	acute	_	acute	_	NN	77	_	_	_	_	_	_	_	I-Trajector_event
24	changes	_	change	_	NNS	77	_	_	_	_	_	_	_	I-Trajector_event
25	in	_	in	_	IN	77	_	_	_	_	_	_	_	I-Trajector_event
26	plasma	_	UNK	_	NN	77	_	_	_	_	_	_	_	I-Trajector_event
27	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	I-Trajector_event
28	control	_	control	_	NN	77	_	_	_	_	_	_	_	I-Trajector_event
29	support	_	support	_	NN	77	_	_	_	_	_	_	_	I-Trajector_event
30	from	_	from	_	IN	77	_	_	_	_	_	_	_	I-Trajector_event
31	an	_	an	_	DT	77	_	_	_	_	_	_	_	I-Trajector_event
32	appropriately	_	UNK	_	RB	77	_	_	_	_	_	_	_	I-Trajector_event
33	trained	_	trained	_	JJ	77	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
35	experienced	_	experience	_	VBD	77	_	_	_	_	_	_	_	O
36	healthcare	_	healthcare	_	JJ	77	_	_	_	_	_	_	_	O
37	professional	_	professional	_	JJ	77	_	_	_	_	_	_	_	O
38	.	_	.	_	.	77	_	_	_	_	_	_	_	O
39	3	_	3	_	CD	77	_	_	_	_	_	_	_	O
40	when	_	When	_	WRB	77	_	_	_	_	_	_	_	O
41	starting	_	start	_	VBG	77	_	_	_	_	_	_	_	O
42	insulin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
43	therapy	_	therapy	_	NN	77	_	_	_	_	_	_	_	O
44	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
45	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
46	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
47	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
50	,	_	,	_	,	77	_	_	_	_	_	_	_	O
51	continue	_	continue	_	VBP	77	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
53	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
56	people	_	people	_	NNS	77	_	_	_	_	_	_	_	O
57	without	_	without	_	IN	77	_	_	_	_	_	_	_	O
58	contraindications	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
60	intolerance	_	UNK	_	NN	77	_	_	_	_	_	_	_	O

1	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	77	_	_	_	_	_	_	_	O
3	(	_	(	_	(	77	_	_	_	_	_	_	_	O
4	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
6	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
7	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
11	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
12	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
14	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
17	)	_	)	_	)	77	_	_	_	_	_	_	_	O
18	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
21	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
23	acute	_	acute	_	NN	77	_	_	_	_	_	acute.a	Importance	O
24	changes	_	change	_	NNS	77	_	_	_	_	_	_	_	B-Factor
25	in	_	in	_	IN	77	_	_	_	_	_	_	_	I-Factor
26	plasma	_	UNK	_	NN	77	_	_	_	_	_	_	_	I-Factor
27	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	I-Factor
28	control	_	control	_	NN	77	_	_	_	_	_	_	_	I-Factor
29	support	_	support	_	NN	77	_	_	_	_	_	_	_	I-Factor
30	from	_	from	_	IN	77	_	_	_	_	_	_	_	O
31	an	_	an	_	DT	77	_	_	_	_	_	_	_	O
32	appropriately	_	UNK	_	RB	77	_	_	_	_	_	_	_	O
33	trained	_	trained	_	JJ	77	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
35	experienced	_	experience	_	VBD	77	_	_	_	_	_	_	_	O
36	healthcare	_	healthcare	_	JJ	77	_	_	_	_	_	_	_	O
37	professional	_	professional	_	JJ	77	_	_	_	_	_	_	_	O
38	.	_	.	_	.	77	_	_	_	_	_	_	_	O
39	3	_	3	_	CD	77	_	_	_	_	_	_	_	O
40	when	_	When	_	WRB	77	_	_	_	_	_	_	_	O
41	starting	_	start	_	VBG	77	_	_	_	_	_	_	_	O
42	insulin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
43	therapy	_	therapy	_	NN	77	_	_	_	_	_	_	_	O
44	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
45	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
46	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
47	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
50	,	_	,	_	,	77	_	_	_	_	_	_	_	O
51	continue	_	continue	_	VBP	77	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
53	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
56	people	_	people	_	NNS	77	_	_	_	_	_	_	_	O
57	without	_	without	_	IN	77	_	_	_	_	_	_	_	O
58	contraindications	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
60	intolerance	_	UNK	_	NN	77	_	_	_	_	_	_	_	O

1	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	77	_	_	_	_	_	_	_	O
3	(	_	(	_	(	77	_	_	_	_	_	_	_	O
4	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
6	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
7	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
11	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
12	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
14	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
17	)	_	)	_	)	77	_	_	_	_	_	_	_	O
18	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
21	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
23	acute	_	acute	_	NN	77	_	_	_	_	_	_	_	O
24	changes	_	change	_	NNS	77	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
26	plasma	_	UNK	_	NN	77	_	_	_	_	_	_	_	B-Dependent_entity
27	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	I-Dependent_entity
28	control	_	control	_	NN	77	_	_	_	_	_	control.n	Being_in_control	O
29	support	_	support	_	NN	77	_	_	_	_	_	_	_	O
30	from	_	from	_	IN	77	_	_	_	_	_	_	_	O
31	an	_	an	_	DT	77	_	_	_	_	_	_	_	O
32	appropriately	_	UNK	_	RB	77	_	_	_	_	_	_	_	O
33	trained	_	trained	_	JJ	77	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
35	experienced	_	experience	_	VBD	77	_	_	_	_	_	_	_	O
36	healthcare	_	healthcare	_	JJ	77	_	_	_	_	_	_	_	O
37	professional	_	professional	_	JJ	77	_	_	_	_	_	_	_	O
38	.	_	.	_	.	77	_	_	_	_	_	_	_	O
39	3	_	3	_	CD	77	_	_	_	_	_	_	_	O
40	when	_	When	_	WRB	77	_	_	_	_	_	_	_	O
41	starting	_	start	_	VBG	77	_	_	_	_	_	_	_	O
42	insulin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
43	therapy	_	therapy	_	NN	77	_	_	_	_	_	_	_	O
44	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
45	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
46	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
47	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
50	,	_	,	_	,	77	_	_	_	_	_	_	_	O
51	continue	_	continue	_	VBP	77	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
53	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
56	people	_	people	_	NNS	77	_	_	_	_	_	_	_	O
57	without	_	without	_	IN	77	_	_	_	_	_	_	_	O
58	contraindications	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
60	intolerance	_	UNK	_	NN	77	_	_	_	_	_	_	_	O

1	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	77	_	_	_	_	_	_	_	O
3	(	_	(	_	(	77	_	_	_	_	_	_	_	O
4	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
6	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
7	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
11	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
12	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
14	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
17	)	_	)	_	)	77	_	_	_	_	_	_	_	O
18	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
21	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
23	acute	_	acute	_	NN	77	_	_	_	_	_	_	_	O
24	changes	_	change	_	NNS	77	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
26	plasma	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
28	control	_	control	_	NN	77	_	_	_	_	_	_	_	O
29	support	_	support	_	NN	77	_	_	_	_	_	_	_	O
30	from	_	from	_	IN	77	_	_	_	_	_	_	_	O
31	an	_	an	_	DT	77	_	_	_	_	_	_	_	O
32	appropriately	_	UNK	_	RB	77	_	_	_	_	_	_	_	O
33	trained	_	trained	_	JJ	77	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
35	experienced	_	experience	_	VBD	77	_	_	_	_	_	experience.v	Feeling	O
36	healthcare	_	healthcare	_	JJ	77	_	_	_	_	_	_	_	B-Emotional_state
37	professional	_	professional	_	JJ	77	_	_	_	_	_	_	_	I-Emotional_state
38	.	_	.	_	.	77	_	_	_	_	_	_	_	O
39	3	_	3	_	CD	77	_	_	_	_	_	_	_	O
40	when	_	When	_	WRB	77	_	_	_	_	_	_	_	O
41	starting	_	start	_	VBG	77	_	_	_	_	_	_	_	O
42	insulin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
43	therapy	_	therapy	_	NN	77	_	_	_	_	_	_	_	O
44	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
45	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
46	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
47	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
50	,	_	,	_	,	77	_	_	_	_	_	_	_	O
51	continue	_	continue	_	VBP	77	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
53	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
56	people	_	people	_	NNS	77	_	_	_	_	_	_	_	O
57	without	_	without	_	IN	77	_	_	_	_	_	_	_	O
58	contraindications	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
60	intolerance	_	UNK	_	NN	77	_	_	_	_	_	_	_	O

1	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	77	_	_	_	_	_	_	_	O
3	(	_	(	_	(	77	_	_	_	_	_	_	_	O
4	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
6	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
7	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
11	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
12	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
14	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
17	)	_	)	_	)	77	_	_	_	_	_	_	_	O
18	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
21	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
23	acute	_	acute	_	NN	77	_	_	_	_	_	_	_	O
24	changes	_	change	_	NNS	77	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
26	plasma	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
28	control	_	control	_	NN	77	_	_	_	_	_	_	_	O
29	support	_	support	_	NN	77	_	_	_	_	_	_	_	O
30	from	_	from	_	IN	77	_	_	_	_	_	_	_	O
31	an	_	an	_	DT	77	_	_	_	_	_	_	_	O
32	appropriately	_	UNK	_	RB	77	_	_	_	_	_	_	_	O
33	trained	_	trained	_	JJ	77	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
35	experienced	_	experience	_	VBD	77	_	_	_	_	_	_	_	O
36	healthcare	_	healthcare	_	JJ	77	_	_	_	_	_	_	_	O
37	professional	_	professional	_	JJ	77	_	_	_	_	_	_	_	O
38	.	_	.	_	.	77	_	_	_	_	_	_	_	O
39	3	_	3	_	CD	77	_	_	_	_	_	_	_	S-Agent
40	when	_	When	_	WRB	77	_	_	_	_	_	_	_	O
41	starting	_	start	_	VBG	77	_	_	_	_	_	start.v	Activity_start	O
42	insulin	_	UNK	_	NN	77	_	_	_	_	_	_	_	B-Activity
43	therapy	_	therapy	_	NN	77	_	_	_	_	_	_	_	I-Activity
44	in	_	in	_	IN	77	_	_	_	_	_	_	_	I-Activity
45	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	I-Activity
46	with	_	with	_	IN	77	_	_	_	_	_	_	_	I-Activity
47	type	_	type	_	JJ	77	_	_	_	_	_	_	_	I-Activity
48	2	_	2	_	CD	77	_	_	_	_	_	_	_	I-Activity
49	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	I-Activity
50	,	_	,	_	,	77	_	_	_	_	_	_	_	O
51	continue	_	continue	_	VBP	77	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
53	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
56	people	_	people	_	NNS	77	_	_	_	_	_	_	_	O
57	without	_	without	_	IN	77	_	_	_	_	_	_	_	O
58	contraindications	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
60	intolerance	_	UNK	_	NN	77	_	_	_	_	_	_	_	O

1	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	77	_	_	_	_	_	_	_	O
3	(	_	(	_	(	77	_	_	_	_	_	_	_	O
4	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
6	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
7	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
11	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
12	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
14	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
17	)	_	)	_	)	77	_	_	_	_	_	_	_	O
18	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
21	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
23	acute	_	acute	_	NN	77	_	_	_	_	_	_	_	O
24	changes	_	change	_	NNS	77	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
26	plasma	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
28	control	_	control	_	NN	77	_	_	_	_	_	_	_	O
29	support	_	support	_	NN	77	_	_	_	_	_	_	_	O
30	from	_	from	_	IN	77	_	_	_	_	_	_	_	O
31	an	_	an	_	DT	77	_	_	_	_	_	_	_	O
32	appropriately	_	UNK	_	RB	77	_	_	_	_	_	_	_	O
33	trained	_	trained	_	JJ	77	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
35	experienced	_	experience	_	VBD	77	_	_	_	_	_	_	_	O
36	healthcare	_	healthcare	_	JJ	77	_	_	_	_	_	_	_	O
37	professional	_	professional	_	JJ	77	_	_	_	_	_	_	_	O
38	.	_	.	_	.	77	_	_	_	_	_	_	_	O
39	3	_	3	_	CD	77	_	_	_	_	_	_	_	O
40	when	_	When	_	WRB	77	_	_	_	_	_	_	_	O
41	starting	_	start	_	VBG	77	_	_	_	_	_	_	_	O
42	insulin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
43	therapy	_	therapy	_	NN	77	_	_	_	_	_	_	_	O
44	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
45	adults	_	adult	_	NNS	77	_	_	_	_	_	adult.n	People_by_age	S-Person
46	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
47	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
50	,	_	,	_	,	77	_	_	_	_	_	_	_	O
51	continue	_	continue	_	VBP	77	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
53	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
56	people	_	people	_	NNS	77	_	_	_	_	_	_	_	O
57	without	_	without	_	IN	77	_	_	_	_	_	_	_	O
58	contraindications	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
60	intolerance	_	UNK	_	NN	77	_	_	_	_	_	_	_	O

1	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	77	_	_	_	_	_	_	_	O
3	(	_	(	_	(	77	_	_	_	_	_	_	_	O
4	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
6	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
7	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
11	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
12	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
14	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
17	)	_	)	_	)	77	_	_	_	_	_	_	_	O
18	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
21	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
23	acute	_	acute	_	NN	77	_	_	_	_	_	_	_	O
24	changes	_	change	_	NNS	77	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
26	plasma	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
28	control	_	control	_	NN	77	_	_	_	_	_	_	_	O
29	support	_	support	_	NN	77	_	_	_	_	_	_	_	O
30	from	_	from	_	IN	77	_	_	_	_	_	_	_	O
31	an	_	an	_	DT	77	_	_	_	_	_	_	_	O
32	appropriately	_	UNK	_	RB	77	_	_	_	_	_	_	_	O
33	trained	_	trained	_	JJ	77	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
35	experienced	_	experience	_	VBD	77	_	_	_	_	_	_	_	O
36	healthcare	_	healthcare	_	JJ	77	_	_	_	_	_	_	_	O
37	professional	_	professional	_	JJ	77	_	_	_	_	_	_	_	O
38	.	_	.	_	.	77	_	_	_	_	_	_	_	O
39	3	_	3	_	CD	77	_	_	_	_	_	_	_	O
40	when	_	When	_	WRB	77	_	_	_	_	_	_	_	O
41	starting	_	start	_	VBG	77	_	_	_	_	_	_	_	O
42	insulin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
43	therapy	_	therapy	_	NN	77	_	_	_	_	_	_	_	O
44	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
45	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
46	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
47	type	_	type	_	JJ	77	_	_	_	_	_	type.n	Type	S-Subtype
48	2	_	2	_	CD	77	_	_	_	_	_	_	_	B-Category
49	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	I-Category
50	,	_	,	_	,	77	_	_	_	_	_	_	_	O
51	continue	_	continue	_	VBP	77	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
53	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
56	people	_	people	_	NNS	77	_	_	_	_	_	_	_	O
57	without	_	without	_	IN	77	_	_	_	_	_	_	_	O
58	contraindications	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
60	intolerance	_	UNK	_	NN	77	_	_	_	_	_	_	_	O

1	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	77	_	_	_	_	_	_	_	O
3	(	_	(	_	(	77	_	_	_	_	_	_	_	O
4	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
6	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
7	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
11	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
12	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
14	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
17	)	_	)	_	)	77	_	_	_	_	_	_	_	O
18	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
21	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
23	acute	_	acute	_	NN	77	_	_	_	_	_	_	_	O
24	changes	_	change	_	NNS	77	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
26	plasma	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
28	control	_	control	_	NN	77	_	_	_	_	_	_	_	O
29	support	_	support	_	NN	77	_	_	_	_	_	_	_	O
30	from	_	from	_	IN	77	_	_	_	_	_	_	_	O
31	an	_	an	_	DT	77	_	_	_	_	_	_	_	O
32	appropriately	_	UNK	_	RB	77	_	_	_	_	_	_	_	O
33	trained	_	trained	_	JJ	77	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
35	experienced	_	experience	_	VBD	77	_	_	_	_	_	_	_	O
36	healthcare	_	healthcare	_	JJ	77	_	_	_	_	_	_	_	O
37	professional	_	professional	_	JJ	77	_	_	_	_	_	_	_	O
38	.	_	.	_	.	77	_	_	_	_	_	_	_	O
39	3	_	3	_	CD	77	_	_	_	_	_	_	_	O
40	when	_	When	_	WRB	77	_	_	_	_	_	_	_	O
41	starting	_	start	_	VBG	77	_	_	_	_	_	_	_	O
42	insulin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
43	therapy	_	therapy	_	NN	77	_	_	_	_	_	_	_	O
44	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
45	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
46	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
47	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
50	,	_	,	_	,	77	_	_	_	_	_	_	_	O
51	continue	_	continue	_	VBP	77	_	_	_	_	_	continue.v	Activity_ongoing	O
52	to	_	to	_	TO	77	_	_	_	_	_	_	_	B-Activity
53	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	I-Activity
54	metformin	_	UNK	_	NN	77	_	_	_	_	_	_	_	I-Activity
55	for	_	for	_	IN	77	_	_	_	_	_	_	_	I-Activity
56	people	_	people	_	NNS	77	_	_	_	_	_	_	_	I-Activity
57	without	_	without	_	IN	77	_	_	_	_	_	_	_	I-Activity
58	contraindications	_	UNK	_	NNS	77	_	_	_	_	_	_	_	I-Activity
59	or	_	or	_	CC	77	_	_	_	_	_	_	_	I-Activity
60	intolerance	_	UNK	_	NN	77	_	_	_	_	_	_	_	I-Activity

1	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	77	_	_	_	_	_	_	_	O
3	(	_	(	_	(	77	_	_	_	_	_	_	_	O
4	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
6	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
7	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
11	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
12	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
14	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
17	)	_	)	_	)	77	_	_	_	_	_	_	_	O
18	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
21	management	_	management	_	NN	77	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
23	acute	_	acute	_	NN	77	_	_	_	_	_	_	_	O
24	changes	_	change	_	NNS	77	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
26	plasma	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
28	control	_	control	_	NN	77	_	_	_	_	_	_	_	O
29	support	_	support	_	NN	77	_	_	_	_	_	_	_	O
30	from	_	from	_	IN	77	_	_	_	_	_	_	_	O
31	an	_	an	_	DT	77	_	_	_	_	_	_	_	O
32	appropriately	_	UNK	_	RB	77	_	_	_	_	_	_	_	O
33	trained	_	trained	_	JJ	77	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
35	experienced	_	experience	_	VBD	77	_	_	_	_	_	_	_	O
36	healthcare	_	healthcare	_	JJ	77	_	_	_	_	_	_	_	O
37	professional	_	professional	_	JJ	77	_	_	_	_	_	_	_	O
38	.	_	.	_	.	77	_	_	_	_	_	_	_	O
39	3	_	3	_	CD	77	_	_	_	_	_	_	_	O
40	when	_	When	_	WRB	77	_	_	_	_	_	_	_	O
41	starting	_	start	_	VBG	77	_	_	_	_	_	_	_	O
42	insulin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
43	therapy	_	therapy	_	NN	77	_	_	_	_	_	_	_	O
44	in	_	in	_	IN	77	_	_	_	_	_	_	_	O
45	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
46	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
47	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
50	,	_	,	_	,	77	_	_	_	_	_	_	_	O
51	continue	_	continue	_	VBP	77	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
53	offer	_	offer	_	VB	77	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
56	people	_	people	_	NNS	77	_	_	_	_	_	people.n	People	S-Person
57	without	_	without	_	IN	77	_	_	_	_	_	_	_	O
58	contraindications	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
59	or	_	or	_	CC	77	_	_	_	_	_	_	_	O
60	intolerance	_	UNK	_	NN	77	_	_	_	_	_	_	_	O

1	review	_	Review	_	VB	78	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
3	continued	_	continued	_	JJ	78	_	_	_	_	_	_	_	S-Degree
4	need	_	need	_	NN	78	_	_	_	_	_	need.n	Needing	O
5	for	_	for	_	IN	78	_	_	_	_	_	_	_	B-Dependent
6	other	_	other	_	JJ	78	_	_	_	_	_	_	_	I-Dependent
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	I-Dependent
8	glucose	_	UNK	_	JJ	78	_	_	_	_	_	_	_	I-Dependent
9	lowering	_	lower	_	VBG	78	_	_	_	_	_	_	_	I-Dependent
10	therapies	_	therapy	_	NNS	78	_	_	_	_	_	_	_	I-Dependent
11	.	_	.	_	.	78	_	_	_	_	_	_	_	O
12	4	_	4	_	CD	78	_	_	_	_	_	_	_	O
13	start	_	UNK	_	NNP	78	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
15	therapy	_	therapy	_	NN	78	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	78	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
24	choice	_	choice	_	NN	78	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
26	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
27	number	_	number	_	NN	78	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
30	types	_	type	_	NNS	78	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	78	_	_	_	_	_	_	_	O
32	regimens	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
33	:	_	:	_	:	78	_	_	_	_	_	_	_	O

1	review	_	Review	_	VB	78	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
3	continued	_	continued	_	JJ	78	_	_	_	_	_	_	_	O
4	need	_	need	_	NN	78	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	78	_	_	_	_	_	other.a	Increment	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	B-Class
8	glucose	_	UNK	_	JJ	78	_	_	_	_	_	_	_	I-Class
9	lowering	_	lower	_	VBG	78	_	_	_	_	_	_	_	I-Class
10	therapies	_	therapy	_	NNS	78	_	_	_	_	_	_	_	I-Class
11	.	_	.	_	.	78	_	_	_	_	_	_	_	O
12	4	_	4	_	CD	78	_	_	_	_	_	_	_	O
13	start	_	UNK	_	NNP	78	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
15	therapy	_	therapy	_	NN	78	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	78	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
24	choice	_	choice	_	NN	78	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
26	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
27	number	_	number	_	NN	78	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
30	types	_	type	_	NNS	78	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	78	_	_	_	_	_	_	_	O
32	regimens	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
33	:	_	:	_	:	78	_	_	_	_	_	_	_	O

1	review	_	Review	_	VB	78	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
3	continued	_	continued	_	JJ	78	_	_	_	_	_	_	_	O
4	need	_	need	_	NN	78	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	S-Agent
8	glucose	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
9	lowering	_	lower	_	VBG	78	_	_	_	_	_	lower.v	Cause_change_of_position_on_a_scale	O
10	therapies	_	therapy	_	NNS	78	_	_	_	_	_	_	_	O
11	.	_	.	_	.	78	_	_	_	_	_	_	_	O
12	4	_	4	_	CD	78	_	_	_	_	_	_	_	O
13	start	_	UNK	_	NNP	78	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
15	therapy	_	therapy	_	NN	78	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	78	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
24	choice	_	choice	_	NN	78	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
26	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
27	number	_	number	_	NN	78	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
30	types	_	type	_	NNS	78	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	78	_	_	_	_	_	_	_	O
32	regimens	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
33	:	_	:	_	:	78	_	_	_	_	_	_	_	O

1	review	_	Review	_	VB	78	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
3	continued	_	continued	_	JJ	78	_	_	_	_	_	_	_	O
4	need	_	need	_	NN	78	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
9	lowering	_	lower	_	VBG	78	_	_	_	_	_	_	_	O
10	therapies	_	therapy	_	NNS	78	_	_	_	_	_	_	_	O
11	.	_	.	_	.	78	_	_	_	_	_	_	_	O
12	4	_	4	_	CD	78	_	_	_	_	_	_	_	O
13	start	_	UNK	_	NNP	78	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	S-Type
15	therapy	_	therapy	_	NN	78	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
16	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	78	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
24	choice	_	choice	_	NN	78	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
26	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
27	number	_	number	_	NN	78	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
30	types	_	type	_	NNS	78	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	78	_	_	_	_	_	_	_	O
32	regimens	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
33	:	_	:	_	:	78	_	_	_	_	_	_	_	O

1	review	_	Review	_	VB	78	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
3	continued	_	continued	_	JJ	78	_	_	_	_	_	_	_	O
4	need	_	need	_	NN	78	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
9	lowering	_	lower	_	VBG	78	_	_	_	_	_	_	_	O
10	therapies	_	therapy	_	NNS	78	_	_	_	_	_	_	_	O
11	.	_	.	_	.	78	_	_	_	_	_	_	_	O
12	4	_	4	_	CD	78	_	_	_	_	_	_	_	O
13	start	_	UNK	_	NNP	78	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
15	therapy	_	therapy	_	NN	78	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	78	_	_	_	_	_	adult.n	People_by_age	S-Person
18	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	78	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
24	choice	_	choice	_	NN	78	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
26	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
27	number	_	number	_	NN	78	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
30	types	_	type	_	NNS	78	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	78	_	_	_	_	_	_	_	O
32	regimens	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
33	:	_	:	_	:	78	_	_	_	_	_	_	_	O

1	review	_	Review	_	VB	78	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
3	continued	_	continued	_	JJ	78	_	_	_	_	_	_	_	O
4	need	_	need	_	NN	78	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
9	lowering	_	lower	_	VBG	78	_	_	_	_	_	_	_	O
10	therapies	_	therapy	_	NNS	78	_	_	_	_	_	_	_	O
11	.	_	.	_	.	78	_	_	_	_	_	_	_	O
12	4	_	4	_	CD	78	_	_	_	_	_	_	_	O
13	start	_	UNK	_	NNP	78	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
15	therapy	_	therapy	_	NN	78	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	78	_	_	_	_	_	type.n	Type	S-Subtype
20	2	_	2	_	CD	78	_	_	_	_	_	_	_	B-Category
21	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	I-Category
22	from	_	from	_	IN	78	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
24	choice	_	choice	_	NN	78	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
26	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
27	number	_	number	_	NN	78	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
30	types	_	type	_	NNS	78	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	78	_	_	_	_	_	_	_	O
32	regimens	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
33	:	_	:	_	:	78	_	_	_	_	_	_	_	O

1	review	_	Review	_	VB	78	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
3	continued	_	continued	_	JJ	78	_	_	_	_	_	_	_	O
4	need	_	need	_	NN	78	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
9	lowering	_	lower	_	VBG	78	_	_	_	_	_	_	_	O
10	therapies	_	therapy	_	NNS	78	_	_	_	_	_	_	_	O
11	.	_	.	_	.	78	_	_	_	_	_	_	_	O
12	4	_	4	_	CD	78	_	_	_	_	_	_	_	O
13	start	_	UNK	_	NNP	78	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
15	therapy	_	therapy	_	NN	78	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	78	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
24	choice	_	choice	_	NN	78	_	_	_	_	_	choice.n	Choosing	O
25	of	_	of	_	IN	78	_	_	_	_	_	_	_	B-Topic
26	a	_	a	_	DT	78	_	_	_	_	_	_	_	I-Topic
27	number	_	number	_	NN	78	_	_	_	_	_	_	_	I-Topic
28	of	_	of	_	IN	78	_	_	_	_	_	_	_	I-Topic
29	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	I-Topic
30	types	_	type	_	NNS	78	_	_	_	_	_	_	_	I-Topic
31	and	_	and	_	CC	78	_	_	_	_	_	_	_	I-Topic
32	regimens	_	UNK	_	NNS	78	_	_	_	_	_	_	_	I-Topic
33	:	_	:	_	:	78	_	_	_	_	_	_	_	O

1	review	_	Review	_	VB	78	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
3	continued	_	continued	_	JJ	78	_	_	_	_	_	_	_	O
4	need	_	need	_	NN	78	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
9	lowering	_	lower	_	VBG	78	_	_	_	_	_	_	_	O
10	therapies	_	therapy	_	NNS	78	_	_	_	_	_	_	_	O
11	.	_	.	_	.	78	_	_	_	_	_	_	_	O
12	4	_	4	_	CD	78	_	_	_	_	_	_	_	O
13	start	_	UNK	_	NNP	78	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
15	therapy	_	therapy	_	NN	78	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	78	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
24	choice	_	choice	_	NN	78	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
26	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
27	number	_	number	_	NN	78	_	_	_	_	_	number.n	Cardinal_numbers	S-Number
28	of	_	of	_	IN	78	_	_	_	_	_	_	_	B-Entity
29	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	I-Entity
30	types	_	type	_	NNS	78	_	_	_	_	_	_	_	I-Entity
31	and	_	and	_	CC	78	_	_	_	_	_	_	_	I-Entity
32	regimens	_	UNK	_	NNS	78	_	_	_	_	_	_	_	I-Entity
33	:	_	:	_	:	78	_	_	_	_	_	_	_	O

1	review	_	Review	_	VB	78	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
3	continued	_	continued	_	JJ	78	_	_	_	_	_	_	_	O
4	need	_	need	_	NN	78	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
9	lowering	_	lower	_	VBG	78	_	_	_	_	_	_	_	O
10	therapies	_	therapy	_	NNS	78	_	_	_	_	_	_	_	O
11	.	_	.	_	.	78	_	_	_	_	_	_	_	O
12	4	_	4	_	CD	78	_	_	_	_	_	_	_	O
13	start	_	UNK	_	NNP	78	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
15	therapy	_	therapy	_	NN	78	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	78	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
24	choice	_	choice	_	NN	78	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
26	a	_	a	_	DT	78	_	_	_	_	_	_	_	O
27	number	_	number	_	NN	78	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	S-Category
30	types	_	type	_	NNS	78	_	_	_	_	_	type.n	Type	S-Subtype
31	and	_	and	_	CC	78	_	_	_	_	_	_	_	O
32	regimens	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
33	:	_	:	_	:	78	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	79	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	79	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	79	_	_	_	_	_	_	_	O
6	:	_	:	_	:	79	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	79	_	_	_	_	_	_	_	O
8	(	_	(	_	(	79	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	79	_	_	_	_	_	_	_	O
10	)	_	)	_	)	79	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	79	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	79	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
14	)	_	)	_	)	79	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	79	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	79	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	79	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	79	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	79	_	_	_	_	_	_	_	O
8	(	_	(	_	(	79	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	79	_	_	_	_	_	_	_	O
10	)	_	)	_	)	79	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	79	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	79	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
14	)	_	)	_	)	79	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	B-Agent
3	(	_	(	_	(	80	_	_	_	_	_	_	_	I-Agent
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	I-Agent
5	)	_	)	_	)	80	_	_	_	_	_	_	_	I-Agent
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	preparation.n	Activity_prepare	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	B-Activity
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	I-Activity
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	I-Activity
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Activity
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	I-Activity
12	,	_	,	_	,	80	_	_	_	_	_	_	_	I-Activity
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	I-Activity
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	I-Activity
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	I-Activity
16	(	_	(	_	(	80	_	_	_	_	_	_	_	I-Activity
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	I-Activity
18	)	_	)	_	)	80	_	_	_	_	_	_	_	I-Activity
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	I-Activity
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	I-Activity
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	I-Activity
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	I-Activity
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	I-Activity
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Activity
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	I-Activity
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	B-Total
3	(	_	(	_	(	80	_	_	_	_	_	_	_	I-Total
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	I-Total
5	)	_	)	_	)	80	_	_	_	_	_	_	_	I-Total
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	I-Total
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	I-Total
8	include	_	include	_	VBP	80	_	_	_	_	_	include.v	Inclusion	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	B-Part
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Part
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	I-Part
12	,	_	,	_	,	80	_	_	_	_	_	_	_	I-Part
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	I-Part
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	I-Part
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	I-Part
16	(	_	(	_	(	80	_	_	_	_	_	_	_	I-Part
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	I-Part
18	)	_	)	_	)	80	_	_	_	_	_	_	_	I-Part
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	I-Part
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	I-Part
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	I-Part
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	I-Part
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	I-Part
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Part
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	I-Part
26	,	_	,	_	,	80	_	_	_	_	_	_	_	I-Part
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	I-Part
28	:	_	:	_	:	80	_	_	_	_	_	_	_	I-Part
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	I-Part
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	I-Part
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	I-Part
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	I-Part
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Part
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	I-Part
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	I-Part
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	I-Part
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	I-Part
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	I-Part
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Part
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	I-Part
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	I-Part
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	I-Part
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	I-Part
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	I-Part
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Part
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	I-Part
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	I-Part
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	I-Part
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	preparation.n	Activity_prepare	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	B-Activity
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	I-Activity
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	I-Activity
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	I-Activity
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Activity
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	I-Activity
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	S-Total
21	include	_	include	_	VBP	80	_	_	_	_	_	include.v	Inclusion	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	B-Part
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	I-Part
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Part
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	I-Part
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	B-Activity
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	I-Activity
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Activity
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	preparation.n	Activity_prepare	O
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	person.n	People	S-Person
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	problem.n	Predicament	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	B-Item
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	I-Item
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	I-Item
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	I-Item
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Item
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	I-Item
47	rise	_	rise	_	VBP	80	_	_	_	_	_	rise.v	Change_position_on_a_scale	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	S-Time
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	B-Place
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	I-Place
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	S-Exchanger_1
54	switching	_	switch	_	VBG	80	_	_	_	_	_	switch.v	Exchange	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	B-Themes
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	I-Themes
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Themes
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	I-Themes
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Themes
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Themes
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	I-Themes
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	I-Themes
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Themes
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	I-Themes
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	I-Themes
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	I-Themes
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	I-Themes
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	I-Themes
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	I-Themes
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	adult.n	People_by_age	S-Person
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	type.n	Type	S-Subtype
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	B-Category
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	I-Category
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	S-Theme
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	reach.v	Arriving	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	B-Goal
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	I-Goal
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	I-Goal
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	B-Effect
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	I-Effect
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	I-Effect
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	I-Effect
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Effect
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	I-Effect
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	I-Effect
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	I-Effect
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	I-Effect
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	I-Effect
51	.	_	.	_	.	80	_	_	_	_	_	_	_	I-Effect
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	I-Effect
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	I-Effect
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	I-Effect
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	I-Effect
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	I-Effect
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Effect
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	I-Effect
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Effect
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Effect
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	B-Cause
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	I-Cause
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	I-Cause
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	I-Cause
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	I-Cause
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	I-Cause
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	I-Cause
78	because	_	because	_	IN	80	_	_	_	_	_	because.c	Causation	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	B-Effect
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	I-Effect
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Effect
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	significant.a	Importance	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	S-Factor
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	S-Experiencer
84	experience	_	experience	_	VBP	80	_	_	_	_	_	experience.v	Feeling	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	B-Emotional_state
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	I-Emotional_state
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
3	(	_	(	_	(	80	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
5	)	_	)	_	)	80	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
12	,	_	,	_	,	80	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	80	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	80	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
16	(	_	(	_	(	80	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
18	)	_	)	_	)	80	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	80	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	80	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	80	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	80	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	80	_	_	_	_	_	_	_	O
26	,	_	,	_	,	80	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	80	_	_	_	_	_	_	_	O
28	:	_	:	_	:	80	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	80	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	80	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	80	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	80	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	80	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	80	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	80	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	80	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	80	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	80	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	80	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	80	_	_	_	_	_	_	_	O
51	.	_	.	_	.	80	_	_	_	_	_	_	_	O
52	5	_	5	_	CD	80	_	_	_	_	_	_	_	O
53	consider	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
54	switching	_	switch	_	VBG	80	_	_	_	_	_	_	_	O
55	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
56	insulin	_	UNK	_	VB	80	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
58	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
59	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	80	_	_	_	_	_	_	_	O
62	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
63	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	80	_	_	_	_	_	_	_	O
65	adults	_	adult	_	NNS	80	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	80	_	_	_	_	_	_	_	O
67	type	_	type	_	JJ	80	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	80	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	80	_	_	_	_	_	_	_	O
70	:	_	:	_	:	80	_	_	_	_	_	_	_	O
71	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
72	do	_	do	_	VBP	80	_	_	_	_	_	_	_	O
73	not	_	not	_	RB	80	_	_	_	_	_	_	_	O
74	reach	_	reach	_	VB	80	_	_	_	_	_	_	_	O
75	their	_	their	_	PRP$	80	_	_	_	_	_	_	_	O
76	target	_	target	_	NN	80	_	_	_	_	_	_	_	O
77	hba1c	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
78	because	_	because	_	IN	80	_	_	_	_	_	_	_	O
79	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
80	significant	_	significant	_	JJ	80	_	_	_	_	_	_	_	O
81	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
82	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	80	_	_	_	_	_	_	_	O
84	experience	_	experience	_	VBP	80	_	_	_	_	_	_	_	O
85	significant	_	significant	_	JJ	80	_	_	_	_	_	significant.a	Importance	O
86	unk	_	UNK	_	NN	80	_	_	_	_	_	_	_	S-Factor
87	on	_	on	_	IN	80	_	_	_	_	_	_	_	O
88	nph	_	UNK	_	NNP	80	_	_	_	_	_	_	_	O
89	insulin	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
90	irrespective	_	UNK	_	NN	80	_	_	_	_	_	_	_	O
91	of	_	of	_	IN	80	_	_	_	_	_	_	_	O
92	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
93	level	_	level	_	NN	80	_	_	_	_	_	_	_	O
94	of	_	of	_	IN	80	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	81	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	81	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	81	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	81	_	_	_	_	_	_	_	O
6	:	_	:	_	:	81	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	81	_	_	_	_	_	_	_	O
8	(	_	(	_	(	81	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
10	)	_	)	_	)	81	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	81	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	81	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
14	)	_	)	_	)	81	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	81	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	81	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	81	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	81	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	81	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	81	_	_	_	_	_	_	_	O
8	(	_	(	_	(	81	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
10	)	_	)	_	)	81	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	81	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	81	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
14	)	_	)	_	)	81	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	S-Cognizer
6	need	_	need	_	VBP	82	_	_	_	_	_	need.v	Needing	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	S-Helper
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	help.v	Assistance	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	B-Goal
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	I-Goal
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Goal
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	S-Agent
21	switching	_	switch	_	VBG	82	_	_	_	_	_	switch.v	Change_tool	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	B-New_tool
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	I-New_tool
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	I-New_tool
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	I-New_tool
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	I-New_tool
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-New_tool
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	I-New_tool
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	I-New_tool
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	I-New_tool
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	I-New_tool
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	I-New_tool
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	I-New_tool
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	I-New_tool
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	I-New_tool
36	.	_	.	_	.	82	_	_	_	_	_	_	_	I-New_tool
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	I-New_tool
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	I-New_tool
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	I-New_tool
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	I-New_tool
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	I-New_tool
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	B-Agent
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	I-Agent
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Agent
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	I-Agent
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	reduce.v	Cause_change_of_position_on_a_scale	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	B-Item
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	I-Item
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	I-Item
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	I-Item
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	I-Item
36	.	_	.	_	.	82	_	_	_	_	_	_	_	I-Item
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	I-Item
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	I-Item
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	I-Item
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	I-Item
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	I-Item
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	I-Item
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	I-Item
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	I-Item
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	I-Item
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	I-Item
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	I-Item
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Item
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Item
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	I-Item
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	number.n	Cardinal_numbers	S-Number
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	B-Entity
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	I-Entity
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	I-Entity
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	daily.a	Frequency	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	S-Salient_entity
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	adult.n	People_by_age	S-Person
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	type.n	Type	S-Subtype
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	need.n	Needing	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	B-Dependent
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	I-Dependent
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Dependent
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	S-Activity
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	preparation.n	Activity_prepare	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	S-Origin
82	adults	_	adult	_	NNS	82	_	_	_	_	_	adult.n	People_by_age	S-Person
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	type.n	Type	S-Subtype
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	need.n	Needing	S-Requirement
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	B-Dependent
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	I-Dependent
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	I-Dependent
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	I-Dependent
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	I-Dependent
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	I-Dependent
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Dependent
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	further.a	Increment	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	B-Class
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	I-Class
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	I-Class
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Class
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	change.n	Undergo_change	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	B-Final_situation
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	I-Final_situation
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Final_situation
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	I-Final_situation
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	I-Final_situation
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	I-Final_situation
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	I-Final_situation
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Final_situation
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	I-Final_situation
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Final_situation
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Final_situation
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	I-Final_situation
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Final_situation
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Final_situation
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	O
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	O
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	_	_	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	82	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	82	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	82	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	82	_	_	_	_	_	_	_	O
5	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
6	need	_	need	_	VBP	82	_	_	_	_	_	_	_	O
7	help	_	help	_	VBP	82	_	_	_	_	_	_	_	O
8	from	_	from	_	IN	82	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
10	carer	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
12	healthcare	_	healthcare	_	JJ	82	_	_	_	_	_	_	_	O
13	professional	_	professional	_	JJ	82	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
15	administer	_	administer	_	VB	82	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
17	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
20	whom	_	whom	_	WP	82	_	_	_	_	_	_	_	O
21	switching	_	switch	_	VBG	82	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
23	one	_	one	_	CD	82	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
26	long-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
28	analogues	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
29	would	_	would	_	MD	82	_	_	_	_	_	_	_	O
30	reduce	_	reduce	_	VB	82	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
32	number	_	number	_	NN	82	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
34	daily	_	daily	_	JJ	82	_	_	_	_	_	_	_	O
35	injections	_	injection	_	NNS	82	_	_	_	_	_	_	_	O
36	.	_	.	_	.	82	_	_	_	_	_	_	_	O
37	6	_	6	_	CD	82	_	_	_	_	_	_	_	O
38	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
39	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
41	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
42	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
43	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
44	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
45	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
46	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
48	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
49	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
50	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
51	(	_	(	_	(	82	_	_	_	_	_	_	_	O
52	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
53	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
54	,	_	,	_	,	82	_	_	_	_	_	_	_	O
55	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
57	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
58	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
59	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
60	)	_	)	_	)	82	_	_	_	_	_	_	_	O
61	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
63	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
64	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
65	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
66	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
67	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
68	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
69	(	_	(	_	(	82	_	_	_	_	_	_	_	O
70	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
71	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
72	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
73	[	_	[	_	NN	82	_	_	_	_	_	_	_	O
74	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
75	]	_	]	_	NNP	82	_	_	_	_	_	_	_	O
76	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
77	preparation	_	preparation	_	NN	82	_	_	_	_	_	_	_	O
78	)	_	)	_	)	82	_	_	_	_	_	_	_	O
79	.	_	.	_	.	82	_	_	_	_	_	_	_	O
80	7	_	7	_	CD	82	_	_	_	_	_	_	_	O
81	monitor	_	Monitor	_	NNP	82	_	_	_	_	_	_	_	O
82	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
83	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
84	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
85	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
86	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
87	who	_	who	_	WP	82	_	_	_	_	_	_	_	O
88	are	_	be	_	VBP	82	_	_	_	_	_	_	_	O
89	on	_	on	_	IN	82	_	_	_	_	_	_	_	O
90	pre-mixed	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
91	(	_	(	_	(	82	_	_	_	_	_	_	_	O
92	biphasic	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
93	)	_	)	_	)	82	_	_	_	_	_	_	_	O
94	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
95	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
96	the	_	the	_	DT	82	_	_	_	_	_	_	_	O
97	need	_	need	_	NN	82	_	_	_	_	_	_	_	O
98	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
99	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
100	further	_	further	_	JJ	82	_	_	_	_	_	_	_	O
101	injection	_	injection	_	NN	82	_	_	_	_	_	_	_	O
102	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
103	short-acting	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
104	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
105	before	_	before	_	IN	82	_	_	_	_	_	_	_	O
106	meals	_	meal	_	NNS	82	_	_	_	_	_	_	_	O
107	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
108	for	_	for	_	IN	82	_	_	_	_	_	_	_	O
109	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
110	change	_	change	_	NN	82	_	_	_	_	_	_	_	O
111	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
112	a	_	a	_	DT	82	_	_	_	_	_	_	_	O
113	basal	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
114	bolus	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
115	regimen	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
116	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
117	nph	_	UNK	_	NNP	82	_	_	_	_	_	_	_	O
118	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
119	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
120	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
121	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
122	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
123	insulin	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
124	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
125	,	_	,	_	,	82	_	_	_	_	_	_	_	O
126	if	_	if	_	IN	82	_	_	_	_	_	_	_	O
127	blood	_	blood	_	VBN	82	_	_	_	_	_	_	_	B-Entity
128	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Entity
129	control	_	control	_	NN	82	_	_	_	_	_	_	_	I-Entity
130	remains	_	remain	_	VBZ	82	_	_	_	_	_	remain.v	State_continue	O
131	inadequate	_	UNK	_	JJ	82	_	_	_	_	_	_	_	S-State
132	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	insulin	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
3	8	_	8	_	CD	83	_	_	_	_	_	_	_	O
4	for	_	For	_	IN	83	_	_	_	_	_	_	_	O
5	guidance	_	guidance	_	NN	83	_	_	_	_	_	_	_	O
6	on	_	on	_	IN	83	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
8	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	83	_	_	_	_	_	adult.n	People_by_age	S-Person
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
15	,	_	,	_	,	83	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	83	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
19	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
20	section	_	section	_	NN	83	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	83	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	83	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	83	_	_	_	_	_	_	_	O
26	type	_	type	_	NN	83	_	_	_	_	_	_	_	O
27	1	_	1	_	CD	83	_	_	_	_	_	_	_	O
28	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
29	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	insulin	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
3	8	_	8	_	CD	83	_	_	_	_	_	_	_	O
4	for	_	For	_	IN	83	_	_	_	_	_	_	_	O
5	guidance	_	guidance	_	NN	83	_	_	_	_	_	_	_	O
6	on	_	on	_	IN	83	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
8	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	83	_	_	_	_	_	type.n	Type	S-Subtype
13	2	_	2	_	CD	83	_	_	_	_	_	_	_	B-Category
14	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	I-Category
15	,	_	,	_	,	83	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	83	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
19	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
20	section	_	section	_	NN	83	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	83	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	83	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	83	_	_	_	_	_	_	_	O
26	type	_	type	_	NN	83	_	_	_	_	_	_	_	O
27	1	_	1	_	CD	83	_	_	_	_	_	_	_	O
28	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
29	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	insulin	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
3	8	_	8	_	CD	83	_	_	_	_	_	_	_	O
4	for	_	For	_	IN	83	_	_	_	_	_	_	_	O
5	guidance	_	guidance	_	NN	83	_	_	_	_	_	_	_	O
6	on	_	on	_	IN	83	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
8	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
15	,	_	,	_	,	83	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	83	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	83	_	_	_	_	_	_	_	S-Theme
19	delivery	_	delivery	_	NN	83	_	_	_	_	_	delivery.n	Delivery	O
20	section	_	section	_	NN	83	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	83	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	83	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	83	_	_	_	_	_	_	_	O
26	type	_	type	_	NN	83	_	_	_	_	_	_	_	O
27	1	_	1	_	CD	83	_	_	_	_	_	_	_	O
28	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
29	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	insulin	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
3	8	_	8	_	CD	83	_	_	_	_	_	_	_	O
4	for	_	For	_	IN	83	_	_	_	_	_	_	_	O
5	guidance	_	guidance	_	NN	83	_	_	_	_	_	_	_	O
6	on	_	on	_	IN	83	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
8	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
15	,	_	,	_	,	83	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	83	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	83	_	_	_	_	_	_	_	B-Whole
19	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	I-Whole
20	section	_	section	_	NN	83	_	_	_	_	_	section.n	Part_whole	S-Part
21	in	_	in	_	IN	83	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	83	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	83	_	_	_	_	_	_	_	O
26	type	_	type	_	NN	83	_	_	_	_	_	_	_	O
27	1	_	1	_	CD	83	_	_	_	_	_	_	_	O
28	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
29	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	insulin	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
3	8	_	8	_	CD	83	_	_	_	_	_	_	_	O
4	for	_	For	_	IN	83	_	_	_	_	_	_	_	O
5	guidance	_	guidance	_	NN	83	_	_	_	_	_	_	_	O
6	on	_	on	_	IN	83	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
8	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	83	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
15	,	_	,	_	,	83	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	83	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	83	_	_	_	_	_	_	_	O
19	delivery	_	delivery	_	NN	83	_	_	_	_	_	_	_	O
20	section	_	section	_	NN	83	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	83	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	83	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	83	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	83	_	_	_	_	_	_	_	O
26	type	_	type	_	NN	83	_	_	_	_	_	type.n	Type	S-Subtype
27	1	_	1	_	CD	83	_	_	_	_	_	_	_	B-Category
28	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	I-Category
29	.	_	.	_	.	83	_	_	_	_	_	_	_	O

1	think	_	Think	_	VBP	84	_	_	_	_	_	think.v	Opinion	O
2	about	_	about	_	IN	84	_	_	_	_	_	_	_	B-Opinion
3	a	_	a	_	DT	84	_	_	_	_	_	_	_	I-Opinion
4	diagnosis	_	UNK	_	NN	84	_	_	_	_	_	_	_	I-Opinion
5	of	_	of	_	IN	84	_	_	_	_	_	_	_	I-Opinion
6	gastroparesis	_	UNK	_	NN	84	_	_	_	_	_	_	_	I-Opinion
7	in	_	in	_	IN	84	_	_	_	_	_	_	_	I-Opinion
8	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	I-Opinion
9	with	_	with	_	IN	84	_	_	_	_	_	_	_	I-Opinion
10	type	_	type	_	JJ	84	_	_	_	_	_	_	_	I-Opinion
11	2	_	2	_	CD	84	_	_	_	_	_	_	_	I-Opinion
12	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	I-Opinion
13	with	_	with	_	IN	84	_	_	_	_	_	_	_	I-Opinion
14	erratic	_	UNK	_	JJ	84	_	_	_	_	_	_	_	I-Opinion
15	blood	_	blood	_	NN	84	_	_	_	_	_	_	_	I-Opinion
16	glucose	_	UNK	_	VB	84	_	_	_	_	_	_	_	I-Opinion
17	control	_	control	_	NN	84	_	_	_	_	_	_	_	I-Opinion
18	or	_	or	_	CC	84	_	_	_	_	_	_	_	I-Opinion
19	unexplained	_	UNK	_	JJ	84	_	_	_	_	_	_	_	I-Opinion
20	gastric	_	UNK	_	JJ	84	_	_	_	_	_	_	_	I-Opinion
21	bloating	_	UNK	_	NN	84	_	_	_	_	_	_	_	I-Opinion
22	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
24	,	_	,	_	,	84	_	_	_	_	_	_	_	O
25	taking	_	take	_	VBG	84	_	_	_	_	_	_	_	O
26	into	_	into	_	IN	84	_	_	_	_	_	_	_	O
27	account	_	account	_	NN	84	_	_	_	_	_	_	_	O
28	possible	_	possible	_	JJ	84	_	_	_	_	_	_	_	O
29	alternative	_	alternative	_	JJ	84	_	_	_	_	_	_	_	O
30	diagnoses	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
31	[	_	[	_	JJ	84	_	_	_	_	_	_	_	O
32	2009	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
33	,	_	,	_	,	84	_	_	_	_	_	_	_	O
34	amended	_	UNK	_	VBD	84	_	_	_	_	_	_	_	O
35	2015	_	2015	_	CD	84	_	_	_	_	_	_	_	O
36	]	_	]	_	NN	84	_	_	_	_	_	_	_	O

1	think	_	Think	_	VBP	84	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	84	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
4	diagnosis	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	84	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	84	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
14	erratic	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
15	blood	_	blood	_	NN	84	_	_	_	_	_	_	_	O
16	glucose	_	UNK	_	VB	84	_	_	_	_	_	_	_	O
17	control	_	control	_	NN	84	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
20	gastric	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
21	bloating	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
22	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
24	,	_	,	_	,	84	_	_	_	_	_	_	_	O
25	taking	_	take	_	VBG	84	_	_	_	_	_	_	_	O
26	into	_	into	_	IN	84	_	_	_	_	_	_	_	O
27	account	_	account	_	NN	84	_	_	_	_	_	_	_	O
28	possible	_	possible	_	JJ	84	_	_	_	_	_	_	_	O
29	alternative	_	alternative	_	JJ	84	_	_	_	_	_	_	_	O
30	diagnoses	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
31	[	_	[	_	JJ	84	_	_	_	_	_	_	_	O
32	2009	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
33	,	_	,	_	,	84	_	_	_	_	_	_	_	O
34	amended	_	UNK	_	VBD	84	_	_	_	_	_	_	_	O
35	2015	_	2015	_	CD	84	_	_	_	_	_	_	_	O
36	]	_	]	_	NN	84	_	_	_	_	_	_	_	O

1	think	_	Think	_	VBP	84	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	84	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
4	diagnosis	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	84	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	84	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	84	_	_	_	_	_	_	_	B-Category
12	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	I-Category
13	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
14	erratic	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
15	blood	_	blood	_	NN	84	_	_	_	_	_	_	_	O
16	glucose	_	UNK	_	VB	84	_	_	_	_	_	_	_	O
17	control	_	control	_	NN	84	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
20	gastric	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
21	bloating	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
22	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
24	,	_	,	_	,	84	_	_	_	_	_	_	_	O
25	taking	_	take	_	VBG	84	_	_	_	_	_	_	_	O
26	into	_	into	_	IN	84	_	_	_	_	_	_	_	O
27	account	_	account	_	NN	84	_	_	_	_	_	_	_	O
28	possible	_	possible	_	JJ	84	_	_	_	_	_	_	_	O
29	alternative	_	alternative	_	JJ	84	_	_	_	_	_	_	_	O
30	diagnoses	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
31	[	_	[	_	JJ	84	_	_	_	_	_	_	_	O
32	2009	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
33	,	_	,	_	,	84	_	_	_	_	_	_	_	O
34	amended	_	UNK	_	VBD	84	_	_	_	_	_	_	_	O
35	2015	_	2015	_	CD	84	_	_	_	_	_	_	_	O
36	]	_	]	_	NN	84	_	_	_	_	_	_	_	O

1	think	_	Think	_	VBP	84	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	84	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
4	diagnosis	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	84	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
14	erratic	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
15	blood	_	blood	_	NN	84	_	_	_	_	_	_	_	O
16	glucose	_	UNK	_	VB	84	_	_	_	_	_	_	_	O
17	control	_	control	_	NN	84	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
20	gastric	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
21	bloating	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
22	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
24	,	_	,	_	,	84	_	_	_	_	_	_	_	O
25	taking	_	take	_	VBG	84	_	_	_	_	_	_	_	O
26	into	_	into	_	IN	84	_	_	_	_	_	_	_	O
27	account	_	account	_	NN	84	_	_	_	_	_	account.n	Text	O
28	possible	_	possible	_	JJ	84	_	_	_	_	_	_	_	O
29	alternative	_	alternative	_	JJ	84	_	_	_	_	_	_	_	O
30	diagnoses	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
31	[	_	[	_	JJ	84	_	_	_	_	_	_	_	O
32	2009	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
33	,	_	,	_	,	84	_	_	_	_	_	_	_	O
34	amended	_	UNK	_	VBD	84	_	_	_	_	_	_	_	O
35	2015	_	2015	_	CD	84	_	_	_	_	_	_	_	O
36	]	_	]	_	NN	84	_	_	_	_	_	_	_	O

1	think	_	Think	_	VBP	84	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	84	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	84	_	_	_	_	_	_	_	O
4	diagnosis	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	84	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	84	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	84	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	84	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	84	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	84	_	_	_	_	_	_	_	O
14	erratic	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
15	blood	_	blood	_	NN	84	_	_	_	_	_	_	_	O
16	glucose	_	UNK	_	VB	84	_	_	_	_	_	_	_	O
17	control	_	control	_	NN	84	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
20	gastric	_	UNK	_	JJ	84	_	_	_	_	_	_	_	O
21	bloating	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
22	or	_	or	_	CC	84	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	84	_	_	_	_	_	_	_	O
24	,	_	,	_	,	84	_	_	_	_	_	_	_	O
25	taking	_	take	_	VBG	84	_	_	_	_	_	_	_	O
26	into	_	into	_	IN	84	_	_	_	_	_	_	_	O
27	account	_	account	_	NN	84	_	_	_	_	_	_	_	S-Hypothetical_event
28	possible	_	possible	_	JJ	84	_	_	_	_	_	possible.a	Likelihood	O
29	alternative	_	alternative	_	JJ	84	_	_	_	_	_	_	_	O
30	diagnoses	_	UNK	_	NNS	84	_	_	_	_	_	_	_	O
31	[	_	[	_	JJ	84	_	_	_	_	_	_	_	O
32	2009	_	UNK	_	CD	84	_	_	_	_	_	_	_	O
33	,	_	,	_	,	84	_	_	_	_	_	_	_	O
34	amended	_	UNK	_	VBD	84	_	_	_	_	_	_	_	O
35	2015	_	2015	_	CD	84	_	_	_	_	_	_	_	O
36	]	_	]	_	NN	84	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	85	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	85	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	85	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	85	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
16	:	_	:	_	:	85	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	85	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	85	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	85	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	85	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	85	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	85	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	85	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	85	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	85	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
36	,	_	,	_	,	85	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
40	.	_	.	_	.	85	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	85	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
49	,	_	,	_	,	85	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	85	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	85	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	85	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	85	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	85	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	85	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
16	:	_	:	_	:	85	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	85	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	85	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	85	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	85	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	85	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	85	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	85	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	85	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	85	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
36	,	_	,	_	,	85	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
40	.	_	.	_	.	85	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	85	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
49	,	_	,	_	,	85	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	85	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	85	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	85	_	_	_	_	_	_	_	S-Cause
8	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	85	_	_	_	_	_	cause.v	Causation	O
11	by	_	by	_	IN	85	_	_	_	_	_	_	_	B-Effect
12	gastroparesis	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Effect
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	85	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
16	:	_	:	_	:	85	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	85	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	85	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	85	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	85	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	85	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	85	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	85	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	85	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	85	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
36	,	_	,	_	,	85	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
40	.	_	.	_	.	85	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	85	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
49	,	_	,	_	,	85	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	85	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	85	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	85	_	_	_	_	_	_	_	S-Fact
8	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	85	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	85	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	85	_	_	_	_	_	explain.v	Explaining_the_facts	O
15	that	_	that	_	IN	85	_	_	_	_	_	_	_	B-State_of_affairs
16	:	_	:	_	:	85	_	_	_	_	_	_	_	I-State_of_affairs
17	there	_	there	_	EX	85	_	_	_	_	_	_	_	I-State_of_affairs
18	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	I-State_of_affairs
19	not	_	not	_	RB	85	_	_	_	_	_	_	_	I-State_of_affairs
20	strong	_	strong	_	JJ	85	_	_	_	_	_	_	_	I-State_of_affairs
21	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	I-State_of_affairs
22	that	_	that	_	IN	85	_	_	_	_	_	_	_	I-State_of_affairs
23	any	_	any	_	DT	85	_	_	_	_	_	_	_	I-State_of_affairs
24	available	_	available	_	JJ	85	_	_	_	_	_	_	_	I-State_of_affairs
25	antiemetic	_	UNK	_	JJ	85	_	_	_	_	_	_	_	I-State_of_affairs
26	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	I-State_of_affairs
27	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	I-State_of_affairs
28	effective	_	effective	_	JJ	85	_	_	_	_	_	_	_	I-State_of_affairs
29	some	_	some	_	DT	85	_	_	_	_	_	_	_	I-State_of_affairs
30	people	_	people	_	NNS	85	_	_	_	_	_	_	_	I-State_of_affairs
31	have	_	have	_	VBP	85	_	_	_	_	_	_	_	I-State_of_affairs
32	had	_	have	_	VBN	85	_	_	_	_	_	_	_	I-State_of_affairs
33	benefit	_	benefit	_	VBN	85	_	_	_	_	_	_	_	I-State_of_affairs
34	with	_	with	_	IN	85	_	_	_	_	_	_	_	I-State_of_affairs
35	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
36	,	_	,	_	,	85	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
40	.	_	.	_	.	85	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	85	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
49	,	_	,	_	,	85	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	85	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	85	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	85	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	85	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	85	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	85	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
16	:	_	:	_	:	85	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	85	_	_	_	_	_	there.adv	Locative_relation	S-Ground
18	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	85	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	85	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	85	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	85	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	85	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	85	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	85	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	85	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
36	,	_	,	_	,	85	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
40	.	_	.	_	.	85	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	85	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
49	,	_	,	_	,	85	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	85	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	85	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	85	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	85	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	85	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	85	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
16	:	_	:	_	:	85	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	85	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	85	_	_	_	_	_	strong.a	Level_of_force_exertion	O
21	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	S-Exerter
22	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	85	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	85	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	85	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	85	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	85	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	85	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	85	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
36	,	_	,	_	,	85	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
40	.	_	.	_	.	85	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	85	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
49	,	_	,	_	,	85	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	85	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	85	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	85	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	85	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	85	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	85	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
16	:	_	:	_	:	85	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	85	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	85	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	85	_	_	_	_	_	evidence.n	Evidence	S-Support
22	that	_	that	_	IN	85	_	_	_	_	_	_	_	B-Proposition
23	any	_	any	_	DT	85	_	_	_	_	_	_	_	I-Proposition
24	available	_	available	_	JJ	85	_	_	_	_	_	_	_	I-Proposition
25	antiemetic	_	UNK	_	JJ	85	_	_	_	_	_	_	_	I-Proposition
26	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	I-Proposition
27	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	I-Proposition
28	effective	_	effective	_	JJ	85	_	_	_	_	_	_	_	I-Proposition
29	some	_	some	_	DT	85	_	_	_	_	_	_	_	I-Proposition
30	people	_	people	_	NNS	85	_	_	_	_	_	_	_	I-Proposition
31	have	_	have	_	VBP	85	_	_	_	_	_	_	_	I-Proposition
32	had	_	have	_	VBN	85	_	_	_	_	_	_	_	I-Proposition
33	benefit	_	benefit	_	VBN	85	_	_	_	_	_	_	_	I-Proposition
34	with	_	with	_	IN	85	_	_	_	_	_	_	_	I-Proposition
35	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Proposition
36	,	_	,	_	,	85	_	_	_	_	_	_	_	I-Proposition
37	erythromycin	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Proposition
38	or	_	or	_	CC	85	_	_	_	_	_	_	_	I-Proposition
39	metoclopramide	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Proposition
40	.	_	.	_	.	85	_	_	_	_	_	_	_	I-Proposition
41	the	_	the	_	DT	85	_	_	_	_	_	_	_	I-Proposition
42	strongest	_	strongest	_	JJS	85	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
49	,	_	,	_	,	85	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	85	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	85	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	85	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	85	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	85	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	85	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
16	:	_	:	_	:	85	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	85	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	85	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	85	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	85	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	85	_	_	_	_	_	_	_	S-Type
26	therapy	_	therapy	_	NN	85	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
27	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	85	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	85	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	85	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	85	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	85	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
36	,	_	,	_	,	85	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
40	.	_	.	_	.	85	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	85	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
49	,	_	,	_	,	85	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	85	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	85	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	85	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	85	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	85	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	85	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
16	:	_	:	_	:	85	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	85	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	85	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	85	_	_	_	_	_	_	_	B-Entity
24	available	_	available	_	JJ	85	_	_	_	_	_	_	_	I-Entity
25	antiemetic	_	UNK	_	JJ	85	_	_	_	_	_	_	_	I-Entity
26	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	I-Entity
27	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	85	_	_	_	_	_	effective.a	Usefulness	O
29	some	_	some	_	DT	85	_	_	_	_	_	_	_	B-Entity
30	people	_	people	_	NNS	85	_	_	_	_	_	_	_	I-Entity
31	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	85	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	85	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
36	,	_	,	_	,	85	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
40	.	_	.	_	.	85	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	85	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
49	,	_	,	_	,	85	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	85	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	85	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	85	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	85	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	85	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	85	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
16	:	_	:	_	:	85	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	85	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	85	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	85	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	85	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	85	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	85	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	85	_	_	_	_	_	people.n	People	S-Person
31	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	85	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	85	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
36	,	_	,	_	,	85	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
40	.	_	.	_	.	85	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	85	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
49	,	_	,	_	,	85	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	85	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	85	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	85	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	85	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	85	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	85	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
16	:	_	:	_	:	85	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	85	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	85	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	85	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	85	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	85	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	85	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	85	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	85	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	85	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	85	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	85	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	85	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	85	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	85	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
36	,	_	,	_	,	85	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	85	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
40	.	_	.	_	.	85	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	85	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	85	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	85	_	_	_	_	_	evidence.n	Evidence	S-Support
44	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	85	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	85	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
49	,	_	,	_	,	85	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	85	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	85	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	86	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	86	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	86	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	86	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	86	_	_	_	_	_	_	_	O
6	:	_	:	_	:	86	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	86	_	_	_	_	_	_	_	O
8	(	_	(	_	(	86	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	86	_	_	_	_	_	_	_	O
10	)	_	)	_	)	86	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	86	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	86	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	86	_	_	_	_	_	_	_	O
14	)	_	)	_	)	86	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	86	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	86	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	86	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	86	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	86	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	86	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	86	_	_	_	_	_	_	_	O
8	(	_	(	_	(	86	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	86	_	_	_	_	_	_	_	O
10	)	_	)	_	)	86	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	86	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	86	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	86	_	_	_	_	_	_	_	O
14	)	_	)	_	)	86	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	87	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	87	_	_	_	_	_	treat.v	Medical_intervention	O
3	vomiting	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	87	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	87	_	_	_	_	_	_	_	B-Medical_condition
6	gastroparesis	_	UNK	_	NN	87	_	_	_	_	_	_	_	I-Medical_condition
7	in	_	in	_	IN	87	_	_	_	_	_	_	_	I-Medical_condition
8	adults	_	adult	_	NNS	87	_	_	_	_	_	_	_	I-Medical_condition
9	with	_	with	_	IN	87	_	_	_	_	_	_	_	I-Medical_condition
10	type	_	type	_	JJ	87	_	_	_	_	_	_	_	I-Medical_condition
11	2	_	2	_	CD	87	_	_	_	_	_	_	_	I-Medical_condition
12	diabetes	_	UNK	_	NNS	87	_	_	_	_	_	_	_	I-Medical_condition
13	:	_	:	_	:	87	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	87	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	87	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
23	only	_	only	_	RB	87	_	_	_	_	_	_	_	O
24	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
25	exceptional	_	UNK	_	JJ	87	_	_	_	_	_	_	_	O
26	circumstances	_	circumstance	_	NNS	87	_	_	_	_	_	_	_	O
27	(	_	(	_	(	87	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	87	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	87	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	87	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	87	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	87	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	87	_	_	_	_	_	_	_	O
35	)	_	)	_	)	87	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	87	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	87	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	87	_	_	_	_	_	_	_	O
42	.	_	.	_	.	87	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	87	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	87	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	87	_	_	_	_	_	cause.v	Causation	O
5	by	_	by	_	IN	87	_	_	_	_	_	_	_	B-Effect
6	gastroparesis	_	UNK	_	NN	87	_	_	_	_	_	_	_	I-Effect
7	in	_	in	_	IN	87	_	_	_	_	_	_	_	I-Effect
8	adults	_	adult	_	NNS	87	_	_	_	_	_	_	_	I-Effect
9	with	_	with	_	IN	87	_	_	_	_	_	_	_	I-Effect
10	type	_	type	_	JJ	87	_	_	_	_	_	_	_	I-Effect
11	2	_	2	_	CD	87	_	_	_	_	_	_	_	I-Effect
12	diabetes	_	UNK	_	NNS	87	_	_	_	_	_	_	_	I-Effect
13	:	_	:	_	:	87	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	87	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	87	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
23	only	_	only	_	RB	87	_	_	_	_	_	_	_	O
24	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
25	exceptional	_	UNK	_	JJ	87	_	_	_	_	_	_	_	O
26	circumstances	_	circumstance	_	NNS	87	_	_	_	_	_	_	_	O
27	(	_	(	_	(	87	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	87	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	87	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	87	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	87	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	87	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	87	_	_	_	_	_	_	_	O
35	)	_	)	_	)	87	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	87	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	87	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	87	_	_	_	_	_	_	_	O
42	.	_	.	_	.	87	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	87	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	87	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	87	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	87	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	87	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	87	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	87	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	87	_	_	_	_	_	_	_	O
13	:	_	:	_	:	87	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	87	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	87	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
23	only	_	only	_	RB	87	_	_	_	_	_	_	_	O
24	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
25	exceptional	_	UNK	_	JJ	87	_	_	_	_	_	_	_	O
26	circumstances	_	circumstance	_	NNS	87	_	_	_	_	_	_	_	O
27	(	_	(	_	(	87	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	87	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	87	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	87	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	87	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	87	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	87	_	_	_	_	_	_	_	O
35	)	_	)	_	)	87	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	87	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	87	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	87	_	_	_	_	_	_	_	O
42	.	_	.	_	.	87	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	87	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	87	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	87	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	87	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	87	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	87	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	87	_	_	_	_	_	_	_	B-Category
12	diabetes	_	UNK	_	NNS	87	_	_	_	_	_	_	_	I-Category
13	:	_	:	_	:	87	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	87	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	87	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
23	only	_	only	_	RB	87	_	_	_	_	_	_	_	O
24	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
25	exceptional	_	UNK	_	JJ	87	_	_	_	_	_	_	_	O
26	circumstances	_	circumstance	_	NNS	87	_	_	_	_	_	_	_	O
27	(	_	(	_	(	87	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	87	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	87	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	87	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	87	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	87	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	87	_	_	_	_	_	_	_	O
35	)	_	)	_	)	87	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	87	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	87	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	87	_	_	_	_	_	_	_	O
42	.	_	.	_	.	87	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	87	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	87	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	87	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	87	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	87	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	87	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	87	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	87	_	_	_	_	_	_	_	O
13	:	_	:	_	:	87	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	87	_	_	_	_	_	consider.v	Categorization	O
15	alternating	_	UNK	_	VBG	87	_	_	_	_	_	_	_	B-Category
16	use	_	use	_	NN	87	_	_	_	_	_	_	_	I-Category
17	of	_	of	_	IN	87	_	_	_	_	_	_	_	I-Category
18	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	I-Category
19	and	_	and	_	CC	87	_	_	_	_	_	_	_	I-Category
20	metoclopramide	_	UNK	_	NN	87	_	_	_	_	_	_	_	I-Category
21	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	I-Category
22	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	I-Category
23	only	_	only	_	RB	87	_	_	_	_	_	_	_	I-Category
24	in	_	in	_	IN	87	_	_	_	_	_	_	_	I-Category
25	exceptional	_	UNK	_	JJ	87	_	_	_	_	_	_	_	I-Category
26	circumstances	_	circumstance	_	NNS	87	_	_	_	_	_	_	_	I-Category
27	(	_	(	_	(	87	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	87	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	87	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	87	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	87	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	87	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	87	_	_	_	_	_	_	_	O
35	)	_	)	_	)	87	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	87	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	87	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	87	_	_	_	_	_	_	_	O
42	.	_	.	_	.	87	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	87	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	87	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	87	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	87	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	87	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	87	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	87	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	87	_	_	_	_	_	_	_	O
13	:	_	:	_	:	87	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	87	_	_	_	_	_	use.n	Using	O
17	of	_	of	_	IN	87	_	_	_	_	_	_	_	B-Instrument
18	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	I-Instrument
19	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
23	only	_	only	_	RB	87	_	_	_	_	_	_	_	O
24	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
25	exceptional	_	UNK	_	JJ	87	_	_	_	_	_	_	_	O
26	circumstances	_	circumstance	_	NNS	87	_	_	_	_	_	_	_	O
27	(	_	(	_	(	87	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	87	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	87	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	87	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	87	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	87	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	87	_	_	_	_	_	_	_	O
35	)	_	)	_	)	87	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	87	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	87	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	87	_	_	_	_	_	_	_	O
42	.	_	.	_	.	87	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	87	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	87	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	87	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	87	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	87	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	87	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	87	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	87	_	_	_	_	_	_	_	O
13	:	_	:	_	:	87	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	87	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	87	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	87	_	_	_	_	_	consider.v	Categorization	O
22	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	B-Category
23	only	_	only	_	RB	87	_	_	_	_	_	_	_	I-Category
24	in	_	in	_	IN	87	_	_	_	_	_	_	_	I-Category
25	exceptional	_	UNK	_	JJ	87	_	_	_	_	_	_	_	I-Category
26	circumstances	_	circumstance	_	NNS	87	_	_	_	_	_	_	_	I-Category
27	(	_	(	_	(	87	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	87	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	87	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	87	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	87	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	87	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	87	_	_	_	_	_	_	_	O
35	)	_	)	_	)	87	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	87	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	87	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	87	_	_	_	_	_	_	_	O
42	.	_	.	_	.	87	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	87	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	87	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	87	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	87	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	87	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	87	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	87	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	87	_	_	_	_	_	_	_	O
13	:	_	:	_	:	87	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	87	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	87	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	87	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	87	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
23	only	_	only	_	RB	87	_	_	_	_	_	_	_	O
24	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
25	exceptional	_	UNK	_	JJ	87	_	_	_	_	_	_	_	O
26	circumstances	_	circumstance	_	NNS	87	_	_	_	_	_	_	_	O
27	(	_	(	_	(	87	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	87	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	87	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	87	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	87	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	87	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	87	_	_	_	_	_	effective.a	Usefulness	O
34	treatment	_	treatment	_	NN	87	_	_	_	_	_	_	_	S-Entity
35	)	_	)	_	)	87	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	87	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	87	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	87	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	87	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	87	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	87	_	_	_	_	_	_	_	O
42	.	_	.	_	.	87	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	88	_	_	_	_	_	_	_	O
2	gastroparesis	_	UNK	_	NN	88	_	_	_	_	_	_	_	S-Suspect
3	is	_	be	_	VBZ	88	_	_	_	_	_	_	_	O
4	suspected	_	suspect	_	VBN	88	_	_	_	_	_	suspect.v	Suspicion	O
5	,	_	,	_	,	88	_	_	_	_	_	_	_	O
6	consider	_	consider	_	VB	88	_	_	_	_	_	_	_	O
7	referral	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
9	specialist	_	specialist	_	VB	88	_	_	_	_	_	_	_	O
10	services	_	service	_	NNS	88	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	88	_	_	_	_	_	_	_	O
12	:	_	:	_	:	88	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
14	differential	_	differential	_	JJ	88	_	_	_	_	_	_	_	O
15	diagnosis	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	88	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
18	doubt	_	doubt	_	NN	88	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	88	_	_	_	_	_	_	_	O
20	persistent	_	persistent	_	NN	88	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	88	_	_	_	_	_	_	_	O
22	severe	_	severe	_	JJ	88	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
24	occurs	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
25	.	_	.	_	.	88	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	88	_	_	_	_	_	_	_	O
2	gastroparesis	_	UNK	_	NN	88	_	_	_	_	_	_	_	S-Cognizer
3	is	_	be	_	VBZ	88	_	_	_	_	_	_	_	O
4	suspected	_	suspect	_	VBN	88	_	_	_	_	_	_	_	O
5	,	_	,	_	,	88	_	_	_	_	_	_	_	O
6	consider	_	consider	_	VB	88	_	_	_	_	_	consider.v	Categorization	O
7	referral	_	UNK	_	JJ	88	_	_	_	_	_	_	_	B-Category
8	to	_	to	_	TO	88	_	_	_	_	_	_	_	I-Category
9	specialist	_	specialist	_	VB	88	_	_	_	_	_	_	_	I-Category
10	services	_	service	_	NNS	88	_	_	_	_	_	_	_	I-Category
11	if	_	if	_	IN	88	_	_	_	_	_	_	_	I-Category
12	:	_	:	_	:	88	_	_	_	_	_	_	_	I-Category
13	the	_	the	_	DT	88	_	_	_	_	_	_	_	I-Category
14	differential	_	differential	_	JJ	88	_	_	_	_	_	_	_	I-Category
15	diagnosis	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Category
16	is	_	be	_	VBZ	88	_	_	_	_	_	_	_	I-Category
17	in	_	in	_	IN	88	_	_	_	_	_	_	_	I-Category
18	doubt	_	doubt	_	NN	88	_	_	_	_	_	_	_	I-Category
19	or	_	or	_	CC	88	_	_	_	_	_	_	_	I-Category
20	persistent	_	persistent	_	NN	88	_	_	_	_	_	_	_	I-Category
21	or	_	or	_	CC	88	_	_	_	_	_	_	_	I-Category
22	severe	_	severe	_	JJ	88	_	_	_	_	_	_	_	I-Category
23	vomiting	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Category
24	occurs	_	UNK	_	NNS	88	_	_	_	_	_	_	_	I-Category
25	.	_	.	_	.	88	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	88	_	_	_	_	_	_	_	O
2	gastroparesis	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
3	is	_	be	_	VBZ	88	_	_	_	_	_	_	_	O
4	suspected	_	suspect	_	VBN	88	_	_	_	_	_	_	_	O
5	,	_	,	_	,	88	_	_	_	_	_	_	_	O
6	consider	_	consider	_	VB	88	_	_	_	_	_	_	_	O
7	referral	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
9	specialist	_	specialist	_	VB	88	_	_	_	_	_	specialist.n	Expertise	S-Protagonist
10	services	_	service	_	NNS	88	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	88	_	_	_	_	_	_	_	O
12	:	_	:	_	:	88	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
14	differential	_	differential	_	JJ	88	_	_	_	_	_	_	_	O
15	diagnosis	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	88	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
18	doubt	_	doubt	_	NN	88	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	88	_	_	_	_	_	_	_	O
20	persistent	_	persistent	_	NN	88	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	88	_	_	_	_	_	_	_	O
22	severe	_	severe	_	JJ	88	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
24	occurs	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
25	.	_	.	_	.	88	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	88	_	_	_	_	_	_	_	O
2	gastroparesis	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
3	is	_	be	_	VBZ	88	_	_	_	_	_	_	_	O
4	suspected	_	suspect	_	VBN	88	_	_	_	_	_	_	_	O
5	,	_	,	_	,	88	_	_	_	_	_	_	_	O
6	consider	_	consider	_	VB	88	_	_	_	_	_	_	_	O
7	referral	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
9	specialist	_	specialist	_	VB	88	_	_	_	_	_	_	_	S-Domain
10	services	_	service	_	NNS	88	_	_	_	_	_	service.n	Public_services	S-Institution
11	if	_	if	_	IN	88	_	_	_	_	_	_	_	O
12	:	_	:	_	:	88	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
14	differential	_	differential	_	JJ	88	_	_	_	_	_	_	_	O
15	diagnosis	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	88	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
18	doubt	_	doubt	_	NN	88	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	88	_	_	_	_	_	_	_	O
20	persistent	_	persistent	_	NN	88	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	88	_	_	_	_	_	_	_	O
22	severe	_	severe	_	JJ	88	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
24	occurs	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
25	.	_	.	_	.	88	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	88	_	_	_	_	_	_	_	O
2	gastroparesis	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
3	is	_	be	_	VBZ	88	_	_	_	_	_	_	_	O
4	suspected	_	suspect	_	VBN	88	_	_	_	_	_	_	_	O
5	,	_	,	_	,	88	_	_	_	_	_	_	_	O
6	consider	_	consider	_	VB	88	_	_	_	_	_	_	_	O
7	referral	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
9	specialist	_	specialist	_	VB	88	_	_	_	_	_	_	_	O
10	services	_	service	_	NNS	88	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	88	_	_	_	_	_	_	_	O
12	:	_	:	_	:	88	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	88	_	_	_	_	_	_	_	B-Cognizer
14	differential	_	differential	_	JJ	88	_	_	_	_	_	_	_	I-Cognizer
15	diagnosis	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Cognizer
16	is	_	be	_	VBZ	88	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
18	doubt	_	doubt	_	NN	88	_	_	_	_	_	doubt.n	Certainty	O
19	or	_	or	_	CC	88	_	_	_	_	_	_	_	O
20	persistent	_	persistent	_	NN	88	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	88	_	_	_	_	_	_	_	O
22	severe	_	severe	_	JJ	88	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
24	occurs	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
25	.	_	.	_	.	88	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	88	_	_	_	_	_	_	_	O
2	gastroparesis	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
3	is	_	be	_	VBZ	88	_	_	_	_	_	_	_	O
4	suspected	_	suspect	_	VBN	88	_	_	_	_	_	_	_	O
5	,	_	,	_	,	88	_	_	_	_	_	_	_	O
6	consider	_	consider	_	VB	88	_	_	_	_	_	_	_	O
7	referral	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
9	specialist	_	specialist	_	VB	88	_	_	_	_	_	_	_	O
10	services	_	service	_	NNS	88	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	88	_	_	_	_	_	_	_	O
12	:	_	:	_	:	88	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	88	_	_	_	_	_	_	_	O
14	differential	_	differential	_	JJ	88	_	_	_	_	_	_	_	O
15	diagnosis	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	88	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
18	doubt	_	doubt	_	NN	88	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	88	_	_	_	_	_	_	_	O
20	persistent	_	persistent	_	NN	88	_	_	_	_	_	persistent.a	Duration_description	O
21	or	_	or	_	CC	88	_	_	_	_	_	_	_	O
22	severe	_	severe	_	JJ	88	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	88	_	_	_	_	_	_	_	B-Eventuality
24	occurs	_	UNK	_	NNS	88	_	_	_	_	_	_	_	I-Eventuality
25	.	_	.	_	.	88	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	89	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	89	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	89	_	_	_	_	_	_	_	O
4	managing	_	manage	_	VBG	89	_	_	_	_	_	_	_	O
5	painful	_	UNK	_	JJ	89	_	_	_	_	_	_	_	O
6	diabetic	_	UNK	_	JJ	89	_	_	_	_	_	_	_	O
7	peripheral	_	peripheral	_	JJ	89	_	_	_	_	_	_	_	O
8	neuropathy	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	89	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	89	_	_	_	_	_	adult.n	People_by_age	S-Person
11	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	89	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	89	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
15	,	_	,	_	,	89	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	89	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
18	nice	_	UNK	_	NNP	89	_	_	_	_	_	_	_	O
19	guideline	_	guideline	_	NN	89	_	_	_	_	_	_	_	O
20	on	_	on	_	IN	89	_	_	_	_	_	_	_	O
21	neuropathic	_	UNK	_	JJ	89	_	_	_	_	_	_	_	O
22	pain	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
23	in	_	in	_	IN	89	_	_	_	_	_	_	_	O
24	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	O
25	.	_	.	_	.	89	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	89	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	89	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	89	_	_	_	_	_	_	_	O
4	managing	_	manage	_	VBG	89	_	_	_	_	_	_	_	O
5	painful	_	UNK	_	JJ	89	_	_	_	_	_	_	_	O
6	diabetic	_	UNK	_	JJ	89	_	_	_	_	_	_	_	O
7	peripheral	_	peripheral	_	JJ	89	_	_	_	_	_	_	_	O
8	neuropathy	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	89	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	89	_	_	_	_	_	type.n	Type	S-Subtype
13	2	_	2	_	CD	89	_	_	_	_	_	_	_	B-Category
14	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	I-Category
15	,	_	,	_	,	89	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	89	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
18	nice	_	UNK	_	NNP	89	_	_	_	_	_	_	_	O
19	guideline	_	guideline	_	NN	89	_	_	_	_	_	_	_	O
20	on	_	on	_	IN	89	_	_	_	_	_	_	_	O
21	neuropathic	_	UNK	_	JJ	89	_	_	_	_	_	_	_	O
22	pain	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
23	in	_	in	_	IN	89	_	_	_	_	_	_	_	O
24	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	O
25	.	_	.	_	.	89	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	89	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	89	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	89	_	_	_	_	_	_	_	O
4	managing	_	manage	_	VBG	89	_	_	_	_	_	_	_	O
5	painful	_	UNK	_	JJ	89	_	_	_	_	_	_	_	O
6	diabetic	_	UNK	_	JJ	89	_	_	_	_	_	_	_	O
7	peripheral	_	peripheral	_	JJ	89	_	_	_	_	_	_	_	O
8	neuropathy	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	89	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	89	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	89	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
15	,	_	,	_	,	89	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	89	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
18	nice	_	UNK	_	NNP	89	_	_	_	_	_	_	_	O
19	guideline	_	guideline	_	NN	89	_	_	_	_	_	_	_	O
20	on	_	on	_	IN	89	_	_	_	_	_	_	_	O
21	neuropathic	_	UNK	_	JJ	89	_	_	_	_	_	_	_	O
22	pain	_	UNK	_	NN	89	_	_	_	_	_	_	_	O
23	in	_	in	_	IN	89	_	_	_	_	_	_	_	O
24	adults	_	adult	_	NNS	89	_	_	_	_	_	adult.n	People_by_age	S-Person
25	.	_	.	_	.	89	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	90	_	_	_	_	_	think.v	Opinion	O
2	about	_	about	_	IN	90	_	_	_	_	_	_	_	B-Opinion
3	the	_	the	_	DT	90	_	_	_	_	_	_	_	I-Opinion
4	possibility	_	possibility	_	NN	90	_	_	_	_	_	_	_	I-Opinion
5	of	_	of	_	IN	90	_	_	_	_	_	_	_	I-Opinion
6	contributory	_	UNK	_	JJ	90	_	_	_	_	_	_	_	I-Opinion
7	sympathetic	_	UNK	_	JJ	90	_	_	_	_	_	_	_	I-Opinion
8	nervous	_	nervous	_	JJ	90	_	_	_	_	_	_	_	I-Opinion
9	system	_	system	_	NN	90	_	_	_	_	_	_	_	I-Opinion
10	damage	_	damage	_	NN	90	_	_	_	_	_	_	_	I-Opinion
11	for	_	for	_	IN	90	_	_	_	_	_	_	_	I-Opinion
12	adults	_	adult	_	NNS	90	_	_	_	_	_	_	_	I-Opinion
13	with	_	with	_	IN	90	_	_	_	_	_	_	_	I-Opinion
14	type	_	type	_	JJ	90	_	_	_	_	_	_	_	I-Opinion
15	2	_	2	_	CD	90	_	_	_	_	_	_	_	I-Opinion
16	diabetes	_	UNK	_	NNS	90	_	_	_	_	_	_	_	I-Opinion
17	who	_	who	_	WP	90	_	_	_	_	_	_	_	I-Opinion
18	lose	_	lose	_	VBP	90	_	_	_	_	_	_	_	I-Opinion
19	the	_	the	_	DT	90	_	_	_	_	_	_	_	I-Opinion
20	warning	_	warning	_	NN	90	_	_	_	_	_	_	_	I-Opinion
21	signs	_	sign	_	NNS	90	_	_	_	_	_	_	_	I-Opinion
22	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
24	.	_	.	_	.	90	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	90	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	90	_	_	_	_	_	_	_	O
27	,	_	,	_	,	90	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	90	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	90	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	90	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	90	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	90	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	90	_	_	_	_	_	possibility.n	Likelihood	O
5	of	_	of	_	IN	90	_	_	_	_	_	_	_	B-Hypothetical_event
6	contributory	_	UNK	_	JJ	90	_	_	_	_	_	_	_	I-Hypothetical_event
7	sympathetic	_	UNK	_	JJ	90	_	_	_	_	_	_	_	I-Hypothetical_event
8	nervous	_	nervous	_	JJ	90	_	_	_	_	_	_	_	I-Hypothetical_event
9	system	_	system	_	NN	90	_	_	_	_	_	_	_	I-Hypothetical_event
10	damage	_	damage	_	NN	90	_	_	_	_	_	_	_	I-Hypothetical_event
11	for	_	for	_	IN	90	_	_	_	_	_	_	_	I-Hypothetical_event
12	adults	_	adult	_	NNS	90	_	_	_	_	_	_	_	I-Hypothetical_event
13	with	_	with	_	IN	90	_	_	_	_	_	_	_	I-Hypothetical_event
14	type	_	type	_	JJ	90	_	_	_	_	_	_	_	I-Hypothetical_event
15	2	_	2	_	CD	90	_	_	_	_	_	_	_	I-Hypothetical_event
16	diabetes	_	UNK	_	NNS	90	_	_	_	_	_	_	_	I-Hypothetical_event
17	who	_	who	_	WP	90	_	_	_	_	_	_	_	I-Hypothetical_event
18	lose	_	lose	_	VBP	90	_	_	_	_	_	_	_	I-Hypothetical_event
19	the	_	the	_	DT	90	_	_	_	_	_	_	_	I-Hypothetical_event
20	warning	_	warning	_	NN	90	_	_	_	_	_	_	_	I-Hypothetical_event
21	signs	_	sign	_	NNS	90	_	_	_	_	_	_	_	I-Hypothetical_event
22	of	_	of	_	IN	90	_	_	_	_	_	_	_	I-Hypothetical_event
23	unk	_	UNK	_	NN	90	_	_	_	_	_	_	_	I-Hypothetical_event
24	.	_	.	_	.	90	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	90	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	90	_	_	_	_	_	_	_	O
27	,	_	,	_	,	90	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	90	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	90	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	90	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	90	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	90	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	90	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
6	contributory	_	UNK	_	JJ	90	_	_	_	_	_	_	_	O
7	sympathetic	_	UNK	_	JJ	90	_	_	_	_	_	_	_	O
8	nervous	_	nervous	_	JJ	90	_	_	_	_	_	_	_	O
9	system	_	system	_	NN	90	_	_	_	_	_	system.n	System	S-Complex
10	damage	_	damage	_	NN	90	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	90	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	90	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	90	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	90	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	90	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	90	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	90	_	_	_	_	_	_	_	O
18	lose	_	lose	_	VBP	90	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
20	warning	_	warning	_	NN	90	_	_	_	_	_	_	_	O
21	signs	_	sign	_	NNS	90	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
24	.	_	.	_	.	90	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	90	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	90	_	_	_	_	_	_	_	O
27	,	_	,	_	,	90	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	90	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	90	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	90	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	90	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	90	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	90	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
6	contributory	_	UNK	_	JJ	90	_	_	_	_	_	_	_	O
7	sympathetic	_	UNK	_	JJ	90	_	_	_	_	_	_	_	O
8	nervous	_	nervous	_	JJ	90	_	_	_	_	_	_	_	O
9	system	_	system	_	NN	90	_	_	_	_	_	_	_	S-Patient
10	damage	_	damage	_	NN	90	_	_	_	_	_	damage.n	Damaging	O
11	for	_	for	_	IN	90	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	90	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	90	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	90	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	90	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	90	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	90	_	_	_	_	_	_	_	O
18	lose	_	lose	_	VBP	90	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
20	warning	_	warning	_	NN	90	_	_	_	_	_	_	_	O
21	signs	_	sign	_	NNS	90	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
24	.	_	.	_	.	90	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	90	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	90	_	_	_	_	_	_	_	O
27	,	_	,	_	,	90	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	90	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	90	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	90	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	90	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	90	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	90	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
6	contributory	_	UNK	_	JJ	90	_	_	_	_	_	_	_	O
7	sympathetic	_	UNK	_	JJ	90	_	_	_	_	_	_	_	O
8	nervous	_	nervous	_	JJ	90	_	_	_	_	_	_	_	O
9	system	_	system	_	NN	90	_	_	_	_	_	_	_	O
10	damage	_	damage	_	NN	90	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	90	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	90	_	_	_	_	_	adult.n	People_by_age	S-Person
13	with	_	with	_	IN	90	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	90	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	90	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	90	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	90	_	_	_	_	_	_	_	O
18	lose	_	lose	_	VBP	90	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
20	warning	_	warning	_	NN	90	_	_	_	_	_	_	_	O
21	signs	_	sign	_	NNS	90	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
24	.	_	.	_	.	90	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	90	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	90	_	_	_	_	_	_	_	O
27	,	_	,	_	,	90	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	90	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	90	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	90	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	90	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	90	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	90	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
6	contributory	_	UNK	_	JJ	90	_	_	_	_	_	_	_	O
7	sympathetic	_	UNK	_	JJ	90	_	_	_	_	_	_	_	O
8	nervous	_	nervous	_	JJ	90	_	_	_	_	_	_	_	O
9	system	_	system	_	NN	90	_	_	_	_	_	_	_	O
10	damage	_	damage	_	NN	90	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	90	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	90	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	90	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	90	_	_	_	_	_	type.n	Type	S-Subtype
15	2	_	2	_	CD	90	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	90	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	90	_	_	_	_	_	_	_	O
18	lose	_	lose	_	VBP	90	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
20	warning	_	warning	_	NN	90	_	_	_	_	_	_	_	O
21	signs	_	sign	_	NNS	90	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
24	.	_	.	_	.	90	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	90	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	90	_	_	_	_	_	_	_	O
27	,	_	,	_	,	90	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	90	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	90	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	90	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	90	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	90	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	90	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
6	contributory	_	UNK	_	JJ	90	_	_	_	_	_	_	_	O
7	sympathetic	_	UNK	_	JJ	90	_	_	_	_	_	_	_	O
8	nervous	_	nervous	_	JJ	90	_	_	_	_	_	_	_	O
9	system	_	system	_	NN	90	_	_	_	_	_	_	_	O
10	damage	_	damage	_	NN	90	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	90	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	90	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	90	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	90	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	90	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	90	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	90	_	_	_	_	_	_	_	O
18	lose	_	lose	_	VBP	90	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
20	warning	_	warning	_	NN	90	_	_	_	_	_	_	_	S-Reliability
21	signs	_	sign	_	NNS	90	_	_	_	_	_	sign.n	Sign	S-Indicator
22	of	_	of	_	IN	90	_	_	_	_	_	_	_	B-Indicated
23	unk	_	UNK	_	NN	90	_	_	_	_	_	_	_	I-Indicated
24	.	_	.	_	.	90	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	90	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	90	_	_	_	_	_	_	_	O
27	,	_	,	_	,	90	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	90	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	90	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	90	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	91	_	_	_	_	_	think.v	Opinion	O
2	about	_	about	_	IN	91	_	_	_	_	_	_	_	B-Opinion
3	the	_	the	_	DT	91	_	_	_	_	_	_	_	I-Opinion
4	possibility	_	possibility	_	NN	91	_	_	_	_	_	_	_	I-Opinion
5	of	_	of	_	IN	91	_	_	_	_	_	_	_	I-Opinion
6	autonomic	_	UNK	_	JJ	91	_	_	_	_	_	_	_	I-Opinion
7	neuropathy	_	UNK	_	JJ	91	_	_	_	_	_	_	_	I-Opinion
8	affecting	_	affect	_	VBG	91	_	_	_	_	_	_	_	I-Opinion
9	the	_	the	_	DT	91	_	_	_	_	_	_	_	I-Opinion
10	gut	_	UNK	_	NN	91	_	_	_	_	_	_	_	I-Opinion
11	in	_	in	_	IN	91	_	_	_	_	_	_	_	I-Opinion
12	adults	_	adult	_	NNS	91	_	_	_	_	_	_	_	I-Opinion
13	with	_	with	_	IN	91	_	_	_	_	_	_	_	I-Opinion
14	type	_	type	_	JJ	91	_	_	_	_	_	_	_	I-Opinion
15	2	_	2	_	CD	91	_	_	_	_	_	_	_	I-Opinion
16	diabetes	_	UNK	_	NNS	91	_	_	_	_	_	_	_	I-Opinion
17	who	_	who	_	WP	91	_	_	_	_	_	_	_	I-Opinion
18	have	_	have	_	VBP	91	_	_	_	_	_	_	_	I-Opinion
19	unexplained	_	UNK	_	VBN	91	_	_	_	_	_	_	_	I-Opinion
20	diarrhoea	_	UNK	_	RP	91	_	_	_	_	_	_	_	I-Opinion
21	that	_	that	_	IN	91	_	_	_	_	_	_	_	I-Opinion
22	happens	_	happen	_	VBZ	91	_	_	_	_	_	_	_	O
23	particularly	_	particularly	_	RB	91	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	91	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	91	_	_	_	_	_	_	_	O
26	[	_	[	_	NN	91	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	91	_	_	_	_	_	_	_	O
28	,	_	,	_	,	91	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	91	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	91	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	91	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	91	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	91	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	91	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	91	_	_	_	_	_	possibility.n	Likelihood	O
5	of	_	of	_	IN	91	_	_	_	_	_	_	_	B-Hypothetical_event
6	autonomic	_	UNK	_	JJ	91	_	_	_	_	_	_	_	I-Hypothetical_event
7	neuropathy	_	UNK	_	JJ	91	_	_	_	_	_	_	_	I-Hypothetical_event
8	affecting	_	affect	_	VBG	91	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	91	_	_	_	_	_	_	_	O
10	gut	_	UNK	_	NN	91	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	91	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	91	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	91	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	91	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	91	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	91	_	_	_	_	_	_	_	O
18	have	_	have	_	VBP	91	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	VBN	91	_	_	_	_	_	_	_	O
20	diarrhoea	_	UNK	_	RP	91	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	91	_	_	_	_	_	_	_	O
22	happens	_	happen	_	VBZ	91	_	_	_	_	_	_	_	O
23	particularly	_	particularly	_	RB	91	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	91	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	91	_	_	_	_	_	_	_	O
26	[	_	[	_	NN	91	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	91	_	_	_	_	_	_	_	O
28	,	_	,	_	,	91	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	91	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	91	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	91	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	91	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	91	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	91	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	91	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	91	_	_	_	_	_	_	_	O
6	autonomic	_	UNK	_	JJ	91	_	_	_	_	_	_	_	B-Dependent_entity
7	neuropathy	_	UNK	_	JJ	91	_	_	_	_	_	_	_	I-Dependent_entity
8	affecting	_	affect	_	VBG	91	_	_	_	_	_	affect.v	Objective_influence	O
9	the	_	the	_	DT	91	_	_	_	_	_	_	_	O
10	gut	_	UNK	_	NN	91	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	91	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	91	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	91	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	91	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	91	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	91	_	_	_	_	_	_	_	O
18	have	_	have	_	VBP	91	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	VBN	91	_	_	_	_	_	_	_	O
20	diarrhoea	_	UNK	_	RP	91	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	91	_	_	_	_	_	_	_	O
22	happens	_	happen	_	VBZ	91	_	_	_	_	_	_	_	O
23	particularly	_	particularly	_	RB	91	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	91	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	91	_	_	_	_	_	_	_	O
26	[	_	[	_	NN	91	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	91	_	_	_	_	_	_	_	O
28	,	_	,	_	,	91	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	91	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	91	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	91	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	91	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	91	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	91	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	91	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	91	_	_	_	_	_	_	_	O
6	autonomic	_	UNK	_	JJ	91	_	_	_	_	_	_	_	O
7	neuropathy	_	UNK	_	JJ	91	_	_	_	_	_	_	_	O
8	affecting	_	affect	_	VBG	91	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	91	_	_	_	_	_	_	_	O
10	gut	_	UNK	_	NN	91	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	91	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	91	_	_	_	_	_	adult.n	People_by_age	S-Person
13	with	_	with	_	IN	91	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	91	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	91	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	91	_	_	_	_	_	_	_	O
18	have	_	have	_	VBP	91	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	VBN	91	_	_	_	_	_	_	_	O
20	diarrhoea	_	UNK	_	RP	91	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	91	_	_	_	_	_	_	_	O
22	happens	_	happen	_	VBZ	91	_	_	_	_	_	_	_	O
23	particularly	_	particularly	_	RB	91	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	91	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	91	_	_	_	_	_	_	_	O
26	[	_	[	_	NN	91	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	91	_	_	_	_	_	_	_	O
28	,	_	,	_	,	91	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	91	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	91	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	91	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	91	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	91	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	91	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	91	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	91	_	_	_	_	_	_	_	O
6	autonomic	_	UNK	_	JJ	91	_	_	_	_	_	_	_	O
7	neuropathy	_	UNK	_	JJ	91	_	_	_	_	_	_	_	O
8	affecting	_	affect	_	VBG	91	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	91	_	_	_	_	_	_	_	O
10	gut	_	UNK	_	NN	91	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	91	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	91	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	91	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	91	_	_	_	_	_	type.n	Type	S-Subtype
15	2	_	2	_	CD	91	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	91	_	_	_	_	_	_	_	O
18	have	_	have	_	VBP	91	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	VBN	91	_	_	_	_	_	_	_	O
20	diarrhoea	_	UNK	_	RP	91	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	91	_	_	_	_	_	_	_	O
22	happens	_	happen	_	VBZ	91	_	_	_	_	_	_	_	O
23	particularly	_	particularly	_	RB	91	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	91	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	91	_	_	_	_	_	_	_	O
26	[	_	[	_	NN	91	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	91	_	_	_	_	_	_	_	O
28	,	_	,	_	,	91	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	91	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	91	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	91	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	91	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	91	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	91	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	91	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	91	_	_	_	_	_	_	_	O
6	autonomic	_	UNK	_	JJ	91	_	_	_	_	_	_	_	O
7	neuropathy	_	UNK	_	JJ	91	_	_	_	_	_	_	_	O
8	affecting	_	affect	_	VBG	91	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	91	_	_	_	_	_	_	_	O
10	gut	_	UNK	_	NN	91	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	91	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	91	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	91	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	91	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	91	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	91	_	_	_	_	_	_	_	O
18	have	_	have	_	VBP	91	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	VBN	91	_	_	_	_	_	_	_	O
20	diarrhoea	_	UNK	_	RP	91	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	91	_	_	_	_	_	_	_	S-Event
22	happens	_	happen	_	VBZ	91	_	_	_	_	_	happen.v	Event	O
23	particularly	_	particularly	_	RB	91	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	91	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	91	_	_	_	_	_	_	_	O
26	[	_	[	_	NN	91	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	91	_	_	_	_	_	_	_	O
28	,	_	,	_	,	91	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	91	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	91	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	91	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	91	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	91	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	91	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	91	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	91	_	_	_	_	_	_	_	O
6	autonomic	_	UNK	_	JJ	91	_	_	_	_	_	_	_	O
7	neuropathy	_	UNK	_	JJ	91	_	_	_	_	_	_	_	O
8	affecting	_	affect	_	VBG	91	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	91	_	_	_	_	_	_	_	O
10	gut	_	UNK	_	NN	91	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	91	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	91	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	91	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	91	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	91	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	91	_	_	_	_	_	_	_	O
18	have	_	have	_	VBP	91	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	VBN	91	_	_	_	_	_	_	_	O
20	diarrhoea	_	UNK	_	RP	91	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	91	_	_	_	_	_	_	_	O
22	happens	_	happen	_	VBZ	91	_	_	_	_	_	_	_	O
23	particularly	_	particularly	_	RB	91	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	91	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	91	_	_	_	_	_	night.n	Calendric_unit	S-Unit
26	[	_	[	_	NN	91	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	91	_	_	_	_	_	_	_	O
28	,	_	,	_	,	91	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	91	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	91	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	91	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	92	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	92	_	_	_	_	_	use.v	Using	O
3	tricyclic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	B-Instrument
4	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	I-Instrument
5	and	_	and	_	CC	92	_	_	_	_	_	_	_	I-Instrument
6	antihypertensive	_	UNK	_	JJ	92	_	_	_	_	_	_	_	I-Instrument
7	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	I-Instrument
8	treatments	_	treatment	_	NNS	92	_	_	_	_	_	_	_	I-Instrument
9	in	_	in	_	IN	92	_	_	_	_	_	_	_	B-Purpose
10	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	I-Purpose
11	with	_	with	_	IN	92	_	_	_	_	_	_	_	I-Purpose
12	type	_	type	_	JJ	92	_	_	_	_	_	_	_	I-Purpose
13	2	_	2	_	CD	92	_	_	_	_	_	_	_	I-Purpose
14	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	I-Purpose
15	who	_	who	_	WP	92	_	_	_	_	_	_	_	I-Purpose
16	have	_	have	_	VBP	92	_	_	_	_	_	_	_	I-Purpose
17	autonomic	_	UNK	_	VBN	92	_	_	_	_	_	_	_	I-Purpose
18	neuropathy	_	UNK	_	JJ	92	_	_	_	_	_	_	_	I-Purpose
19	,	_	,	_	,	92	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	92	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	92	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	92	_	_	_	_	_	_	_	O
25	likelihood	_	likelihood	_	NN	92	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
27	side	_	side	_	JJ	92	_	_	_	_	_	_	_	O
28	effects	_	effect	_	NNS	92	_	_	_	_	_	_	_	O
29	such	_	such	_	JJ	92	_	_	_	_	_	_	_	O
30	as	_	a	_	IN	92	_	_	_	_	_	_	_	O
31	orthostatic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
32	hypotension	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
33	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	92	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	92	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	92	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	92	_	_	_	_	_	adult.n	People_by_age	S-Person
11	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	92	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	92	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	92	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
19	,	_	,	_	,	92	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	92	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	92	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	92	_	_	_	_	_	_	_	O
25	likelihood	_	likelihood	_	NN	92	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
27	side	_	side	_	JJ	92	_	_	_	_	_	_	_	O
28	effects	_	effect	_	NNS	92	_	_	_	_	_	_	_	O
29	such	_	such	_	JJ	92	_	_	_	_	_	_	_	O
30	as	_	a	_	IN	92	_	_	_	_	_	_	_	O
31	orthostatic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
32	hypotension	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
33	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	92	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	92	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	92	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	92	_	_	_	_	_	type.n	Type	S-Subtype
13	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	92	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	92	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
19	,	_	,	_	,	92	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	92	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	92	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	92	_	_	_	_	_	_	_	O
25	likelihood	_	likelihood	_	NN	92	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
27	side	_	side	_	JJ	92	_	_	_	_	_	_	_	O
28	effects	_	effect	_	NNS	92	_	_	_	_	_	_	_	O
29	such	_	such	_	JJ	92	_	_	_	_	_	_	_	O
30	as	_	a	_	IN	92	_	_	_	_	_	_	_	O
31	orthostatic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
32	hypotension	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
33	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	92	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	92	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	92	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	92	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	92	_	_	_	_	_	_	_	S-Cognizer
16	have	_	have	_	VBP	92	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	92	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
19	,	_	,	_	,	92	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	92	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	92	_	_	_	_	_	aware.a	Awareness	O
22	of	_	of	_	IN	92	_	_	_	_	_	_	_	B-Content
23	the	_	the	_	DT	92	_	_	_	_	_	_	_	I-Content
24	increased	_	increase	_	VBN	92	_	_	_	_	_	_	_	I-Content
25	likelihood	_	likelihood	_	NN	92	_	_	_	_	_	_	_	I-Content
26	of	_	of	_	IN	92	_	_	_	_	_	_	_	I-Content
27	side	_	side	_	JJ	92	_	_	_	_	_	_	_	I-Content
28	effects	_	effect	_	NNS	92	_	_	_	_	_	_	_	I-Content
29	such	_	such	_	JJ	92	_	_	_	_	_	_	_	I-Content
30	as	_	a	_	IN	92	_	_	_	_	_	_	_	I-Content
31	orthostatic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	I-Content
32	hypotension	_	UNK	_	NN	92	_	_	_	_	_	_	_	I-Content
33	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	92	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	92	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	92	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	92	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	92	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	92	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
19	,	_	,	_	,	92	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	92	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	92	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	92	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
25	likelihood	_	likelihood	_	NN	92	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	92	_	_	_	_	_	_	_	B-Attribute
27	side	_	side	_	JJ	92	_	_	_	_	_	_	_	I-Attribute
28	effects	_	effect	_	NNS	92	_	_	_	_	_	_	_	I-Attribute
29	such	_	such	_	JJ	92	_	_	_	_	_	_	_	I-Attribute
30	as	_	a	_	IN	92	_	_	_	_	_	_	_	I-Attribute
31	orthostatic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	I-Attribute
32	hypotension	_	UNK	_	NN	92	_	_	_	_	_	_	_	I-Attribute
33	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	92	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	92	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	92	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	92	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	92	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	92	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
19	,	_	,	_	,	92	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	92	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	92	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	92	_	_	_	_	_	_	_	O
25	likelihood	_	likelihood	_	NN	92	_	_	_	_	_	likelihood.n	Likelihood	O
26	of	_	of	_	IN	92	_	_	_	_	_	_	_	B-Hypothetical_event
27	side	_	side	_	JJ	92	_	_	_	_	_	_	_	I-Hypothetical_event
28	effects	_	effect	_	NNS	92	_	_	_	_	_	_	_	I-Hypothetical_event
29	such	_	such	_	JJ	92	_	_	_	_	_	_	_	I-Hypothetical_event
30	as	_	a	_	IN	92	_	_	_	_	_	_	_	I-Hypothetical_event
31	orthostatic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	I-Hypothetical_event
32	hypotension	_	UNK	_	NN	92	_	_	_	_	_	_	_	I-Hypothetical_event
33	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	92	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	92	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	92	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	92	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	92	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	92	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
19	,	_	,	_	,	92	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	92	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	92	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	92	_	_	_	_	_	_	_	O
25	likelihood	_	likelihood	_	NN	92	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
27	side	_	side	_	JJ	92	_	_	_	_	_	side.v	Taking_sides	O
28	effects	_	effect	_	NNS	92	_	_	_	_	_	_	_	O
29	such	_	such	_	JJ	92	_	_	_	_	_	_	_	O
30	as	_	a	_	IN	92	_	_	_	_	_	_	_	O
31	orthostatic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
32	hypotension	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
33	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	92	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	92	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	92	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	92	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	92	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	92	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	92	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	92	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
19	,	_	,	_	,	92	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	92	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	92	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	92	_	_	_	_	_	_	_	O
25	likelihood	_	likelihood	_	NN	92	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
27	side	_	side	_	JJ	92	_	_	_	_	_	_	_	S-Influencing_entity
28	effects	_	effect	_	NNS	92	_	_	_	_	_	effect.n	Objective_influence	O
29	such	_	such	_	JJ	92	_	_	_	_	_	_	_	O
30	as	_	a	_	IN	92	_	_	_	_	_	_	_	O
31	orthostatic	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
32	hypotension	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
33	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	93	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	93	_	_	_	_	_	_	_	O
3	possibility	_	possibility	_	NN	93	_	_	_	_	_	possibility.n	Likelihood	O
4	of	_	of	_	IN	93	_	_	_	_	_	_	_	B-Hypothetical_event
5	autonomic	_	UNK	_	JJ	93	_	_	_	_	_	_	_	I-Hypothetical_event
6	neuropathy	_	UNK	_	JJ	93	_	_	_	_	_	_	_	I-Hypothetical_event
7	affecting	_	affect	_	VBG	93	_	_	_	_	_	_	_	I-Hypothetical_event
8	the	_	the	_	DT	93	_	_	_	_	_	_	_	I-Hypothetical_event
9	bladder	_	UNK	_	NN	93	_	_	_	_	_	_	_	I-Hypothetical_event
10	in	_	in	_	IN	93	_	_	_	_	_	_	_	I-Hypothetical_event
11	adults	_	adult	_	NNS	93	_	_	_	_	_	_	_	I-Hypothetical_event
12	with	_	with	_	IN	93	_	_	_	_	_	_	_	I-Hypothetical_event
13	type	_	type	_	JJ	93	_	_	_	_	_	_	_	I-Hypothetical_event
14	2	_	2	_	CD	93	_	_	_	_	_	_	_	I-Hypothetical_event
15	diabetes	_	UNK	_	NNS	93	_	_	_	_	_	_	_	I-Hypothetical_event
16	who	_	who	_	WP	93	_	_	_	_	_	_	_	I-Hypothetical_event
17	have	_	have	_	VBP	93	_	_	_	_	_	_	_	I-Hypothetical_event
18	unexplained	_	UNK	_	VBN	93	_	_	_	_	_	_	_	I-Hypothetical_event
19	unk	_	UNK	_	JJ	93	_	_	_	_	_	_	_	I-Hypothetical_event
20	problems	_	problem	_	NNS	93	_	_	_	_	_	_	_	I-Hypothetical_event
21	.	_	.	_	.	93	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	93	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	93	_	_	_	_	_	_	_	O
3	possibility	_	possibility	_	NN	93	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	93	_	_	_	_	_	_	_	O
5	autonomic	_	UNK	_	JJ	93	_	_	_	_	_	_	_	B-Dependent_entity
6	neuropathy	_	UNK	_	JJ	93	_	_	_	_	_	_	_	I-Dependent_entity
7	affecting	_	affect	_	VBG	93	_	_	_	_	_	affect.v	Objective_influence	O
8	the	_	the	_	DT	93	_	_	_	_	_	_	_	B-Dependent_entity
9	bladder	_	UNK	_	NN	93	_	_	_	_	_	_	_	I-Dependent_entity
10	in	_	in	_	IN	93	_	_	_	_	_	_	_	I-Dependent_entity
11	adults	_	adult	_	NNS	93	_	_	_	_	_	_	_	I-Dependent_entity
12	with	_	with	_	IN	93	_	_	_	_	_	_	_	I-Dependent_entity
13	type	_	type	_	JJ	93	_	_	_	_	_	_	_	I-Dependent_entity
14	2	_	2	_	CD	93	_	_	_	_	_	_	_	I-Dependent_entity
15	diabetes	_	UNK	_	NNS	93	_	_	_	_	_	_	_	I-Dependent_entity
16	who	_	who	_	WP	93	_	_	_	_	_	_	_	I-Dependent_entity
17	have	_	have	_	VBP	93	_	_	_	_	_	_	_	I-Dependent_entity
18	unexplained	_	UNK	_	VBN	93	_	_	_	_	_	_	_	I-Dependent_entity
19	unk	_	UNK	_	JJ	93	_	_	_	_	_	_	_	I-Dependent_entity
20	problems	_	problem	_	NNS	93	_	_	_	_	_	_	_	I-Dependent_entity
21	.	_	.	_	.	93	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	93	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	93	_	_	_	_	_	_	_	O
3	possibility	_	possibility	_	NN	93	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	93	_	_	_	_	_	_	_	O
5	autonomic	_	UNK	_	JJ	93	_	_	_	_	_	_	_	O
6	neuropathy	_	UNK	_	JJ	93	_	_	_	_	_	_	_	O
7	affecting	_	affect	_	VBG	93	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	93	_	_	_	_	_	_	_	O
9	bladder	_	UNK	_	NN	93	_	_	_	_	_	_	_	O
10	in	_	in	_	IN	93	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	93	_	_	_	_	_	adult.n	People_by_age	S-Person
12	with	_	with	_	IN	93	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	93	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	93	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	93	_	_	_	_	_	_	_	O
16	who	_	who	_	WP	93	_	_	_	_	_	_	_	O
17	have	_	have	_	VBP	93	_	_	_	_	_	_	_	O
18	unexplained	_	UNK	_	VBN	93	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	93	_	_	_	_	_	_	_	O
20	problems	_	problem	_	NNS	93	_	_	_	_	_	_	_	O
21	.	_	.	_	.	93	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	93	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	93	_	_	_	_	_	_	_	O
3	possibility	_	possibility	_	NN	93	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	93	_	_	_	_	_	_	_	O
5	autonomic	_	UNK	_	JJ	93	_	_	_	_	_	_	_	O
6	neuropathy	_	UNK	_	JJ	93	_	_	_	_	_	_	_	O
7	affecting	_	affect	_	VBG	93	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	93	_	_	_	_	_	_	_	O
9	bladder	_	UNK	_	NN	93	_	_	_	_	_	_	_	O
10	in	_	in	_	IN	93	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	93	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	93	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	93	_	_	_	_	_	type.n	Type	S-Subtype
14	2	_	2	_	CD	93	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	93	_	_	_	_	_	_	_	O
16	who	_	who	_	WP	93	_	_	_	_	_	_	_	O
17	have	_	have	_	VBP	93	_	_	_	_	_	_	_	O
18	unexplained	_	UNK	_	VBN	93	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	93	_	_	_	_	_	_	_	O
20	problems	_	problem	_	NNS	93	_	_	_	_	_	_	_	O
21	.	_	.	_	.	93	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	93	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	93	_	_	_	_	_	_	_	O
3	possibility	_	possibility	_	NN	93	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	93	_	_	_	_	_	_	_	O
5	autonomic	_	UNK	_	JJ	93	_	_	_	_	_	_	_	O
6	neuropathy	_	UNK	_	JJ	93	_	_	_	_	_	_	_	O
7	affecting	_	affect	_	VBG	93	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	93	_	_	_	_	_	_	_	O
9	bladder	_	UNK	_	NN	93	_	_	_	_	_	_	_	O
10	in	_	in	_	IN	93	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	93	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	93	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	93	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	93	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	93	_	_	_	_	_	_	_	O
16	who	_	who	_	WP	93	_	_	_	_	_	_	_	O
17	have	_	have	_	VBP	93	_	_	_	_	_	_	_	O
18	unexplained	_	UNK	_	VBN	93	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	93	_	_	_	_	_	_	_	S-Place
20	problems	_	problem	_	NNS	93	_	_	_	_	_	problem.n	Predicament	S-Situation
21	.	_	.	_	.	93	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	94	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	94	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	94	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	94	_	_	_	_	_	_	_	O
6	:	_	:	_	:	94	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	94	_	_	_	_	_	_	_	O
8	(	_	(	_	(	94	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	94	_	_	_	_	_	_	_	O
10	)	_	)	_	)	94	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	94	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	94	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
14	)	_	)	_	)	94	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	94	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	94	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	94	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	94	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	94	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	94	_	_	_	_	_	_	_	O
8	(	_	(	_	(	94	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	94	_	_	_	_	_	_	_	O
10	)	_	)	_	)	94	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	94	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	94	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
14	)	_	)	_	)	94	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	95	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	95	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	95	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	95	_	_	_	_	_	_	_	O
5	0	_	0	_	CD	95	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	95	_	_	_	_	_	_	_	O
7	managing	_	manage	_	VBG	95	_	_	_	_	_	_	_	O
8	autonomic	_	UNK	_	JJ	95	_	_	_	_	_	_	_	B-Indicated
9	neuropathy	_	UNK	_	NN	95	_	_	_	_	_	_	_	I-Indicated
10	symptoms	_	symptom	_	NNS	95	_	_	_	_	_	symptom.n	Sign	O
11	,	_	,	_	,	95	_	_	_	_	_	_	_	O
12	include	_	include	_	VBP	95	_	_	_	_	_	_	_	O
13	specific	_	specific	_	JJ	95	_	_	_	_	_	_	_	O
14	interventions	_	UNK	_	NNS	95	_	_	_	_	_	_	_	O
15	indicated	_	indicate	_	VBN	95	_	_	_	_	_	_	_	O
16	by	_	by	_	IN	95	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	95	_	_	_	_	_	_	_	O
18	manifestations	_	UNK	_	NNS	95	_	_	_	_	_	_	_	O
19	(	_	(	_	(	95	_	_	_	_	_	_	_	O
20	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
21	example	_	example	_	NN	95	_	_	_	_	_	_	_	O
22	,	_	,	_	,	95	_	_	_	_	_	_	_	O
23	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
24	abnormal	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
25	sweating	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
26	or	_	or	_	CC	95	_	_	_	_	_	_	_	O
27	nocturnal	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
28	diarrhoea	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
29	)	_	)	_	)	95	_	_	_	_	_	_	_	O
30	.	_	.	_	.	95	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	95	_	_	_	_	_	_	_	B-Total
2	updated	_	update	_	VBD	95	_	_	_	_	_	_	_	I-Total
3	may	_	May	_	NNP	95	_	_	_	_	_	_	_	I-Total
4	2017	_	UNK	_	CD	95	_	_	_	_	_	_	_	I-Total
5	0	_	0	_	CD	95	_	_	_	_	_	_	_	I-Total
6	in	_	In	_	IN	95	_	_	_	_	_	_	_	I-Total
7	managing	_	manage	_	VBG	95	_	_	_	_	_	_	_	I-Total
8	autonomic	_	UNK	_	JJ	95	_	_	_	_	_	_	_	I-Total
9	neuropathy	_	UNK	_	NN	95	_	_	_	_	_	_	_	I-Total
10	symptoms	_	symptom	_	NNS	95	_	_	_	_	_	_	_	I-Total
11	,	_	,	_	,	95	_	_	_	_	_	_	_	I-Total
12	include	_	include	_	VBP	95	_	_	_	_	_	include.v	Inclusion	O
13	specific	_	specific	_	JJ	95	_	_	_	_	_	_	_	B-Part
14	interventions	_	UNK	_	NNS	95	_	_	_	_	_	_	_	I-Part
15	indicated	_	indicate	_	VBN	95	_	_	_	_	_	_	_	I-Part
16	by	_	by	_	IN	95	_	_	_	_	_	_	_	I-Part
17	the	_	the	_	DT	95	_	_	_	_	_	_	_	I-Part
18	manifestations	_	UNK	_	NNS	95	_	_	_	_	_	_	_	I-Part
19	(	_	(	_	(	95	_	_	_	_	_	_	_	I-Part
20	for	_	for	_	IN	95	_	_	_	_	_	_	_	I-Part
21	example	_	example	_	NN	95	_	_	_	_	_	_	_	I-Part
22	,	_	,	_	,	95	_	_	_	_	_	_	_	I-Part
23	for	_	for	_	IN	95	_	_	_	_	_	_	_	I-Part
24	abnormal	_	UNK	_	JJ	95	_	_	_	_	_	_	_	I-Part
25	sweating	_	UNK	_	NN	95	_	_	_	_	_	_	_	I-Part
26	or	_	or	_	CC	95	_	_	_	_	_	_	_	I-Part
27	nocturnal	_	UNK	_	JJ	95	_	_	_	_	_	_	_	I-Part
28	diarrhoea	_	UNK	_	NN	95	_	_	_	_	_	_	_	I-Part
29	)	_	)	_	)	95	_	_	_	_	_	_	_	I-Part
30	.	_	.	_	.	95	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	95	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	95	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	95	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	95	_	_	_	_	_	_	_	O
5	0	_	0	_	CD	95	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	95	_	_	_	_	_	_	_	O
7	managing	_	manage	_	VBG	95	_	_	_	_	_	_	_	O
8	autonomic	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
9	neuropathy	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
10	symptoms	_	symptom	_	NNS	95	_	_	_	_	_	_	_	O
11	,	_	,	_	,	95	_	_	_	_	_	_	_	O
12	include	_	include	_	VBP	95	_	_	_	_	_	_	_	O
13	specific	_	specific	_	JJ	95	_	_	_	_	_	_	_	B-Message
14	interventions	_	UNK	_	NNS	95	_	_	_	_	_	_	_	I-Message
15	indicated	_	indicate	_	VBN	95	_	_	_	_	_	indicate.v	Communication	O
16	by	_	by	_	IN	95	_	_	_	_	_	_	_	B-Message
17	the	_	the	_	DT	95	_	_	_	_	_	_	_	I-Message
18	manifestations	_	UNK	_	NNS	95	_	_	_	_	_	_	_	I-Message
19	(	_	(	_	(	95	_	_	_	_	_	_	_	O
20	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
21	example	_	example	_	NN	95	_	_	_	_	_	_	_	O
22	,	_	,	_	,	95	_	_	_	_	_	_	_	O
23	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
24	abnormal	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
25	sweating	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
26	or	_	or	_	CC	95	_	_	_	_	_	_	_	O
27	nocturnal	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
28	diarrhoea	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
29	)	_	)	_	)	95	_	_	_	_	_	_	_	O
30	.	_	.	_	.	95	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	95	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	95	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	95	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	95	_	_	_	_	_	_	_	O
5	0	_	0	_	CD	95	_	_	_	_	_	_	_	O
6	in	_	In	_	IN	95	_	_	_	_	_	_	_	O
7	managing	_	manage	_	VBG	95	_	_	_	_	_	_	_	O
8	autonomic	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
9	neuropathy	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
10	symptoms	_	symptom	_	NNS	95	_	_	_	_	_	_	_	O
11	,	_	,	_	,	95	_	_	_	_	_	_	_	O
12	include	_	include	_	VBP	95	_	_	_	_	_	_	_	O
13	specific	_	specific	_	JJ	95	_	_	_	_	_	_	_	O
14	interventions	_	UNK	_	NNS	95	_	_	_	_	_	_	_	O
15	indicated	_	indicate	_	VBN	95	_	_	_	_	_	_	_	O
16	by	_	by	_	IN	95	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	95	_	_	_	_	_	_	_	O
18	manifestations	_	UNK	_	NNS	95	_	_	_	_	_	_	_	O
19	(	_	(	_	(	95	_	_	_	_	_	_	_	O
20	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
21	example	_	example	_	NN	95	_	_	_	_	_	example.n	Instance	S-Instance
22	,	_	,	_	,	95	_	_	_	_	_	_	_	O
23	for	_	for	_	IN	95	_	_	_	_	_	_	_	O
24	abnormal	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
25	sweating	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
26	or	_	or	_	CC	95	_	_	_	_	_	_	_	O
27	nocturnal	_	UNK	_	JJ	95	_	_	_	_	_	_	_	O
28	diarrhoea	_	UNK	_	NN	95	_	_	_	_	_	_	_	O
29	)	_	)	_	)	95	_	_	_	_	_	_	_	O
30	.	_	.	_	.	95	_	_	_	_	_	_	_	O

1	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	S-Possessor
2	foot	_	foot	_	NN	96	_	_	_	_	_	foot.n	Body_parts	S-Body_part
3	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
4	1	_	1	_	CD	96	_	_	_	_	_	_	_	O
5	for	_	For	_	IN	96	_	_	_	_	_	_	_	O
6	guidance	_	guidance	_	NN	96	_	_	_	_	_	_	_	O
7	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
8	preventing	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	96	_	_	_	_	_	_	_	O
10	managing	_	manage	_	VBG	96	_	_	_	_	_	_	_	O
11	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
12	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	96	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	96	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	96	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	96	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	96	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	96	_	_	_	_	_	_	_	O
19	,	_	,	_	,	96	_	_	_	_	_	_	_	O
20	see	_	see	_	VBP	96	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	96	_	_	_	_	_	_	_	O
22	nice	_	UNK	_	NNP	96	_	_	_	_	_	_	_	O
23	guideline	_	guideline	_	NN	96	_	_	_	_	_	_	_	O
24	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
25	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
26	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
27	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
28	.	_	.	_	.	96	_	_	_	_	_	_	_	O

1	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	B-Experiencer
2	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	I-Experiencer
3	problems	_	problem	_	NNS	96	_	_	_	_	_	problem.n	Predicament	O
4	1	_	1	_	CD	96	_	_	_	_	_	_	_	O
5	for	_	For	_	IN	96	_	_	_	_	_	_	_	O
6	guidance	_	guidance	_	NN	96	_	_	_	_	_	_	_	O
7	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
8	preventing	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	96	_	_	_	_	_	_	_	O
10	managing	_	manage	_	VBG	96	_	_	_	_	_	_	_	O
11	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
12	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	96	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	96	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	96	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	96	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	96	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	96	_	_	_	_	_	_	_	O
19	,	_	,	_	,	96	_	_	_	_	_	_	_	O
20	see	_	see	_	VBP	96	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	96	_	_	_	_	_	_	_	O
22	nice	_	UNK	_	NNP	96	_	_	_	_	_	_	_	O
23	guideline	_	guideline	_	NN	96	_	_	_	_	_	_	_	O
24	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
25	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
26	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
27	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
28	.	_	.	_	.	96	_	_	_	_	_	_	_	O

1	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
2	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
3	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
4	1	_	1	_	CD	96	_	_	_	_	_	_	_	O
5	for	_	For	_	IN	96	_	_	_	_	_	_	_	O
6	guidance	_	guidance	_	NN	96	_	_	_	_	_	_	_	O
7	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
8	preventing	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	96	_	_	_	_	_	_	_	O
10	managing	_	manage	_	VBG	96	_	_	_	_	_	_	_	O
11	foot	_	foot	_	NN	96	_	_	_	_	_	foot.n	Body_parts	S-Body_part
12	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	96	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	96	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	96	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	96	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	96	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	96	_	_	_	_	_	_	_	O
19	,	_	,	_	,	96	_	_	_	_	_	_	_	O
20	see	_	see	_	VBP	96	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	96	_	_	_	_	_	_	_	O
22	nice	_	UNK	_	NNP	96	_	_	_	_	_	_	_	O
23	guideline	_	guideline	_	NN	96	_	_	_	_	_	_	_	O
24	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
25	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
26	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
27	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
28	.	_	.	_	.	96	_	_	_	_	_	_	_	O

1	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
2	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
3	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
4	1	_	1	_	CD	96	_	_	_	_	_	_	_	O
5	for	_	For	_	IN	96	_	_	_	_	_	_	_	O
6	guidance	_	guidance	_	NN	96	_	_	_	_	_	_	_	O
7	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
8	preventing	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	96	_	_	_	_	_	_	_	O
10	managing	_	manage	_	VBG	96	_	_	_	_	_	_	_	O
11	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	S-Domain
12	problems	_	problem	_	NNS	96	_	_	_	_	_	problem.n	Predicament	S-Situation
13	in	_	in	_	IN	96	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	96	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	96	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	96	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	96	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	96	_	_	_	_	_	_	_	O
19	,	_	,	_	,	96	_	_	_	_	_	_	_	O
20	see	_	see	_	VBP	96	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	96	_	_	_	_	_	_	_	O
22	nice	_	UNK	_	NNP	96	_	_	_	_	_	_	_	O
23	guideline	_	guideline	_	NN	96	_	_	_	_	_	_	_	O
24	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
25	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
26	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
27	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
28	.	_	.	_	.	96	_	_	_	_	_	_	_	O

1	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
2	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
3	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
4	1	_	1	_	CD	96	_	_	_	_	_	_	_	O
5	for	_	For	_	IN	96	_	_	_	_	_	_	_	O
6	guidance	_	guidance	_	NN	96	_	_	_	_	_	_	_	O
7	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
8	preventing	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	96	_	_	_	_	_	_	_	O
10	managing	_	manage	_	VBG	96	_	_	_	_	_	_	_	O
11	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
12	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	96	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	96	_	_	_	_	_	adult.n	People_by_age	S-Person
15	with	_	with	_	IN	96	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	96	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	96	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	96	_	_	_	_	_	_	_	O
19	,	_	,	_	,	96	_	_	_	_	_	_	_	O
20	see	_	see	_	VBP	96	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	96	_	_	_	_	_	_	_	O
22	nice	_	UNK	_	NNP	96	_	_	_	_	_	_	_	O
23	guideline	_	guideline	_	NN	96	_	_	_	_	_	_	_	O
24	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
25	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
26	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
27	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
28	.	_	.	_	.	96	_	_	_	_	_	_	_	O

1	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
2	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
3	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
4	1	_	1	_	CD	96	_	_	_	_	_	_	_	O
5	for	_	For	_	IN	96	_	_	_	_	_	_	_	O
6	guidance	_	guidance	_	NN	96	_	_	_	_	_	_	_	O
7	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
8	preventing	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	96	_	_	_	_	_	_	_	O
10	managing	_	manage	_	VBG	96	_	_	_	_	_	_	_	O
11	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
12	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	96	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	96	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	96	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	96	_	_	_	_	_	type.n	Type	S-Subtype
17	2	_	2	_	CD	96	_	_	_	_	_	_	_	B-Category
18	diabetes	_	UNK	_	NNS	96	_	_	_	_	_	_	_	I-Category
19	,	_	,	_	,	96	_	_	_	_	_	_	_	O
20	see	_	see	_	VBP	96	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	96	_	_	_	_	_	_	_	O
22	nice	_	UNK	_	NNP	96	_	_	_	_	_	_	_	O
23	guideline	_	guideline	_	NN	96	_	_	_	_	_	_	_	O
24	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
25	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
26	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
27	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
28	.	_	.	_	.	96	_	_	_	_	_	_	_	O

1	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
2	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
3	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
4	1	_	1	_	CD	96	_	_	_	_	_	_	_	O
5	for	_	For	_	IN	96	_	_	_	_	_	_	_	O
6	guidance	_	guidance	_	NN	96	_	_	_	_	_	_	_	O
7	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
8	preventing	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	96	_	_	_	_	_	_	_	O
10	managing	_	manage	_	VBG	96	_	_	_	_	_	_	_	O
11	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
12	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	96	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	96	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	96	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	96	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	96	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	96	_	_	_	_	_	_	_	O
19	,	_	,	_	,	96	_	_	_	_	_	_	_	O
20	see	_	see	_	VBP	96	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	96	_	_	_	_	_	_	_	O
22	nice	_	UNK	_	NNP	96	_	_	_	_	_	_	_	O
23	guideline	_	guideline	_	NN	96	_	_	_	_	_	_	_	O
24	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
25	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	S-Possessor
26	foot	_	foot	_	NN	96	_	_	_	_	_	foot.n	Body_parts	S-Body_part
27	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
28	.	_	.	_	.	96	_	_	_	_	_	_	_	O

1	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
2	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
3	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
4	1	_	1	_	CD	96	_	_	_	_	_	_	_	O
5	for	_	For	_	IN	96	_	_	_	_	_	_	_	O
6	guidance	_	guidance	_	NN	96	_	_	_	_	_	_	_	O
7	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
8	preventing	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	96	_	_	_	_	_	_	_	O
10	managing	_	manage	_	VBG	96	_	_	_	_	_	_	_	O
11	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	O
12	problems	_	problem	_	NNS	96	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	96	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	96	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	96	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	96	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	96	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	96	_	_	_	_	_	_	_	O
19	,	_	,	_	,	96	_	_	_	_	_	_	_	O
20	see	_	see	_	VBP	96	_	_	_	_	_	_	_	O
21	the	_	the	_	DT	96	_	_	_	_	_	_	_	O
22	nice	_	UNK	_	NNP	96	_	_	_	_	_	_	_	O
23	guideline	_	guideline	_	NN	96	_	_	_	_	_	_	_	O
24	on	_	on	_	IN	96	_	_	_	_	_	_	_	O
25	diabetic	_	UNK	_	JJ	96	_	_	_	_	_	_	_	B-Domain
26	foot	_	foot	_	NN	96	_	_	_	_	_	_	_	I-Domain
27	problems	_	problem	_	NNS	96	_	_	_	_	_	problem.n	Predicament	S-Situation
28	.	_	.	_	.	96	_	_	_	_	_	_	_	O

1	diabetic	_	UNK	_	NNP	97	_	_	_	_	_	_	_	B-Patient
2	kidney	_	UNK	_	NN	97	_	_	_	_	_	_	_	I-Patient
3	disease	_	disease	_	NN	97	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
4	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
5	for	_	For	_	IN	97	_	_	_	_	_	_	_	O
6	guidance	_	guidance	_	NN	97	_	_	_	_	_	_	_	O
7	on	_	on	_	IN	97	_	_	_	_	_	_	_	O
8	managing	_	manage	_	VBG	97	_	_	_	_	_	_	_	O
9	kidney	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
10	disease	_	disease	_	NN	97	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	97	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	97	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	97	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	97	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	97	_	_	_	_	_	_	_	O
17	,	_	,	_	,	97	_	_	_	_	_	_	_	O
18	see	_	see	_	VBP	97	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	97	_	_	_	_	_	_	_	O

1	diabetic	_	UNK	_	NNP	97	_	_	_	_	_	_	_	O
2	kidney	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
3	disease	_	disease	_	NN	97	_	_	_	_	_	_	_	O
4	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
5	for	_	For	_	IN	97	_	_	_	_	_	_	_	O
6	guidance	_	guidance	_	NN	97	_	_	_	_	_	_	_	O
7	on	_	on	_	IN	97	_	_	_	_	_	_	_	O
8	managing	_	manage	_	VBG	97	_	_	_	_	_	_	_	O
9	kidney	_	UNK	_	NN	97	_	_	_	_	_	_	_	S-Patient
10	disease	_	disease	_	NN	97	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
11	in	_	in	_	IN	97	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	97	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	97	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	97	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	97	_	_	_	_	_	_	_	O
17	,	_	,	_	,	97	_	_	_	_	_	_	_	O
18	see	_	see	_	VBP	97	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	97	_	_	_	_	_	_	_	O

1	diabetic	_	UNK	_	NNP	97	_	_	_	_	_	_	_	O
2	kidney	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
3	disease	_	disease	_	NN	97	_	_	_	_	_	_	_	O
4	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
5	for	_	For	_	IN	97	_	_	_	_	_	_	_	O
6	guidance	_	guidance	_	NN	97	_	_	_	_	_	_	_	O
7	on	_	on	_	IN	97	_	_	_	_	_	_	_	O
8	managing	_	manage	_	VBG	97	_	_	_	_	_	_	_	O
9	kidney	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
10	disease	_	disease	_	NN	97	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	97	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	97	_	_	_	_	_	adult.n	People_by_age	S-Person
13	with	_	with	_	IN	97	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	97	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	97	_	_	_	_	_	_	_	O
17	,	_	,	_	,	97	_	_	_	_	_	_	_	O
18	see	_	see	_	VBP	97	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	97	_	_	_	_	_	_	_	O

1	diabetic	_	UNK	_	NNP	97	_	_	_	_	_	_	_	O
2	kidney	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
3	disease	_	disease	_	NN	97	_	_	_	_	_	_	_	O
4	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
5	for	_	For	_	IN	97	_	_	_	_	_	_	_	O
6	guidance	_	guidance	_	NN	97	_	_	_	_	_	_	_	O
7	on	_	on	_	IN	97	_	_	_	_	_	_	_	O
8	managing	_	manage	_	VBG	97	_	_	_	_	_	_	_	O
9	kidney	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
10	disease	_	disease	_	NN	97	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	97	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	97	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	97	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	97	_	_	_	_	_	type.n	Type	S-Subtype
15	2	_	2	_	CD	97	_	_	_	_	_	_	_	B-Category
16	diabetes	_	UNK	_	NNS	97	_	_	_	_	_	_	_	I-Category
17	,	_	,	_	,	97	_	_	_	_	_	_	_	O
18	see	_	see	_	VBP	97	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	97	_	_	_	_	_	_	_	O

1	nice	_	UNK	_	NNP	98	_	_	_	_	_	_	_	O
2	guideline	_	guideline	_	NN	98	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	98	_	_	_	_	_	_	_	O
4	chronic	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
5	kidney	_	UNK	_	NN	98	_	_	_	_	_	_	_	S-Patient
6	disease	_	disease	_	NN	98	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
7	in	_	in	_	IN	98	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	98	_	_	_	_	_	_	_	O
9	.	_	.	_	.	98	_	_	_	_	_	_	_	O

1	nice	_	UNK	_	NNP	98	_	_	_	_	_	_	_	O
2	guideline	_	guideline	_	NN	98	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	98	_	_	_	_	_	_	_	O
4	chronic	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
5	kidney	_	UNK	_	NN	98	_	_	_	_	_	_	_	O
6	disease	_	disease	_	NN	98	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	98	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	98	_	_	_	_	_	adult.n	People_by_age	S-Person
9	.	_	.	_	.	98	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	type.n	Type	S-Subtype
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	discuss.v	Discussion	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	B-Topic
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	I-Topic
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	B-Purpose
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	I-Purpose
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	I-Purpose
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	I-Purpose
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	I-Purpose
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	I-Purpose
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	part.n	Part_whole	S-Part
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	B-Whole
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	I-Whole
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	I-Whole
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	I-Whole
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	annual.a	Frequency	S-Interval
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	educate.v	Education_teaching	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	type.n	Type	S-Subtype
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	S-Patient
46	disease	_	disease	_	NN	99	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	possible.a	Likelihood	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	B-Hypothetical_event
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	I-Hypothetical_event
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	treatment.n	Cure	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	treat.v	Medical_intervention	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	B-Medical_condition
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	I-Medical_condition
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	I-Medical_condition
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	I-Medical_condition
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	I-Medical_condition
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	I-Medical_condition
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	I-Medical_condition
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	I-Medical_condition
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	I-Medical_condition
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	type.n	Type	S-Subtype
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	B-Category
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	I-Category
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	B-Chosen
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	I-Chosen
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	I-Chosen
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	I-Chosen
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	I-Chosen
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	I-Chosen
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	I-Chosen
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	I-Chosen
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	I-Chosen
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	I-Chosen
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	I-Chosen
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	I-Chosen
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	I-Chosen
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	I-Chosen
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	I-Chosen
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	I-Chosen
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	I-Chosen
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	I-Chosen
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	I-Chosen
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	I-Chosen
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	I-Chosen
22	.	_	.	_	.	99	_	_	_	_	_	_	_	I-Chosen
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	I-Chosen
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	I-Chosen
25	,	_	,	_	,	99	_	_	_	_	_	_	_	I-Chosen
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	I-Chosen
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	I-Chosen
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	I-Chosen
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	I-Chosen
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	I-Chosen
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	I-Chosen
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	I-Chosen
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	I-Chosen
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	I-Chosen
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	I-Chosen
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	I-Chosen
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	I-Chosen
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	I-Chosen
39	,	_	,	_	,	99	_	_	_	_	_	_	_	I-Chosen
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	I-Chosen
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	B-Cognizer
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	I-Cognizer
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	I-Cognizer
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	I-Cognizer
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	I-Cognizer
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	I-Cognizer
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	I-Cognizer
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	I-Cognizer
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	I-Cognizer
70	,	_	,	_	,	99	_	_	_	_	_	_	_	I-Cognizer
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	S-Manner
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	choose.v	Choosing	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	B-Chosen
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	I-Chosen
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	I-Chosen
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	I-Chosen
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	I-Chosen
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	I-Chosen
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	I-Chosen
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	I-Chosen
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	I-Chosen
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	I-Chosen
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	I-Chosen
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	I-Chosen
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	I-Chosen
86	.	_	.	_	.	99	_	_	_	_	_	_	_	I-Chosen
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	I-Chosen
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	I-Chosen
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	I-Chosen
90	,	_	,	_	,	99	_	_	_	_	_	_	_	I-Chosen
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	I-Chosen
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	I-Chosen
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	I-Chosen
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	I-Chosen
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	I-Chosen
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	I-Chosen
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	I-Chosen
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	I-Chosen
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	I-Chosen
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	I-Chosen
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	I-Chosen
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	I-Chosen
103	,	_	,	_	,	99	_	_	_	_	_	_	_	I-Chosen
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	I-Chosen
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	I-Chosen
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	I-Chosen
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	I-Chosen
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	I-Chosen
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	I-Chosen
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	I-Chosen
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	I-Chosen
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	I-Chosen
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	B-Goods
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	I-Goods
79	cost	_	cost	_	NN	99	_	_	_	_	_	cost.n	Expensiveness	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	account.n	Text	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	B-Text
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	I-Text
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	discussion.n	Discussion	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	refer.v	Referring_by_name	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	S-Entity
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	type.n	Type	S-Subtype
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	other.a	Increment	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	S-Class
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	treatment.n	Cure	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	S-Part
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	include.v	Inclusion	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	B-Part
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	I-Part
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	I-Part
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	O
121	)	_	)	_	)	99	_	_	_	_	_	_	_	O
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	_	_	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	erectile	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
3	3	_	3	_	CD	99	_	_	_	_	_	_	_	O
4	offer	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	VBZ	99	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
11	opportunity	_	opportunity	_	NN	99	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
13	discuss	_	discuss	_	VB	99	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
17	part	_	part	_	NN	99	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
19	their	_	their	_	PRP$	99	_	_	_	_	_	_	_	O
20	annual	_	annual	_	JJ	99	_	_	_	_	_	_	_	O
21	review	_	review	_	NN	99	_	_	_	_	_	_	_	O
22	.	_	.	_	.	99	_	_	_	_	_	_	_	O
23	4	_	4	_	CD	99	_	_	_	_	_	_	_	O
24	assess	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
25	,	_	,	_	,	99	_	_	_	_	_	_	_	O
26	educate	_	educate	_	NN	99	_	_	_	_	_	_	_	O
27	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
28	support	_	support	_	NN	99	_	_	_	_	_	_	_	O
29	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
30	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
31	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
32	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
33	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
34	who	_	who	_	WP	99	_	_	_	_	_	_	_	O
35	have	_	have	_	VBP	99	_	_	_	_	_	_	_	O
36	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
37	erectile	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
38	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
39	,	_	,	_	,	99	_	_	_	_	_	_	_	O
40	addressing	_	address	_	VBG	99	_	_	_	_	_	_	_	O
41	contributory	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
42	factors	_	factor	_	NNS	99	_	_	_	_	_	_	_	O
43	such	_	such	_	JJ	99	_	_	_	_	_	_	_	O
44	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
45	cardiovascular	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
46	disease	_	disease	_	NN	99	_	_	_	_	_	_	_	O
47	as	_	a	_	RB	99	_	_	_	_	_	_	_	O
48	well	_	well	_	RB	99	_	_	_	_	_	_	_	O
49	as	_	a	_	IN	99	_	_	_	_	_	_	_	O
50	possible	_	possible	_	JJ	99	_	_	_	_	_	_	_	O
51	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
52	options	_	option	_	NNS	99	_	_	_	_	_	_	_	O
53	.	_	.	_	.	99	_	_	_	_	_	_	_	O
54	5	_	5	_	CD	99	_	_	_	_	_	_	_	O
55	consider	_	UNK	_	VB	99	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
57	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
58	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
59	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
60	treat	_	treat	_	VB	99	_	_	_	_	_	_	_	O
61	problematic	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
62	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
63	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
64	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
65	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
66	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
67	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
68	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
69	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
70	,	_	,	_	,	99	_	_	_	_	_	_	_	O
71	initially	_	initially	_	RB	99	_	_	_	_	_	_	_	O
72	choosing	_	choose	_	VBG	99	_	_	_	_	_	_	_	O
73	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
74	drug	_	drug	_	NN	99	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
76	the	_	the	_	DT	99	_	_	_	_	_	_	_	O
77	lowest	_	lowest	_	JJS	99	_	_	_	_	_	_	_	O
78	acquisition	_	acquisition	_	NN	99	_	_	_	_	_	_	_	O
79	cost	_	cost	_	NN	99	_	_	_	_	_	_	_	O
80	and	_	and	_	CC	99	_	_	_	_	_	_	_	O
81	taking	_	take	_	VBG	99	_	_	_	_	_	_	_	O
82	into	_	into	_	IN	99	_	_	_	_	_	_	_	O
83	account	_	account	_	NN	99	_	_	_	_	_	_	_	O
84	any	_	any	_	DT	99	_	_	_	_	_	_	_	O
85	contraindications	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
86	.	_	.	_	.	99	_	_	_	_	_	_	_	O
87	6	_	6	_	CD	99	_	_	_	_	_	_	_	O
88	following	_	Following	_	VBG	99	_	_	_	_	_	_	_	O
89	discussion	_	discussion	_	NN	99	_	_	_	_	_	_	_	O
90	,	_	,	_	,	99	_	_	_	_	_	_	_	O
91	refer	_	refer	_	VBP	99	_	_	_	_	_	_	_	O
92	men	_	men	_	NNS	99	_	_	_	_	_	_	_	O
93	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
94	type	_	type	_	NN	99	_	_	_	_	_	_	_	O
95	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
96	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	99	_	_	_	_	_	_	_	O
98	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
99	service	_	service	_	NN	99	_	_	_	_	_	_	_	O
100	offering	_	offer	_	VBG	99	_	_	_	_	_	_	_	O
101	other	_	other	_	JJ	99	_	_	_	_	_	_	_	O
102	medical	_	medical	_	JJ	99	_	_	_	_	_	_	_	O
103	,	_	,	_	,	99	_	_	_	_	_	_	_	O
104	surgical	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
105	or	_	or	_	CC	99	_	_	_	_	_	_	_	O
106	psychological	_	psychological	_	JJ	99	_	_	_	_	_	_	_	O
107	management	_	management	_	NN	99	_	_	_	_	_	_	_	O
108	of	_	of	_	IN	99	_	_	_	_	_	_	_	O
109	erectile	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
110	dysfunction	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
111	if	_	if	_	IN	99	_	_	_	_	_	_	_	O
112	treatment	_	treatment	_	NN	99	_	_	_	_	_	_	_	O
113	(	_	(	_	(	99	_	_	_	_	_	_	_	O
114	including	_	include	_	VBG	99	_	_	_	_	_	_	_	O
115	a	_	a	_	DT	99	_	_	_	_	_	_	_	O
116	unk	_	UNK	_	JJ	99	_	_	_	_	_	_	_	O
117	inhibitor	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
118	,	_	,	_	,	99	_	_	_	_	_	_	_	O
119	as	_	a	_	IN	99	_	_	_	_	_	_	_	B-Agent
120	appropriate	_	appropriate	_	NN	99	_	_	_	_	_	_	_	I-Agent
121	)	_	)	_	)	99	_	_	_	_	_	_	_	I-Agent
122	has	_	have	_	VBZ	99	_	_	_	_	_	_	_	O
123	been	_	be	_	VBN	99	_	_	_	_	_	_	_	O
124	unsuccessful	_	unsuccessful	_	JJ	99	_	_	_	_	_	unsuccessful.a	Success_or_failure	O
125	.	_	.	_	.	99	_	_	_	_	_	_	_	O

1	eye	_	UNK	_	NNP	100	_	_	_	_	_	_	_	S-Patient
2	disease	_	disease	_	NN	100	_	_	_	_	_	disease.n	Medical_conditions	O
3	7	_	7	_	CD	100	_	_	_	_	_	_	_	O
4	on	_	On	_	IN	100	_	_	_	_	_	_	_	O
5	diagnosis	_	UNK	_	NN	100	_	_	_	_	_	_	_	O
6	,	_	,	_	,	100	_	_	_	_	_	_	_	O
7	gps	_	UNK	_	NNP	100	_	_	_	_	_	_	_	O
8	should	_	should	_	MD	100	_	_	_	_	_	_	_	O
9	immediately	_	immediately	_	RB	100	_	_	_	_	_	_	_	O
10	refer	_	refer	_	VB	100	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	100	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	100	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	100	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	100	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	100	_	_	_	_	_	_	_	O
16	to	_	to	_	TO	100	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	100	_	_	_	_	_	_	_	O
18	local	_	local	_	JJ	100	_	_	_	_	_	_	_	O
19	eye	_	eye	_	NN	100	_	_	_	_	_	_	_	O
20	screening	_	screening	_	NN	100	_	_	_	_	_	_	_	O
21	service	_	service	_	NN	100	_	_	_	_	_	_	_	O

1	eye	_	UNK	_	NNP	100	_	_	_	_	_	_	_	O
2	disease	_	disease	_	NN	100	_	_	_	_	_	_	_	O
3	7	_	7	_	CD	100	_	_	_	_	_	_	_	O
4	on	_	On	_	IN	100	_	_	_	_	_	_	_	O
5	diagnosis	_	UNK	_	NN	100	_	_	_	_	_	_	_	O
6	,	_	,	_	,	100	_	_	_	_	_	_	_	O
7	gps	_	UNK	_	NNP	100	_	_	_	_	_	_	_	S-Speaker
8	should	_	should	_	MD	100	_	_	_	_	_	_	_	O
9	immediately	_	immediately	_	RB	100	_	_	_	_	_	_	_	O
10	refer	_	refer	_	VB	100	_	_	_	_	_	refer.v	Referring_by_name	O
11	adults	_	adult	_	NNS	100	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	100	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	100	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	100	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	100	_	_	_	_	_	_	_	O
16	to	_	to	_	TO	100	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	100	_	_	_	_	_	_	_	O
18	local	_	local	_	JJ	100	_	_	_	_	_	_	_	O
19	eye	_	eye	_	NN	100	_	_	_	_	_	_	_	O
20	screening	_	screening	_	NN	100	_	_	_	_	_	_	_	O
21	service	_	service	_	NN	100	_	_	_	_	_	_	_	O

1	eye	_	UNK	_	NNP	100	_	_	_	_	_	_	_	O
2	disease	_	disease	_	NN	100	_	_	_	_	_	_	_	O
3	7	_	7	_	CD	100	_	_	_	_	_	_	_	O
4	on	_	On	_	IN	100	_	_	_	_	_	_	_	O
5	diagnosis	_	UNK	_	NN	100	_	_	_	_	_	_	_	O
6	,	_	,	_	,	100	_	_	_	_	_	_	_	O
7	gps	_	UNK	_	NNP	100	_	_	_	_	_	_	_	O
8	should	_	should	_	MD	100	_	_	_	_	_	_	_	O
9	immediately	_	immediately	_	RB	100	_	_	_	_	_	_	_	O
10	refer	_	refer	_	VB	100	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	100	_	_	_	_	_	adult.n	People_by_age	S-Person
12	with	_	with	_	IN	100	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	100	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	100	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	100	_	_	_	_	_	_	_	O
16	to	_	to	_	TO	100	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	100	_	_	_	_	_	_	_	O
18	local	_	local	_	JJ	100	_	_	_	_	_	_	_	O
19	eye	_	eye	_	NN	100	_	_	_	_	_	_	_	O
20	screening	_	screening	_	NN	100	_	_	_	_	_	_	_	O
21	service	_	service	_	NN	100	_	_	_	_	_	_	_	O

1	eye	_	UNK	_	NNP	100	_	_	_	_	_	_	_	O
2	disease	_	disease	_	NN	100	_	_	_	_	_	_	_	O
3	7	_	7	_	CD	100	_	_	_	_	_	_	_	O
4	on	_	On	_	IN	100	_	_	_	_	_	_	_	O
5	diagnosis	_	UNK	_	NN	100	_	_	_	_	_	_	_	O
6	,	_	,	_	,	100	_	_	_	_	_	_	_	O
7	gps	_	UNK	_	NNP	100	_	_	_	_	_	_	_	O
8	should	_	should	_	MD	100	_	_	_	_	_	_	_	O
9	immediately	_	immediately	_	RB	100	_	_	_	_	_	_	_	O
10	refer	_	refer	_	VB	100	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	100	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	100	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	100	_	_	_	_	_	type.n	Type	S-Subtype
14	2	_	2	_	CD	100	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	100	_	_	_	_	_	_	_	O
16	to	_	to	_	TO	100	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	100	_	_	_	_	_	_	_	O
18	local	_	local	_	JJ	100	_	_	_	_	_	_	_	O
19	eye	_	eye	_	NN	100	_	_	_	_	_	_	_	O
20	screening	_	screening	_	NN	100	_	_	_	_	_	_	_	O
21	service	_	service	_	NN	100	_	_	_	_	_	_	_	O

1	eye	_	UNK	_	NNP	100	_	_	_	_	_	_	_	O
2	disease	_	disease	_	NN	100	_	_	_	_	_	_	_	O
3	7	_	7	_	CD	100	_	_	_	_	_	_	_	O
4	on	_	On	_	IN	100	_	_	_	_	_	_	_	O
5	diagnosis	_	UNK	_	NN	100	_	_	_	_	_	_	_	O
6	,	_	,	_	,	100	_	_	_	_	_	_	_	O
7	gps	_	UNK	_	NNP	100	_	_	_	_	_	_	_	O
8	should	_	should	_	MD	100	_	_	_	_	_	_	_	O
9	immediately	_	immediately	_	RB	100	_	_	_	_	_	_	_	O
10	refer	_	refer	_	VB	100	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	100	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	100	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	100	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	100	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	100	_	_	_	_	_	_	_	O
16	to	_	to	_	TO	100	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	100	_	_	_	_	_	_	_	O
18	local	_	local	_	JJ	100	_	_	_	_	_	local.a	Political_locales	B-Locale
19	eye	_	eye	_	NN	100	_	_	_	_	_	_	_	I-Locale
20	screening	_	screening	_	NN	100	_	_	_	_	_	_	_	I-Locale
21	service	_	service	_	NN	100	_	_	_	_	_	_	_	I-Locale

1	eye	_	UNK	_	NNP	100	_	_	_	_	_	_	_	O
2	disease	_	disease	_	NN	100	_	_	_	_	_	_	_	O
3	7	_	7	_	CD	100	_	_	_	_	_	_	_	O
4	on	_	On	_	IN	100	_	_	_	_	_	_	_	O
5	diagnosis	_	UNK	_	NN	100	_	_	_	_	_	_	_	O
6	,	_	,	_	,	100	_	_	_	_	_	_	_	O
7	gps	_	UNK	_	NNP	100	_	_	_	_	_	_	_	O
8	should	_	should	_	MD	100	_	_	_	_	_	_	_	O
9	immediately	_	immediately	_	RB	100	_	_	_	_	_	_	_	O
10	refer	_	refer	_	VB	100	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	100	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	100	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	100	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	100	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	100	_	_	_	_	_	_	_	O
16	to	_	to	_	TO	100	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	100	_	_	_	_	_	_	_	O
18	local	_	local	_	JJ	100	_	_	_	_	_	_	_	S-Possessor
19	eye	_	eye	_	NN	100	_	_	_	_	_	eye.n	Body_parts	S-Body_part
20	screening	_	screening	_	NN	100	_	_	_	_	_	_	_	O
21	service	_	service	_	NN	100	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	101	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	101	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	101	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	101	_	_	_	_	_	_	_	O
6	:	_	:	_	:	101	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	101	_	_	_	_	_	_	_	O
8	(	_	(	_	(	101	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	101	_	_	_	_	_	_	_	O
10	)	_	)	_	)	101	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	101	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	101	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
14	)	_	)	_	)	101	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	101	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	101	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	101	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	101	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	101	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	101	_	_	_	_	_	_	_	O
8	(	_	(	_	(	101	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	101	_	_	_	_	_	_	_	O
10	)	_	)	_	)	101	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	101	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	101	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
14	)	_	)	_	)	101	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	O
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	reason.n	Causation	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	B-Effect
10	,	_	,	_	,	102	_	_	_	_	_	_	_	I-Effect
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	I-Effect
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	I-Effect
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	I-Effect
14	,	_	,	_	,	102	_	_	_	_	_	_	_	I-Effect
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	I-Effect
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	I-Effect
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	I-Effect
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	I-Effect
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	I-Effect
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	I-Effect
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	I-Effect
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	I-Effect
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	I-Effect
24	,	_	,	_	,	102	_	_	_	_	_	_	_	I-Effect
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	I-Effect
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	I-Effect
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	I-Effect
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	I-Effect
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	success.n	Success_or_failure	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	O
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	eye.n	Body_parts	S-Body_part
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	B-Use
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	I-Use
17	systems	_	system	_	NNS	102	_	_	_	_	_	system.n	Gizmo	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	O
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	adult.n	People_by_age	S-Person
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	O
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	type.n	Type	S-Subtype
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	B-Category
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	I-Category
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	O
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	attendance.n	Attending	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	O
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	S-Item
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	reduce.v	Cause_change_of_position_on_a_scale	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	B-Value_2
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	I-Value_2
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	I-Value_2
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	I-Value_2
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	O
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	lack.n	Possession	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	B-Possession
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	I-Possession
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	O
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	knowledge.n	Awareness	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	O
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	fear.n	Fear	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	B-Stimulus
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	I-Stimulus
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	O
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	prior.a	Relative_time	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	B-Landmark_occasion
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	I-Landmark_occasion
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	O
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	S-Descriptor
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	agreement.n	Make_agreement_on_action	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	O
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	102	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	102	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	102	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	102	_	_	_	_	_	_	_	O
5	8	_	8	_	CD	102	_	_	_	_	_	_	_	O
6	explain	_	UNK	_	NNPS	102	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	102	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
10	,	_	,	_	,	102	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
12	success	_	success	_	NN	102	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
14	,	_	,	_	,	102	_	_	_	_	_	_	_	O
15	eye	_	eye	_	NN	102	_	_	_	_	_	_	_	O
16	screening	_	screen	_	VBG	102	_	_	_	_	_	_	_	O
17	systems	_	system	_	NNS	102	_	_	_	_	_	_	_	O
18	to	_	to	_	TO	102	_	_	_	_	_	_	_	O
19	adults	_	adult	_	NNS	102	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
21	type	_	type	_	JJ	102	_	_	_	_	_	_	_	O
22	2	_	2	_	CD	102	_	_	_	_	_	_	_	O
23	diabetes	_	UNK	_	NNS	102	_	_	_	_	_	_	_	O
24	,	_	,	_	,	102	_	_	_	_	_	_	_	O
25	so	_	so	_	IN	102	_	_	_	_	_	_	_	O
26	that	_	that	_	DT	102	_	_	_	_	_	_	_	O
27	attendance	_	attendance	_	NN	102	_	_	_	_	_	_	_	O
28	is	_	be	_	VBZ	102	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	102	_	_	_	_	_	_	_	O
30	reduced	_	reduce	_	VBN	102	_	_	_	_	_	_	_	O
31	by	_	by	_	IN	102	_	_	_	_	_	_	_	O
32	lack	_	lack	_	NN	102	_	_	_	_	_	_	_	O
33	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
34	knowledge	_	knowledge	_	NN	102	_	_	_	_	_	_	_	O
35	or	_	or	_	CC	102	_	_	_	_	_	_	_	O
36	fear	_	fear	_	NN	102	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
38	outcome	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
39	.	_	.	_	.	102	_	_	_	_	_	_	_	O
40	9	_	9	_	CD	102	_	_	_	_	_	_	_	O
41	use	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
42	mydriasis	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
45	when	_	when	_	WRB	102	_	_	_	_	_	_	_	O
46	photographing	_	UNK	_	VBG	102	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	102	_	_	_	_	_	_	_	O
48	retina	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
49	,	_	,	_	,	102	_	_	_	_	_	_	_	O
50	after	_	after	_	IN	102	_	_	_	_	_	_	_	O
51	prior	_	prior	_	JJ	102	_	_	_	_	_	_	_	O
52	informed	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
53	agreement	_	agreement	_	NN	102	_	_	_	_	_	_	_	O
54	following	_	follow	_	VBG	102	_	_	_	_	_	_	_	O
55	discussion	_	discussion	_	NN	102	_	_	_	_	_	discussion.n	Discussion	O
56	of	_	of	_	IN	102	_	_	_	_	_	_	_	B-Topic
57	the	_	the	_	DT	102	_	_	_	_	_	_	_	I-Topic
58	advantages	_	advantage	_	NNS	102	_	_	_	_	_	_	_	I-Topic
59	and	_	and	_	CC	102	_	_	_	_	_	_	_	I-Topic
60	disadvantages	_	UNK	_	NNS	102	_	_	_	_	_	_	_	I-Topic
61	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	S-Total
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	include.v	Inclusion	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	B-Part
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	I-Part
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	I-Part
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	B-Total
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	I-Total
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	I-Total
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	I-Total
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	I-Total
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	I-Total
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	I-Total
34	.	_	.	_	.	103	_	_	_	_	_	_	_	I-Total
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	I-Total
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	I-Total
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	I-Total
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	I-Total
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	I-Total
40	,	_	,	_	,	103	_	_	_	_	_	_	_	I-Total
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	I-Total
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	I-Total
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	I-Total
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	I-Total
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	I-Total
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	S-Driver
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	drive.v	Operate_vehicle	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	B-Agent
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	I-Agent
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	I-Agent
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	I-Agent
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	I-Agent
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	I-Agent
16	using	_	use	_	VBG	103	_	_	_	_	_	use.v	Using	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	B-Instrument
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	I-Instrument
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	I-Instrument
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	staff.n	Employing	S-Employee
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	B-Product
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	I-Product
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	I-Product
25	testing	_	test	_	VBG	103	_	_	_	_	_	test.v	Operational_testing	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	B-Product
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	I-Product
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	I-Product
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	I-Product
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	I-Product
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	I-Product
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	I-Product
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	I-Product
34	.	_	.	_	.	103	_	_	_	_	_	_	_	I-Product
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	I-Product
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	I-Product
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	I-Product
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	I-Product
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	I-Product
40	,	_	,	_	,	103	_	_	_	_	_	_	_	I-Product
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	I-Product
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	I-Product
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	I-Product
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	I-Product
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	I-Product
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	S-Part_prop
29	part	_	part	_	NN	103	_	_	_	_	_	part.n	Part_whole	S-Part
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	B-Whole
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	I-Whole
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	I-Whole
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	I-Whole
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	eye.n	Body_parts	S-Body_part
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	finding.n	Documents	S-Document
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	follow.v	Relative_time	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	B-Focal_occasion
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	I-Focal_occasion
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	I-Focal_occasion
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	S-Explanation
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	eye.n	Body_parts	S-Body_part
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	S-Relative_time
51	year	_	year	_	NN	103	_	_	_	_	_	year.n	Calendric_unit	S-Unit
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	earlier.a	Temporal_subregion	S-Subpart
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	S-Time_period
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	rapid.a	Taking_time	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	S-Activity
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	new.a	Age	S-Age
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	B-Entity
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	I-Entity
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	vessel.n	Vehicle	S-Vehicle
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	S-Created_entity
93	formation	_	formation	_	NN	103	_	_	_	_	_	formation.n	Creating	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	_	_	O
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	103	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	103	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	103	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
6	driving	_	drive	_	VBG	103	_	_	_	_	_	_	_	O
7	.	_	.	_	.	103	_	_	_	_	_	_	_	O
8	0	_	0	_	CD	103	_	_	_	_	_	_	_	O
9	use	_	UNK	_	IN	103	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
12	digital	_	digital	_	JJ	103	_	_	_	_	_	_	_	O
13	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
14	photography	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
16	using	_	use	_	VBG	103	_	_	_	_	_	_	_	O
17	appropriately	_	UNK	_	RB	103	_	_	_	_	_	_	_	O
18	trained	_	trained	_	JJ	103	_	_	_	_	_	_	_	O
19	staff	_	staff	_	NN	103	_	_	_	_	_	_	_	O
20	.	_	.	_	.	103	_	_	_	_	_	_	_	O
21	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
22	perform	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
23	visual	_	visual	_	JJ	103	_	_	_	_	_	_	_	O
24	acuity	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	testing	_	test	_	VBG	103	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	103	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
28	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
29	part	_	part	_	NN	103	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
31	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
32	screening	_	screen	_	VBG	103	_	_	_	_	_	_	_	O
33	programmes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O
35	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
36	depending	_	UNK	_	VBG	103	_	_	_	_	_	_	_	O
37	on	_	on	_	IN	103	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
39	findings	_	finding	_	NNS	103	_	_	_	_	_	_	_	O
40	,	_	,	_	,	103	_	_	_	_	_	_	_	O
41	follow	_	follow	_	VBP	103	_	_	_	_	_	_	_	O
42	structured	_	structure	_	VBN	103	_	_	_	_	_	_	_	O
43	eye	_	eye	_	NN	103	_	_	_	_	_	_	_	O
44	screening	_	screening	_	NN	103	_	_	_	_	_	_	_	O
45	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
46	:	_	:	_	:	103	_	_	_	_	_	_	_	O
47	routine	_	routine	_	JJ	103	_	_	_	_	_	_	_	O
48	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
49	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	103	_	_	_	_	_	_	_	O
51	year	_	year	_	NN	103	_	_	_	_	_	_	_	O
52	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
53	earlier	_	earlier	_	JJR	103	_	_	_	_	_	_	_	O
54	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
55	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
56	referral	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
57	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
58	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
59	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
60	.	_	.	_	.	103	_	_	_	_	_	_	_	O
61	3	_	3	_	CD	103	_	_	_	_	_	_	_	O
62	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
63	emergency	_	emergency	_	NN	103	_	_	_	_	_	_	_	O
64	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
65	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
66	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
67	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
68	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
69	:	_	:	_	:	103	_	_	_	_	_	_	_	O
70	sudden	_	sudden	_	JJ	103	_	_	_	_	_	_	_	O
71	loss	_	loss	_	NN	103	_	_	_	_	_	_	_	O
72	of	_	of	_	IN	103	_	_	_	_	_	_	_	O
73	vision	_	vision	_	NN	103	_	_	_	_	_	_	_	O
74	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
75	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
76	unk	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
77	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
78	vitreous	_	vitreous	_	JJ	103	_	_	_	_	_	_	_	O
79	haemorrhage	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
80	retinal	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
81	detachment	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
82	.	_	.	_	.	103	_	_	_	_	_	_	_	O
83	4	_	4	_	CD	103	_	_	_	_	_	_	_	O
84	arrange	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
85	rapid	_	rapid	_	JJ	103	_	_	_	_	_	_	_	O
86	review	_	review	_	NN	103	_	_	_	_	_	_	_	O
87	by	_	by	_	IN	103	_	_	_	_	_	_	_	O
88	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
89	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	103	_	_	_	_	_	_	_	O
91	new	_	new	_	JJ	103	_	_	_	_	_	_	_	O
92	vessel	_	vessel	_	NN	103	_	_	_	_	_	_	_	O
93	formation	_	formation	_	NN	103	_	_	_	_	_	_	_	O
94	.	_	.	_	.	103	_	_	_	_	_	_	_	O
95	5	_	5	_	CD	103	_	_	_	_	_	_	_	O
96	refer	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
97	to	_	to	_	TO	103	_	_	_	_	_	_	_	O
98	an	_	an	_	DT	103	_	_	_	_	_	_	_	O
99	ophthalmologist	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
100	in	_	in	_	IN	103	_	_	_	_	_	_	_	O
101	accordance	_	accordance	_	NN	103	_	_	_	_	_	_	_	O
102	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
103	the	_	the	_	DT	103	_	_	_	_	_	_	_	O
104	national	_	National	_	NNP	103	_	_	_	_	_	national.n	Political_locales	B-Locale
105	screening	_	UNK	_	NNP	103	_	_	_	_	_	_	_	I-Locale

1	type	_	Type	_	$	104	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	104	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	104	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	104	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	104	_	_	_	_	_	_	_	O
6	:	_	:	_	:	104	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	104	_	_	_	_	_	_	_	O
8	(	_	(	_	(	104	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	104	_	_	_	_	_	_	_	O
10	)	_	)	_	)	104	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	104	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	104	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	104	_	_	_	_	_	_	_	O
14	)	_	)	_	)	104	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	104	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	104	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	104	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	104	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	104	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	104	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	104	_	_	_	_	_	_	_	O
8	(	_	(	_	(	104	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	104	_	_	_	_	_	_	_	O
10	)	_	)	_	)	104	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	104	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	104	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	104	_	_	_	_	_	_	_	O
14	)	_	)	_	)	104	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	105	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	105	_	_	_	_	_	aware.a	Awareness	O
3	that	_	that	_	IN	105	_	_	_	_	_	_	_	O
4	,	_	,	_	,	105	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	105	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	105	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	105	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	105	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
12	,	_	,	_	,	105	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	105	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	105	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	105	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	105	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	105	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	105	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	105	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	105	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	105	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	105	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	105	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	105	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	105	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	105	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	105	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	105	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	105	_	_	_	_	_	_	_	O
4	,	_	,	_	,	105	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	105	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	105	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	105	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	105	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
12	,	_	,	_	,	105	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	105	_	_	_	_	_	_	_	S-Entity
14	is	_	be	_	VBZ	105	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	105	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	105	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	105	_	_	_	_	_	effective.a	Usefulness	O
18	and	_	and	_	CC	105	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	105	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	105	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	105	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	105	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	105	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	105	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	105	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	105	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	105	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	105	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	105	_	_	_	_	_	_	_	O
4	,	_	,	_	,	105	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	105	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	105	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	105	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	105	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
12	,	_	,	_	,	105	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	105	_	_	_	_	_	_	_	S-Goods
14	is	_	be	_	VBZ	105	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	105	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	105	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	105	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	105	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	105	_	_	_	_	_	cost.n	Expensiveness	O
20	effective	_	effective	_	JJ	105	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	105	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	105	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	105	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	105	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	105	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	105	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	105	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	105	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	105	_	_	_	_	_	_	_	O
4	,	_	,	_	,	105	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	105	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	105	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	105	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	105	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
12	,	_	,	_	,	105	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	105	_	_	_	_	_	_	_	S-Entity
14	is	_	be	_	VBZ	105	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	105	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	105	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	105	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	105	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	105	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	105	_	_	_	_	_	effective.a	Usefulness	O
21	in	_	in	_	IN	105	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	105	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	105	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	105	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	105	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	105	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	105	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	105	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	105	_	_	_	_	_	_	_	O
4	,	_	,	_	,	105	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	105	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	105	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	105	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	105	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
12	,	_	,	_	,	105	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	105	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	105	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	105	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	105	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	105	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	105	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	105	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	105	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	105	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	105	_	_	_	_	_	adult.n	People_by_age	S-Person
23	with	_	with	_	IN	105	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	105	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	105	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	105	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	105	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	105	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	105	_	_	_	_	_	_	_	O
4	,	_	,	_	,	105	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	105	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	105	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	105	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	105	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	105	_	_	_	_	_	_	_	O
12	,	_	,	_	,	105	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	105	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	105	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	105	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	105	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	105	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	105	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	105	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	105	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	105	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	105	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	105	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	105	_	_	_	_	_	type.n	Type	S-Subtype
25	2	_	2	_	CD	105	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	105	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	106	_	_	_	_	_	_	_	O
2	,	_	,	_	,	106	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	106	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	106	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	106	_	_	_	_	_	person.n	People	S-Person
7	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	106	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	106	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	106	_	_	_	_	_	_	_	O
13	,	_	,	_	,	106	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	106	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	106	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	106	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	106	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	106	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	106	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	106	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	106	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	106	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	106	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	106	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
30	.	_	.	_	.	106	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	106	_	_	_	_	_	_	_	O
2	,	_	,	_	,	106	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	106	_	_	_	_	_	_	_	B-Item
4	with	_	with	_	IN	106	_	_	_	_	_	_	_	I-Item
5	any	_	any	_	DT	106	_	_	_	_	_	_	_	I-Item
6	person	_	person	_	NN	106	_	_	_	_	_	_	_	I-Item
7	for	_	for	_	IN	106	_	_	_	_	_	_	_	I-Item
8	whom	_	whom	_	WP	106	_	_	_	_	_	_	_	I-Item
9	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	I-Item
10	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	106	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	106	_	_	_	_	_	consider.v	Categorization	O
13	,	_	,	_	,	106	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	106	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	106	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	106	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	106	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	106	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	106	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	106	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	106	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	106	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	106	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	106	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
30	.	_	.	_	.	106	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	106	_	_	_	_	_	_	_	O
2	,	_	,	_	,	106	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	106	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	106	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	106	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	106	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	106	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	106	_	_	_	_	_	_	_	O
13	,	_	,	_	,	106	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	106	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	106	_	_	_	_	_	there.adv	Locative_relation	S-Ground
16	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	106	_	_	_	_	_	_	_	B-Ground
18	licensed	_	UNK	_	JJ	106	_	_	_	_	_	_	_	I-Ground
19	unk	_	UNK	_	JJ	106	_	_	_	_	_	_	_	I-Ground
20	combination	_	combination	_	NN	106	_	_	_	_	_	_	_	I-Ground
21	containing	_	contain	_	VBG	106	_	_	_	_	_	_	_	I-Ground
22	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	I-Ground
23	that	_	that	_	WDT	106	_	_	_	_	_	_	_	I-Ground
24	can	_	can	_	MD	106	_	_	_	_	_	_	_	I-Ground
25	be	_	be	_	VB	106	_	_	_	_	_	_	_	I-Ground
26	offered	_	offer	_	VBN	106	_	_	_	_	_	_	_	I-Ground
27	at	_	at	_	IN	106	_	_	_	_	_	_	_	I-Ground
28	first	_	first	_	JJ	106	_	_	_	_	_	_	_	I-Ground
29	intensification	_	UNK	_	NN	106	_	_	_	_	_	_	_	I-Ground
30	.	_	.	_	.	106	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	106	_	_	_	_	_	_	_	O
2	,	_	,	_	,	106	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	106	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	106	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	106	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	106	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	106	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	106	_	_	_	_	_	_	_	O
13	,	_	,	_	,	106	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	106	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	106	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	106	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	106	_	_	_	_	_	_	_	B-Aggregate_property
19	unk	_	UNK	_	JJ	106	_	_	_	_	_	_	_	I-Aggregate_property
20	combination	_	combination	_	NN	106	_	_	_	_	_	combination.n	Aggregate	S-Aggregate
21	containing	_	contain	_	VBG	106	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	106	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	106	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	106	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	106	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	106	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	106	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
30	.	_	.	_	.	106	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	106	_	_	_	_	_	_	_	O
2	,	_	,	_	,	106	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	106	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	106	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	106	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	106	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	106	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	106	_	_	_	_	_	_	_	O
13	,	_	,	_	,	106	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	106	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	106	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	106	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	106	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	106	_	_	_	_	_	contain.v	Containing	O
22	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	B-Contents
23	that	_	that	_	WDT	106	_	_	_	_	_	_	_	I-Contents
24	can	_	can	_	MD	106	_	_	_	_	_	_	_	I-Contents
25	be	_	be	_	VB	106	_	_	_	_	_	_	_	I-Contents
26	offered	_	offer	_	VBN	106	_	_	_	_	_	_	_	I-Contents
27	at	_	at	_	IN	106	_	_	_	_	_	_	_	I-Contents
28	first	_	first	_	JJ	106	_	_	_	_	_	_	_	I-Contents
29	intensification	_	UNK	_	NN	106	_	_	_	_	_	_	_	I-Contents
30	.	_	.	_	.	106	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	106	_	_	_	_	_	_	_	O
2	,	_	,	_	,	106	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	106	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	106	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	106	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	106	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	106	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	106	_	_	_	_	_	_	_	O
13	,	_	,	_	,	106	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	106	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	106	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	106	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	106	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	106	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	B-Entity
23	that	_	that	_	WDT	106	_	_	_	_	_	_	_	I-Entity
24	can	_	can	_	MD	106	_	_	_	_	_	can.v	Capability	O
25	be	_	be	_	VB	106	_	_	_	_	_	_	_	B-Event
26	offered	_	offer	_	VBN	106	_	_	_	_	_	_	_	I-Event
27	at	_	at	_	IN	106	_	_	_	_	_	_	_	I-Event
28	first	_	first	_	JJ	106	_	_	_	_	_	_	_	I-Event
29	intensification	_	UNK	_	NN	106	_	_	_	_	_	_	_	I-Event
30	.	_	.	_	.	106	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	106	_	_	_	_	_	_	_	O
2	,	_	,	_	,	106	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	106	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	106	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	106	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	106	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	106	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	106	_	_	_	_	_	_	_	O
13	,	_	,	_	,	106	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	106	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	106	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	106	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	106	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	106	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	106	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	106	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	106	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	106	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	106	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	106	_	_	_	_	_	first.a	Ordinal_numbers	O
29	intensification	_	UNK	_	NN	106	_	_	_	_	_	_	_	S-Type
30	.	_	.	_	.	106	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	107	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	107	_	_	_	_	_	risk.n	Run_risk	O
3	factors	_	factor	_	NNS	107	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	107	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	107	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	107	_	_	_	_	_	_	_	O
7	,	_	,	_	,	107	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	107	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	107	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	107	_	_	_	_	_	_	_	O
11	,	_	,	_	,	107	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	107	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	107	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	107	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	107	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	107	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	107	_	_	_	_	_	_	_	O
18	:	_	:	_	:	107	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	107	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	107	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	107	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	107	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	107	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	107	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	107	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	107	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	107	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	107	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	107	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	107	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	107	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	107	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	107	_	_	_	_	_	_	_	B-Total
6	conditions	_	condition	_	NNS	107	_	_	_	_	_	_	_	I-Total
7	,	_	,	_	,	107	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	107	_	_	_	_	_	include.v	Inclusion	O
9	increased	_	increase	_	VBN	107	_	_	_	_	_	_	_	B-Part
10	age	_	age	_	NN	107	_	_	_	_	_	_	_	I-Part
11	,	_	,	_	,	107	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	107	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	107	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	107	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	107	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	107	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	107	_	_	_	_	_	_	_	O
18	:	_	:	_	:	107	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	107	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	107	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	107	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	107	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	107	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	107	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	107	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	107	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	107	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	107	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	107	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	107	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	107	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	107	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	107	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	107	_	_	_	_	_	_	_	O
7	,	_	,	_	,	107	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	107	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	107	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
10	age	_	age	_	NN	107	_	_	_	_	_	_	_	S-Item
11	,	_	,	_	,	107	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	107	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	107	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	107	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	107	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	107	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	107	_	_	_	_	_	_	_	O
18	:	_	:	_	:	107	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	107	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	107	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	107	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	107	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	107	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	107	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	107	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	107	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	107	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	107	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	107	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	107	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	107	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	107	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	107	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	107	_	_	_	_	_	_	_	O
7	,	_	,	_	,	107	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	107	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	107	_	_	_	_	_	_	_	S-Relative_time
10	age	_	age	_	NN	107	_	_	_	_	_	age.n	Calendric_unit	S-Unit
11	,	_	,	_	,	107	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	107	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	107	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	107	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	107	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	107	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	107	_	_	_	_	_	_	_	O
18	:	_	:	_	:	107	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	107	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	107	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	107	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	107	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	107	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	107	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	107	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	107	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	107	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	107	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	107	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	107	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	107	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	107	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	107	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	107	_	_	_	_	_	_	_	O
7	,	_	,	_	,	107	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	107	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	107	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	107	_	_	_	_	_	_	_	O
11	,	_	,	_	,	107	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	107	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	107	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	107	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	107	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	107	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	107	_	_	_	_	_	_	_	O
18	:	_	:	_	:	107	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	107	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	107	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	107	_	_	_	_	_	manufacturer.n	Manufacturing	S-Producer
22	'	_	'	_	POS	107	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	107	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	107	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	107	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	107	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	107	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	107	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	107	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	107	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	107	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	107	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	107	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	107	_	_	_	_	_	_	_	O
7	,	_	,	_	,	107	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	107	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	107	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	107	_	_	_	_	_	_	_	O
11	,	_	,	_	,	107	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	107	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	107	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	107	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	107	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	107	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	107	_	_	_	_	_	_	_	O
18	:	_	:	_	:	107	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	107	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	107	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	107	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	107	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	107	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	107	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	107	_	_	_	_	_	_	_	S-Entity
26	characteristics	_	characteristic	_	NNS	107	_	_	_	_	_	characteristic.n	Distinctiveness	O
27	for	_	for	_	IN	107	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	107	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	108	_	_	_	_	_	_	_	B-Speaker
2	and	_	and	_	CC	108	_	_	_	_	_	_	_	I-Speaker
3	healthcare	_	UNK	_	NNP	108	_	_	_	_	_	_	_	I-Speaker
4	products	_	product	_	NNS	108	_	_	_	_	_	_	_	I-Speaker
5	regulatory	_	Regulatory	_	NNP	108	_	_	_	_	_	_	_	I-Speaker
6	agency	_	Agency	_	NNP	108	_	_	_	_	_	_	_	I-Speaker
7	(	_	(	_	(	108	_	_	_	_	_	_	_	I-Speaker
8	mhra	_	UNK	_	NNP	108	_	_	_	_	_	_	_	I-Speaker
9	)	_	)	_	)	108	_	_	_	_	_	_	_	I-Speaker
10	guidance	_	guidance	_	NN	108	_	_	_	_	_	_	_	I-Speaker
11	(	_	(	_	(	108	_	_	_	_	_	_	_	I-Speaker
12	2011	_	2011	_	CD	108	_	_	_	_	_	_	_	I-Speaker
13	)	_	)	_	)	108	_	_	_	_	_	_	_	I-Speaker
14	advises	_	advise	_	VBZ	108	_	_	_	_	_	advise.v	Telling	O
15	that	_	that	_	IN	108	_	_	_	_	_	_	_	B-Message
16	unk	_	UNK	_	NNS	108	_	_	_	_	_	_	_	I-Message
17	should	_	should	_	MD	108	_	_	_	_	_	_	_	I-Message
18	review	_	review	_	VB	108	_	_	_	_	_	_	_	I-Message
19	the	_	the	_	DT	108	_	_	_	_	_	_	_	I-Message
20	safety	_	safety	_	NN	108	_	_	_	_	_	_	_	I-Message
21	and	_	and	_	CC	108	_	_	_	_	_	_	_	I-Message
22	efficacy	_	UNK	_	NN	108	_	_	_	_	_	_	_	I-Message
23	of	_	of	_	IN	108	_	_	_	_	_	_	_	I-Message
24	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	I-Message
25	in	_	in	_	IN	108	_	_	_	_	_	_	_	I-Message
26	individuals	_	individual	_	NNS	108	_	_	_	_	_	_	_	I-Message
27	after	_	after	_	IN	108	_	_	_	_	_	_	_	I-Message
28	unk	_	UNK	_	CD	108	_	_	_	_	_	_	_	I-Message
29	months	_	month	_	NNS	108	_	_	_	_	_	_	_	I-Message
30	of	_	of	_	IN	108	_	_	_	_	_	_	_	I-Message
31	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	I-Message
32	to	_	to	_	TO	108	_	_	_	_	_	_	_	I-Message
33	ensure	_	ensure	_	VB	108	_	_	_	_	_	_	_	I-Message
34	that	_	that	_	IN	108	_	_	_	_	_	_	_	I-Message
35	only	_	only	_	JJ	108	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	108	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	108	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	108	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	108	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	108	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	108	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	108	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	108	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	108	_	_	_	_	_	_	_	O
46	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	108	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	108	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	108	_	_	_	_	_	_	_	O
7	(	_	(	_	(	108	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
9	)	_	)	_	)	108	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	108	_	_	_	_	_	_	_	O
11	(	_	(	_	(	108	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	108	_	_	_	_	_	_	_	O
13	)	_	)	_	)	108	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	108	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	108	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	108	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	108	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	108	_	_	_	_	_	safety.n	Being_at_risk	O
21	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	108	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	108	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	108	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	108	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	108	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	108	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	108	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	108	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	108	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	108	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	108	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	108	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	108	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	108	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	108	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	108	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	108	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	108	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	108	_	_	_	_	_	_	_	O
46	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	108	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	108	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	108	_	_	_	_	_	_	_	O
7	(	_	(	_	(	108	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
9	)	_	)	_	)	108	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	108	_	_	_	_	_	_	_	O
11	(	_	(	_	(	108	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	108	_	_	_	_	_	_	_	O
13	)	_	)	_	)	108	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	108	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	108	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	108	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	108	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	108	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	108	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	108	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	108	_	_	_	_	_	individual.n	People	S-Person
27	after	_	after	_	IN	108	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	108	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	108	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	108	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	108	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	108	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	108	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	108	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	108	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	108	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	108	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	108	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	108	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	108	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	108	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	108	_	_	_	_	_	_	_	O
46	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	108	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	108	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	108	_	_	_	_	_	_	_	O
7	(	_	(	_	(	108	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
9	)	_	)	_	)	108	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	108	_	_	_	_	_	_	_	O
11	(	_	(	_	(	108	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	108	_	_	_	_	_	_	_	O
13	)	_	)	_	)	108	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	108	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	108	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	108	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	108	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	108	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	108	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	108	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	108	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	108	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	108	_	_	_	_	_	_	_	S-Count
29	months	_	month	_	NNS	108	_	_	_	_	_	month.n	Calendric_unit	S-Unit
30	of	_	of	_	IN	108	_	_	_	_	_	_	_	B-Whole
31	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	I-Whole
32	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	108	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	108	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	108	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	108	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	108	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	108	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	108	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	108	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	108	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	108	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	108	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	108	_	_	_	_	_	_	_	O
46	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	108	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	108	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	108	_	_	_	_	_	_	_	O
7	(	_	(	_	(	108	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
9	)	_	)	_	)	108	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	108	_	_	_	_	_	_	_	O
11	(	_	(	_	(	108	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	108	_	_	_	_	_	_	_	O
13	)	_	)	_	)	108	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	108	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	108	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	108	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	108	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	108	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	108	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	108	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	108	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	108	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	108	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	108	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	108	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	108	_	_	_	_	_	treatment.n	Cure	S-Patient
32	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	108	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	108	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	108	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	108	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	108	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	108	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	108	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	108	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	108	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	108	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	108	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	108	_	_	_	_	_	_	_	O
46	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	108	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	108	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	108	_	_	_	_	_	_	_	O
7	(	_	(	_	(	108	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
9	)	_	)	_	)	108	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	108	_	_	_	_	_	_	_	O
11	(	_	(	_	(	108	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	108	_	_	_	_	_	_	_	O
13	)	_	)	_	)	108	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	108	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	108	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	108	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	108	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	108	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	108	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	108	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	108	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	108	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	108	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	108	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	108	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	108	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	108	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	108	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	108	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	108	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	108	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	108	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	108	_	_	_	_	_	_	_	S-Manner
41	continue	_	continue	_	NN	108	_	_	_	_	_	continue.v	Process_continue	O
42	to	_	to	_	TO	108	_	_	_	_	_	_	_	B-Event
43	be	_	be	_	VB	108	_	_	_	_	_	_	_	I-Event
44	treated	_	treat	_	VBN	108	_	_	_	_	_	_	_	I-Event
45	'	_	'	_	POS	108	_	_	_	_	_	_	_	I-Event
46	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	108	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	108	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	108	_	_	_	_	_	_	_	O
7	(	_	(	_	(	108	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
9	)	_	)	_	)	108	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	108	_	_	_	_	_	_	_	O
11	(	_	(	_	(	108	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	108	_	_	_	_	_	_	_	O
13	)	_	)	_	)	108	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	108	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	108	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	108	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	108	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	108	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	108	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	108	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	108	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	108	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	108	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	108	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	108	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	108	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	108	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	108	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	108	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	108	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	108	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	108	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	108	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	108	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	108	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	108	_	_	_	_	_	treat.v	Medical_intervention	O
45	'	_	'	_	POS	108	_	_	_	_	_	_	_	S-Patient
46	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	109	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	109	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	109	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	109	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	109	_	_	_	_	_	_	_	O
6	:	_	:	_	:	109	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	109	_	_	_	_	_	_	_	O
8	(	_	(	_	(	109	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
10	)	_	)	_	)	109	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	109	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	109	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	109	_	_	_	_	_	_	_	O
14	)	_	)	_	)	109	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	109	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	109	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	109	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	109	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	109	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	109	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	109	_	_	_	_	_	_	_	O
8	(	_	(	_	(	109	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
10	)	_	)	_	)	109	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	109	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	109	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	109	_	_	_	_	_	_	_	O
14	)	_	)	_	)	109	_	_	_	_	_	_	_	O
